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Preface 
 
This PhD dissertation is prepared within the framework of the Special Research Fund – Concerted 
Research Action (2004 – 2009) project, entitled “Enhancement of folate content in rice: an analytical-
molecular and economic study” (BOF-GOA 1251204), financed by Ghent University. Both the 
Laboratory of Functional Plant Biology of Department of Physiology, led by Prof. dr. ir. Dominique Van 
Der Straeten, and the Laboratory of Toxicology of the Department of Bioanalysis, led by Prof dr. apr. 
Willy Lambert, were involved in the biotechnological and analytical part of this study, which aimed to 
develop rice with high folate content through genetic engineering. This PhD dissertation reports the 
results of the third part of the research, conducted by the division of Agri-food Marketing of the 
Department of Agricultural Economics. This part encompasses research activities to explore the 
market potential of folate biofortified rice (FBR) in China and Shanxi Province specifically, with a focus 
on the level of consumer acceptance and the potential health impact.  
In 2011, I received financial support through the IMRD (International Master in Rural Development) 
staff exchange program, to set up a collaboration with Nanjing Agricultural University, in order to 
investigate the willingness-to-pay (WTP) for FBR with experimental auctions in Shanxi Province.  
 
1.1. General introduction  
 
Worldwide, micronutrient malnutrition or a chronic lack of essential vitamins and minerals affects over 
two billion people, particularly pregnant women and children in less developed regions (Micronutrient 
Initiative, 2009). Due to its far-reaching consequences for global health and development, international 
organizations have set specific nutritional goals in the 1990 World Summit for Children (Sanghvi et al., 
2007) as well as the 2015 UN millennium development goals (MDG)(UN, 2004). Presently, despite the 
progress made towards eliminating the global burden of this ‘hidden hunger’, these goals are far from 
being reached (UNICEF, 2006; UN, 2010), necessitating an increase in efforts to support, develop, 
introduce or improve micronutritional interventions (Mason et al., 2001; Dalziel and Segal, 2007). 
 
In addition to the current policy tools to address micronutrient malnutrition, e.g. supplementation, 
fortification and dietary diversification, biofortification has been explored and advocated as a novel, 
potential strategy (Horton et al., 2008; Mayer et al., 2008), at both the policy and research level (Johns 
and Eyzaguirre, 2007). By enriching the natural micronutrient content of staple crops, such as rice, 
wheat or potatoes, biofortification aims to alleviate the burden of micronutrient deficiencies, in 
particular for the people who need it the most (Qaim et al., 2007). In this respect, folate biofortified rice 
(FBR) was recently developed through genetic engineering in order to tackle folate deficiency 
(Storozhenko et al., 2007). As a consequence, FBR is considered a Genetically Modified (GM)4 food 
product with health benefits.  
                                                 
4Although several proponents of GM food avoid the term ‘GM’, due to the controversy it already generated (Novotorova and Mazzocco, 2009), and prefer 
the more neutral term ‘biotechnology’ (Brooks, 2010), this thesis consequently refers to the term ‘GM’ as this is the concept to which people are more likely 
familiar with.  
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Due to the controversial nature of this micronutrient enriched staple crop, governments, decision-
makers and health planners are interested in the consumer reactions to this product as well as the 
benefits and costs of introducing it as an alternative health intervention. In order to justify the allocated 
resources of setting FBR as a priority to address folate deficiency, stakeholders should have access to 
information about the importance of this micronutrient deficiency on the one hand, and understand 
how FBR would contribute to reduce its burden on the other. Information on the burden of disease is 
considered an essential factor for a successful implementation of micronutrient interventions, in 
addition to a supportive government (Faillace et al., 2008). As the asynchronous approval of currently 
available GM foods demonstrates, consumer acceptance and intention will also play an important 
factor in political support and farmer adoption. Not surprisingly, market failure of novel products or 
technologies is often caused by a lack of, or inadequate consumer market research (Davidson, 1988; 
Lusk and Norwood, 2006). Because FBR is not (yet) available in the marketplace, it is deemed crucial 
to explore ex-ante its market potential. 
 
Even though field trials of Vitamin A biofortified ‘Golden’ rice have recently started in the Philippines 
(Serapio, 2010; NCBP, 2011), the commercialization of GM biofortified crops as such has not 
proceeded. As transgenic crops like FBR are still under development, little is known about the 
acceptance (Gonzalez et al., 2009), purchase intentions (Lusk, 2003) and public health impacts (Stein, 
2006) of such 2nd generation GM crops. However, due to China’s recent approval of the first GM rice 
crop (Wang and Johnston, 2007b; Waltz, 2010), the future commercialization of GM biofortified crops 
is likely to happen (James, 2009b). This thesis anticipates these events.   
 
This PhD dissertation is a compilation of research papers that investigate ex-ante the market potential 
of FBR in China and Shanxi Province, a poor, rural, less developed, and high-risk region in Northern 
China. This province is characterized by one of the highest prevalence rates of maternal folate 
deficiency (Ren et al., 2007) and neural-tube defects (NTDs)(Gu et al., 2007). Despite large efforts to 
tackle folate deficiency in this province, the currently existing folate strategies are less successful, e.g. 
folic acid supplements (Ren et al., 2006), or less feasible, e.g. folic acid fortified rice (Alavi et al., 2008; 
Bertebos Foundation, 2008).  
 
In section 1.2, the rationale behind the relation between the topic and the research location is 
described from a practical point of view. Section 1.3 presents the conceptual framework and the 
underlying theories and methods. The research questions are outlined in section 1.4, followed by a 
discussion about the contributions of this dissertation and the policy relevance of the findings (section 
1.5). In section 1.6, I outline the research design and the structure of the thesis. 
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1.2. Scope and relevance of the topic and the research location 
 
The objective of this thesis is to evaluate the market potential of FBR in China and Shanxi Province in 
particular. The scope of the research will follow three main lines of inquiry: acceptance, WTP and cost-
effectiveness. While the former two examine the market potential of FBR by focusing on the 
consumer, the latter investigates its potential as a public health intervention (see section 1.3).  
The rationale behind this research scope is closely related to the scope of the topic, i.e. FBR as both a 
novel, controversial good with consumer/health benefits and a micronutrient intervention, and the 
research location, i.e. China and Shanxi Province in particular.  
Figure 1 illustrates the link between the topic and the research location.   
 
 
Figure 1 Focus of the PhD dissertation 
FD, folate deficiency; GM, Genetically Modified; NTD, neural-tube defect 
aSee section 2.4.4; bSee section 2.5; cSee section 2.2 (micronutrient malnutrition) and section 2.3.2.1 (folate deficiency); dSee 
section 2.3.3; eSee section 2.4 (folate interventions). 
 
Topic 
This study focuses on folate enriched rice as a novel, non-market good, which makes this thesis an 
ex-ante evaluation study. Due to its significantly higher concentrations of natural folate or vitamin B9, 
FBR is categorized as a biofortified food product, i.e. a staple crop of which the micronutrient content 
is enhanced (Storozhenko et al., 2007). It is currently the most advanced folate biofortified crop (see 
section 2.4.4). Compared to conventional biofortification, FBR is based on transgenic technology. 
Therefore, it is considered as a GM biofortified crop and, thus, belongs to the 2nd generation of GM 
food products5. While the first generation led to substantial farmer benefits by improving agronomic 
traits, the focus here is on consumer benefits through increasing the micronutrient content of staple 
crops (Engel et al., 2002)6. In the case of FBR, the higher folate content is beneficial as it reduces the 
                                                 
5 Throughout this dissertation, the terms “transgenic” and “GM” will be interchangeably used. In other words, transgenic crops are considered the same as 
GM crops. Thus, FBR is based on GM or transgenic breeding techniques to increase the micronutritional level, i.e. transgenic or GM biofortification. In that 
way, FBR is opposed to rice based on conventional breeding, i.e. non-GM or non-transgenic rice. 
6 However, first generation crops, such as Bt cotton (Huang et al., 2002) and Bt rice (Huang et al., 2005b), are assumed to be also beneficial to health due 
to the reduced farmers’ sickness, saved labor days and decreasing health costs, which are associated with the lower levels of pesticide use. On the other 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
R
es
ea
rc
h
 l
o
ca
ti
o
n
 
 
 
Folate  
biofortified  
ricea 
 
 
 
 
China 
 
 
Shanxi  
Province 
 
T
o
p
ic
 
 
Health intervention 
to reduce  
folate deficiencyc  
and neural-tube defectsd 
 
 
2nd generation 
GM food crop 
 
 
 
Rice as the  
food vehicle  
for biofortification 
 
 
 
 
CHINAb 
 
Key player in R&D and  
commercialization of  
GM food/rice products 
 
Key player in R&D 
regarding biofortification 
 
Governmental support 
 
CHINA/SHANXIe 
 
High prevalence of FD & NTDs 
 
Suboptimal folate intake: 
- Low dietary folate intake  
- Low pharmaceutical intake 
 
Limited success interventions: 
- Supplementation programs 
- Fortification programs 
 
 
CHINAb 
 
Largest rice producer 
 
Largest rice market 
 
Main staple crop 
 
Low folate content  
in rice varieties  
 
5 
 
occurrence of several folate deficiency related diseases, of which the risk of having a baby with an 
NTD is the most important (Berry, et al., 1999; see section 2.3).  
In this way, FBR can also be considered as a novel, agriculture-based, health intervention to tackle 
folate deficiency. In health literature, an intervention is defined as: “an activity using human, physical, 
and financial resources in a deliberate attempt to improve health by reducing the risk, duration, or 
severity of a health problem” (Musgrove and Fox-Rushby, 2006, p. 273). At the population level, three 
intervention types can be distinguished: those promoting to change personal behavior, those aiming to 
control environmental hazard and (mass)-medical interventions. Regarding folate deficiency, there are 
currently three policy interventions7 that could be implemented in order to increase folate intake levels: 
folic acid supplementation, folic acid fortification and dietary diversification. While the former two refer 
to a ‘medical’ intervention, the latter aims to alter the dietary habits of the population. Although some of 
these folate interventions will be included in this thesis, e.g. the provision of folic acid supplements as 
an auction design characteristic in the study to elicit WTP for FBR (see section 1.3.2.2), or discussed, 
e.g. costs of folic acid supplementation and fortification (see section 1.3.3.3), FBR remains the key 
focus. By using the world’s most consumed crop as the food vehicle for biofortification, the aim is to 
maximize the potential health benefits of folate biofortification and, as a consequence, help to further 
alleviate the burden of folate deficiency and micronutrient malnutrition. 
 
Besides the focus on FBR as a potential alternative to these three existing folate interventions, this 
thesis will also address multi-biofortification of rice (MBR), by which not only folate, but also zinc, iron 
and vitamin A deficiency can be tackled (see section 2.4.4.3). This will be done in the cost-
effectiveness study of chapter 5. An overview of the different folate interventions, including multi-
biofortification, their characteristics, advantages and shortcomings, their applicability and feasibility in 
China and the link with the Chinese policy context, is extensively described in section 2.4. 
 
Research location 
The potential of FBR is investigated by focusing on Shanxi Province, and China as a whole. Broadly 
three reasons can be cited for the selection of this research location. First, China is one of the key 
players in research, development and production of GM crops, and rice in particular (Huang et al., 
2004; Jia et al., 2004; Wang and Johnston, 2007b). It is the sixth largest GM producer of the world 
(James, 2010) and will likely be the first to commercialize GM rice (Xiong, 2004; Waltz, 2010). Due to 
the governmental support towards biotechnology (Biosafety Clearinghouse of China, 2004; Xi and 
Harris, 2006) and reducing malnutrition (Micronutrient Initiative, 2011b), it is one of the main actors in 
conventional (HarvestPlus China, 2009, 2011) and GM biofortification research (Campos-Bowers and 
Wittenmyer, 2007; Pray and Huang, 2007).  
Second, China is characterized by a high prevalence of folate deficiency, with about 20 % of its 
population being folate deficient (see section 2.3.2.1), and a high NTD rate (12.2 per 10000 births, see 
section 2.3.2.2). The reason to improve folate consumption is even more relevant in Shanxi Province, 
                                                                                                                                                        
hand, biofortification itself might address agronomic traits as well, such as the improvement of disease resistance (Welch and Graham, 2004). Nevertheless, 
the focus throughout this thesis will be solely on the health benefits of biofortification. 
7 When dealing with interventions to tackle folate deficiency, the terms ‘policy’, ‘micronutrient’ and ‘health’ interventions will be interchangeably used.  
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where suboptimal folate intake levels occur in 43.8 % of all pregnant women, leading to one of the 
world’s highest numbers of NTDs per year, i.e. between 0.3 (Dai et al., 2002) and 1 NTD per 50 births 
(Gu et al., 2007). This is confirmed by the currently low (correct) use of folic acid supplements and the 
low dietary folate intake in China (Zhao et al., 2009) and Shanxi Province (Ren et al., 2006; Zhang et 
al., 2008). Moreover, past folic acid supplementation programs were not successful, at least not in the 
long term (see section 2.4.1.2), and folic acid fortification is less feasible when aiming to tackle poor, 
developing regions, like Shanxi Province (see section 2.4.2.2).  
Third, biofortifying rice would be particularly relevant for China, as it is the world leader in rice 
production and has the largest rice consumer market (see also Figure 22). In 2007, China was 
responsible for a rice production of 185.5 million tons or a world share of 28.5 % (FAOSTAT Database, 
2008). 
 
The relevance of this topic and research location is extensively described in Chapter 2. In that chapter, 
the main concepts related to FBR and folate deficiency are defined and discussed in relation to the 
broader (policy) context, in China as well as in the world. In this way, chapter 2 encompasses the 
rationale of this PhD dissertation and provides a foundation for the research chapters on acceptance 
(chapter 3), WTP (chapter 4) and cost-effectiveness (chapter 5).  
 
1.3. Conceptual framework  
 
Consumer market research is considered a crucial factor to successfully introduce a novel, 
controversial good, such as GM food (Davidson, 1998; Lusk and Hudson, 2004; Lusk and Norwood, 
2006). Despite the large number of developed biofortified crops, knowledge on consumer acceptance 
of, and WTP for these products is scarce (Lusk, 2003), especially in high-risk regions. Therefore, this 
thesis obtains insight in the way consumers accept and value FBR in a folate deficient region, i.e. 
Shanxi Province. But an agricultural innovation like FBR can also be perceived as a health strategy 
that aims to contribute to public health by tackling micronutrient malnutrition, i.e. folate deficiency. 
From a policy point of view, knowledge of the importance of the micronutrient deficiency (ADB, 2004b; 
Faillace et al., 2008) and an economic evaluation is needed to assess whether this health intervention 
is worthwhile to undertake (Laxminarayan et al., 2006; Musgrove and Fox-Rushby, 2006). As previous 
burden of disease studies solely focused on the three main micronutrients (vitamin A, zinc and iron), 
this thesis addresses this knowledge gap by conducting a disease burden study of folate deficiency 
and an ex-ante health impact analysis of FBR.  
 
Figure 2 presents the conceptual framework that will be applied to analyze the market potential of FBR 
in China. The different components of the conceptual framework and the rationale to investigate them 
will be discussed in the subsequent sections. Thereby, emphasis is put on the three different research 
domains, i.e. acceptance (see section 1.3.1), WTP (see section 1.3.2) and cost-effectiveness (see 
section 1.3.3). Each of these topics refers to a specific chapter in this PhD dissertation and can be 
categorized based on the level of analysis, micro versus macro. While acceptance of, and WTP for 
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FBR are examined at the level of the individual consumer (micro), the macro-level looks at the 
potential health benefits of FBR, and MBR, for the society as a whole, as well as the potential cost-
effectiveness of introducing this policy intervention in China (macro). Also the research location differs 
according to this level: at micro-level, the consumer studies are conducted with rice consumers from 
Shanxi Province; at macro-level, FBR as a policy intervention is evaluated from the point of view of the 
broad society, i.e. China and its regions (see also section 1.2).  
Regarding the micro-level, broadly two consumer studies can be distinguished. The study on 
acceptance of FBR consists of three main parts. The determinants of FBR acceptance are 
investigated, including objective GM knowledge and subjective GM rice knowledge, consumer 
perceptions of GM food (benefits, risks, safety and price impact) and socio-demographic indicators 
(see section 1.3.1.1); a segmentation analysis is conducted to further define the market of FBR (not 
presented, see section 1.3.1.2); and the influence of negative changes of the regular product 
characteristics, such as taste and appearance, on FBR acceptance is explored (see section 1.3.1.3). 
The second micro-level analysis examines WTP for FBR, by which two value elicitation studies are 
compared, i.e. WTP as stated preferences and WTP values derived from experimental auctions (see 
section 1.3.2.1). Regarding the latter, the effect of GM food acceptance, knowledge (e.g. folate 
benefits), socio-demographic indicators and auction design characteristics (e.g. provision of a folate 
substitute, timing, auction size) on WTP in different information rounds is determined. Moreover, the 
effect of the provision of specific information related to the folate content, the folate benefits, the 
application of GM technology, including conflicting GM information and information about the link 
between FBR and the research location, is analyzed in the auctions (see section 1.3.2.2) .  
The macro-level study analyzes the cost-effectiveness of FBR in China and its regions, based on three 
subsequent steps8. First, the current burden of the micronutrient deficiency in China and its regions is 
quantified (see section 1.3.3.1). Second, the health gap between a situation with and without 
biofortified rice is assessed. By comparing both burdens, the health benefits can be estimated (see 
section 1.3.3.2). Third, the cost-effectiveness of this health intervention are estimated by juxtaposing 
the intervention costs and the potential health impacts (see section 1.3.3.3). 
 
It is important to note that this conceptual framework provides an overview of the key concepts in this 
thesis. In the following subsections, reference will be made to related concepts, e.g. the DALY concept 
as a health impact measure, or concepts will be defined according to the investigated research topic, 
e.g. GM food knowledge versus knowledge of folate benefits. The main contributions of this 
conceptual framework will be described separately in section 1.5.1. 
                                                 
8 A similar approach is taken to evaluate the potential cost-effectiveness of MBR in China. Here, the micronutrient deficiency refers to the lack of folate, 
vitamin A, zinc and iron.  
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1.3.1. Acceptance (Chapter 3) 
 
The analysis of FBR acceptance as a GM food product with health benefits addresses three 
challenging issues in GM food consumer research. First, the main determinants of a biofortified crop 
as a GM food product in a high-risk region are investigated. Second, the variance of consumer and 
information characteristics regarding GM food is segmented in order to define target groups for FBR in 
China. Third, the trade-off between consumer oriented benefits and potential negative attribute 
changes of biofortification is examined. Below, each of these aspects is elaborated with reference to 
the concepts of the conceptual framework, theory and research literature. 
 
1.3.1.1. Determinants of GM food acceptance 
 
In this study, the concept of acceptance measures whether a consumer is favorable, indifferent or 
unfavorable to FBR as a GM food product with health benefits. Due to its health benefits, this GM food 
product of the second generation is expected to be more appreciated than its first generation 
counterparts and may be able to compensate for the negative perception that might be associated with 
the GM food technology (Frewer et al., 1997a; Lähteenmäki et al., 2002; Hossain et al., 2003; Lusk et 
al., 2005; O’Conner et al., 2005; Anand et al., 2007; Schnettler et al., 2008a). Scientific research to 
underpin the larger GM food acceptance when health benefits are present, is scarce (Lusk, 2003), but 
steadily growing. Among these GM food products that are explored in consumer preference studies, 
are dairy spread (O’Conner et al., 2005), beer (Burton and Pearse, 2002), oil seed (Cox et al., 2008), 
cheese (Frewer et al., 1997a; Lähteenmäki et al., 2002), grains (Onyango and Nayga, 2004; Zhang et 
al., 2010) or a combination of products (Magnusson and Koivisto Hursti, 2002). Although they did not 
mention the term ‘biofortification’, the latter three studies (partially) focused on the acceptance of 
nutritionally enriched GM foods. As expected, they found large support for this health oriented 
application of GM technology, especially in comparison with other GM applications. However, these 
authors investigated consumer reaction towards the use of GM technology to increase the nutritional 
content of crops in general. To date, only two studies examined consumer acceptance of a specific 
biofortified food crop, i.e. conventionally bred provitamin A enriched maize (De Groote and Kimenju, 
2008; Stevens and Winter-Nelson, 2008). Except for a qualitative study on Golden Rice (GR) which 
reported high farmer acceptance rates in the Philippines (Chong, 2003) and few valuation elicitation 
studies on vitamin A enriched crops (see chapter 4), consumer research on acceptance of transgenic 
biofortified crops is lacking. Section 3.3.2 addresses this by identifying the factors that influence 
consumer reaction towards FBR in a problematic region in terms of folate intake.  
 
In the aforementioned conceptual framework (Figure 2), the analysis of consumer acceptance of FBR 
focuses on different concepts derived from the explanatory GM food acceptance model (Costa-Font et 
al., 2008) and scientific evidence on acceptance of GM and/or biofortified food crops. In their review of 
consumer acceptance studies of GM food, Costa-Font et al. (2008) developed a framework that builds 
on the attitude model of Bredahl et al. (1998) and Fishbein’s multi-attribute theory (Fishbein, 1963). It 
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considers GM food attitudes and acceptance as complex constructs, which are determined by 
consumer perceptions of benefits and risks, general attitudes, knowledge and socio-demographic 
factors. In line with previous research (Hamstra, 1995; Verdurme and Viaene, 2003; Pope et al., 
2004), the focus in the FBR acceptance study in this thesis will be on the role of the two GM related 
concepts, namely knowledge and consumer perceptions of GM food.  
 
Knowledge is one of the most important determinants of food acceptance (Chen and Li, 2007; Costa-
Font and Mossialos, 2007) and plays an important role in the framework. However, the direction of this 
effect remains a topic for discussion (Hamstra, 1995; House et al., 2004; Kassardjian et al., 2005). 
Here, GM food knowledge is split up into a subjective and an objective component. This approach is 
based on previous studies where objective knowledge is found to be significantly lower than subjective 
knowledge (Li et al., 2002; Verdurme et al., 2003b; House et al., 2004; Ganiere et al., 2006; Ho et al., 
2006; Costa-Font et al., 2008). Besides GM food knowledge, subjective or perceived knowledge of 
GM rice is also explored. 
 
Cognitive variables such as consumer perceptions regarding GM food have an important influence on 
consumer acceptance (Bredahl et al., 1998; Baker and Burnham, 2001; Li et al., 2002), especially 
benefits and risks (Frewer and Shepherd, 1995; Hamstra, 1995; 2005; Costa-Font et al., 2008). 
Several studies used a multi-item scale to measure consumer perceptions towards GM food, 
containing knowledge, labeling and trust issues (Pope et al., 2004); health risks, environmental risks, 
benefits, trust and safety (Verdurme et al., 2003b); or process-related and product-related beliefs 
(Bredahl et al., 1998). Such GM food perceptions are closely related to beliefs towards an object 
(Fishbein and Ajzen, 1975) in that they measure how people evaluate specific attributes of GM food, 
such as its capability of lowering environmental pollution. In line with Verdurme et al. (2001), consumer 
perceptions in the conceptual framework deal with risks, benefits, safety and price impact.   
 
In addition, there is a need to further explore the influence of socio-demographic indicators, such as 
age, gender, income, education and residence, which generated mixed and inconclusive results in the 
past (Costa-Font et al., 2008). While several studies conclude that socio-demographic variables 
(alone) do not have a strong explanatory power to predict acceptance of GM food products (Bredahl et 
al., 1998; Baker and Burnham, 2001; Li et al., 2002; Kontoleon and Yabe, 2006; Anand et al., 2007), 
other studies found several socio-demographic differences in GM food acceptance (Hoban, 1998; 
Chen and Li, 2007). For example, women (Siegrist et al., 2000; Moerbeek and Casimir, 2005), older 
people (Ganiere et al., 2006) and those with a low education (Hoban, 1998; Traill et al., 2004) or a low 
income level (Wachenheim et al., 2008; Yee et al., 2008) are generally more skeptical of GM food. 
However, there is still discussion about the strength and the sign of these determinants (Costa-Font et 
al., 2008). Therefore, socio-demographic factors are included in the conceptual framework. Given that 
the consumer study on FBR acceptance will be conducted in a poor, rural region of China (see section 
3.2.1), residence (rural/urban), education and income level of the respondents are integrated in the 
analysis. Gender, age and family-related indicators (family size, number of children and age of the 
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youngest child) are included due to the specific relationship between maternal folate deficiency and 
the risk of giving birth to a baby with an NTD. Another relevant variable, farmer status (farmer/non-
farmer), is added because small farmers operate on both supply and demand side for home 
consumption. The inclusion of consumer characteristics is further supported by their influence on the 
acceptance of conventional biofortification, as shown by De Grootte and Kimenju (2008). 
 
1.3.1.2. Reviewing GM food segmentation studies  
 
Due to the global, persistent controversy about GM food, consumer segmentation is often used to 
further analyze the variance of consumer reactions to GM food. As this is a technique that will be used 
to further explore the market of FBR, based on the main concepts of the previous section, rather than 
a concept as such, it is not presented in the conceptual framework. This section will present the results 
of a review on GM food studies that segmented the market for GM food in general, or specific GM food 
products in particular, as a foundation for, and the rationale to conduct a segmentation analysis. 
Table 1 summarizes the results of this literature review. The studies mainly focus on improved 
agronomic traits and, in a few cases, consumer oriented traits, such as GM dairy spread and GM oil 
seed. While almost all consumer research on GM food acceptance can be understood as a binary 
segmentation analysis, where a group of accepting consumers is compared with a segment that 
refuses GM food, this table goes beyond these studies. Therefore, this overview only includes 
segmentation analyses that discovered more than two groups of consumers, who also differ from each 
other with respect to underlying determinants of GM food acceptance. 
 
Table 1 Overview of market segmentation studies on GM food, per product category, research location, name and 
size (% of sample) of the identified clusters, and source  
Product category Location Identified clusters (% respondents)  Source 
GM food   EU-15  
   
 
1 - Trade-off (18 %) 
2 - Relaxed (14 %) 
3 - Sceptical (62 %) 
4 - Uninterested (6 %) 
 4th Eurobarometer Surveyb   
 (Gaskell et al., 2004) 
   EU-15;  
  EU-25;  
  EU-27 
# - Cluster name (EU-15;   EU-25;   EU-27) 
1 - Optimistic (22%; 27%; 23%) 
2 - Pessimistic (50 %; 54%; 61%) 
3 - Undecided (28 %c; 16%; 16 %) 
5th, 6th & 7th Eurobarometer 
Surveysb (Gaskell et al., 
2003; Gaskell et al., 2006; 
Gaskell et al., 2010) 
 Belgium 1 - Halfhearted (34.5 %)  
2 - Enthusiasts (23.5 %)  
3 - Balancers (26.5 %)  
4 - Green opponents (15.5 %)  
 (Verdurme and Viaene, 
2003) 
 China 1 - Neutral (46.5 %)  
2 - Knowledgeable (18.1 %) 
3 - Biotechnology learners (26.9 %) 
4 - Price-conscious (8.5 %) 
  (Li et al., 2003) 
 China 1 - Food safety (31 %) 
2 - Nutritional technologist (14 %) 
3 - GM Skepticism (26 %) 
4 - GM for non-food promoter (29 %) 
  (Zhang et al., 2010) 
 Germany 1 - Supporters (25 %) 
2 - Indifferent (47 %) 
3 - Opponents (28 %) 
  (Christophe et al., 2008) 
12 
 
 
Table 1 Continued 
Product category Location Identified clusters (% respondents)  Source 
GM food Greece 1 - Opposition (38 %) 
2 - Potential (10.8 %) 
3 - Early adopter (41.3 %) 
4 - Extreme opposition (9.8 %) 
  (Arvanitoyannis and 
Krystallis, 2005) 
 South Korea 1 - Open mindedness (29 %)  
2 - Convenience/familiarity seekers (47 %) 
3 - Biotechnology opponents (24 %) 
  (Onyango et al., 2006) 
 United States 1 - Proponents (4.7 %) 
2 - Non-opponents (61.0 %) 
3 - Moderate opponents (22.7 %) 
4 - Extreme opponents (11.7 %) 
  (Ganiere et al., 2006) 
GM apples New Zealand 1 - Price sensitive (15.3 %)  
2 - True believing (13.0 %) 
3 - Appreciative (23.3 %) 
4 - Middle of the road (18.3 %) 
5 - Opposed (16.3 %) 
6 - Concerned (13.7 %) 
  (Kaye-Blake et al., 2007) 
GM chocolate & 
GM tomatoes 
New Zealand 1 - Price sensitive (c: 7 %; t: 13%) 
2 - Price and technology sensitive  
(c: 40%; t: 25 %) 
3 - Anti-GM, not price/benefit sensitive  
(c: 30 %; t: 21 %) 
4 - Neophobic (c: 12 %; t: 11 %) 
  (Gamble et al., 2000)d 
 
GM corn flakes United States 1 - Brand buyers (40.5  %) 
2 - Safety seekers (30.3 %) 
3 - Price pickers (29.2 %) 
  (Baker and Burnham, 2001) 
GM dairy spreada Ireland 1 - Pro-2nd generation (29.4 %) 
2 - Anti-2nd generation (24.4 %) 
3 - 2nd generation accepters (14.4 %) 
4 - 2nd generation rejecters (31.8 %) 
  (O’Conner et al., 2005) 
GM derived 
animal foods 
UK 1 - Opponents (7.6  %) 
2 - Cautious (41.3 %) 
3 - Optimists (51.1 %) 
  (Kontoleon and Yabe, 2006) 
GM maize South Africa 1 - Anti-GM, brand aware (35 %)  
2 - Brand unaware, farmer sympathetic (20 %) 
3 - GM consumer benefit, brand aware (25 %) 
4 - Brand aware, Pro-GM (20 %) 
  (Vermeulen et al., 2005) 
GM oil seeda Australia 1 - Conservatives (28 %) 
2 - Confident protectors (51 %)  
3 - Anti-GM (20 %) 
  (Cox et al., 2008) 
GM tofu Taiwan 1 - Conventional Buyer (45 %) 
2 - GMO Buyer (32 %) 
3 - Non-GMO buyer (23 %) 
  (Jan et al., 2007) 
Note: c = chocolate; t = tomato 
aTo our knowledge these are the only segmentation studies solely focusing on GM products with consumer benefits, the so-
called 2nd generation GM products; b4th, 5th, 6th and 7th Eurobarometer Surveys are conducted in 1999, 2002, 2005 and 2010, 
respectively; cIn the 5th Eurobarometer ‘undecided’ is replaced by ‘risk-tolerant’; dAlthough the authors discovered three 
additional, smaller segments with respect to GM tomatoes, only the common clusters are shown. 
 
According to the review of Costa-Font et al. (2008), the consumer’s reaction towards GM food can be 
generally classified into three groups: ‘pessimistic’, ‘risk-tolerant’ or ‘information searchers’, and 
‘optimistic’. In respect of the European Union, the last four Eurobarometer Surveys confirm the large, 
growing European opposition or skepticism towards GM food (Gaskell et al., 2003; Gaskell et al., 
2004; Gaskell et al., 2006; Gaskell et al., 2010). When focusing on the GM food perceptions in specific 
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European countries, studies discovered three German (Christophe et al., 2008), four Greek 
(Arvanitoyannis and Krystallis, 2005) and four Belgian consumer segments (Verdurme and Viaene, 
2003). The latter study, for instance, identified the following clusters: ‘halfhearted’ and ‘green 
opponents’, both reluctant, versus ‘balancers’ and ‘enthusiasts’. Except for the large indifferent 
segment in Germany, these studies follow the trend of the Eurobarometer, by which the size of the 
opposed cluster is about two times as large as the optimistic segment. In the United States, such a 
reluctant segment is less represented, as Ganiere et al. (2006) demonstrated, with about 34.4 % 
(moderate) refusing consumers. 
Several segmentation studies focus on specific GM food products, such as GM apples (Kaye-Blake et 
al., 2007), GM chocolate and tomatoes in New Zealand (Gamble et al., 2000), foods derived from 
animals fed with GM feed in the United Kingdom (Kontoleon and Yabe, 2006), GM corn flakes in the 
United States (Baker and Burnham, 2001) and GM maize in South Africa (Vermeulen et al., 2005). All 
authors analyzed the market potential for products with improved agricultural traits, except for 
O’Conner et al. (2005) and Cox et al. (2008). These two studies focus on GM food products with 
consumer benefits, respectively GM oil seed as a source of omega-3 fatty acids and cholesterol 
reducing GM dairy spread. 
Only a few GM food segmentation studies have been conducted in Asia. Onyango et al. (2006) 
pointed out the existence of three South Korean segments, denoted as ‘open mindedness’, 
‘convenience seekers’ and ‘biotechnology opponents’. Another study generated three distinct clusters 
regarding GM tofu in Taiwan: ‘GMO buyer’, ‘Non-GMO buyer’ and the indifferent ‘conventional buyer’ 
in between. In China, Li et al. (2003) identified four consumer segments: “neutral”, ‘knowledgeable’, 
‘biotechnology learners’ and ‘price-conscious’. Recently, four distinct urban consumer segments were 
discovered in China: ‘food safety’, ‘nutritional technologist’, ‘GM skepticism’ and ‘GM for non-food 
promoter’ (Zhang et al., 2010). They demonstrated that there is a significant group of Chinese 
consumers (14 %) who attaches importance to improved nutrition of GM rice products, i.e. 
biofortification. So far, these are the only Chinese studies that segmented consumers’ reactions to GM 
food. I have no knowledge of market segmentation studies of specific GM food products in China. 
Nevertheless, there is a great variance in acceptance of GM food products between Chinese 
consumers (Huang et al., 2006b) resulting in different segments (Li et al., 2003; Zhang et al., 2010), 
which supports the importance to segment the potential interest of Shanxi rice consumers in GM food 
and FBR. In the end, as Onyango and Nayga (2004) stated, market segmentation strategies will be 
required to efficiently target the consumer in the market of GM food products with tangible consumer 
benefits. Identifying consumer segments is a prerequisite to reach this goal. 
  
Consumer or market segmentation identifies potential consumer segments based on socio-
demographic, attitudinal and behavioral differences (Kotler, 2001). GM food segmentation studies 
typically also include important determinants of GM food acceptance, such as knowledge and 
consumer perceptions (Verdurme and Viaene, 2003; Christophe et al., 2008; Zhang et al., 2010). The 
segmentation study in this thesis does not only focus on these two GM food related concepts but 
additionally incorporates trust in information channels and sources to identify distinct consumer 
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segments in Shanxi Province. Trustworthiness of information sources or channels are expected to 
account for differences in GM food knowledge (Chen and Li, 2007), consumer perceptions (Siegrist, 
2000) and acceptance of the GM technology (Frewer et al., 1998; Govindasamy et al., 2008). When 
consumers evaluate GM technologies, they usually depend on knowledge derived from information 
sources/channels (Frewer et al., 2003; James, 2003; Meijnders et al., 2009). Moreover, to successfully 
disseminate information regarding GM food, one needs to discover the appropriate information 
channels and sources, given the targeted market segment (Hovland et al., 1953). Currently, 
information acquisition and trustworthiness of information sources and channels are largely neglected 
when segmenting the market for GM food (see Table 1).  Due to the inclusion of trust levels and GM 
food related variables, differences among the segments in FBR acceptance and information 
acquisition are examined in this thesis.  
 
1.3.1.3. GM food attributes and consumer acceptance 
 
People evaluate GM food products by the attribute changes caused by the GM technology, rather than 
the technology itself (Ganiere et al., 2006). When linking Fishbeins’ Multi-attribute theory to GM food, 
acceptance not only depends on knowledge and consumer perceptions of the benefits and risks of GM 
food, but also on the consumer perceptions of its specific product attributes (Bredahl et al., 1998; 
Rimal et al., 2007; Siegrist, 2008). According to Lancaster (1966), consumers maximize utility through 
the combination of product attributes. By improving nutritive, sensory and other product attributes, 
consumers are more likely to acknowledge the advantage of GM crops (Bourn and Prescott, 2002; 
Engel et al., 2002; Verdurme et al., 2003a; Siegrist, 2008). As a consequence, acceptance studies on 
2nd generation GM food products mainly focused on the evaluation of the product-enhancing attributes 
of GM food, such as the nutritional benefits in section 3.3.2. Although biofortification was initially 
applied to improve the micronutritional content of staple crops, it may involve other product attribute 
changes, such as an undesired taste and appearance (Bouis et al., 2000). Furthermore, the 
characteristics of the introduction of a biofortified crop could negatively affect its availability, cultivation 
potential and price. As consumers are often not accustomed to these new properties, these traits may 
be important deterrents to consumer acceptance, regardless of the consumers’ evaluation of the 
technology, and reduce the potential impact of biofortification. When targeting folate biofortification of 
rice, a consumer could be in favor of its improved health benefits, but may become reluctant if other 
rice attributes would be negatively affected. Below, evidence of the impact of the most relevant 
product attributes of GM and/or biofortified food, such as appearance and taste, is described. 
 
Differences in external appearance, for instance, could be useful to distinguish a biofortified product 
from the conventional product, especially when targeting specific risk groups (Bouis et al., 2000). 
Nevertheless, there is scientific evidence that a GM food product is more likely to be accepted if it 
resembles the natural product (Onyango et al., 2004; Tenbült et al., 2005; Siegrist, 2008). The impact 
of color changes due to fortification of rice depends on its nutritional components (Porasuphatana et 
al., 2008). Fortifying rice with iron, for instance, intensifies its yellow color, which negatively affected 
consumer acceptance in Bangladesh and Thailand (Prom-u-thai et al., 2009). Another well known 
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example is the yellowish GR, biofortified in order to tackle vitamin A deficiency. Although the visible 
difference is recognized as a potential constraint of consumer acceptance of GR, it is still not 
scientifically proven. According to Brooks (2010), the yellow color of this rice variant is likely to be 
perceived as an indicator of being a too long stored product and thus of a lower quality than regular 
rice. Two other studies investigated the impact of color on the acceptance of provitamin A enriched 
maize in Kenya (De Groote and Kimenju, 2008) and Mozambique (Stevens and Winter-Nelson, 2008). 
Both authors found a preference for white unfortified maize over the yellow-orange biofortified maize, 
which is reflected in the consumers’ WTP (De Groote et al., 2011).  
Genetic modification sometimes intensified the sensory properties of food products, such as taste. The 
“Flavr Savr” tomato, for instance, was primarily intended to increase its shelf life, but is also 
characterized by an improved flavor (Kramer and Redenbaugh, 1994). Also iron fortification of rice can 
change the initial flavor and chewiness (Prom-u-thai et al., 2009). According to the International Food 
Information Council (IFIC) study in 2001, about 58% of US consumers indicated that they would like to 
purchase products which have been modified to taste better (IFIC/Wirthlin, 2001). As taste as such is 
not an objective of biofortification, there is little evidence of sensory differences between biofortified 
and conventional staple crops (Engel et al., 2002). Stevens and Winter-Nelson (2008) however, found 
negative reactions to the flavor and aroma of provitamin A-biofortified maize, which is expected to 
influence consumer acceptance (Hossain et al., 2003). Product attributes related to preserving and 
processing GM food, such as the shelf life, and the duration and the sensory quality of cooking, could 
also play a role (Bonti-Ankomah and Yiridoe, 2006; De Groote and Kimenju, 2008; Prom-u-thai et al., 
2009). 
Although folate biofortification is not expected to change taste and visual product attributes (Bekaert et 
al., 2008), contrary to folic acid fortified rice (Shrestha et al., 2003), the impact of both attributes are 
included. One of the main reasons is that the product is still under development and the rice attributes 
might be altered depending on the rice varieties that will be selected. For instance, if the folate trait 
would be inserted in another biofortified rice crop, such as MBR, there is evidence that the higher 
vitamin A content would alter the color and flavor.  
 
Other attributes, such as the availability, the cultivation potential, and the environmental and price 
impact, mainly refer to market features related to the production or the distribution. For example, if the 
availability is hampered, consumers are less likely to switch from the conventional to the GM food 
product (Foster et al., 2003; Verdurme et al., 2003a). Furthermore, the cultivation potential of GM food 
or biofortified staple crops may influence especially farmer’s opinion, but also consumers in China as 
they are often subsistence farmers and grow and mill rice themselves (Gale et al., 2002). 
 
Based on this literature review, section 3.3.4 analyzes the potential impact of a negative change in six 
rice attributes on the acceptance of FBR in Shanxi Province: taste, external appearance, availability, 
cultivation potential, price impact and environmental impact. 
 
 
16 
 
1.3.2. Willingness-to-pay (Chapter 4) 
 
Following acceptance, the next step to determine the market potential of novel goods is to analyze 
consumers’ WTP. When evaluating the potential demand for novel products, whether it is an 
environmental issue (Hanemann, 1984; Hanley et al., 2006), an agricultural product (Lusk and Hudson, 
2004), such as organic products (Bonti-Ankomah and Yiridoe, 2006), or controversial technologies in 
food, like irradiation (Fox et al., 2002), insecticide use (Roosen et al., 1998), GM food (Bredahl, 2001; 
Lusk et al., 2005) and biofortified crops (Chowdhury et al., 2009), the aim is determine their economic 
value.  
 
As the economic value of a good refers to the value consumers place on it, i.e. what this product is 
worth to consumers (Pearce and Özdemiroglu, 2002), WTP for a GM food product is understood as a 
subjective trade-off, namely the highest amount a consumer is prepared to pay to exchange a GM 
food product for another, or vice versa. This exchange or preference can be also defined as the lowest 
compensation a consumer is prepared to accept to sell a product, i.e. willingness-to-accept (WTA)9. 
Because FBR is not commercialized, the value elicitation study in the conceptual framework estimates 
the monetary value of this non-market product. FBR is clearly beneficial to consumers, unlike 1st 
generation GM crops, by which the aim is to determine the premium for this GM rice product rather 
than discount.  
Several other reasons can be outlined to underpin the appropriateness of determining WTP over WTA. 
First, endowing an existing, familiar product and asking if people want to pay more for an improved 
alternative is in accordance to what consumers are facing in a real market situation. Second, WTP and 
WTA measures should theoretically generate similar results (Hanemann, 1991), but in practice there is 
often a clear divergence with substantially higher WTA values (Lusk et al., 2005; Moon et al., 2007), 
especially when used in a non-repeated auction design (Shogren et al., 2001a). Another difficulty of 
using WTA is to define at what value someone becomes opposed, because reluctance in the 
compensation approach will be reflected by huge monetary values (Jaeger et al., 2004).  
 
Despite the large body of scientific studies on WTP and purchase intentions of GM food (Lusk et al., 
2005), biofortified crops with proven health benefits received little attention thus far (Chowdhury et al., 
2009). Valuation studies focused solely on provitamin A enriched products, such as maize in Kenya 
(De Groote et al., 2011), cassava in Brazil (Gonzalez et al., 2009), or Golden Rice in India (Deodhar et 
al., 2008), the Philippines (Depositario et al., 2009a) and the United States (Lusk, 2003). Moreover, 2nd 
generation GM food products are a relatively new research topic in value elicitation experiments 
(Rousu et al., 2005). However, in both cases, there is scientific evidence that the improved health 
benefits lead to higher WTP values compared to GM food products that are not directly oriented 
towards the consumer. Given the optimistic consumer reactions to GM rice in China (Li et al., 2002; 
Liu, 2009), one could expect similar increases in WTP valuations of FBR in a Chinese high-risk region.  
                                                 
9 This price-determining concept differs from the previously mentioned variable ‘acceptance’ (see section 1.3.1 or chapter 3).  
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In the following subsections, the concepts and the rationale behind the part of the conceptual 
framework that aims to study WTP for FBR in Shanxi Province are discussed. While section 1.3.2.1 
focuses on conceptualization of WTP, section 1.3.2.2 deals with the determinants of WTP.  
 
1.3.2.1. Conceptualization of WTP 
 
There are several approaches to define the concept of WTP which can be broadly categorized into 
stated or revealed values or preferences, where economic values are directly or indirectly measured 
(Blamires, 1997; Balistreri et al., 2001; Pearce and Özdemiroglu, 2002; Hanley et al., 2006; Lusk and 
Shogren, 2007).  
Table 2 classifies the most commonly used WTP values, namely stated, revealed and auction-based 
WTP. These concepts are defined by the technique that is applied to measure WTP, i.e. the value 
elicitation method. In theory, they should all obtain the same WTP value. However, a discrepancy 
between different WTP values is often observed in practice (Balistreri et al., 2001). According to Lusk 
et al. (2005), the value elicitation method is a crucial factor that accounts for differences in WTP values 
between GM food studies.  
Although the difference between the two selected WTP values, i.e. stated and auction-based WTP, is 
based on the way they are measured, respectively through open-ended contingent-valuation (CV) and 
(laboratory) experimental auctions, these two concepts are included in the conceptual framework. This 
is because the WTP study in this PhD dissertation will investigate the difference between these two 
WTP values. Below the table, both concepts and value elicitation methods are discussed and the 
rationale to compare them is provided. In addition, indirect WTP values will be examined during the 
experimental auctions as a depersonalized alternative to the auction-based values.  
 
Table 2 Overview of the main types of WTP values, based on the applied value elicitation method  
WTP value Value elicitation method Specific types/examples 
Stated WTP Stated preference methods  
 Contingent valuation 
(CV, survey-based10) 
open-ended (OE); closed-ended, e.g. dichotomous  
choice (DC); payment card; bidding game 
 Choice modeling conjoint analysis; contingent ranking 
Revealed WTP Revealed preference methods 
 
 
Market data analysis panel data analysis, store scanner data analysis  
Travel cost  recreational value of places of interest  
Hedonic pricing  house pricing 
Auction-based WTP Experimental auctions  laboratory experiment; field experiment 
 
Source: Own compilation, based on Bateman et al. (2002), Breidert et al. (2006), Venkachalam (2004) and the Competition 
Commission report (2010). 
Note: Bold indicates the focus of the PhD dissertation. Although experimental auctions are sometimes categorized as revealed 
preference methods, they actually combine the strengths of both revealed and stated preference methods.  
 
Stated WTP (sWTP) 
Stated WTP is derived from stated preference methods. It is the most investigated WTP value in GM 
food studies, especially when the survey-based contingent valuation (CV) method is applied to find out 
if consumers prefer a premium or a discount for GM food products (Lusk et al., 2005). Other stated 
                                                 
10 These methods are typically build upon consumer estimations. One could also attempt to investigate WTP through expert estimates, e.g. sale managers’ 
assessment of WTP values. 
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preference methods, such as choice-based conjoint analysis, are often less applicable to estimate 
economic values of novel food products, due to its complexity, the limited possibility of including 
important determinants of buying behavior (Lusk and Hudson, 2004), or because of the low explained 
variation (Lusk and Shogren, 2007), but are generally accepted as multi-attribute modeling tools to 
measure trade-offs between various factors (Lucking-Reiley, 2000; Lusk and Shogren, 2007; De 
Groote et al., 2010).  
 
The most important CV approach is built upon an open-ended (OE) or a single or double-bounded 
dichotomous choice (DC) format (Bishop and Heberlein, 1979; Hanemann, 1984)11. While the former 
directly measures the amount one is willing to pay, the latter includes a take-it-or-leave-it bid in 
advance, with (double) or without (single) follow-up (Langford and Bateman, 1993). As the WTP 
values are built on different CV-based approaches, they are likely to be different (Hanemann and 
Kanninen, 1999). As Venkatachalam (2004) stated, the choice of the applied CV technique depends 
on different factors, including the nature of the investigated product, the characteristics of the targeted 
sample, the applied statistical technique and the cost of the survey. Regarding our stated WTP 
valuation study, an open-ended WTP value is determined. The reasons to measure this type of stated 
preferences are described in the methodology section of chapter 4 (see section 4.2.1).  
 
Although direct survey-based stated values are still widely used in economic valuation studies about 
GM food (Lusk et al., 2005), inferring stated preferences for novel products has been shown to lead to 
substantially higher values than the auction-based WTP values, partially due to the absence of a 
market situation which attaches monetary consequences to the participant’s responses (Johannesson 
et al., 1998; Balistreri et al., 2001; List and Gallet, 2001; Huffman et al., 2007), by which bidding 
truthfully is not a (weakly) dominant strategy (Wertenbroch and Skiera, 2002). This ‘hypothetical bias’, 
is defined as the difference between consumers’ stated (saying) and the real WTP (doing), by which 
stated values overestimate the WTP values in experimental auctions. It is considered one of the key 
shortcomings of stated value elicitation methods (Lusk, 2003; Hanley et al., 2006). Other relevant 
biases which might occur, are method bias (e.g. differences in elicitation mechanisms)(Völckner, 
2005), information biases (e.g. hidden value-clues to consumers, impact of the relevance of the 
information, confirmation bias)(Ajzen et al., 1996; Schulz-Hardt et al., 2000), negativity (Rozin and 
Royzman, 2001) or optimism bias (Lee and Job, 1995)(respectively over- or underestimating negative 
information), strategic bias (e.g. stating high values to influence expected actions based on the 
research findings)(Mitchell and Carson, 1989; Lusk et al., 2007), starting point bias (e.g. influence of 
benchmark price, see Herriges and Shogren, 1996; Ready et al., 1996; or the offered bid in DC-CV 
formats, see(Venkatachalam, 2004), operational bias (e.g. wrong interpretation of information), and 
social desirability bias (Fisher, 1993; Lusk and Norwood, 2009). The methodology to measure sWTP 
for FBR is presented in section 4.2.1.  
                                                 
11 Other contingent valuation techniques include the bidding game and payment card (Boyle et al., 1996), but are less popular stated preference methods 
regarding GM food valuation studies (Lusk et al., 2005). While in the bidding game a participant is offered several times a hypothetical bid to which he 
reacts, until he becomes reluctant, the payment card presents a list of potential values out of which participants select the one near their WTP 
(Venkatachalam, 2004). 
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Auction-based WTP (WTP) 
The auction-based WTP is the value that is obtained through experimental auctions, a non-
hypothetical value-elicitation method. Experimental auctions became increasingly popular as an 
alternative method to elicit consumer valuations for novel, non-market products, i.e. homegrown, 
auction-based values. Originated five decades ago (Becker et al., 1964), experimental auctions 
address the shortcomings of the stated (e.g. hypothetical bias) and revealed preference methods (e.g. 
indirectly deducting WTP from empirical patterns) while improving the conventional contingent 
valuation approach (Lusk and Shogren, 2007). First, the simulation of an active market with real 
products and money implies that people have an incentive to state their true value, especially when 
the responses differ from the true values (Klemperer, 1999; Milgrom, 2004). Second, the created 
market environment allows the researcher to conduct non-hypothetical research on non-market 
products while controlling the setting in order to assess the effect of potential determinants of interest. 
In that way, experimental auctions are promoted as a convenient tool to stimulate consumers to put 
forth cognitive effort to their stated preferences for novel products (Fox, 1995). As a consequence, 
auction-based values are typically lower than the values obtained through hypothetical contingent 
valuation methods (Balistreri et al., 2001; Chern and Chang, 2009). Due to the aforementioned 
hypothetical bias, hypothetical bids generally exceeded auction values by a factor of 1.65 (Balistreri et 
al., 2001) to 3 (List and Gallet, 2001).  
In the respective methodology section of chapter 4, the different steps, the selected procedures and 
the assumptions regarding the development and organization of the experimental auction design are 
thoroughly described and justified with reference to auction theory and research literature. The study 
will adopt a 2nd price auction mechanism that is based on several procedures, such as the endowment 
approach, single binding and sealed bidding procedures, inclusion of trial auctions and an auction 
survey (section 4.3). 
 
Indirect  WTP (iWTP) 
The aforementioned WTP values are generally based on self-reported statements that refer to the 
participants’ own valuation. For example, in this thesis the respondents have to state the highest 
amount they are willing to pay for FBR (sWTP, see section 4.2) or to exchange the endowed rice bag 
with FBR (auction-based WTP, see section 4.3). Such personal statements may lead to auction fever, 
i.e. high bidding to win the auction, and social desirability bias (SDB), a tendency to please the 
interviewer or experimental monitor by submitting high bids. Although there is evidence of SDB in 
hypothetical value elicitation studies (Leggett et al., 2003; Lusk and Norwood, 2009; Olynk et al., 
2010), SDB is not explored in a non-hypothetical research setting. However, given the characteristics 
of our experimental auctions, e.g. female consumers, a controversial good and a controlled setting, it 
is important to take into account the risk of social desirable behavior. One of the strategies to measure 
SDB is the indirect valuation method, by which the personal character of bidding, i.e. self-reported 
bids, is detached from the valuation exercise (Lusk and Norwood, 2006). As such, ‘indirect’ refers to 
the elicitation of consumers’ estimation of the valuation of other consumers, e.g. the typical consumer. 
This differs from the meaning of ‘indirect’ in comparing stated and revealed preferences, where the 
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former are based on direct statements and the latter refers to the indirect method of deducting WTP 
from price-related behavioral patterns. 
In the experimental auctions of this study, indirect WTP refers to the consumer’s stated estimation of 
the WTP of the average female rice consumer in Shanxi Province. Instead of switching completely to 
indirect valuation, our auction design obtains revealed, personalized bids during the bidding rounds 
and asks for a stated, indirect, depersonalized WTP value in the auction survey (see also section 
4.3.2.1).  
 
As a consequence, three types of valuations are analyzed and compared in this study: sWTP and 
iWTP as direct and indirect survey-based values, respectively, and auction-based WTP. The objective 
is then to explore hypothetical bias (sWTP versus WTP) and SDB (WTP and iWTP) in economic 
valuation studies. 
 
1.3.2.2. WTP determinants and information effects  
 
The conceptual framework of this line of inquiry further aims to investigate the determinants of WTP 
for FBR and explores the role of information (see Figure 2). 
 
Determinants of WTP 
In line with the study about FBR acceptance (see section 1.3.1.1), WTP for a GM product is expected 
to be influenced by GM food knowledge, consumer perceptions, and socio-demographic indicators 
(Bredahl et al., 1998; Verdurme et al., 2003b; House et al., 2004; Ajzen, 2005; Han and Harrison, 
2006; Lin et al., 2006; Costa-Font et al., 2008; De Groote and Kimenju, 2008), although research 
regarding the effect of the latter is inconclusive (Lusk et al., 2001a; Umberger and Feuz, 2004). The 
importance of these determinants are investigated for the stated WTP, which is based on the survey 
that is used to explain FBR acceptance (see section 3.2.2). 
 
In the case of the experimental auctions, the determinants of the auction-based WTP are measured in 
the third information round of the auction (an overview of the auction design is presented in Figure 13). 
In this round, consumers were aware of the higher folate content (round 1) and the benefits of FBR 
(round 2), and were informed about the GM technology that is applied. In this way, the WTP values 
reflects consumer’s valuation of the impact of being aware of the GM nature of FBR. Therefore, two 
GM related variables were entered, objective GM knowledge and GM food acceptance. Rather than 
including FBR acceptance, specific attention is paid to the importance of GM food acceptance as a 
potential determinant of WTP (and in relation to information provision, see below). Previous studies 
showed a positive effect on the WTP values for GM technologies (Colson and Huffman, 2009) or GM 
food products (Kassardjian et al., 2005).  
Due to the auction design, by which two specific target groups are involved, namely female students 
versus women of childbearing age, the target group variable was considered as a proxy for socio-
demographic differences. Therefore, only residence (rural/urban) and farmer family (i.e. involvement in 
farming) are explored as potential determinants. The inclusion of the target group as a design 
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characteristic makes it possible to analyze WTP between student versus non-student samples. Based 
on the current auction literature on GM food products, both subsamples are expected to generate 
similar WTP values (Lusk et al., 2005; Depositario et al., 2009b).  
Another potential determinant related to the design characteristics is the impact of the presence of an 
auctioned substitute, which is currently lacking in GM food auctions (Kassardjian et al., 2005; Corrigan 
et al., 2009). Given that FBR is a GM rice crop with folate benefits, half of the participants could opt for 
a non-GM folate product, i.e. rice sold together with free folic acid pills. In this way, two folate 
interventions are brought into the experiment, FBR and folic acid supplementation. The aim is then to 
measure the effect of the auction type, i.e. having the option to bid on a GM-free product or not. 
Other design characteristics refer to the timing (i.e. time and day), and the size of the auction. 
Previous research demonstrated that the auction sample size is positively associated with higher 
values (Umberger and Feuz, 2004), whereas WTP values are higher during morning sessions 
(Rutsaert et al., 2009; De Groote et al., 2010), known as the time-of-the-day effect (Hoffman et al., 
1993). Furthermore, conducting experiments during working hours may exhibit a sampling bias, 
leading to higher rates of unemployed people (Wang and McCluskey, 2010), which may affect the 
results of the study. 
 
Information effects 
With respect to the auction-based WTP values, additional attention is devoted to the effect of 
information. As the focus is on the provision of different information treatments, the experimental 
auctions were designed in such a way that they allow the isolation of information effects on the 
obtained WTP values. A detailed overview of the five information treatments/auction rounds in the 
design of the experimental auctions is shown in Figure 13 (see section 4.3.4). 
 
Information about the improved folate concentrations and the associated benefits might increase WTP 
for FBR, as is the case with conventional biofortified crops (De Groote et al., 2011), but may be 
negatively affected when consumers are aware of the GM technology that is implemented (Depositario 
et al., 2009a). In this WTP study, information about the folate content, the folate benefits and the GM 
nature of the product is provided through separate information rounds. In other words, the study 
compares FBR as if it would be perceived as a conventional or a GM biofortified crop. As a 
consequence, the auction survey was administered in between the information rounds, so that the 
measurement of information-related determinants preceded the respective treatment. For example, 
the GM related determinants (i.e. objective GM knowledge, GM food acceptance) are measured 
before consumers learn about the applied GM technology, while the other knowledge variables, e.g. 
knowledge of a woman who delivered an NTD and prior knowledge of folate benefits, refer to the 
auction round which dealt with information about the folate benefits of FBR. 
 
Due to the controversy surrounding the use of GM technology in food products, there is a large body 
of research on the role of specific GM information. In general, positive information about the GM 
technology increases consumers’ WTP for GM food products (Tegene et al., 2003; Colson and 
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Huffman, 2009), in particular when potential health benefits are mentioned (Frewer et al., 1996; Jaeger 
et al., 2004; Lusk et al., 2004b; Kassardjian et al., 2005; Hobbs et al., 2006). However, when providing 
conflicting information treatments, i.e. both positive and negative statements about GM food, there is 
less consensus about the information effect on WTP (Parkhurst et al., 2004; Rousu et al., 2004b; Hu 
et al., 2006; Colson and Huffman, 2009; Corrigan et al., 2009; Depositario et al., 2009a). A similar 
discussion is being held in valuation experiments with other controversial foods, such as irradiated 
meat (Fox et al., 2002; Parkhurst et al., 2004). The study on WTP for FBR further investigates the 
impact of different types of GM information, namely single, two-sided (positive, negative) or combined 
GM information treatments (positive, negative, objective). In addition, information order effects are 
measured in the two-sided treatments to identify the presence of a primacy or recency effect. 
According to these cognitive biases, a message that is presented first will be more (primacy) or less 
(recency) effective than the last presented information (Haugtvedt and Wegener, 1994). 
 
The last information effect, as measured in the experimental auctions, is closely related to the 
characteristics of the study location. Since the study was conducted in a high-risk region of folate 
deficiency (Shanxi Province), it is also examined how consumers value FBR after being informed 
about the current situation in their region, i.e. the high prevalence and burden of folate deficiency.  
 
1.3.3. Health impact and cost-effectiveness (Chapter 5) 
 
While the study on consumer acceptance and WTP provides insight in the consumer reactions to FBR, 
one needs to realize that FBR as a health intervention may only be supported and implemented when 
the generated health effects verify the allocated resources. An economic evaluation is an essential tool 
to evaluate whether FBR is worthwhile to consider and should be given priority as a means to alleviate 
the burden of folate deficiency. In this study, the widely used Disability-Adjusted Life Year (DALY) 
approach is applied as the framework to evaluate the current burden of folate deficiency in China on 
the one hand and to determine the potential health benefits of this intervention on the other. Given the 
costs incurred for the development and introduction of this GM rice variant, its cost-effectiveness can 
be assessed and benchmarked against other health interventions or standardized cut-off levels. The 
DALY approach is also applied to MBR in China, which not only addresses folate deficiency, but also 
inadequate iron, zinc and vitamin A levels.  
 
1.3.3.1. Burden of disease 
 
When evaluating the impact of health interventions that aim to tackle a specific disease in a society, 
like biofortification intends to do with micronutrient malnutrition, and to adequately inform decision-
makers and health planners about the potential of such strategies, it is essential to analyze the current 
status of the targeted disease, i.e. the ‘burden of disease’. According to the World Health Organization 
(WHO) definition (Lopez et al., 2006) this concept is defined as the overall impact of, or the economic 
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costs associated with, the disease and its outcomes at the individual or societal levels. It represents 
the health gap between the (current) health status and a hypothetical, ideal situation without diseases. 
One of the key objectives of estimating the burden of disease is to inform stakeholders involved in 
setting the health agenda and formulating priorities. In their Global Burden of Disease (GBD) reports, 
WHO estimates the global burden of a large set of diseases and injuries, in terms of age-, sex- and 
region-specific mortality and morbidity. Since the first study in 1990 (Murray et al., 1994), WHO 
published updated versions in 1996, 2000, 2004 (Murray and Lopez, 1996; WHO, 2002; Lopez et al., 
2006; WHO, 2008a) and, upcoming, in 2010 (http://www.globalburden.org/). Together with their 
Comparative Risk Factor Assessment (CRA) reports (WHO, 2009a, 2011c), which provide evidence of 
the impact of 26 global health risk factors, the GBD series serve as one of the most comprehensive 
datasets of the current health situation.  
 
In their World Development Report, WHO and the World Bank introduced the Disability-Adjusted Life 
Year (DALY) concept to assess the burden of disease (World Bank, 1993). Since then, the DALY 
framework is considered as the standard measurement tool in disease burden studies and has been 
used to compare the (cost-)effectiveness of health interventions, e.g. the Disease Control Priorities in 
Developing Countries (DCP) reports of the World Bank initiative (Jamison, 2006; Musgrove and Fox-
Rushby, 2006), as shown in the next sections. The DALY framework quantifies the burden of a 
disease as a single index, i.e. the number of DALYs lost. This number reflects both deaths and 
disabilities that can be attributed to the disease and its functional outcomes, in particular. As a 
consequence, the concept of a DALY is a health unit, defined as the sum of years of life that are lost 
due to the fatal causes of a disease and the years of life that are lived with a disability. Therefore, the 
DALY concept, on which the DALY approach is built, is expressed by the DALY formula (Murray and 
Lopez, 1996; see section 5.2). 
 
Regarding the conceptual framework of this PhD dissertation, the DALY concept is used and applied 
in order to assess the current burden of folate deficiency alone and of micronutrient malnutrition 
(folate, vitamin A, zinc and iron deficiencies) in China. Based on epidemiological and demographic 
data, the number of DALYs lost represents an aggregated estimate that encompasses the health 
impact of different functional outcomes on various target groups (see also Figure 3). Given the specific 
use of the DALY, some of the original methodological assumptions of the DALY framework, such as 
age weighting, have been adjusted or excluded. A comprehensive overview of the implications and the 
data assumptions of applying the DALY framework to micronutrient deficiency is presented in section 
5.2. The rationale behind the selection of the DALY concept, rather than other health units of the 
disease burden, such as the closely related Quality-Adjusted Life Years (QALYs) framework, or cost 
approaches of burden, such as cost-minimization analysis (CMA), will be discussed in section 1.3.3.3. 
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1.3.3.2. The health impact of interventions 
 
The second main purpose of the DALY approach is to determine the health benefits due to the 
implementation of a health intervention, i.e. the health impact.  
 
Figure 3 shows how the DALY approach can be applied to estimate the potential health impact of 
biofortified staple crops as a particular type of micronutrient interventions. First, the current burden of 
the micronutrient deficiency is estimated, where the number of DALYs lost reflects the current health 
status related to a micronutrient deficiency and its functional outcomes, as discussed in the previous 
section. This is the scenario without biofortification (i.e. the status quo). The next step is then to 
estimate how biofortification can contribute to alleviate this burden. This can be done by comparing the 
current situation with a scenario where biofortification would be implemented. The health impact is 
then defined as the difference between the simulation before and after biofortification, expressed in the 
number of gained DALYs. The health impact of the introduction of a biofortified crop mainly depends 
on the product characteristics of the micronutrient enriched crop (i.e. the initial nutrient content, the 
nutritional losses due to processing and the bioavailability of the nutrient) and the potential coverage 
rate of the intervention, which refers to consumers’ acceptance and access (Stein et al., 2005b). 
Together with the dose-response relationship, i.e. the effect of the enhanced micronutrient content on 
the functional outcomes, the reduction of the current burden can be determined.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Ex-ante health impact assessment of biofortified crops. Application of the DALY framework 
Source: Own compilation, based on Zimmerman and Qaim (2004) and Meenakshi et al. (2007). 
 
The DALY framework is well recognized and recommended (Tan-Torres Edejer et al., 2003), 
especially for developing countries/regions (World Bank, 1994; Evans et al., 2005), and is widely 
applied in health impact studies with other biofortified crops (Stein et al., 2005b; Horton, 2006; 
Meenakshi et al., 2007; Fan et al., 2009). In the current health impact literature, the focus of 
micronutrient interventions was, and still is, on the main micronutrient deficiencies, i.e. iron, zinc and 
vitamin A deficiencies (Manyong, 2004; Zimmermann and Qaim, 2004; Horton, 2006; Meenakshi et 
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al., 2006; Qaim et al., 2007; Fan et al., 2009; Suárez, 2010). There is currently no evidence of the 
health impact to tackle folate deficiency through biofortification, or the burden of folate deficiency.  
 
Despite China’s support for GM technology and biofortification (Campos-Bowers and Wittenmyer, 
2007)(see section 2.5), China is a relatively new area to conduct health impact studies on biofortified 
staple crops (Ma et al., 2007; Fan et al., 2009). At present, no (health impact) studies focused on GM 
biofortification in China. Due to the regional differences in folate intake, rice consumption and NTD 
prevalence, the health impact of FBR is assessed for both northern and southern provinces, at 
regional and administrative divisional level (see also annex 1). This makes it also possible to assess 
the health impacts of the high-risk region of China, Shanxi Province, and compare the findings with 
another high-risk region in the world, Balrampur District in India, where the number of NTDs is among 
the world’s highest (Cherian et al., 2005). 
 
Furthermore, previous studies only examined the health impact of crops that are biofortified with single 
micronutrients, while poor people often suffer from multiple micronutrient deficiencies (Gwatkin and 
Guillot, 2000). Therefore, a country-wide analysis of the potential health benefits of rice multi-
biofortification (MBR) in China is also carried out, which determines the health impact of enriching rice 
with folate and the three main micronutrients, i.e. zinc, iron and vitamin A. Because FBR is in a 
development phase and because there is no published evidence that the investigated MBR (see 
section 2.4.4.3) is being developed, the evaluation of the potential health benefits of both interventions 
are conducted prospectively. 
 
1.3.3.3. The cost-effectiveness of health interventions 
 
While the health impact of an intervention primarily refers to the measurement of the improved health 
outcomes, a full economic evaluation brings in the cost factors associated with this intervention. In 
principle, an economic evaluation aims to compare the consequences (e.g. health benefits) and costs 
of an intervention (or between different alternative interventions), in order to contribute to priority-
setting and to facilitate decision-making about the resource allocation (Haddix et al., 2003; Drummond 
et al., 2005).  
 
Basically, there are two main approaches in economic health literature, each built on a different 
economic evaluation method: cost-effectiveness analysis (CEA) and cost-benefit analysis (CBA)(see 
Table 3). Their objective is to identify interventions that maximizes the effectiveness per unit of cost, i.e. 
the (health) value for money, rather than to focus on minimizing the costs, which is done in cost-
minimization analysis (CMA)(Weinstein and Stason, 1977). In the latter, also known as programmatic 
cost analysis, cost identification, cost outcome or consequence analysis, the total costs of the 
intervention are estimated and compared with other interventions that generate identical (health) 
outcomes (CDC, 2011). As only the costs are taken into account, this approach is useful when aiming 
to identify the cheapest strategy to reach the same objective, but strictly speaking is not an economic 
evaluation as the benefits are not incorporated (Drummond et al., 2005).  
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The major difference between CEA and CBA is that the former expresses cost-effectiveness in natural 
health units, while these health outcomes are converted into monetary values in the latter 
(Johannesson, 1995; Boardman et al., 2006). The most important strength of the concept of cost-
effectiveness, i.e. avoiding to monetize the health effects, is often considered its main weakness and 
can be addressed by a cost-benefit analysis (CBA). Basically, the cost-benefit concept is concerned 
with a comparison of the monetary value of the health outcomes and the costs. A monetary value can 
be attached to a DALY or another health outcome by using, for example, country-specific annual per 
capita incomes (WHO, 2001b; Zimmermann and Qaim, 2004), a standardized international value for a 
DALY, i.e. US$ 1 000 (World Bank, 1994), a WTP value threshold for incremental risk reductions or a 
WTA value as a compensation for a lost health unit (Willan et al., 2001; Gyrd-Hansen, 2005). 
Proponents of CEA emphasize the necessity of reporting health consequences, especially when 
reporting health intervention evaluation results, while questioning the CBA for the attribution of a 
monetary value to health benefits on ethical grounds and the uncertainty regarding the level of the 
assigned value (Johannesson, 1995; Barbieri et al., 2001; Willan et al., 2001; Laxminarayan et al., 
2006). As a consequence, economic evaluation studies of health interventions are mainly based on 
CEA, while the CBA is less preferred in the (environmental) health (care) sector (WHO, 2000; Grosse 
et al., 2007; Ngorsuraches, 2008). Although the cost-benefit concept certainly has its merits over the 
concept of cost-effectiveness, e.g. improved attractiveness, easier to comprehend, inclusion of non-
health benefits and comparability between different sectors (Coast, 2004; Musgrove and Fox-Rushby, 
2006; Stein et al., 2008b), the latter will be selected to evaluate the introduction of FBR and MBR in 
order to maintain the non-monetary dimension of the DALY framework, instead of using a purely 
economic indicator. The main objective of this approach is then to inform decision-makers whether an 
intervention can be considered cost-effective and which strategies provide the largest health benefits 
at population level, given the budgetary constraints (Gold et al., 1996; Haddix et al., 2003; Tan-Torres 
Edejer et al., 2003). As the cost-effectiveness in this thesis refers to an ex-ante evaluation of the costs 
and health benefits, the results are expected to be relevant for policy makers when deciding to 
promote and speed up the approval of biofortification technology. 
 
Table 3 presents an overview of the different approaches to describe the current burden of disease 
and to evaluate health interventions. This overview does not aim to offer an exhaustive overview, but 
focuses on the most commonly used approaches in economic health literature and health impact 
studies, and the underlying evaluation methods. In this PhD dissertation the DALY framework is 
selected to analyze the current burden of folate deficiency and micronutrient malnutrition in China (see 
section 1.3.3.1) and to investigate whether, respectively, FBR and MBR, are cost-effective 
interventions to reduce these burdens.  
 
Together with the Quality-Adjusted Life Years (QALY) framework, the DALY framework (the successor 
of QALYs) is one of the most applied approaches to determine the cost-effectiveness of health 
interventions (Tan-Torres Edejer et al., 2003; Evans et al., 2005). Both QALYs and DALYs are 
considered as Health-Adjusted Life Years (HALYs) methods, i.e. techniques to describe both mortality 
27 
 
and morbidity of a health condition as a single number (Gold et al., 2002; Robberstad, 2005). Due to 
the inclusion of preference weights (‘utilities’) for the quality of life, these standardized health 
measures are often categorized under cost-utility analyses (CUA), an extended CEA (Ngorsuraches, 
2008). When controlling for age-weighting and discounting, a QALY (health gain) is considered the 
opposite of a DALY (health loss). While the former uses a ‘health related quality of life’ weight 
(HRQoL), the latter uses its inverse, i.e. disability weights. Although using QALYs has its own 
advantages, there is evidence that it results in higher health impact, especially in the case of childhood 
diseases (Sassi, 2006), and may result in a different ranking of cost-effective interventions (Arioldi, 
2007). The selection of the DALY approach was mainly motivated by the historical use of DALYs in 
World Bank (World Bank, 1993; Jamison et al., 2006) and WHO reports on developing countries 
(Evans et al., 2005) as well as in biofortification studies (Meenakshi et al., 2007; Meenakshi, 2008a). 
Although this health indicator is often criticized, e.g. less transparent to decision makers (Arnesen and 
Kapiriri, 2004), it is widely recognized as an economic evaluation tool without the need to attach a 
monetary value to a health benefit (an overview of the most relevant criticized issues is presented in 
section 5.1). Musgrove and Fox-Rushby (2006), for instance, argue that the DALY approach in CEA 
allows policy makers to underpin their investment in scarce health resources, and is an appropriate 
tool to identify a ‘best buy’ for developing countries.  
 
Building upon the health impact study and the intervention costs (e.g. R&D costs, country-specific 
costs, social marketing costs and maintenance breeding costs), this thesis determines the cost-
effectiveness of both FBR and MBR in China. Given the evidence on the cost-effectiveness of 
micronutrient interventions (World Bank, 1994; Mason et al., 1999; Mannar, 2001; Wallich et al., 2001; 
WHO, 2002; Baltussen et al., 2004; Horton, 2006; Fiedler et al., 2008; Klemm et al., 2009; Horton et 
al., 2010), including biofortification (Meenakshi et al., 2007; Meenakshi, 2008a; Qaim, 2009), both 
interventions are expected to be cost-effective strategies to reduce folate deficiency and micronutrient 
malnutrition, respectively.  
The cost-effectiveness is expressed in a standardized unit, i.e. US$ per gained DALY (see also 
section 5.3). This implies that interventions based on CEA can only be compared when the same unit 
is applied. Another option is to use a fixed cut-off level to define whether this health intervention is 
cost-effective (Tan-Torres Edejer et al., 2003; Laxminarayan et al., 2006), such as the US$ 150-
threshold of the World Bank (1993) and the per capita income levels, as proposed by the WHO (Evans 
et al., 2005; WHO, 2011a). To interpret the findings of this cost-effectiveness study, the results are 
evaluated against the World Bank cost-effectiveness threshold (see section 5.4.3) and compared with 
other cost-effectiveness studies on biofortified crops in developing countries (see section 5.4.4.2). 
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Table 3 Approaches to the estimation of disease burdens, health impact assessment and economic evaluation of interventions 
Approach Description Health 
unit 
Cost 
unit 
Examples Selected 
approach/unit 
Burden of disease     DALY Framework 
Health approach, e.g. DALY 
framework 
Estimation of the burden of a disease through health outcome 
measures. The DALY framework, for example, calculates the number 
of DALYs lost. 
Natural 
units 
/ DALYs/QALYs lost; 
mortality; morbidity 
DALYs lost 
 
 
Cost approach, e.g. cost-of-
illness analysis (COI) 
According to the COI, the importance of the disease burden is 
evaluated by the direct and indirect costs that are associated to the 
disease. 
/ Monetary 
units 
US$ / 
Intervention                
Health impact                DALY Framework 
Health approach, e.g. DALY 
framework 
The health impact is evaluated in terms of improved health outcomes. 
The DALY framework, for example, estimates the number of DALYs 
lost that can be averted through an intervention. 
Natural 
units 
/ DALYs/QALYs saved; 
deaths averted 
DALYs saved 
Cost analysis      
Cost approach, e.g. CMA Cost-minimization analysis (CMA) analyzes the intervention costs in 
order to identify the least expensive intervention; also known as cost 
analysis, cost identification, programmatic cost analysis, cost 
outcome analysis or cost consequence analysis. 
(Equal 
benefits) 
Monetary 
units 
US$ / 
Economic evaluation     CEA 
CEA,  
Cost-effectiveness analysis 
All costs are related to a single health index, i.e. the outcome 
measure, and expressed as the additional cost spent per unit of 
health outcome.  
Natural 
units 
Monetary 
units 
Reduced prevalence; 
US$ per DALY/QALY 
saved 
US$ per  
DALY saved 
 
 
CBA,  
Cost-benefit analysis 
Both costs and benefits are converted into monetary units and 
outcomes are expressed as the value of the benefits per dollars 
expended; sometimes referred to as benefit-cost analysis 
Monetary 
units 
Monetary 
units 
Benefit-cost ratio (B/C) 
Net benefit (B-C) 
/ 
 
DALY, disability-adjusted life year; QALY, quality-adjusted life year 
Source: Own compilation, based on Ngorsuraches (2008) and Drummond et al. (2005). Descriptions based on the CDC economic evaluation glossary index (CDC, 2011).  
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1.4. Research questions 
 
The objective of this PhD dissertation is to determine the market potential of FBR as a GM rice product 
with consumer benefits in China and a high-risk region in particular. Based on the conceptual 
framework to achieve this objective (Figure 2), eight key research questions are specified with respect 
to the three domains of interest, namely acceptance, WTP and cost-effectiveness. As most of these 
research questions are broadly formulated, specific sub-questions are added to test particular 
relations, analyze methodological issues or to put the question in the broader context. Due to the large 
number of sub-questions, these questions often deal with concepts that are not presented in the 
conceptual framework as such, but are described in the corresponding part of section 1.3. Below, a 
brief description of the rationale for the research (sub)questions is provided. Each question is 
examined in the dedicated research chapters and summarized in section 6.1 of the concluding 
chapter. 
The research contributions that are associated with these questions will be discussed in the next 
section. Given the characteristics of the research design (section 1.6.1), the answers mainly refer to 
Shanxi Province as a poor, rural high-risk region. This is true, except for the last two research 
questions, where the focus is extended to China and/or an Indian high-risk region (Balrampur District). 
 
RQ1. Is consumer acceptance of FBR determined by socio-demographic indicators, 
knowledge and consumer perceptions related to GM food? 
RQ1A.       How do consumer perceptions of GM food affect FBR acceptance? 
RQ1B. Does objective GM knowledge determine FBR acceptance? 
RQ1C. How do socio-demographic variables influence FBR acceptance? 
 
Based on underlying theories and empirical evidence to explain GM food acceptance (see section 
1.3.1.1), acceptance of FBR as a GM rice variant with health benefits is expected to be determined by 
GM food knowledge, consumer beliefs and socio-demographic attributes.  
The appropriateness and influence of using multi-item scales of GM food consumer perceptions, which 
are generally recognized as determinants of 1st generation GM food (Bredahl et al., 1998; Verdurme 
and Viaene, 2001, 2003; Pope et al., 2004) is tested for this 2nd generation GM food product (RQ1A). 
GM food benefits and risks, especially the former (Hamstra, 1995), are expected to be the most 
determining consumer perceptions (Frewer and Shepherd, 1995; Costa-Font et al., 2008).  
Although a positive relationship between knowledge and GM food acceptance is generally observed 
(Huang et al., 2006b; Chen and Li, 2007; Costa-Font and Mossialos, 2007), other studies countered 
this (Hamstra, 1995) and stress the need to further explore the effect of knowledge, especially with 
respect to objective GM knowledge (House et al., 2004; Kassardjian et al., 2005)(RQ1B).  
Similarly, the evidence of the impact of socio-demographic variables on GM food acceptance is 
inconclusive. Whereas several studies question the explanatory power as such (Bredahl et al., 1998; 
Baker and Burnham, 2001; Li et al., 2002; Kontoleon and Yabe, 2006; Anand et al., 2007), others 
found significant effects of age, gender, education or income (Hoban, 1998; Siegrist et al., 2000; Traill 
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et al., 2004; Moerbeek and Casimir, 2005; Ganiere et al., 2006; Wachenheim et al., 2008; Yee et al., 
2008), but often in the opposite way (Costa-Font et al., 2008)(RQ1C). Given the objective of FBR as 
an agriculture-based health intervention to reduce NTDs, family-related factors and farmer status are 
added to the model.  
The influence of these determinants on FBR acceptance is investigated in the consumer study in 
Shanxi Province (see section 3.3.2). 
 
RQ2. What kind of segments of Shanxi rice consumers can be distinguished based 
on GM food knowledge, consumer perceptions and trust in information 
sources/channels? 
 
The review of GM food segmentation studies in section 1.3.1.2 revealed a lack of studies on 2nd 
generation GM food studies and, given the applicability of market segmentation to detect distinct 
consumer segments as a basis for future communication, the need to incorporate the way consumers 
acquire GM food information and the trust levels regarding different information sources and channels. 
Market segmentation is conducted to find out if Shanxi rice consumers cluster around objective GM 
knowledge, GM food perceptions and the trustworthiness in information channels and sources, and 
how these clusters differ in terms of FBR acceptance, socio-demographic indicators and GM 
information acquisition (see section 3.3.3). 
 
RQ3. Which negative changes in rice attributes would deter FBR acceptance? 
 
As the underlying Fishbeins’ Multi-attribute theory postulates, FBR acceptance will be determined by 
the evaluation of its altered attributes (Bredahl et al., 1998; Ganiere et al., 2006; Siegrist, 2008). The 
impact of the improved health benefits of GM food (Bourn and Prescott, 2002; Engel et al., 2002; 
Verdurme et al., 2003a; Siegrist, 2008), i.e. the enhanced nutritional content of FBR, is explored in 
RQ1 (acceptance) and RQ4 (WTP). This research question reflects the need to extend such 
acceptance studies by determining the effect of potential negative rice attribute changes due to 
biofortification (Bouis et al., 2000; Stein et al., 2006). 
By focusing on rice consumers who are not averse of FBR, derived from the 2008 consumer survey, 
section 3.3.4 deals with the reduction of FBR acceptance due to negative changes in six rice attributes 
(taste, external appearance, price impact, market availability, the cultivation potential and the 
environmental impact). 
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RQ4. How much are consumers willing to pay for FBR in a high-risk region? 
RQ4A. What determines consumers’ valuation of FBR? 
RQ4B. How does information about the applied GM technology affects WTP for FBR? 
RQ4C. What is the effect of providing information about the regional situation on WTP for 
FBR? 
RQ4D. Is there a difference between non-student and student samples in experimental 
auctions?          
RQ4E. Does the provision of a non-GM substitute influence WTP for FBR? 
RQ4F. Do design characteristics (time, day, size) matter in auctions? 
 
Compared to the 1st generation GM food products (Lusk et al., 2005), measuring consumers’ WTP for 
2nd generation GM crops, and biofortified crops in particular, is still relatively new (Chowdhury et al., 
2009), especially when using experimental auctions to elicit the valuations (Rousu et al., 2005). 
Nevertheless, transgenic biofortification is an interesting topic to explore WTP, as consumers need to 
make a trade-off between the consumer benefits of biofortification and the controversial nature of the 
applied GM technology. Given the large premiums in previous WTP studies on GM biofortified Golden 
Rice (Deodhar et al., 2008; Depositario et al., 2009a; Gonzalez et al., 2009) and the supportive 
consumer reactions to GM rice in China (Li et al., 2002; Liu, 2009), high WTP values are expected for 
FBR in Shanxi Province. However, it still needs to be determined if the folate benefits are capable of 
mitigating negative reactions towards the application of GM technology in FBR. 
Chapter 4 examines the WTP for FBR by using two main value elicitation methods: survey based 
contingent valuation versus experimental auctions. As the next research question deals with the 
difference between these methods, the focus here is on the experimental auctions that are organized 
with the key target group of FBR, i.e. women of childbearing age, in a poor county of Shanxi Province.  
The auction design allows investigation of the determinants of WTP for FBR, based on different 
information rounds and the auction survey (RQ4A, see section 4.4.2.4). The difference between the 
folate and the ‘GM technology’ information rounds explores the impact of awareness of the use of GM 
technology in FBR on WTP, i.e. if folate benefits are capable of mitigating potential negative reactions 
towards the GM nature of FBR (RQ4B, see section 4.4.2.5). Stated differently, this research question 
compares FBR if it would have been developed by using conventional or transgenic technology. 
Another information effect that is examined, refers to information about the current burden of folate 
deficiency and the potential of FBR in the region (RQ4C). Specific GM information effects are 
addressed in RQ6. 
The last three sub-questions investigate specific auction design characteristics in experimental 
auctions. First, our auction design incorporates two female target groups, a student versus a non-
student subsample, to detect a target group effect (RQ4D). Although auction literature found no 
significant differences in valuations between student and population based auctions (Lusk et al., 2005; 
Depositario et al., 2009b), the involvement, the socio-demographic characteristics and the acceptance 
of GM food might lead to diverse bidding behavior. This is examined in various subsections of section 
4.4.2., e.g. zero bidding behavior and the determinants of WTP for FBR. Second, unlike other 
valuation studies on biofortified crops, this study measures the effect of an additional non-GM folate 
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substitute by auctioning rice with free folic acid supplements in half of the auctions (RQ4E). Thereby, I 
address the need to incorporate substitutes in GM food auctions (Corrigan, 2005; Kassardjian et al., 
2005; Corrigan et al., 2009). Other design characteristics refer to the timing (i.e. time and day) and the 
size of the auction (2004; Rutsaert et al., 2009; De Groote et al., 2010). 
 
RQ5. Is there a difference between stated willingness-to-pay (sWTP) and auction-
based values (WTP)? 
RQ5A.       Do the WTP values reveal a hypothetical bias in the stated valuation method? 
RQ5B. Are the WTP values subject to a social desirability bias? 
 
The impact of the value elicitation method on WTP values has been widely investigated (Johannesson 
et al., 1998; List and Gallet, 2001; Lusk et al., 2005; Huffman et al., 2007). Generally, hypothetical 
valuation methods are found to generate significantly higher values than the non-hypothetical 
methods, a phenomenon which is mainly attributed to the lack of hypothetical bias in the latter 
(Balistreri et al., 2001). For example, a discrepancy is observed between hypothetical contingent 
valuation methods, such as open-ended stated WTP values, and the auction-based WTP values 
(Balistreri et al., 2001; List and Gallet, 2001; Chern and Chang, 2009). As both are incorporated in the 
study on WTP for FBR, the existence of hypothetical bias is examined by comparing sWTP and WTP 
values (RQ5A).  
Despite the advantages of experimental auctions over stated preferences, the former is also criticized 
for stimulating social desirable behavior, especially when conducted in a laboratory setting with 
controversial products (see section 1.3.2.1). A novel approach to evaluate social desirability bias 
(SDB) in experimental auctions is indirect valuation (Lusk and Norwood, 2006). In the experimental 
auctions of chapter 4, indirect (iWTP) and direct valuations (WTP) are compared to analyze the 
presence of this bias (RQ5B). 
 
RQ6. To which GM information are consumers most susceptible when valuing FBR? 
RQ6A.       What information dominates in conflicting GM information? 
RQ6B. Is there a primacy or recency effect in the evaluation of conflicting GM information? 
RQ6C. Does the GM information effect differ according to consumer acceptance of GM food? 
 
Auction literature on WTP for 1st generation GM crops has pointed out the importance of GM related 
information, with higher WTP (or lower WTA) values when positive statements are provided, and vice 
versa (Jaeger et al., 2004; Lusk et al., 2004b; Kassardjian et al., 2005; Liu, 2009). Also the evidence 
on the effects of combined GM information treatments is growing (Tegene et al., 2003; Huffman et al., 
2007; Colson and Huffman, 2009; Depositario et al., 2009a). Nevertheless, there is still discussion 
about the impact of information when dealing with two-sided treatments. First, while negative 
information is generally prevailing (Fox et al., 2002; Tegene et al., 2003; Parkhurst et al., 2004; Hu et 
al., 2006), some authors found support for the opposite (Rousu et al., 2004b; Colson and Huffman, 
2009; Corrigan et al., 2009).  
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Second, although evidence is extremely thin, order effects in conflicting information treatments might 
influence WTP for GM food (Liu, 2009). When evaluating novel food products, a recency effect is 
expected to occur, unless the information is highly relevant to consumers (Buda and Zhang, 2000).  
Third, due to the well established positive relationship between GM food acceptance and WTP values 
(Kassardjian et al., 2005; Colson and Huffman, 2009), its role in the effect of GM information is further 
explored (RQ6C). According to previous research, reluctant consumers are less susceptible to new 
information (Lusk et al., 2004b).  
Section 4.4.2.5 of chapter 4 investigates the role of GM information in WTP for FBR, based on six, 
scientifically underpinned, information sheets (positive, negative, positive + negative, negative + 
positive, objective, all) that are randomly distributed during the 4th information round of the 
experimental auctions in Shanxi Province.  
 
RQ7. What is the current burden of folate deficiency in China and Shanxi Province?    
RQ7A.       What is the relative importance of folate deficiency in micronutrient malnutrition in 
China? 
RQ7B. How large is the burden of folate deficiency in two of the most important high-risk 
regions, Shanxi Province (China) and Balrampur District (India)? 
 
In order to determine the potential health benefits of FBR in China, the current burden of folate 
deficiency needs to be determined. Until today, there is no evidence of studies that have calculated 
the health impact of folate deficiency at population level (see section 2.2). Given that Northern China 
(Hao et al., 2003; see also Figure 7), and Shanxi Province in particular (Ren et al., 2007), has one of 
the highest folate deficiency rates in the world, there is a need to estimate the current burden of this 
micronutritional disease at regional/provincial level. 
In chapter 5, the current burden of folate deficiency in China and its 31 administrative areas, among 
which Shanxi Province, are assessed by applying the DALY approach. Based on epidemiological and 
population data, the number of DALYs lost due to fatal and non-fatal outcomes of folate deficiency is 
estimated (see section 5.4.1.1). To evaluate the relative importance of the burden, the results are 
benchmarked with evidence from other health burden studies in developing countries (see section 
5.4.4.1). However, given the scope of this PhD dissertation, benchmarking the country-wide burden 
against the main micronutrient deficiencies (vitamin A zinc and iron) in China (RQ7A) and comparing 
the situation in Shanxi Province with one of the most important high-risk regions in the world, 
Balrampur District (Cherian et al., 2005)(RQ7B), is more appropriate.  
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RQ8. How cost-effective would folate and multi-biofortified rice be when introduced 
in China? 
RQ8A.       Does the cost-effectiveness of FBR and MBR in China achieve the World Bank 
thresholds of highly cost-effective health interventions? 
RQ8B. When compared with other biofortified crops in other developing regions, how cost-
effective is FBR and MBR in China? 
RQ8C. What is the health impact of FBR when introduced in the most important high-risk 
regions of China and India? 
 
The World Health Organization (WHO, 2002) emphasized the need to examine the cost-effectiveness 
when evaluating (novel) health interventions. Especially in Asian countries, there is an urgent need to 
provide information on health strategies in order to adequately and efficiently address major public 
health problems (Mason et al., 1999). Given the controversy surrounding GM biofortification as a novel 
micronutrient intervention, ex-ante cost-effectiveness studies are required to provide the stakeholders 
with an evaluation tool to assess its potential (Stein, 2006) and to compare it with other interventions 
(Klemm et al., 2009). 
This research question deals with the health impact assessment and the economic evaluation of FBR 
and MBR in China. Improving the folate content of China’s major staple crop alone or together with 
vitamin A, zinc and iron, is expected to have a large impact on folate related health problems. In line 
with other health impact studies (Stein et al., 2005b; Horton, 2006; Meenakshi et al., 2007; Fan et al., 
2009), the DALY framework is applied to FBR and MBR as potential health interventions in China. 
Building upon a large, comprehensive literature review, the number of DALYs that can be saved 
through FBR and MBR, in comparison with the current burden of folate or micronutrient malnutrition 
(see RQ7), is estimated.  
By comparing the potential health benefits and the costs of biofortification, the cost-effectiveness of 
both interventions is measured. To put the country-wide results in perspective, this economic valuation 
measure is then compared with the low (US$ 258.12 per DALY saved) and high (US$86.04 per gained 
DALY) World Bank thresholds (RQ8A) and compared with other cost-effectiveness studies to combat 
micronutrient malnutrition in developing countries (RQ8B). As in the burden analysis (RQ7), a regional 
scope is used to measure the health benefits of FBR in China, which allows comparison of the results 
of Shanxi Province with another high-risk region in India, i.e. the Balrampur District (RQ8C). 
Whereas section 5.4.1 and 5.4.2 assess the potential impacts of, respectively, FBR and MBR, the 
cost-effectiveness of both interventions are calculated in section 5.4.3. The sub-questions are tackled 
in section 5.4.4. 
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1.5. Research contribution 
 
The major research contribution of this PhD dissertation refers to: 
- the originality of the investigated topic, which is the first to evaluate consumer acceptance 
of FBR as a GM rice with consumer/health benefits in a region where folate deficiency is 
considered to be a major health problem; 
- the combined empirical research focus on both the micro and macro-level, by determining 
acceptance of, and WTP for a GM food product with health benefits in a high-risk region, 
while evaluating the benefits and costs of introducing it as a health intervention in China, 
e.g., the value elicitation methods and the targeted sampling approach for WTP, the 
impact of product attributes, a regional health impact study and a CEA of a multi-
biofortified product; 
- the methodological adaptations and improvements in the experimental auctions,  
e.g. comparison of valuation methods, indirect valuation, non-GM substitute and 
information effects (product attributes and the regional situation) and a targeted sample; 
- its relevance towards the nutritional community, (health) policy makers and program 
planners, stakeholders in the field of (GM) biofortification, GM rice and/or birth defect 
prevention; 
e.g. importance of burden of folate deficiency and health intervention analysis.  
 
1.5.1. Scientific contribution 
 
This section describes how this PhD dissertation contributes to scientific research following the three 
lines of inquiry. These contributions are made on methodological and/or empirical level (see Table 4).  
 
Table 4 Scientific contribution per contribution area and level of contribution 
Contribution area Contribution level 
Replication Extension Innovation 
Methodological     
Acceptance Standardized survey   
Willingness-to-pay Stated WTP 
Experimental auctions: 
GM information effects 
Design effects (time, size,...) 
Experimental auctions:  
In-between auction survey  
GM information order effects 
Experimental auctions: 
Indirect valuation 
Non-GM substitute effect  
GM product attribute effects 
Cost-effectiveness DALY framework; CEA   
Empirical    
Acceptance GM food with health benefits 
Determinants of acceptance  
High-risk region  
GM food market segmentation 
Impact negative attributes  
 
Willingness-to-pay GM food with health benefits  
Determinants  
High-risk region 
Comparing 3 valuation methods 
Comparing technologies 
Comparing interventions  
Role of (GM) information 
Targeted sample 
Cost-effectiveness  Burden of deficiencies:  
Folate/MM 
CEA of biofortification:  
Folate/multi-micronutrient 
Regional/provincial focus 
Comparing high-risk regions  
 
CEA, cost-effectiveness analysis; DALY, disability-adjusted life year; GM, genetic modification; MM, micronutrient malnutrition; 
WTP, Willingness-to-pay 
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1.5.1.1. Methodological contribution 
 
This thesis mainly builds upon existing data collection methods, such as a standardized survey 
(acceptance) and experimental auctions (WTP), and uses appropriate statistical methods, such as 
cluster analysis, multinomial logistic regression and double hurdle model regression (an overview of 
the applied methods is presented in section 1.6.1.).  
 
Regarding WTP, the study incorporates two common value elicitation methods, namely the stated 
preference method (sWTP) versus experimental auctions (WTP). Whereas both techniques replicate 
the standard methodology, the latter goes beyond current auction literature on GM food by measuring 
the impact of information about FBR attributes and the regional situation on WTP through distinct 
auction rounds, which allows the measurement of the effect of biofortification technologies, i.e. 
conventional versus GM biofortification. A specific auction design effect deals with the option of a GM-
free substitute to explore consumers’ WTP for GM food when alternative folate options are present. 
Other auction design effects refer to the time-of-the-day effect, the ‘weekend’ effect and the size of the 
auctions. 
To examine the determinants of WTP, our auction survey was organized in-between information 
rounds, rather than before or after the bidding process. The auction design is based on 5 non-
repeating information rounds, of which one is used to determine the role of six different GM 
information treatments. Hereby, specific attention is paid to the sequence of conflicting GM information 
in order to explore the presence of a primacy or recency bias/effect. 
The bidding methodology in the experimental auctions also involved indirect valuation method in the 
third auction round, which is an innovative modification of the general auction methodology. Although 
this approach is useful when eliciting values for controversial goods, it is currently not applied to GM 
food. Compared to the indirect valuation method of Lusk and Norwood (2006), this thesis separates 
the indirect valuations from the general bidding rounds in order to measure social desirability behavior 
rather than to control it. Another methodological contribution refers to the adapted negative valuing 
approach of Parkhurst et al. (2004), by which people have the option to submit a negative bid after the 
3rd auction round. As this approach was used to further investigate the reasons of zero bidding 
behavior, this concept is not included in the conceptual framework and the research questions. 
Nevertheless, this is the first to apply such as an approach in GM food auctions.  
 
With respect to the study on cost-effectiveness, replication of the DALY framework is justified as it is 
the recommended CEA tool of the World Bank (Laxminarayan et al., 2006) and WHO (Tan-Torres 
Edejer et al., 2003; Evans et al., 2005), and because it is the common method to measure the health 
impact of biofortification and other micronutrient strategies (Horton, 2006; Meenakshi et al., 2007). 
Moreover, it also allows comparison of the results with most of the published cost-effectiveness 
analyses of biofortification strategies in developing countries. Nevertheless, in line with similar study 
approaches (Stein et al., 2005b), some of the initial assumptions of the DALY framework are relaxed 
or adjusted. 
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1.5.1.2. Empirical contribution 
 
The empirical contribution of this thesis primarily lies in the nature of the investigated product and the 
selected research location. By exploring the market potential of a GM rice variant with health benefits, 
i.e. folate biofortification of rice, this dissertation focuses on a relatively new area in GM food 
consumer research. The main advantage of investigating consumer reactions towards second instead 
of first generation GM crops, is that the former is both controversial and beneficial to humans, by 
which consumers have to make a trade-off between its benefits and potential risks.  
Although the development of biofortified crops initiated in the 1990s, a knowledge gap still exists in 
research on consumer acceptance and WTP (Lusk, 2003), especially in high-risk regions (Gonzalez et 
al., 2009), and when using experimental auctions (Rousu et al., 2005) in developing countries 
(Rutsaert et al., 2009).  
In the field of health intervention analysis, a lot of efforts have been made to close the knowledge gap 
of biofortified crops (Meenakshi et al., 2006; Table 52). Still, to our knowledge all these health impact 
studies solely focus on one of the three key micronutrients, vitamin A, iron or zinc. The focus on folate 
enriched and multi-biofortified rice further closes this gap in GM biofortification research. 
By combining research on both the micro (i.e. consumer studies about the acceptance of, and WTP for 
FBR) and macro-level (i.e. CEA of FBR), this thesis aims to address the aforementioned knowledge 
gaps simultaneously. 
 
Given the product under investigation, the selection of the research locations is justified (see section 
1.2.). This thesis one of the first to conduct consumer research about a ‘consumer-friendly’ GM food 
crop in a high-risk region where the need of exploiting its benefits is the highest. When reviewing 
Chinese consumer studies on GM food, whether the objective is to analyze acceptance (Lin et al., 
2004; Ho et al., 2006; Huang et al., 2006b), conduct a segmentation study (Li et al., 2003; Zhang et 
al., 2010) or to investigate the WTP for GM food and rice (Li et al., 2002; Liu, 2009), or when 
experimental auctions are applied (Kachelmeier and Shehata, 1992; Li et al., 2002; Wang and 
McCluskey, 2010), the focus is solely on urban China, which further supports the selected research 
location. 
 
Regarding consumer acceptance, the major contribution is to assess what determines acceptance of 
GM rice with health benefits in a relevant research location, i.e. a poor, rural region that lacks 
alternative options to obtain these health benefits. It is also the first study that describes the potential 
impact of negative attributes of biofortified staple crops, and one of the first market segmentation 
studies on a 2nd generation GM food crop.  
Empirical novelties in the experimental auctions include the comparison of consumers’ WTP for 
different options to increase micronutrient intake levels and, in combination with the high-risk region, a 
targeted sample of women of childbearing age. Furthermore, this thesis seeks to obtain scientific 
insight in the role of five different types of information, related to the product characteristics (GM 
technology, folate content, folate benefits, …) or the link with the region, when explaining WTP for  
FBR.  
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The CEA is the first to assess the burden of folate deficiency (and micronutrient malnutrition in China), 
and the potential cost-effectiveness of both FBR and MBR, respectively. It contributes to a wider 
understanding of the phenomenon of folate deficiency and anticipates multi-biofortification as the next 
phase in GM biofortification research. Whereas previous health impact studies on biofortification 
strategies focus on national estimates, this thesis also includes a regional and provincial comparison 
of the burden and health impacts of folate biofortification in China. As a consequence, the results of 
the most important risk region, Shanxi Province, can be compared with a similar problem area in India, 
Balrampur District. The potential impact of MBR is only investigated at the national level, but a 
distinction is made according to the applied GM technology.  
 
1.5.2. Policy and stakeholder relevance 
 
This PhD dissertation also seeks to be of practical relevance for policy makers (health and agriculture) 
and other stakeholders in the field of biofortification, folate interventions and birth defect programs, 
such as health planners and aid agencies. It broadly addresses the need to evaluate ex-ante 
biofortification strategies by determining the market potential of FBR on consumer side and evaluating 
the impacts of this health strategy for the society as a whole. The practical contributions are twofold. 
  
Firstly, governments are faced with restricted resources to address competing public health problems. 
They are seeking a process for deciding the best way to invest their funds for public health. A first step 
to assist decision makers in setting a strategic health agenda and formulating priorities is to investigate 
the current status of the targeted disease, i.e. the ‘burden of disease’ (Lopez et al., 2006). This thesis 
is the first to provide information about the importance of folate deficiency as a particular type of 
micronutrient malnutrition (see section 2.2). The lack of adequate knowledge of the importance and 
prevalence of micronutrient deficiencies is considered one of the main bottlenecks to successfully 
introduce micronutrient health interventions (ADB, 2004b; Faillace et al., 2008). Although the focus is 
limited to China, the low folate intake levels and high prevalence of NTDs, and the regional differences 
in folate intake and rice consumption further support the need to identify its impact at the regional and 
national level.  
The second step is then to obtain ex-ante information on how folate biofortification could contribute to 
alleviate this burden. CEA is largely acknowledged as an essential tool to adequately evaluate the 
potential gains of a health strategy, given the budgetary constraints (Gold et al., 1996; Haddix et al., 
2003; Tan-Torres Edejer et al., 2003). When conducted ex-ante, highly cost-effective interventions that 
policy makers are hesitating to support or even not aware of, can be discovered (Laxminarayan et al., 
2006). Stein (2006, p. 3) formulates the social and policy relevance of bringing cost-effectiveness into 
biofortification research as follows: “Filling this knowledge gap regarding the possible impact of 
biofortification is both vital and urgent: neglecting a potentially effective intervention and any delays in 
its implementation may literally cost lives”. Given that biofortification technology is moving towards a 
multi-biofortification approach of product development (Naqvi et al., 2009), I anticipate this trend by 
investigating if adding vitamin A, zinc and iron to FBR would be still cost-effective in China.  
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Notwithstanding the focus on China and rice biofortification, the results are assumed to be relevant for 
developing (rice consuming) countries or regions. As such, this thesis aims to increase the awareness 
of the burden of folate deficiency and micronutrient malnutrition on the one hand, and offers potential 
stakeholders insight in FBR and MBR as alternative micronutrient interventions. Not only the nutritional 
community, but also agricultural policy makers can benefit from the results in this study, as they will be 
responsible for evaluating the potential of introducing biofortification by taking into account the 
explored advantages and disadvantages, e.g. health and cost consequences, and consumers’ 
evaluation of FBR in regions at high risk of folate deficiency. 
 
Secondly, even if folate biofortification would be considered as highly cost-effective, this health 
intervention is based on a controversial technology. As public acceptance is often a precursor of 
governmental efforts to support the development and introduction of GM food, governments are 
interested in the voice of the consumer, i.e. the potential demand for non-market goods (Boardman et 
al., 2006). Future commercialization of FBR is less feasible when consumers are not willing to buy it. 
Due to the recent history and the specific nature of GM biofortification, which combines health benefits 
and GM technology, stakeholders from different related fields, such as the biotechnology industry, 
governments and health planners, seek to obtain insight in the potential market for biofortification. 
Especially in the developing world, where commercialized GM food crops with agronomic traits are 
largely accepted and adopted, and where biofortification is needed the most, understanding 
consumers’ reactions to 2nd generation GM products is crucial to reinforce and justify the delivery of 
this health strategy, especially when the reduction of the respective deficiency is given high priority. As 
Gonzalez et al. (2009, p. 606) have pointed out: “In developing countries, hardly any related research 
[to explore consumer acceptance and purchase intentions towards 2nd generation products] has been 
carried out so far. This is considered a knowledge gap, especially with respect to GM biofortified crops 
which offer solutions to widespread nutritional problems among the poor”. While it is particularily 
relevant to focus on GM rice in China in order to close this gap (Liu, 2009; see section 1.2), conducting 
biofortification research in a high-risk research location is considered both innovative and 
recommended.  
This thesis will demonstrate if consumers would accept and be willing to pay for FBR, and how much. 
By exploring the determinants of their reactions, target groups can be defined. I further seek out how 
(GM) information can affect consumers’ valuations for FBR. The consumer research focuses on a 
particular high-risk region, which can be justified from a health planning point of view (e.g. birth defects 
programs), in a country known to be supportive of GM food and biofortification research (see section 
2.5). 
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1.6. Research design and structure of the thesis 
1.6.1. Research design 
 
The results of this PhD research stem from several published research studies, where different 
research methods are applied to analyze specific parts of the general conceptual framework (Figure 
2). In order to adequately answer the research questions and achieve the main objective of this PhD 
dissertation, data is gathered through secondary and primary data sources, and analyzed by using 
exploratory and conclusive statistical techniques. The research design of this thesis summarizes the 
different studies that are conducted in each of the research chapters (chapter 3-5), as shown in Figure 
4. As the methodology sections in these chapters provide a more detailed discussion of the data 
sources and the procedures to gather, measure and analyze the data, this section will be limited to a 
brief overview of the studies that are conducted between 2008 and 2011: 
 
- Acceptance: Based on a literature review of GM food acceptance, a standardized survey was 
developed, translated, tested and administered with 944 rice consumers from Shanxi Province 
in July 2008. Therefore, this dataset has been used to explore acceptance of FBR and potential 
negative rice attributes, to explain FBR acceptance (multinomial logistic regression) and to 
conduct a market segmentation study (cluster analysis; multinomial logistic regression).  
- Willingness-to-pay: By investigating the literature regarding the use of valuation methods, with a 
specific focus on novel technologies, among which GM (biofortified) food, an experimental 
auction design was constructed and, together with an auction survey, tested and used in Shanxi 
Province in April 2011 with 252 female rice consumers of childbearing age. Besides univariate 
statistical analyses to test the differences in (zero) bidding behavior, information effects and 
auction design effects, a double hurdle model is used to identify significant determinants of 
FBR. A part of the aforementioned consumer acceptance survey is used to determine stated 
WTP (multiple regression).  
- Cost-effectiveness: Data collection is primarily based on secondary data sources, e.g. 
epidemiological, population based and biotechnological data, cost estimates and intervention 
assumptions. Regarding the assumptions to introduce folate biofortification, experts in the field 
of R&D of GM food and biofortification, such as the Chinese Academy of Agricultural Sciences 
(CAAS), HUMBO (Golden Rice Humanitarian Board), Nanjing Medical University, and 
colleagues involved in the development of FBR (see Preface), were consulted through e-mail, 
telephone or face-to-face. As the objective of such ‘interviews’ was to collect, verify or update 
data, these contacts were held on a regular, informal and/or non-structured basis 12 . The 
analysis itself applies the DALY framework by entering primary and secondary data into the 
DALY formula in order to measure the health impact of FBR and MBR on folate and 
micronutrient malnutrition in China. By combining the respective health outcomes and costs, the 
cost-effectiveness of these health strategies are assessed.  
                                                 
12  Throughout this PhD dissertation, reference will be made to several meetings that were held with several stakeholders in China, among which: 
HarvestPlus China; CDC Food Fortification Office Beijing; a key biotechnology company in China; Biotechnology Research Institute, Center for Chinese 
Academy of Agricultural Sciences and the Chinese Biosafety Committee. When the outcome of an interview refers to data collection or verification, 
reference is made in the footnotes of the respective tables. 
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Figure 4 Research design, data sources and statistical techniques, per investigated topic   
M: multivariate statistical analysis; U: univariate statistical analysis 
a Refer not only to face-to-face interviews, but also to short correspondences in order to retrieve primary or secondary data. 
 
1.6.2. Thesis outline 
 
This thesis distinguishes six dissertation chapters as outlined in Figure 5. Chapter 3 to 5 provide an 
answer to the aforementioned research questions and represent one or more research papers. 
The introductory chapter presents the rationale of the conceptual framework, research questions, 
research contribution and the research design. This chapter builds upon a book chapter, which 
describes the main conceptual framework and the key results of this PhD dissertation. Chapter 2 is 
mainly adapted from the supplementary discussion of a paper studying the potential health impact of 
FBR in China. The overall aim of this chapter is to provide the reader a broader understanding of the 
rationale of this PhD dissertation and a foundation for subsequent chapters. As a consequence, the 
research objectives, the methodologies, the discussion and the conclusions of the respective studies 
in the forthcoming chapters refer to this underlying overview. Chapter 3 is dedicated to the consumer 
survey on FBR acceptance in Shanxi Province and investigates research questions 1 to 3. This study 
builds upon a published paper that deals with the consumer survey in 2008. The research questions 4 
to 6 are addressed in chapter 4. Here, WTP with regard to FBR are determined through stated 
preferences and experimental auctions with (female) Shanxi rice consumers. In chapter 5, the burden 
of folate deficiency and micronutrient malnutrition (RQ7) and the potential impacts and costs to 
implement FBR and MBR (RQ8) are measured. Finally, chapter 6 summarizes the main results and 
answers the research questions. Also the limitations, policy implications and directions for future 
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research are highlighted. The last section addresses several important issues to advance towards a 
successful implementation of FBR in China. 
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2010. The health benefits of folate biofortified rice in China. Nat. Biotechnol. 28, 554-556. 
Supplementary discussion: S1-42.  
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2.1. Introduction 
 
This chapter describes the context of FBR in relation to folate deficiency as a specific type of 
micronutrient malnutrition on the one hand, and as a novel folate intervention to combat this deficiency 
on the other hand. In each section, the global situation, as well as the position of China will be 
discussed with specific attention to the policy context. Furthermore, FBR is positioned in the 
framework of biofortification, genetic modification and, together, with 2nd generation GM biofortified 
crops. As a consequence, this chapter provides definitions, data and assumptions that will be used in 
the forthcoming chapters, e.g. the definitions of folate deficiency and NTDs, the attribution levels of 
folate deficiency to NTDs, the Chinese status of folate deficiency, micronutrient malnutrition and the 
number of NTDs, and the technological assumptions and data regarding the development of FBR. 
 
2.2. Micronutrient malnutrition 
 
Micronutrient malnutrition13 is defined by a chronic lack of micronutrients, i.e. essential vitamins and 
minerals that are needed in small quantities, and has a large impact on global health and (indirectly) 
hinders social and economic prosperity, e.g. through productivity losses, cognitive impairment and 
soaring health care costs (FAO, 2004b; Micronutrient Initiative, 2009). Malnutrition is considered one 
of the principal causes of morbidity and mortality among the poor (Gwatkin and Guillot, 2000). 
Most people are not aware of their lack of micronutrients, due to the subclinical character of such 
deficiencies, and because the underlying causes and health functions of different micronutrients are 
neglected, poorly addressed, or still undiscovered. Therefore, this form of malnutrition is often referred 
to as the ‘hidden hunger’. Insufficient intake of micronutrients reflects a lack of dietary quality and 
especially strikes poor, low educated people living in rural, less developed areas, because they largely 
depend on staple crops (e.g. rice, maize and wheat), which are known to contain little micronutrients 
(Gwatkin and Guillot, 2000; FAO, 2004b; UNICEF, 2004b; Micronutrient Initiative, 2009). As a 
consequence, multiple micronutrient deficiency is the rule rather than the exception. Half of 
malnourished children, for instance, are deficient on several vital micronutrients (UNICEF, 2004b). 
 
Despite a growing number of global and regional initiatives to control micronutrient malnutrition, 
especially the main micronutrient deficiencies (Vitamin A, zinc and iron)(Mason et al., 2001), it remains 
a serious threat to the health of populations worldwide, in particular for pregnant woman and children. 
Micronutrient malnutrition affects about two billion people worldwide, mainly in low-income countries 
(Micronutrient Initiative, 2009). Its magnitude differs when looking at specific micronutrient deficiencies 
and different data sources. The number of people with insufficient vitamin A intake, for example, varies 
between 140 (West, 2002), 190 (WHO, 2009b) and 254 million (West, 2002; Rice et al., 2004). Iodine 
and zinc deficiency figures show that a total estimate of nearly 2 billion people is at risk (FAO, 2004b; 
Hotz and Brown, 2004; UN, 2004). Iron deficiency is another widespread type of micronutrient 
                                                 
13 There is a clear difference between under- and malnutrition in that the former is a specific type of the latter. Whereas undernutrition refers to an 
inadequate intake of specific nutrients, malnutrition covers both under and over-nutrition, such as obesity but also micronutrient deficiency (Shettya, 2003). 
In this dissertation, we will use the term “malnutrition”. 
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malnutrition, with 1.7 billion people below the recommended intake levels (FAO, 2004b; UN, 2004). 
However, the public health significance of a micronutrient deficiency must be evaluated by looking 
beyond its prevalence, i.e. by estimating its health impact. According to Horton et al. (2010), an annual 
number of 10.3 billion US$ is still required to successfully fight the global burden of malnutrition, of 
which at least 1.5 billion US$ is needed to adequately combat micronutrient deficiency. 
 
Table 5 lists some key figures regarding the devastating health and socio-economic impact of global 
micronutrient malnutrition. Its large importance is underpinned by its share in the global burden of 
disease. Together, vitamin A, iron, zinc and iodine deficiencies account for 4 % of the global burden of 
disease in 2004. Regarding regional malnutrition, Southeast Asia is found to be the most problematic 
region, followed by Africa (Ezzati et al., 2004). However, not all micronutrient deficiencies are included 
in the current burden analyses, among which folate deficiency. Therefore, the contribution of 
micronutrient malnutrition to the global health impact is underestimated. According to the Micronutrient 
Initiative (2011a), the total share in the global burden of disease is expected to be around 10 %.  
The  lack of data on the global burden of specific micronutrient deficiencies, such as folate deficiency, 
confirms that cost-effectiveness analyses and public health programs are mainly targeting on the three 
most important micronutrient deficiencies (zinc, vitamin A and iron)(Mason et al., 1999; Fiedler et al., 
2008; Horton et al., 2010). As children below 5 years are mainly suffering from these deficiencies, it is 
not surprising that the nutritional targets of the Millennium Development Goals (MDG)(UN, 2011) and 
the nutritional challenge of the 2008 Copenhagen Consensus (CC, 2011) focus on this age group. In 
the framework of MDG 1 (eradicate extreme poverty and hunger), for instance, the United Nations 
strives to halve the prevalence of underweight children, i.e. one of the proxy indicators of poor 
nutrition, between 1990 and 2015 (UNICEF, 2006; UN, 2010). Furthermore, malnutrition should also 
be addressed to reduce child mortality (MDG 4), maternal health (MDG 5) and, indirectly, other major 
diseases (MDG 6), and to help to achieve the goals on education (MDG 2) and gender equality   
(MDG 3)(UN, 2004).  
The rough estimations of the global burden of folate deficiency based on NTDs caused by folate 
deficiency, i.e. 4.8 million DALYs lost per year (see Annex 2), show that the importance of this 
deficiency might be underestimated. It further underpins the need for folate burden studies, which is 
tackled in this dissertation.  
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Table 5 Key figures of the estimated global impact of micronutrient malnutrition, estimated burden of disease in 
million DALYs lost and as a percentage of the Global Burden of Disease, per main micronutrient deficiency  
Type of micronutrient deficiency Estimated burden of diseasef 
 2000g 2004 
 mi. 
DALYs 
lost 
%  
of GBD 
mi. 
DALYs 
lost 
%  
of GBD 
Micronutrient malnutrition (MM) 93.2 6.3 60.9 4.0 
 2 million children may die each year due to MMa     
 MM is the world's leading cause of mental impairmentb     
 MM is responsible for productivity losses of up to 2% of GDPb     
Vitamin A deficiency (VAD)  26.6h 1.8h 22.1l 1.5l 
 VAD-related night-blindness and blindness are affecting 5 million  
and 350.000 children, respectivelyc 
    
 VAD is responsible for 0.5 to 1 million child deaths each year.b,c     
Iron deficiency (ID)  35.1d 2.4d 19.7l 1.3l 
 ID affects the health and energy of 40% (women)a and the mental 
development of 40-60 % (children)b,d in developing countries. 
    
 ID is estimated to result in the annual death of 841.000 personsg,  
of which 50.000 young women in pregnancy and childbirthb.  
    
Zinc deficiency (ZD)  28.0e 1.9e 15.6l 1.0l 
 About 800 000 child deaths per year are related to ZDe     
 ZD is associated with approximately 176.000 diarrhoea deaths,  
406.000 pneumonia deaths and 207. 000 malaria deaths each 
yeare 
    
Iodine deficiency (IOD)  3.5i 0.2i 3.5l 0.2l 
 Each year, IOD leads to an estimated number of 18-20 million  
mentally impaired babies are born.a,b 
    
 IOD is estimated to lower the intellectual capacity of developing  
countries by 10 to 15 percentage points.b 
    
Folate deficiency (FD) NDj NDj NDj NDj 
 FD is estimated to result in approximately 200.000 severe birth  
defects every year.b 
    
 About 1 in 10 adult deaths from heart diseases are attributed to FDb.     
 
DALY, Disability-Adjusted Life Year; FD, folate deficiency; GBD, Global Burden of Disease; ID, iron deficiency; IOD, iodine 
deficiency; MM, micronutrient malnutrition; ND, no data available; VAD, vitamin A deficiency; ZD, zinc deficiency  
Note: Figures on the global burden of malnutrition are not presented. According to the FAO report on the state of food insecurity 
in the world (2004b), malnutrition in the developing world leads to a total loss of 220 million (childhood and maternal 
undernutrition) to 430 million (including nutrition-related risk factors) DALYs. 
aMicronutrient Initiative (2011a); bUNICEF (2004a, b); c Micronutrient Initiative report (2009); dStoltzfus et al. (2004); eCaulfield 
and Black (2004); fMore information on DALYs and the DALY-approach, see Section 5.2; gThe burden of different micronutrient 
deficiencies in 2000 are based on the Comparative Risk Factor Assessment (CRA) of the WHO (Ezzati et al., 2004). The data 
are available at the WHO website (2011b); hRice et al. (2004); iWHO World Health Report  (2002); jThe global folate deficiency 
prevalence is not established, as Kennedy et al. (2003) demonstrate, but is expected not to be a marginal phenomenon (see, for 
instance, section 2.3.2). Based on the most important outcome of FD, i.e. NTDs, own calculations reveal a global burden of FD 
of at least 4.8 million DALYs (see Annex 2), which is significantly more than the rough 2.3 mi. estimation of Blencowe et al. 
(2010). However, this is still an underestimation, as other functional outcomes are not included; lWHO report on Global Health 
Risks (2009a). The statistics from the report are available at the WHO website (2011c).   
 
 
 
 
 
 
 
 
48 
 
2.3. Folate deficiency 
2.3.1. Defining folate deficiency  
 
Nutritional deficiency of folate or folate deficiency is generally characterized by an inadequate intake of 
folate (Vitamin B9), i.e. below 400 µg per person, per day. This is the daily recommended dose, as 
advised by the World Health Organization (WHO, 2006a) and the US Public Health Service (USFDA, 
1996). Besides a low dietary folate intake, folate deficiency could also be triggered by specific 
medications or diseases, such as kidney dialysis, which increase folate losses or needs (Carmel, 
2006).  
Figure 6 depicts the main (underlying) causes and health outcomes of folate deficiency. The generally 
low folate content of staple crops is one of the determinants of inadequate folate intake, as it is for the 
intake of other micronutrients. Folate is water-soluble vitamin, found in a wide variety of foods with 
green and/or leafy vegetables (e.g. beans, peas and spinach), eggs, liver and certain fruits (e.g. citrus 
fruits) as the most important dietary folate sources (USDA, 2008). Insufficient folate consumption is 
thus caused by low access and limited consumption of such folate-rich foods. It is then not difficult to 
understand why poor people, whose diet is predominantly based on low quality foods, are at high risk 
of folate deficiency. Other deeper underlying causes of inadequate intake and other micronutrients are 
the poor (maternal) caring practices and the limited access to health services or a disease stimulating 
environment, such as the lack of proper sanitation, which are associated with low socio-economic 
levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Causes and consequences of folate deficiency 
Source: Adapted from the UN 5th report on the world nutrition situation (2004) and the global report on vitamin and mineral 
deficiencies of the Micronutrient Initiative (2009), and applied on folate deficiency.  
 
Suboptimal folate intake plays a pivotal role in the onset of diseases and disorders, such as the 
occurrence and recurrence of NTDs (see 2.3.3), strokes, megaloblastic anemia and aggravation of 
iron deficiency anemia (Geisel, 2003; Blancquaert et al., 2010) and can be prevented by an adequate 
folate intake (Lumley et al., 2001; Rader and Schneeman, 2006). In addition, albeit that a causal link 
still needs to be proven, folate deficiency has been correlated with certain types of cancer, such as 
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leukemia, colorectal, breast, cervical, pancreatic and bronchial cancer, but also Alzheimer’s disease, 
coronary and cardiovascular diseases (Molloy and Scott, 2001; Bailey et al., 2003; National Library of 
Medicine, 2011). According to UNICEF (2004a), this deficiency is responsible for 1 out of 10 adult 
deaths from heart diseases. The role of a low folate status on male reproduction, fetal growth and the 
syndrome of Down needs to be further explored (Tamura and Picciano, 2006). Potential side effects of 
consuming high amounts of folate include cognitive impairment (only in combination with Vitamin B12 
deficiency), facilitated progression and growth of preneoplastic lesions and subclinical cancers, and 
impaired immune function of postmenopausal women (Tamura and Picciano, 2006; Smith et al., 2008; 
Tam et al., 2009).  
 
Folic acid is a synthetic form of folate, which does not occur naturally, but is commercially produced 
into pills (supplementation) or added to foods (fortification). Contrary to folate, humans may be much 
poorer at handling folic acid than what had been previously thought and there is now more concern 
that circulating unmetabolized folic acid may have some downsides (Wright et al., 2007). Very high 
intakes of folic acid (>1 000 µg/day) lead to cognitive decline in the elderly, reduce the response to 
antifolate drugs used against rheumatoid arthritis, psoriasis, and cancer (Smith et al., 2008), and can 
mask Vitamin B12 deficiency (Mills et al., 2003), which in turn further increases the risk of an NTD (Ray 
and Blom, 2003). Furthermore, dual effects are observed for colorectal cancer (Lewis et al., 2006; 
Smith et al., 2008; Ebbing et al., 2009; 2010), breast cancer (Lewis et al., 2006) and prostate cancer 
(Smith et al., 2008). Ulrich and Potter (2007) found that the time of intake plays a pivotal role in the 
positive effect on the reduced risk of cancer. 
As the research findings on these interactions are often mixed, the potential negative health outcomes 
of raising the folic acid status resulted in a political reluctance to proceed to mandatory folic acid 
fortification in Europe (EUROCAT, 2005; Finglas et al., 2006) (see section 2.4). The debate of 
introducing folic acid interventions in a large population scale is still going on, both at the policy level 
and in the research world. Building upon their review of the dual effects of folic acid intake, Smith et al. 
(2008, p. 517) summarize their concerns about mandatory folic acid fortification in the United Kingdom 
(UK) as follows: “… a high folic acid intake may be harmful for some people. Nations considering 
fortification should be cautious and stimulate further research to identify the effects, good and bad, 
caused by a high intake of folic acid from fortified food or dietary supplements. Only then can 
authorities develop the right strategies for the population as a whole”. However, exceedingly high 
levels of folic acid seem to be more attributable to folic acid supplementation rather than to fortification 
(Yang et al., 2010).  
 
2.3.2. Folate deficiency in China and the world 
 
As the most important staple foods, such as potatoes and grains, are poor sources of folate (USDA, 
2008), folate deficiency is a global problem for public health. Figure 7 and Figure 8 summarize the 
scientific evidence of the magnitude of folate deficiencies, based on the plasma folate concentrations 
and the folate deficiency rate, respectively. These findings are based on a review of adult folate 
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deficiency (Mclean et al., 2008), which compared the results of the most representative survey of each 
reviewed country. The threshold of folate deficiency is defined by a plasma folate status below 10 
Nmol/L (Selhub et al., 2008), as suggested at the WHO Technical Consultation on folate and vitamin 
B12 deficiencies in 2005 (De Benoist, 2008; Selhub et al., 2008). Unlike other micronutrient 
deficiencies, global estimates of its prevalence or burden are still non-existing. Nevertheless, as the 
figures confirm, folate deficiency deserves more attention than has received in the past and present by 
researchers (Oakley, 2003). In line with other micronutrient deficiencies, folate deficiency is more 
prevalent in less developed, non-western countries, especially where rice is the staple crop (Dexter, 
1998; ADB, 2004a). Most of the Western countries are well above this threshold; especially after the 
implementation of folic acid programs (see section 2.4). However, a high average folate status does 
not imply that folate deficiency is absent, as Figure 8 shows.  
With respect to China, a regional comparison is made. If only the figures of China as a whole would be 
presented, the differences between Northern and Southern China would be masked. The average 
plasma folate concentration in Northern China is below the threshold of folate deficiency, by which the 
number of folate deficient adults is significantly higher than in Southern China (see section 2.3.2.1). 
 
 
Figure 7 Folate deficiency in the world. Average plasma folate concentrations (in Nmol/L), per country  
Source: Adapted from Mclean et al. (2008), and Hao et al. (2003) for China. 
Note: Pre-fortification values are presented in countries with mandatory fortification programs (Canada, Chile, Costa Rica, and 
the United States). The solid line represents the threshold of folate deficiency, defined by a plasma folate concentration below 
10 Nmol/L (De Benoist, 2008; Selhub et al., 2008). A low value indicates a high prevalence of folate deficiency. 
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Figure 8 Folate deficiency in the world. Percentage of adults with folate deficiency, per country  
Source: Mclean et al. (2008), and Hao et al. (2003) for China 
Note: In countries with mandatory fortification programs, such as Costa Rica and the United States, pre-fortification values are 
presented. 
 
2.3.2.1. Folate deficiency in China 
 
Given the low folate content of China’s main staple crop, rice, folate deficiency in China is expected to 
be high. However, evidence on the total number of folate deficient people in China is scarce (WHO, 
2009a; Micronutrient Initiative, 2011b). Only two studies reported the folate deficiency rate in Chinese 
regions, spread across the country (Hao et al., 2003; Zhao et al., 2009). Other folate status and intake 
assessment studies in China focused on specific regions, characterized by a low NTD prevalence rate, 
such as in Shanghai (Shrubsole et al., 2001), Jiangsu (Li et al., 1996; Ren et al., 2007) and Anqing 
(Ronnenberg et al., 2000), or a high prevalence of NTDs, for instance in Shanxi (Li et al., 1996; Zhang 
et al., 2006; Ren et al., 2007; Zhang et al., 2008) and Beijng (Gao et al., 2003). The target group in 
most of these studies was limited to Chinese women of childbearing age, premarital women or 
pregnant women, due to their potential risk of having a baby with an NTD caused by folate deficiency. 
 
The results of the two countrywide studies in China, i.e. a study on folate deficiency of men and 
women (Hao et al., 2003) versus the regional folate status of women of childbearing age (Zhao et al., 
2009), are summarized in Table 6. The regional distribution of the number of folate deficient people, 
regardless of gender, indicates substantial disparities between Northern and Southern China. In total, 
about 19.6 % or 258.8 million people in China are considered to be folate deficient, of which 81.7 % is 
living in Northern China. Chinese men tend to be more folate deficient than women, with male folate 
deficiency rates 2 to 5 times higher in Northern and Southern China, respectively. Although these 
estimates are derived from only two Chinese studies, it cannot be neglected that folate deficiency in 
(Northern) China is largely prevalent. 
The higher number of folate deficient people in Northern China is partly attributable to the lower 
availability and the limited variety of fresh vegetables, and the lower consumption of folate-rich food 
products (Hao et al., 2003). The dietary folate intake of people from Northern China mainly depends 
on their consumption of grains, while folate-rich food products, such as (green) vegetables, are the 
main folate sources in Southern China (Zhao et al., 2009). With respect to Han populations, the most 
common ethnicity in China, regional differences could be also due to the higher frequency of mutation 
in the MTHFR (5-methyl-tetrahydrofolate reductase) gene of Han people from Northern China, which 
is associated with lower folate blood levels (Ren et al., 2007).  
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Folate deficiency is of particular importance in one of the northern provinces in China, namely Shanxi 
Province. Together with the Balrampur District in India (Cherian et al., 2005)14, this poor coal mining 
region has one of the highest NTD prevalence rates in the world with rates ranging between 60 and 
150 NTDs per 10 000 births (Xiao, 1989; Moore et al., 1997; Dai et al., 2002; Li et al., 2006), up to an 
NTD rate of 199 (Gu et al., 2007). This high incidence is correlated with the high folate deficiency rates 
of pregnant women (43.8 %)(Ren et al., 2007) and the limited use of folic acid pills in this region (Ren 
et al., 2006; Li et al., 2007; Ren et al., 2007; Zhang et al., 2008) (see section 5.1.1.). 
 
Table 6 Folate deficiency in China. Percentage of folate deficient men and women (of childbearing age), and the 
estimated population affected by folate deficiency in China, per region  
Region Folate deficiency rate (%) 
                          
Populationc 
(million) 
 
Mena Womena 
Women of 
cbab Totala Total 
NORTH 51.5 24.1 20.0 38.0 211.4 
Northeast / / 22.8 / / 
Northwest / / 14.5 / / 
SOUTH 11.0 1.9 1.5 6.2 47.4 
Southeast / / 1.0 / / 
Southwest / / 2.0 / / 
CHINAd 28.1 13.3 9.3 19.6 258.8 
 
cba, childbearing age 
aOwn calculations, based on Hao et al. (2003); bZhao et al.(2009); cOwn calculations, based on the total folate deficiency rate 
(column 5) and the total population size (Table 40); dOwn calculations, means are weighted by population size 
 
2.3.2.2. Folate deficiency compared with other micronutritional deficiencies in China 
 
Controlling micronutrient deficiency is a major public health priority in China (Micronutrient Initiative, 
2011b). China has made noteworthy progress to reduce malnutrition and is on its way to achieve the 
MDG target on malnutrition (see section 2.2), as compared to most of the East-Asian and Pacific 
region (UN, 2004; UNICEF, 2006). For instance, the underweight prevalence rate of children (<5 
years) in 1990 (~19 %) was more than halved in 2002 (UNICEF, 2006). Nevertheless, it remains a 
serious problem for children and women of childbearing age in rural areas (MoH China; WHO; 
UNFPA; UNICEF, 2006). According to the FAO and UN, about 140 million Chinese people (~11 %) 
were undernourished at the beginning of the century (FAO, 2004b; UN, 2004). One third of diabetes 
and one out of ten strokes and coronary heart diseases are attributed to malnutrition of Chinese 
children (Popkin et al., 2001). Also micronutrient deficiencies are still largely present and account for 
an annual GDP loss of 2.5 to 5 billion US$ (World Bank, 2006), mainly due to iron deficiency (Haas 
and Brownlie, 2001; Ross et al., 2003).  
 
 
 
                                                 
14 The NTD prevalence of this region varies between 65.7 and 82.1 NTDs per 10 000 births. Besides other regions of the Uttar Pradesh State (Sharma et al., 
1994), most Indian NTD risk regions are located in the northwest, such as Rajasthan or Pondicherry (Mahadevan and Vishnu Bhat, 2005; Blencowe et al., 
2010) or the southwest, like Chandigarh and Davangere (Krishnaswamy and Madhavan Nair, 2001)(see also section 5.4.4.3). 
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Table 7 summarizes the key indicators of folate deficiency and other micronutrient deficiencies (iron, 
vitamin A, iodine and zinc) in China. Although these indicators differ according to the type of 
micronutrient deficiency, this table benchmarks the importance of different micronutrient deficiencies in 
China.  
Vitamin A deficiency, for instance, remains a serious health problem for Chinese preschool children 
and mothers, especially those living in rural areas (Shi-an et al., 2004). The average share of Vitamin 
A deficient preschool children varies between 12.2 % (Jingxiong et al., 2006) and 16.0 %, of which    
30 500 children die from increased susceptibility to infection (UNICEF, 2004a).  
With respect to zinc deficiency, estimates of people with an inadequate intake of zinc vary between 86 
(Ma et al., 2007) and 183 million (Micronutrient Initiative, 2009).  
Another important type of micronutrient deficiency is iron deficiency. The number of people affected by 
iron deficiency anemia (IDA), i.e. 208.6 million, is a reliable indicator of the importance of iron 
deficiency in China (Ma et al., 2007). The high IDA prevalence rate of women of childbearing age    
(21 %) demonstrates that China’s fight against iron deficiency is still going on (Brabin et al., 2001; Shi-
an et al., 2004; UNICEF, 2004a).  
In comparison with important iodine deficient countries, the goiter (thyroid swelling) rate in China - the 
main cause of iodine deficiency - is rather low. Nevertheless, more than 425 million people in China 
live in areas of endemic iodine deficiency (Shi-an et al., 2004), including 24.0 million affected children 
(6-12 years). Iodine deficiency in pregnancy, for instance, is responsible for the annual birth of nearly 2 
million Chinese babies with intellectual impairment (UNICEF, 2004a). Although recent figures reveal 
that most of the Chinese household consume iodized salt (93 %), several provinces still have not 
achieved universal salt iodization (UNICEF, 2006; Dary et al., 2009). 
The only available indicator of folate deficiency is the NTD prevalence rate (see section 2.3.3), i.e. 
12.2 NTDs per 10 000 births in China (Dai et al., 2002). However, the number of NTDs only covers a 
part of the total estimated folate deficient population, i.e. 258 million people in China.    
Data on other micronutrient deficiencies in China, like thiamin (vitamin B1), riboflavin (vitamin B2), 
niacin (B3), cobalamin (vitamin B12), pyridoxine (vitamin B6) and Vitamin D are not available. 
 
Table 7 Estimations of the main micronutritional deficiencies in China  
 
Vitamin A 
deficiency 
Zinc 
deficiency 
Iron 
deficiency 
Iodine 
deficiency 
Folate 
deficiency 
Estimated affected 
population (million) 
 
11.4a 
(< 6 yrs) 
0.4a 
(maternal) 
86.0d 208.6d 425f 
(living in ID areas) 
24a  
(children 5-12 yrs) 
258.8h 
Prevalence rate of 
micronutrient 
deficiency 
(indicators) 
VAD 
12.2 %b  
16.0 %c  
(< 6 yrs)  
Stunting  
5.95 %e 
 
 
IDA 
8 % (< 5 years)c 
21 %  
(women of cba)b 
Goiter rate 
5g to 10c 
 
 
NTD 
12.2 NTDs  
per 
10 000 birthsi 
 
cba, childbearing age; VAD, Vitamin A deficiency; IDA, iron deficiency anemia; ID, Iodine deficiency; NTD, neural-tube defects  
aBased on the 5th UN Report on the World Nutrition Situation (2004); bBased on a Chinese study of Jingxiong et al. (2006); 
cBased on a report of UNICEF and The Micronutrient Initiative (2004a); dBased on a Chinese study of Ma et al. (2007); eStunting 
or a reduced growth rate is one of the most important indicators of zinc deficiency (Gibson et al., 2008). Stunting incidence is 
based on the 10-year report on nutrition status in China (Chen et al., 2004); fBased on a Chinese review of Shi-an et al. (2004); 
gBased on the micronutrient status in China, from MI (Micronutrient Initiative, 2011b); hOwn calculations, see Table 6; iBased on 
Dai et al. (2002), see Table 6 and Table 40. 
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2.3.3. Neural-tube Defects   
 
This section focuses on the most important adverse health outcome of folate deficiency, i.e. NTDs, 
which will be the starting point to measure the health impact of folate biofortification in China (see 
chapter 5).  
An NTD is defined as a birth defect that occurs after a failed closure of the neural tube. NTDs are 
characterized by malformations of the spine (such as spina bifida), skull or brain (e.g. anencephaly; 
encephalocele or cranium bifidum), and are considered to be the most common congenital 
malformations in the world (Pinar et al., 1998). These malformations occur when the open neural tube, 
formed in the early stages in the development of the human embryo, fails to close around the 28th day 
after fertilization. As a consequence, the development of skull and/or spine is hampered (Figure 9).  
 
 
Figure 9 Main types of neural-tube defects 
Source: The Gale Encyclopedia of Nursing and Allied Health (Krapp, 2001) 
Note: This picture has been used during the experimental auctions when participants learned about the benefits of FBR (see 
section 4.3.4). 
 
Each year, between 200 000 and 300 000 NTDs occur (UNICEF, 2004b; Christianson et al., 2006; 
Kondo et al., 2009). Like all birth defects, NTDs are considered a global health problem, but almost all 
severe or fatal defects occur in developing, low-income countries (Christianson et al., 2006). 
Nevertheless, NTDs are still present in the Western world (EUROCAT, 2005). Every year more than   
4 500 births in the European Union are affected by a neural tube defect (Busby, 2005). In the United 
States the prevalence rates for the two most common NTDs, spina bifida and anencephaly, were 1.8 
per 10 000 live births and 1.1 per 10 000 live births, respectively (Mathews, 2007). The lower 
prevalence of NTDs in the United States, about 3 000 per year, is partly based on the successful 
implementation of policy interventions to increase folate intake (see section 2.4). 
 
Figure 10 gives an overview of the top 20 countries according to the estimated annual number of 
NTDs, which is considered as the most important indicator of the magnitude of folate deficiency. There 
is a significant difference in the estimated number of NTDs between the two highest ranked countries, 
India and China, and the other countries. When controlled for population size, African and Middle-
Eastern countries are considered the most problematic. 
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Figure 10 The estimated annual number of neural-tube defects, Top 20 countries. 
Source: Own calculations based on UNICEF (2004b), Busby et al. (2005) for EU, Cherian et al. (2005) for India and own 
calculations for China (see section 5.2.1.1). 
Note: NTD estimates of 80 (mainly developing) countries are available in the UNICEF Global Damage Assessment Report 
(2004b). For a global report on all birth defects, see Christianson et al. (2006). The Indian NTD figure is based on an average 
NTD prevalence rate of 8.8. 
 
Approximately 18 000 NTDs are born in China each year, about 9 % of the lower global estimate. 
These NTDs account for one-third of stillbirths and a quarter to a third of neonatal deaths, mainly due 
to the high prevalence of NTDs in Northern China (Dai et al., 2002; Li et al., 2006)(see section 3.2.). 
With respect to Shanxi Province as a high-risk region in Northern China, the situation is even worse. 
Each day, an estimated number of 6.5 births is affected with an NTD15.  
 
The relationship between maternal folate deficiency and the risk of having a baby with an NTD is 
widely established in scientific literature (for a review, see Lumley et al. 2010). Worldwide, studies 
investigated the impact of periconceptional folate intake on the prevalence of NTDs (MRC Vitamin 
Study Research Group, 1991; Daly et al., 1997; Moore et al., 2003; Tamura and Picciano, 2006; De 
Wals et al., 2007). Given that folate deficiency refers to a daily folate intake below 400 µg, between  
50 % and 70 % of all NTDs in the world are considered to be attributable to folate deficiency16. These 
global protective rates define the percentage of NTDs that can be prevented by consuming the daily 
recommended folate level of 400 µg. Given the increased risk of recurrence of NTD babies (MRC 
Vitamin Study Research Group, 1991), periconceptional folate intake recommendations for mothers at 
high risk are often elevated to 4 or 5 mg per day (Lumley et al., 2001; EUROCAT, 2005)17. 
In China, the North-South disparities in terms of folate deficiency (see section 2.3.2.1) determine the 
number of NTDs and, thus, the attribution level. Based on a folic acid supplementation study among 
pregnant women, Berry et al. (1999) estimated that women in Northern and Southern China are able 
to reduce the risk of having a baby with an NTD by 85 % and 40 %, respectively, if they achieve the 
daily folate recommendation. In other words, respectively 85 % and 40 % of all NTDs are attributable 
to folate deficiency in northern and southern regions. Although this study only investigated some of the 
                                                 
15 Based on the most conservative NTD prevalence rate in Shanxi Province (see Table 54) and the demographic profile of the region (see Table 40). 
16 Other potential NTD risk factors are related to the mother, e.g. an ‘NTD affected’ mother, a spontaneous abortion, hyperthermia, use of anti-epileptic 
drugs and other medication, or the newborn, e.g. female newborns (Todoroff and Shaw, 2000; Kondo et al., 2009). 
17 1 mg = 1 000 µg 
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provinces in Northern and Southern China, similar rates are found in a Chinese study of Chen et al. 
(2008). Therefore, the attribution levels of Berry et al. will be used to measure the current burden of 
folate deficiency in the health impact study (see chapter 5). Due to the Chinese one-child policy and 
folate biofortification as a population based strategy, the focus in this dissertation will be on the 
prevention of NTDs in first-births and its recommended dose of 0.4 mg. 
 
2.4. Micronutrient interventions to tackle folate deficiency 
 
Like other micronutrient deficiencies, folate deficiency can be mainly addressed by three currently 
existing interventions, i.e. distributing folic acid supplements (pharmaceutical supplementation) 18 , 
fortifying foods with folic acid (industrial fortification) and diversifying people’s diets to increase the 
consumption of folate-rich foods (dietary diversification). Or by folate biofortification as a novel and 
alternative agricultural technology based approach, e.g. by which people consume folate through FBR. 
The common objective of these interventions is primary prevention, i.e. tackling folate deficiency as a 
risk factor of various diseases. While the two folic acid based interventions aim to limit folate deficiency 
through the increased intake of synthetic folic acid, the objective of dietary diversification and 
biofortification is to enhance the natural folate intake level. The former are often criticized because of 
the relationship between excessive folic acid intake and masking anemia caused by vitamin B12 
deficiency (Czernichow et al., 2005)(see section 2.3.1). Although the folic acid fortification policy in the 
United States did not cause a major increase in the number of vitamin B12 deficient people (Mills et al., 
2003), a multi-micronutrient fortification or supplementation policy to increase both folic acid and 
vitamin B12 could be a partial solution (Czernichow et al., 2005; Finglas et al., 2006). Nevertheless, the 
debate about the adverse health effects of high folic acid intake still hampers the introduction of 
(mandatory) folic acid fortification in many (European) countries (Cornel et al., 2005). 
 
Key differences between the three existing folate interventions and folate biofortification are listed in 
Table 8. The characteristics of each of the different policy interventions and, if applicable, its relation to 
the (Chinese) policy context will be discussed in the next sections. As not all interventions have been 
implemented in China, the experiences of folate or other nutritional programs in other countries are 
also drawn.  
 
 
 
 
 
 
 
 
 
                                                 
18 Although evidence is limited, some authors also advocate to add folic acid to oral contraceptives, which increases the folate levels in blood, up to 12 
weeks after it is discontinued (Cornel and De Smit, 2010). 
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Table 8 Current policy interventions to reduce folate deficiency and biofortification as a novel and alternative 
health strategy 
 
Folic acid based interventions Folate based interventions 
Supplementation Food fortification 
Dietary 
diversification 
Biofortification 
Micronutrient dose RNI dose  
 
(High) 
Folic acid enriched 
staple crops 
(Low) 
Folate-rich  
foods  
(Low) 
Folate enriched 
staple crops 
 (Low) 
     
Potential coverage People taking  
folic acid 
supplements 
(Narrow)  
Consumers  
of processed  
staple crops  
(Wide) 
Consumers taking 
part in promotion/ 
education program  
(Narrow) 
Consumers  
of GMa  
staple crops 
(Wide) 
     
Target group (Rural)  
risk regions 
(Specific) 
(Urban)  
populations 
(General) 
Rural  
risk regions 
 (Specific) 
Urban and rural, 
poor populations 
(General)  
     
Behavioral changes Taking pills 
(correctly) 
None Changing 
dietary habits 
None, unless a 
product attribute 
is changed 
     
Examples of  
selected countries  
e.g. Philippines, 
Cambodia, & 
Vietnam  
  (Cordero et al., 2008) 
e.g. Australia, 
Ireland,  
UK and US  
(Lawrence et al., 2009) 
None specifically  
oriented towards 
folate-rich foods 
 
Noneb 
 
GM, genetically modified; RNI, recommended nutrient intake 
Source: Main characteristics adapted from Stein et al. (2005a) and applied on folate or folic acid. 
aAlthough biofortified staple crops could also be developed by conventional breeding techniques, folate biofortified crops are 
based on transgenic biofortification (see also 2.4.4.2). Therefore, the coverage rate may not be as wide as for ’conventional’ 
biofortified crops; bAs with other transgenic biofortified crops, folate biofortification is not commercialized. Regarding other 
micronutrients, only conventionally bred biofortification is implemented, see also 2.4.4. 
 
2.4.1. Folic acid supplementation 
 
Folic acid supplementation is an ‘external’ nutritional intervention to tackle folate deficiency in specific 
target groups by promoting the use of folic acid or multivitamin supplements, in addition to their diet. 
This intervention is categorized as either a ‘pharmaceutical’ or a ‘dietary’ supplementation intervention, 
depending on the circumstances to which it is consumed: respectively, prescribed and taken home or 
voluntarily taken. Folic acid supplementation programs mainly target vulnerable subgroups, such as 
women of childbearing age living in poor, rural areas. By encouraging them to consume folic acid pills 
daily, from the periconceptional period until approximately three months of pregnancy, the number of 
NTDs can be reduced. The ability to focus on specific population groups is considered both an 
advantage and disadvantage of this intervention. On the one hand, targeting women of childbearing 
age tackles folate deficiency where it is most needed. On the other hand, a population-based 
approach is needed, as folate deficiency is present in all sections of the population (Mclean et al., 
2008). 
Folic acid pills generally contain 400 µg of folic acid, which is in line with the folate recommendations 
(i.e. RNI). Therefore, a daily consumption of such pills is currently considered as the most effective 
strategy for women of childbearing age in order to prevent them against a pregnancy affected by an 
NTD caused by folate deficiency (Lumley et al., 2001). Besides these daily supplements, folic acid can 
also be given less frequently, e.g. 5 mg on a weekly basis. Although weekly supplementation could be 
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a practical answer to the low compliance to consume folic acid supplements, evidence is needed to 
demonstrate that it is as effective as daily folic acid supplements (Cordero et al., 2008). Folic acid 
supplements can also be delivered with other micronutrients. By implementing such a multivitamin 
program, by which folic acid is incorporated in another vitamin supplement, e.g. iron and folic acid 
capsules, duplication of costs and efforts can be avoided (Klemm et al., 2009). 
 
2.4.1.1. Folic acid supplementation programs 
 
Effective programs were introduced in the Philippines, Cambodia, and Vietnam, where pregnant 
women received free daily iron and folic acid supplements and non-pregnant women were encouraged 
to take weekly supplements (Cavalli-Sforza et al., 2005). Due to its importance for women of 
childbearing age, folic acid supplementation is often promoted in countries with low rates of unplanned 
pregnancies, such as with countries in Europe (Cornel and De Smit, 2010). Although folic acid 
supplementation policies are well established in Western and Northern Europe, their effectiveness to 
reduce NTDs is rather limited (Busby et al., 2005; Czernichow et al., 2005; EUROCAT, 2005), partly 
due to incorrect use (Busby, 2005). The success of supplementation programs depends on the 
duration and the intensity of supplementation efforts, the accessibility and adequate supply of 
supplements, the effectiveness of the health system, the involvement of health personnel and/or the 
community, and the inclusion of a targeted educational and information component in the social 
marketing efforts of the program (World Bank, 1994; Hotz and Brown, 2004; Campos-Bowers and 
Wittenmyer, 2007; Cordero et al., 2008). However, pharmaceutical supplementation is not considered 
as a long-term solution to tackle folate deficiency. Previous campaigns to promote folic acid 
supplementation in the United States (CDC, 2005) and The Netherlands (Van Der Pal-De Bruin et al., 
2003) for instance, increased knowledge about folic acid, but were less effective in stimulating the use 
of folic acid supplements. And if a program is effective, the increased folic acid intake is often not 
sustainable and decreases again once the program ceased (Underwood and Smitasiri, 1999; 
Lawrence et al., 2003), partly due to poor obedience and compliance of taking folic acid pills 
(correctly)(Ren et al., 2006).  
Supplementation programs are therefore considered to be a potential (cost-)effective, but short-term 
strategy to improve the nutritional intake of high-risk populations, especially when these subgroups 
have no access to fortified products or if changing dietary patterns is not an option (WHO, 2002; Hotz 
and Brown, 2004), or if the rate of unplanned pregnancies is low to moderate (CDC, 2010). 
Furthermore, while supplementation programs can improve the intake of folic acid, they often fail to 
address socio-economic disparities (De Walle and De Jong-Van Den Berg, 2008). 
 
2.4.1.2. China and folic acid supplementation 
 
Because of the one child per family policy and the high prevalence of birth defects19, the prevention 
and control of birth defects is a high priority for the Chinese government. In their “2002-2010 National 
                                                 
19 In China, 6 % of the newborns are affected with a birth defect. resulting in 2 birth defects per minute (Yinan, 2007). 
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Action Plan for Reducing Birth Defects and Disabilities in China”, the Ministry of Health (MoH) and the 
Chinese Disabled Person Federation (CDPF) recommend that all women of child-bearing age should 
obtain folic acid and health information on folic acid supplementation, in order to bring birth defects 
under effective control by 2010 (Chinese Ministry of Health, 2001). By the end of 2010, at least 60% of 
all married women who plan to be pregnant will need to achieve the daily recommendation for folate. 
Therefore, a national public health education campaign and a national preconception care program 
was launched. In 2009, for instance, the Ministry of Health and its provincial divisions set up initiatives 
to improve the folic acid intake of Chinese women of child-bearing age, mainly from rural areas            
(90 %)(Juan, 2009). The aim was to distribute free folic acid pills for 6 months to 12 million women 
through (biweekly) medical consultations, coordinated by regional health workers. Hereby, women with 
a history of NTDs received 4 µg instead of the regular 0.4 µg daily dose. Prolongation of the free folic 
acid supplementation support was only allowed when a woman is pregnant within the period of 6 
months. In that way, this program aims to anticipate the unplanned pregnancies, which is considered 
an important bottleneck of folic acid supplementation interventions (Durkin et al., 2006). 
 
Although folic acid or multivitamin supplementation programs are expected to reduce the number of 
NTDs, the costs of such programs are generally high (see section 5.4.4.2), while the reduction is likely 
to be a short term effect in China. Between 1993 and 1995 for instance, a successful folic acid 
supplementation intervention was conducted as a part of the public health campaign (Berry et al., 
1999). This intervention reduced the number of NTDs by delivering folic acid supplements to women 
during their mandatory premarital health examination. However, once the program ceased, the NTD 
prevalence rate increased to its pre-supplementation value (Li and Hao, 2008).    
Despite the previous supplementation efforts, the current intake of folic acid supplements is very low in 
rural areas and high-risk regions. In Shanxi Province, for example, only 10 % of women of childbearing 
age once used folic acid pills, regardless of their knowledge about the correct time of use (Ren et al., 
2006; Li et al., 2007)20. The low intake of folic acid supplements in such poor, rural areas might be 
determined by the price of folic acid (30 pills of 400 µg folic acid is about ¥ 10 or US$ 1.5) and the 
limited access (Li and Hao, 2008). Low compliance of taking folic acid pills is also a consequence of 
the large number of unintended pregnancies in China (Singh et al., 2009). Most Chinese women in 
high-risk regions are not aware of the need to take folic acid supplements during the periconceptual 
period (Ren et al., 2006; Zeng et al., 2011). Furthermore, implementing a targeted folic acid 
supplementation program will be more difficult when all women of childbearing age need to be 
reached and continuation of the program is crucial to keep them motivated (Cordero et al., 2008). 
Instead of providing solely folic acid supplements, encouraging the use of multi-micronutrient 
supplementation or at least a combination of iron and folic acid might be a better strategy to reach 
high-risk groups, as previous intervention studies in rural China showed (Zeng et al., 2001; Ma et al., 
2008). 
 
                                                 
20 The low knowledge/use of folic acid supplements is also found in the Shanxi experimental auctions, of which the results are reported in chapter 4 (see, for 
instance, Table 34): about 17.5 % of the female participants stated to have used folic acid once. However, only four persons indicated to use it before and 
during pregnancy. Moreover, only 1 out 5 women of the auctions indicated that they know the national birth defect program.  
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2.4.2. Folic acid food fortification 
 
While folic acid supplementation targets a specific population group, (industrial) folic acid fortification, 
i.e. adding folic acid directly to staple crops during the first stage of milling, is currently considered the 
most (cost-)effective population-based strategy to fight folate deficiency without altering dietary habits 
(Wallich et al., 2001; Hardjanti, 2005; Finglas et al., 2006). In line with multivitamin supplementation, 
folic acid can also be added to existing fortified foods, which has been successfully demonstrated in 
Costa Rica (Chen and Rivera, 2004). Nevertheless, this long-term strategy can only increase vitamin 
intake of consumers who purchase and consume centrally processed foods. As these are often not the 
ones that need it the most, i.e. the poor, deficient people from rural regions, who regularly cultivate 
crops themselves, effectiveness of this intervention may be hampered and limited to middle- and 
upper-income class consumers, which urges the need for public education (Hotz and Brown, 2004). 
Furthermore, as successful folic acid fortification requires specialized infrastructure (i.e. few large mills 
with fortification equipment), strict quality control and capital, strong partnerships between public and 
private sectors, it is less feasible in developing countries and regions that are characterized by large 
micronutrient deficiencies and a segmented milling sector (Mason et al., 1999; Underwood, 2000; 
Mannar, 2001; Durkin et al., 2006; Campos-Bowers and Wittenmyer, 2007; Cordero et al., 2008). Also 
the public concern that mainly stems from the largely unknown effects and potential risk of excessive 
nutritional intake levels might be a constraint (Allen, 2006). In any case, the selection of an appropriate 
food vehicle will be crucial to the success of food fortification (Baltussen et al., 2004). 
 
2.4.2.1. Folic acid food fortification programs 
 
Historically, food fortification interventions have been used for three reasons: restoring 
(micro)nutritional levels of foods that are affected by food processing, replacing nutrients in substitute 
foods and improving (micro)nutrients in staple foods to counter malnutrition (Allen, 2006). In 2005, 
about 38 mainly industrialized countries had opted for a mandatory folic acid fortification policy 
(Czernichow et al., 2005). In the United States (Choumenkovitch et al., 2002; Quinlivan and Gregory, 
2003; Rader and Schneeman, 2006) and Canada (De Wals et al., 2007; Shakur et al., 2010), for 
example, cereal grain products were fortified with folic acid to a level of 140 and 150 μg per 100 g, 
respectively, and proved to successfully enhance folate status. Other countries focused their 
mandatory folic acid fortification policy on one, e.g. wheat flour in Chile (Hertrampf et al., 2003) and 
Australia (Oakley et al., 2004), or more food vehicles, e.g. wheat flour, maize flour, milk and rice in 
Costa Rica (Chen and Rivera, 2004). As expected, these mandatory fortification programs led to folic 
acid consumption levels above the recommended nutrient intake (RNI)(Cordero et al., 2008; Dary et 
al., 2009; CDC, 2010), especially in developed countries (FAO/ILSI, 1997; Hotz and Brown, 2004). In 
the United States, for instance, the folate intake requirements for most adults were met or exceeded, 
by which the number of NTDs decreased from 4 000 to 3 000 NTD affected pregnancies in a few 
years (CDC, 2004). In (Eastern) Europe, most countries have started to embrace voluntarily folic acid 
fortified foods (Abramsky et al., 2007; FFI, 2011). In some cases, such as in Ireland and in the UK, the 
introduction of mandatory folic acid fortification of bread has been advocated (SACN, 2005) and, 
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despite the rising concerns about potential adverse health effects of high folic acid intake levels (Smith 
et al., 2008; BBC News, 2009, October 20)(see section 2.3.1), implemented. These concerns were 
also heard in the United States (CDC, 2010) when a recently published study concluded that 2.7% of 
the adults exceeded the tolerable upper level (UL) of 1 000 µg folic acid per day (Yang et al., 2010). 
 
2.4.2.2. China and folic acid fortification 
 
In 2003, the flour fortification pilot program “Flour Fortification in the Western Region of China” was 
initiated by the State Grain Bureau and the Chinese Ministry of Health (FFI, 2009; Lawrence et al., 
2009). With the support of the Global Alliance for Improved Nutrition (GAIN), a market-based, 
voluntary fortification program was introduced, with a folic acid fortification level of 200 μg per 100 g. 
This resulted in the production of fortified flour, often known as “7+1 flour”, in a few companies. 
However, due to delays in implementation, this project came to an end in 2008. 
Between 2006 and 2007, folic acid fortified flour was introduced to more than 60 000 consumers in 
Shanxi Province, as a part of the “Strong Newborn” project (FFI, 2009). The objective of this program 
was to evaluate the effect of flour fortification in the prevention of NTDs. Although the findings indicate 
a positive effect, there were significant problems to guarantee the quality of fortified flour and to obtain 
funding in order to start a province-wide implementation. 
In 2008, the Chinese Public Nutrition and Development Center (PNDC) developed a voluntary flour 
fortification standard, which was released by the State Grain Authority (SGA)(FFI, 2009; WHO et al., 
2009). However, at present, very little flour is voluntary fortified in China (about 1 %; FFI, 2009). Given 
the limited access to voluntary folic acid fortified foods in China, the main challenge will be to 
guarantee that the fortified food vehicle will actually (continue to) reach the Chinese consumer, 
especially in the rural regions of China. As policy makers have still concerns on the feasibility of folic 
acid fortification in China, the Chinese Ministry of Health (MoH) intends to undertake additional flour 
and rice fortification trials in the future (Li and Hao, 2008; FFI, 2009; PNDC, 2011). Nevertheless, the 
actual implementation of provincial flour fortification in the market will depend largely on provincial 
authorities’ interest and commitment.  
While folic acid fortification is still a marginal phenomenon in China, other fortification programs are 
more advanced. While the introduction of iodized salt proved to protect 133 million Chinese infants 
from iodine related brain damage (UNICEF, 2006), large scale programs on iron fortified wheat flour 
and soy sauce hold the promise to be effective (Chunming, 2001; ADB, 2004a; Dary et al., 2009; 
GAIN, 2011)(see also section 5.4.4.2). For example, the Ministry of Health’s Centers for Disease 
Control and the China Soy Sauce Manufacturers Association have agreed to promote fortified soy 
sauce through a 5-year collaborative plan to engage 200 major producers (ADB, 2004a). Regarding 
folic acid fortification of rice in China, the different bottlenecks are discussed in section 5.4.4.2. 
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2.4.3. Dietary diversification 
 
Dietary diversification aims to modify the dietary patterns of consumers through interventions that 
promote the consumption or production of micronutrient-rich foods, e.g. home gardening, as well as 
nutrition education, e.g. teaching consumers to retain micronutrients during processing. Previous food-
based strategies focused mainly on the reduction of Vitamin A or iron deficiencies (Soleri et al., 1991; 
Ruel, 2001). Although this strategy is considered to be the most sustainable solution, especially when 
targeting several micronutrients simultaneously (FAO/ILSI, 1997; Hotz and Brown, 2004), they are less 
successful in practice due to the need of making the micronutrient rich products accessible, affordable, 
and more attractive to consumers (CDC, 2010). 
There are currently no scientific reports of population-based interventions which promoted a folate-rich 
diet, e.g. green leafy vegetables and orange-fleshed fruits (Cordero et al., 2008). While a vegetarian 
eating pattern, characterized by long-term high consumption of vegetables, positively affects the folate 
intake (Koebnick et al., 2001), dietary folate interventions would not necessarily be effective to address 
folate deficiency as such food-based strategies rely on food varieties that are already available in the 
market (Cuskelly et al., 1996). Due to the limited availability and consumption of folate-rich products in 
Northern China, it will be difficult to alter the eating behaviors in this high NTD risk region (Hao et al., 
2003; Zhao et al., 2009). But also in the poor rural areas throughout China, where folate-poor staple 
crops are the mainstay of the diet, increasing the production or consumption of folate-rich food 
products is practically, economically and culturally less feasible than other pro-poor interventions, such 
as folate biofortification (see section 2.4.4.).  
If folate interventions primarily aim to improve the situation for the poor, rural populations, one could 
also argue that initiatives to reduce poverty and strengthening health care systems could be as 
effective as dietary interventions. However, this is not necessarily the case, as improving income 
levels in developing regions did not necessarily lead to an increased demand for micronutrient-rich 
foods (ADB, 2004b). 
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2.4.4. Folate biofortification of rice as a new, potential strategy 
 
2.4.4.1. Biofortification 
 
Biofortification is considered a novel strategy to combat the ‘hidden hunger’, by which the nutritional 
content of staple crops is enhanced. By sharing the advantages of fortification (e.g. wide coverage) 
and addressing the limitations of supplementation (e.g. short term strategy, limited coverage, 
compliance of taking pills), it is intended to be a pro-rural and pro-poor health intervention (see Table 
8). According to Welch (2004), agricultural approaches are a prerequisite to sustainably control 
micronutrient malnutrition. Biofortification is considered an agriculture-based approach as it uses the 
regular food chain and goes beyond fortification, because the crops are fortifying themselves (Stein, 
2006; Johns and Eyzaguirre, 2007) 21 . Contrary to dietary diversification and supplementation, 
biofortification uses staple food crops as its food vehicle, by which behavioral changes are unlikely to 
be required. As a consequence, biofortification is self-targeting: besides the whole population, it 
especially addresses the groups at risk that need to benefit the most from the biofortified crops (Bouis, 
2002). In that way, biofortification can be a complementary policy intervention by fighting micronutrient 
malnutrition where other interventions fail to do so. 
Due to the relatively low costs of biofortified crops, e.g. a one-time investment in R&D and the ability of 
farmers to reproduce their biofortified crop seeds, the cost-effectiveness of biofortified crops is often 
argued as one of the main arguments in favor of this strategy (Bouis, 2002; Stein, 2006; Meenakshi et 
al., 2007)(further elaborated in chapter 5). Whereas supplementation and fortification were the two key 
strategies to control micronutrient malnutrition in the past, biofortification receives more and more 
attention (Micronutrient Initiative, 2009). During the 2008 Copenhagen Consensus, where a panel of 
economists evaluated the top priorities to counter the world biggest challenges, biofortification was 
placed fifth (Horton et al., 2008). 
 
Before biofortification, efforts to improve crop content were mainly focusing on agronomic traits, such 
as increasing yield potential and productivity, drought resistance and pest resistance, which primarily 
benefit the farmer. As these developments were based on two different techniques, conventional 
versus transgenic technology (i.e. using biotechnology in agriculture), they marked the Green and 
Gene Revolution, respectively (Underwood, 2000; Pingali and Raney, 2005; Stein, 2006; Mayer et al., 
2008)22. Conventional or transgenic biofortification has to be seen as the next phase of these two 
                                                 
21 Not to confuse with the research initiatives to improve the crop efficiency in the uptake of trace minerals (zinc, iron) from deficient soils, which resulted in 
higher yields, but not necessarily improved the mineral concentrations in the grain (Brooks, 2010). Nevertheless, as about 50 % of the arable land for crop 
production in China is micronutritional deficient, this type of biofortification might be another interesting pathway for future research (Campos-Bowers and 
Wittenmyer, 2007). 
22 The Green Revolution refers to a broad public sector led transformation of agricultural sectors in developing countries, mainly between the 1960s and 
1980s, which focused on developing high yielding staple crop varieties (wheat, rice), promoting the utilization of hybridized seeds, pesticides (insecticides) 
and fertilizers, and providing agricultural extension in order to reduce food shortages and hunger and stimulate overall development (Brooks, 2010). Nobel 
Peace Prize winner Norman Borlaug is seen as the founding father of this breakthrough in crop development. In the last decennium of the 20th century, a 
novel private led agricultural revolution took place, the Gene (biotech) Revolution, which built upon the previous revolution by implementing GM technology 
in agriculture to improve productivity and, thereby, reduce hunger.  
The history of biofortification followed a similar approach, starting with the introduction of conventionally bred nutritionally enriched products in the 2000s, 
and now making progress to commercialize the ‘gene revolution’ in biofortification through private-public partnerships. In other words, what the two 
revolutions meant for agricultural productivity and hunger, biofortification hopes to achieve in the field of malnutrition or hidden hunger. Next to this 
tendency, some people argue the need for an ‘evergreen’ revolution, which combines the economic viability of  the Green revolution with a need for 
ecological sustainability, while improving awareness and knowledge (Seshia and Scoones, 2003). 
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revolutions, where improving the micronutrient content of the crop is the targeted ‘trait’. In this respect, 
FBR is based on transgenic technology and is therefore considered as a GM food product (see section 
2.4.4.2). Such transgenic biofortified crops belong to the 2nd generation of GM crops, which are 
primarily designed to benefit the consumer by improving quality traits, such as nutritional and sensory 
properties. This generation followed the 1st generation of GM products (Gene Revolution, started in 
1990s), which dealt with improvements of agronomic traits, such as insect resistance and herbicide 
tolerance. In other words, the shift from first to second generation involves a shift from producer-
friendly to consumer-friendly genetic modification (Engel et al., 2002)23. An overview of the consumer 
and farmer benefits of first and second generation GM food products is described in Toenniessen et 
al. (2003) and Lönnerdal (2003), respectively.    
 
Biofortification research was accelerated when the international, multidisciplinary HarvestPlus 
(Biofortification Challenge) program was launched in 2004 by the Consultative Group on International 
Agricultural Research (CGIAR) and the International Food Policy Research Institute (IFPRI) 
(HarvestPlus, 2009; Brooks, 2010). It became the key project in development and dissemination of 
biofortified crops, with an emphasis on iron, zinc and vitamin A deficiencies in Africa and Asia. Initially, 
only conventional biofortified crops were explored, until the development of Golden rice as the first 
biofortified staple crop genetically engineered to tackle Vitamin A deficiency in 1999 (Beyer et al., 
2002; Potrykus, 2008). This was the starting point of the humanitarian HarvestPlus supported ‘Golden 
Rice project’ (HUMBO, 2011b).  
While Africa and Asia fall within the scope of HarvestPlus, AgroSalud coordinates the biofortification 
efforts in Latin America and the Caribbean (LAC), and aims to increase the iron and zinc content of 
beans, rice, maize, and sweet potatoes, and develops yellow maize and orange-fleshed sweet potato 
with higher beta-carotene contents (CIAT, 2004; Agrosalud, 2011a). Between 2007 and 2010, 
AgroSalud introduced 42 biofortified cultivars in 13 LAC countries (Agrosalud, 2011b). Depending on 
each country’s policy, the seeds are sold at full or subsidized price, or given for free to farmers. 
 
The global status of biofortified staple crops, developed and/or released by HarvestPlus or AgroSalud, 
is shown in Table 9. To date, only conventionally bred biofortified staple crops, such as vitamin A 
enriched sweet potatoes, iron biofortified beans and rice, and maize with higher vitamin B3 content, 
are released. Also the future releases will be mainly dominated by conventional breeding techniques, 
such as vitamin A biofortified cassava and maize, and wheat, rice and beans with higher zinc and iron 
levels. However, the progress of Golden Rice or vitamin A biofortified rice shows that transgenic 
biofortified staple crops are in the pipeline of approval. Also other crops, like banana, barley, cowpeas, 
groundnuts, lentils, pigeon peas, potatoes and sorghum, are expected to become the subject of 
biofortification (Stein, 2006). A more exhaustive overview of biofortified products, including 
strawberries (vitamin C), maize and canola (vitamin E), potatoes and mustard (beta-carotene), carrots 
(calcium), lettuce (iron) is available in Hirschi (2009) and Johns and Eyzaguirre (2007). In China, only 
                                                 
23 Others refer to a shift from input to output traits (GMO EFSA, 2008). There is also a third generation of GM crops, where products are developed to be 
used as industrial or pharmaceutical products. Among the examples are vaccines or biodegradable plastics. In this case, regulatory issues are even more 
stringent then for crops from the preceding generations (Naranjo, 2008). 
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the conventional biofortified zinc enriched wheat (“Jingdong 8”) is commercialized, but at a very small-
scale. Vitamin A fortified sweet potatoes will be disseminated in the near future (Sun Hui, HarvestPlus 
China, personal communication, 20-04-2011). Nevertheless, 16 crop varieties/lines are developed, of 
which 4 have been approved for advanced testing.  
 
Table 9 A brief overview of the currently biofortified products in the world, developed by HarvestPlus or 
Agrosalud, according to the improved micronutrient, applied technology, target area of first release and 
(expected) release year. 
Micronutrient Product 
Applied  
technology 
Target Areac 
Release year 
  (# cultivars released) 
Expected  
release year 
Vitamin A 
(Beta-carotene)a 
Cassava CB DR Congo and Nigeria  2011-2012 
Maize CB Zambia  2012 
Sweet Potato      CB Uganda and Mozambique 2007  
Brazil, Cuba, Dominican 
Republic, Haiti and Peru 
2009-2010 (8)  
Rice TB Philippines,  
Bangladesh, India 
 2012, 
2013, 2014e 
Iron Pearl Millet CB India  2012 
Rice CB Bolivia, Cuba and Panama 2009-2010 (8)  
Brazil, Colombia, Nicaragua  
and Dominican Republic 
 2011 
Bean CB Bolivia, Brazil, Cuba and 
Guatemala 
2008-2010 (5)  
Colombia, Costa Rica, El 
Salvador, Honduras and 
Nicaragua 
 2011 
Iron,  Zinc Wheat CB India and Pakistan  2013 
Bean CB DR Congo  
and Rwanda 
  2011-2012 
Rice CB India, Bangladesh  2013 
Vitamin B3 
(Niancin)b 
Maize CB Bolivia, Colombia, El Salvador, 
Guatemala, Haiti, Honduras, 
Mexico, Nicaragua  
and Panama 
2008-2010 (21)  
Folate  Rice TB Chinad  NDd 
 
ND, No data 
Source: Own compilation, based on Agrosalud (2011b) for Latin America and the Carribean, and HarvestPlus (2009) for Asia 
and Africa, except for Vitamin A enriched rice (HUMBO, 2011b) and FBR (Storozhenko et al., 2007). 
aThe human body converts beta-carotene or provitamin A into vitamin A; bNiancin or Vitamin B3 is an essential nutrient which is 
mainly lacking in maize consuming populations (IOM, 1998a). Niancin is available in different foods, but can also be made in the 
human body through tryptophan, i.e. an amino acid that is improved by biofortification; cThese are the selected countries where 
the biofortified crops are released or expected to be tested and released. However, after the first release, these crops are 
intended to benefit also other countries characterized by similar micronutrient deficiencies; dBecause these crops are still in a 
development phase, it is too early to select a target country and a release date. Nevertheless, the remainder of this PhD will 
focus on the market potential of FBR in China; eAlthough the transgenic Golden Rice was expected to be released in 2011 
(ISAAA, 2007), field tests and biosafety regulations are still ongoing in the Philippines (Tony Alfonso, PhilRice, personal 
communication, 05-02-2011). The GR trait was also bred into rice varieties in, for example, India, Vietnam, Bangladesh and 
Indonesia.  
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2.4.4.2. Folate biofortified rice as a 2nd generation genetically modified crop 
 
Folate biofortification, the enhancement of folate in staple food crops, can improve the folate intake of 
malnourished rural populations that are unlikely to benefit from folic acid supplementation or 
fortification. Currently, rice with high folate content, developed by metabolic engineering, is the most 
advanced folate biofortified staple crop (Bekaert et al., 2008; Blancquaert et al., 2010)24. Storozhenko 
et al. (2007) obtained different transgenic lines with a natural folate content ranging from 350 to 1 700 
µg per 100 g of raw polished rice grains. These figures are 20 to 100 times higher than normal folate 
levels in rice (USDA, 2008). Folate in food is subject to additional losses due to the processing 
methods, such as cooking (Scott et al., 2000), and its bioavailability degree (50 %) is significantly 
lower than in folic acid fortified foods (85 %) or supplements (100 %) (Bailey, 2004; FSAI, 2006). The 
selection of rice as the food vehicle for biofortification is in line with the technical considerations of 
fortification, i.e. using an inexpensive, country-wide staple crops, as postulated by the Asian 
Development Bank (Mason et al., 1999; Mannar, 2001).  
Even though there is a clear potential to use conventional plant breeding techniques to increase the 
folate content of rice, similar to conventional biofortification developments in maize, wheat, beans, 
cassava and rice (Bouis, 2002), it may be hard to reach the same level of enhancement as in 
transgenic techniques, because of the low intrinsic folate concentrations in natural rice varieties 
(Rébeillé et al., 2006; Bekaert et al., 2008). Therefore, folate enriched rice in this study is seen as a 
transgenic biofortified staple crop or a GM rice variant of the 2nd generation.  
 
As such, folate biofortification of China’s and the world’s main staple crop is considered as an 
alternative and complementary approach to the above mentioned strategies, especially in poor, rural 
regions where other interventions are less successful or feasible. First of all, unlike folic acid 
fortification or supplementation, folate biofortification does not rely on industrial food processing, 
specialized distribution channels or accessible health systems. Although fortification is often promoted 
as the primary option to reduce micronutrient deficiencies (Micronutrient Initiative, 2004), the key 
target group of this intervention rarely consumes processed foods suitable for fortification (ADB, 
2004b). In addition, folic acid supplementation programs were less successful in risk-regions of China 
(see section 2.4.1.2). Second, given the technical and practical difficulties it will be hard to successfully 
implement folic acid fortified rice (see section 5.4.4.2). Third, biofortification uses staple crops as its 
food vehicle and, therefore, can easily target the folate deficient subgroups, without the need to 
administer pills or to promote the consumption of, generally more expensive, folate-rich foods. 
Furthermore, industrial fortified foods and supplements are often only available in cities and hence 
cannot reach the poor rural populations. Fourth, possible negative side effects of folic acid fortification, 
such as masking Vitamin B12 deficiency and the increased risk of colorectal cancer, are less likely to 
occur with folate biofortification (see section 2.3.1). 
 
                                                 
24 An overview of the typical steps in the development process of transgenic biofortified crops, e.g. efficacy testing, elite event selection and trait integration, 
is available in Dubock (2008). For a detailed discussion on the technological issues regarding folate biofortification of food plants (DellaPenna, 2007; 
Bekaert et al., 2008), rice (Storozhenko et al., 2007), wheat (McIntosh et al., 2008) and tomatoes (Diaz de la Garza et al., 2007).  
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2.4.4.3. From folate biofortified rice towards multi-biofortified rice  
 
Despite the large potential of FBR, one could argue that the large prevalence of multiple micronutrient 
deficiencies (see section 2.2) and the generally low micronutritional content of rice require a combined 
biofortification strategy. In other words, there is a need to increase the intake of different 
micronutrients simultaneously through nutritionally complete crops. This is where multi-biofortification 
enters the public health debate. By enhancing different vitamins and minerals, through conventional or 
transgenic technology, multi-biofortification could address micronutrient malnutrition more adequately 
and efficiently. Despite several ongoing initiatives that attempt to develop multi-biofortified crops, 
especially those that were or are supported by the Bill & Melinda Gates Foundation under the Grand 
Challenges in Global Health Initiative, such as rice, sorghum, cassava and banana (Qaim et al., 2007; 
B&M Gates Foundation, 2009), evidence of a developed staple crop which stacks different nutrient 
traits is scarce. Recently, Naqvi et al. (2009) published the development of the first transgenic multi-
biofortified crop, i.e. maize enriched with vitamin A, vitamin C and folate. However, these technologies 
are still in the research pipeline, and little is known about their potential from a public health and 
economics perspective. 
Targeting different micronutrient deficiencies at once is a strategy which is also found in other policy 
interventions, such as pharmaceutical multi-vitamin supplementation, e.g. iron-folic acid multivitamin 
pills in India (Micronutrient Initiative, 2006) and other Asian countries (Sanghvi et al., 2010), multi-
micronutrient food fortification, e.g. fortifying grain with folic acid, Vitamin B12 and several minerals 
(Alavi et al., 2008), and dietary diversification. 
 
In chapter 5, I explore the potential health benefits and cost-effectiveness of multi-biofortification of 
rice (MBR). This crop is enriched with beta-carotene (pro-vitamin A), zinc and iron, in addition to folate, 
in order to address the main micronutrient deficiencies in China (see Table 7).  
The development of multi-biofortified crops may occur in two ways. The different micronutrient traits 
could be combined in one gene construct (‘single insertion’) and be transferred such that a new 
stacked event is generated.25 Such gene stacking was successfully done for transgenic crops with 
modified agronomic characteristics, combining insect-resistance and herbicide-tolerance traits (James, 
2009b). Alternatively, each micronutrient trait could be developed and deregulated independently, and 
then the four traits could be combined later on through backcrossing. The ‘single insertion’ approach 
may have advantages from a cost perspective (Storozhenko et al., 2007; Blancquaert et al., 2010). 
Due to high regulatory hurdles, the time and money required for the testing and approval of each new 
transformation event are extremely high (Miller, 2010), so that significant resources could potentially 
be saved when dealing with one stacked rather than multiple single trait events. In practice, however, 
the four traits were currently being developed independently by different research institutes, so that the 
single trait approach with later backcrossing seems to be the more realistic avenue in the short run.  
 
                                                 
25 One could stack the transgenic provitamin A and folate traits and add the conventional iron and zinc traits through backcrossing. On the other hand, iron 
and zinc contents may also be further increased though transgenic approaches (Vasconcelos et al., 2003), so that eventually all four traits could be stacked 
in one gene construct. However, increasing zinc and iron levels through genetic modification was not always successful (Ghandilyan et al., 2006; Cakmak, 
2008). 
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2.5. The status of genetic modification & biofortification in China 
 
The global commercialization of GM crops is an asynchronous process, where a few developed 
countries are leading the way, apart from the marginal involvement of Europe, and where the large 
GM food producers are more and more outnumbered by the poor farmers that introduce biotechnology 
in their small-scale farms (Stein and Rodríguez-Cerezo, 2009). Albeit the dominance of North and 
South America, the developing world, among which Africa and South-East Asia, is increasingly 
involved (Karembu et al., 2009). 
 
Worldwide, the global area of biotech crops amount to 148 million ha., of which maize, cotton, canola 
(rapeseed) and soybeans were the most important crops (Figure 11). These GM crops are 
characterized by an improved agronomic trait, such as herbicide tolerance, virus and insect resistance, 
an extended shelf life or a delayed ripening process, or a combination of these characteristics, the so-
called stacked traits. It is important to note that these traits only refer to the 1st generation of GM crops. 
Biofortified, 2nd generation GM varieties are not commercialized yet (see section 2.4.4.1). 
The global agricultural sector of GM crops is traditionally dominated by the US (45.1 %), followed by 
Brazil (17.2 %), Argentina (15.5 %), India (6.4 %) and Canada (6.0%). Together with China, which 
produced 3.5 million ha. of GM biotech crops in 2010, these countries were the protagonists of the 
global commercialization of biotech crops, which started in 1996 (James, 2010). 
 
 
 
69 
 
 
Figure 11 Overview of commercialized genetically modified crops in China and the world  
Source: Figure based on the ISAAA 2010 global status report (James, 2010) 
Note: A country in a green box, marked with an asterisk (*), is considered to be one of the 17 biotech mega-countries, which 
grow 50 000 hectares, or more, of biotech crops.  
 
After the approval of Bt Cotton in 1997, China became the biggest producer of this insect-resistant 
crop. At least seven million small, subsistence Chinese farmers grew one of the 64 Bt cotton varieties 
in 2009, which successfully led to higher yields, lower production costs and diminished use of 
insecticides in China (Huang et al., 2002; Rozelle et al., 2006). Two types of cotton are commercially 
produced, one from the Chinese Academy of Sciences, the other from Monsanto. Since then, eight 
different GM crop varieties were approved and/or cultivated in China, such as sweet peppers, papayas 
and tomatoes that have been modified to be insect- or virus-resistant, herbicide-tolerant, to increase 
shelf life or to improve the appearance (Table 10). Three GM crops are currently imported to China: 
rapeseed, maize and soybeans. Their modified product characteristics aim to make either the plant 
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resistant against insects (pests) or tolerant of herbicides. Despite the limited approval rate of 
commercialized GM crops in China, 1044 GM applications were submitted in 2005, of which more than 
100 varieties were approved for advanced testing (Pray et al., 2006; Wang and Johnston, 2007a). 
 
Table 10 Status of key GM crops in China, per biotech crop, by year of approval and improved trait. 
Status Biotech crop Approval year Trait 
Approved  
Rice  2009a Insect-resistant (Bt) 
Maize  Phytase-richc 
Produced 
Cotton 1997 Insect-resistant (Bt) and herbicide-tolerant 
Petunia 1997 Modified flower color 
Tomato 1997; 1998 Virus resistant; Delayed ripening  
Sweet pepper 1998 Virus resistant 
Poplar trees 2003 Insect-resistant (Bt) 
Papaya 2006 Virus-resistant 
Imported 
Rapeseedb 2004 Herbicide-tolerant 
Maize 2004; 2005 Insect-resistant (Bt) and/or herbicide-tolerant 
Soybean 2004; 2008 Herbicide-tolerant 
 
Source: Own compilation, based on James (2009b), Huang (2004), Biosafety clearing house of China (2004) and Elisa Zhang 
(ISAAA ChinaBIC, personal communication, 30-05-2011) 
Note: Approval does not necessarily imply commercialization (e.g. Bt rice in China, see section 6.5.2) 
aThe own production of GM rice and GM maize is now under the procedure of variety registration; bArgentine canola; cPhytase 
maize is generally used as feed for poultry and chickens. It influences the digestion and growth of the animals, by which the 
meat production can be optimized.  
 
China’s world leading position in terms of R&D and commercialization of GM crops is further reflected 
in its large and increasing investments. Between 2001-2005, for instance, almost 120 million US 
dollars were made available for public-sector R&D regarding transgenic rice (Jia et al., 2004), making 
China the biggest investor in rice biotechnology (Wang and Johnston, 2007a). The positive 
government position on GM rice (research) are closely related to its large domestic consumer market, 
which allows testing of GM food products on a substantial scale, without jeopardizing the smaller rice 
exports (Glover, 2003). In 2008, nearly ¥ 30 billion (US$ 4.6 billion) is allocated to a key GM crop 
research project over 15 years (Jiao, 2011). One of the main reasons for these funding decisions is 
China’s traditional strategy of self-sufficiency, where the government seeks ways to avoid or at least 
minimize the dependence on other countries (Huang et al., 2003; Wang and Johnston, 2007b; James, 
2009b). According to Stone (2008), this will lead to a “transgenic green revolution” by which China’s 
food supply is secured and the competition to identify and patent plant genes is strengthened. As a 
consequence, Chinese research institutions are more and more setting up collaborations with foreign 
biotech oriented companies, such as Monsanto (2009) and Bayer Crop Science (2008, 2009), who 
seek to grasp the opportunities this country offers as one of the rising governmental supported biotech 
areas26. 
 
Although genetic modification remains a subject of discussion, both in political and research forums, 
the widespread adoption of (transgenic) biofortified food crops in China is likely to happen. Given the 
traditional support of the Chinese government, research on biofortification of staple crops became 
increasingly important for China’s food security policy, especially after China’s entry into the World 
                                                 
26 Other initiatives include the Green super rice Project, funded by The Bill and Melinda Gates Foundation, which builds upon the Green revolution to 
develop, refine and promote a rice variant which combines more than 250 rice (hybrid) varieties (CAAS, 2011). 
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Trade Organization (WTO) in 2001 (Campos-Bowers and Wittenmyer, 2007; Pray and Huang, 2007). 
In 2004, for instance, the HarvestPlus China Program (HarvestPlus China, 2009, 2011), initiated eight 
research projects related to the development of biofortified maize, wheat, sweet potato and rice in 
China, in order to address specific deficiencies of micronutrients, such as iron or vitamin A (Bouis and 
McClafferty, 2008). 
Nevertheless, no transgenic staple feed or feed crop was approved in China, until recently, when 
China’s Ministry of Agriculture (MoA) granted two biosafety certificates and approved phytase maize, 
i.e. a feed crop, and pest-resistant Bt rice, i.e. a food crop (Shuping and Miles, 2009; Waltz, 2010)(See 
also Table 10). This is considered the final regulatory check and is expected to lead to full 
commercialization of these major transgenic crops in the near future. As a consequence, China will be 
the first to introduce a troika of key transgenic crops into the market place, i.e. Bt cotton (fiber), 
phytase maize (feed) and Bt rice (food) (James, 2009a, b)27. The approval and deployment of the 
latter might lead to the approval of many other transgenic food crops, including biofortified staple 
crops. Dr Clive James, founder of the International Service of the Acquisition of Agri-biotech 
Applications (ISAAA) formulates it as follows: “The approval by China of the first major biotech food 
crop, Bt rice, can be the unique global catalyst for both the public and private sectors from developing 
and industrial countries to work together in a global initiative towards the noble goal of food for all and 
self sufficiency” (James, 2009a, p. 2). As China is one of the key players in terms of producing and 
consuming rice, as well as GM rice research (Huang et al., 2004; Jia et al., 2004; Xiong, 2004; Wang 
and Johnston, 2007b), this decision is expected to facilitate and speed up the approval of transgenic 
biofortified crops and clear the path for other GM (rice) varieties in China. Even though this might be 
promising for biofortified staple crops, the process and outcomes of the standard food safety and 
environmental field trials makes it impossible to predict if and when these biotech crops will be 
approved in China. Furthermore, if transgenic biofortified crops will be introduced, GM labeling will be 
required, alongside other policy issues (for an overview of implementation issues, see section 6.5.2).  
                                                 
27 China is traditionally considered the largest user of pesticides, which underpins China’s governmental support for pest-resistant (Bt) GM crops, especially 
Bt rice, as rice production accounts for about 40 % of the pest-resistant use (Chunyi Zhang, CAAS, personal communication, 18-04-2011). 
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3.1. Introduction   
 
Since the 1990’s, the success of the Gene Revolution in agriculture, whether it focused on producer 
(1st generation) or consumer oriented (2nd generation) GM crops (see section 2.4.1.1), was closely 
related to political support. Thereby, public acceptance was often considered an important precursor. 
Due to the controversial nature surrounding the use of biotechnology in food, GM food products 
remain a subject of discussion. While environmental organizations and a number of scientists and 
politicians question the technology, biotechnology proponents and several governmental organizations 
point out the potential benefits to producers and consumers. The United States is one of few 
developed countries to feel positively about the technology, however, the positive orientation toward 
GM food is more common among developing countries (Gaskel et al., 1999; Macer et al., 2000; 
Bredahl, 2001; Magnusson and Koivisto Hursti, 2002; Paarlberg, 2002; Anand et al., 2007). China, for 
example, is also characterized by consumers who are typically in favor of 1st generation GM food 
products (Li et al., 2002; Ho et al., 2006; Huang et al., 2006b; Lin et al., 2006; Xi and Harris, 2006) and 
a government with a supportive position towards biotechnology (Huang et al., 2004; Xi and Harris, 
2006). According to Gonzalez et al. (2009) the positive reactions in developing regions might be 
related to the (increasing) food insecurity they are facing, by which new technologies, among which 
biotechnology, are viewed as one of the potential strategies to help ensure food security. This is true 
for China, where one of the top priorities of the Chinese government is universal food security (Huang 
et al., 2004; Fang, 2010), especially after China’s entry into the WTO (Campos-Bowers and 
Wittenmyer, 2007). 
In line with the asynchronous approval and commercialization of GM food (see section 2.5), 
consumers’ attitudes towards GM food differ across and within countries (Costa-Font et al., 2008). In 
turn, these trends led to substantial differences in consumer acceptance between GM products 
(Kuznesof and Ritson, 1996; Magnusson and Koivisto Hursti, 2002; Frewer et al., 2003), and between 
the type of applications (Grunert et al., 2001). For example, consumers are more favorable to GM 
plants than to applications involving human genetic material or animals (Frewer et al., 1997b; 
Verdurme et al., 2003a), but GM food is significantly less positively embraced than medical 
biotechnology (Frewer and Shepherd, 1995). Regarding biofortified staple crops, such as FBR, one 
could expect that its intrinsic nutritional health benefits would increase public approval compared to 
GM crops with improved agronomic traits (Lusk et al., 2005; Anand et al., 2007). However, future 
development and refinement of FBR could imply undesired changes in rice attributes, which might 
influence the initial acceptance rate of this nutritionally enhanced crop. This chapter addresses the 
need to explore consumer acceptance of GM food with consumer benefits, as formulated by Lusk 
(2003), by focusing on a high-risk region.  
 
In scientific literature, the concept of GM food acceptance and its underlying determinants is largely 
analyzed (see section 1.3.1). In order to identify and explain the market potential of FBR, 944 random 
interviews have been administered in the Chinese Shanxi Province. Therefore, a questionnaire was 
mainly built upon three complementary approaches of GM food consumer acceptance (Bredahl et al., 
1998; Verdurme and Viaene, 2001; Costa-Font et al., 2008). It consists of important consumer 
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characteristics that might influence consumer acceptance of FBR: socio-demographic attributes, GM 
knowledge and consumer perceptions of GM food (see also Figure 2, section 1.3).   
Besides analyzing the determinants of FBR acceptance (see section 3.3.2), this chapter further 
investigates GM food knowledge acquisition and trust in information channels and sources (see 
section 3.3.3) and the role of negative rice attributes in FBR acceptance (see section 3.3.4), based on 
specific parts of the sample, namely respondents with subjective knowledge and consumers favorable 
to this GM rice variant, respectively. So far, relatively few segmentation studies on 2nd generation GM 
food products, such as biofortified crops, exist (see section 1.3.1.2).   
 
3.2. Methodology 
3.2.1. Study design  
 
A standardized questionnaire was developed based on the different concepts of Figure 2. The content 
and the structure of this questionnaire were evaluated during expert meetings with the developers of 
FBR. The survey was conducted in July 2008 and comprises 944 random face-to-face interviews with 
rice consumers from the Chinese Shanxi Province, in particular in its capital city of Taiyuan, three 
counties (Mingxing, Houcheng, and Beiwang) and ten villages. For ease of understanding, the 
interviews were conducted by trained Chinese students of Shanxi Agricultural University and 
researchers of Liaoning Rural Economy Research Institute. To ensure a random sample 
encompassing a cross-section of the urban and rural population in Shanxi Province, the survey was 
performed in supermarkets, outdoor markets or shopping areas. Respondents were randomly selected 
with the criterion that the interviewer was to solicit every fifth consumer that came into the survey area 
(street-intercept method). Consumers who did not purchase rice were not considered to take part in 
the study.  
 
3.2.2. Survey design 
 
The standardized questionnaire consisted of six main sections.  
 
The first section focused on consumers’ behavior at rice purchase. Respondents were required to 
evaluate the importance of seven attributes when buying rice: health benefits, taste, external 
appearance, price, market availability, the cultivation potential or the possibility to cultivate the rice on 
their own, and the environmental impact. These variables were measured on a 7-point Likert scale, 
ranging from ‘not important’ to ‘very important’. 
 
The second section dealt with information on the consumer’s knowledge of GM food and GM rice, the 
acquisition of GM food information and trust in information channels and sources. Subjective or 
perceived knowledge of GM food and GM rice was measured on a 5-point Likert (and recoded into a 
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dummy variable) and dichotomous scale, respectively. Given that GM food knowledge was determined 
by multiple information sources and channels (Costa-Font and Mossialos, 2007), consumers were also 
asked where (channels) and by whom (sources) they learned about GM food. In general, the majority 
of GM related information in China is disseminated by the mass media, while Chinese consumers 
have restricted access to different information sources (Ho et al., 2006; Lin et al., 2006). As the 
respondents are living in a rural province, different categories of information channels were included: 
‘Radio/television’, ‘Internet’, ‘Newspaper/magazine/book’, ‘Market’ and ‘Oral conversation’. Analogues, 
the categories of information sources are ‘Personal’ (friends, neighbors, relatives), ‘Medical experts’ 
(doctors, scientists), ‘Industry’ (biotechnology, food) and ‘Consumer or environmental associations’. 
This classification takes into account the importance of both personal and public information channels 
and sources (Costa-Font and Mossialos, 2007; Kornelis et al., 2007). In addition, data about trust in 
several information channels and sources was collected. Based on a 5-point Likert scale, ranging from 
1 (=‘strongly distrust’) to 5 (= ‘strongly trust’), participants were asked to specify how much they trust 
information from the different channels or sources. This part ended with the measurement of the 
respondents’ objective knowledge, based on six different true-or-false statements related to genetic 
modification (Verdurme et al., 2003a; Christophe et al., 2008). This variable only refers to consumers 
who believe to know what GM food is (subjective GM food knowledge). 
 
The third part consisted of questions with respect to consumer perceptions of GM food and FBR 
acceptance as a 2nd generation GM food product. Consumers with subjective knowledge were 
presented a series of statements about beliefs on benefits (7 statements), risks (4), safety (4) and 
price impact (2), derived from different GM food acceptance studies (Verdurme and Viaene, 2003; 
Pope et al., 2004). Each of the statements was measured by five-point scale statements (1 = “strongly 
disagree”, 5 = “strongly agree”, with 3 = “neutral” as the midpoint). To introduce the concept of FBR, 
information about the specific benefits of this GM product was provided (adapted from section 2.3). 
Consumers were also informed about the application of the GM technology, through a GM food 
definition that was provided alongside the second part of the survey (i.e. after the subjective 
knowledge item): “GM food is food of which the genetic material has been modified by technology in 
order to make the plant more resistant against diseases or to grow plant varieties with a better 
nutritional value or positive health effects”. As such, they evaluated this GM rice crop by its main 
product and process characteristics. The importance of mentioning both attributes has been pointed 
out by Frewer et al. (1997a) and Bredahl et al. (1998). FBR acceptance was then measured as an 
agreement to consume (no, indifferent, yes)(House et al., 2001; Chern et al., 2002; Ganiere et al., 
2004; Onyango and Nayga, 2004; Wachenheim et al., 2008). Although some theorists propose to 
measure the evaluation of objects on a bipolar scale (Fishbein and Ajzen, 1975), i.e. acceptance 
versus rejection, GM food acceptance also included an ‘indifferent’ option to distinguish indifferent 
from favorable consumers. Due to the low socio-economic status of Shanxi Province, the specific 
source of the transferred genes was not mentioned, i.e. Arabidopsis thaliana (Storozhenko et al., 
2007). This could have influenced the results, as plant-to-plant gene transfer technology is generally 
causing more reluctance when the transferred genes are derived from unrelated species (Aerni and 
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Rieder, 2000; Schnettler et al., 2008a; Schnettler et al., 2008b; Colson and Huffman, 2009), but not as 
much as when animal genes are transferred to plants (Onyango and Nayga, 2004). Although it is 
reasonable to expect that the source of the GM technology could alter acceptance, the perceived 
consumer benefits may still dominate consumer decisions (Frewer et al., 1997a). 
 
Fourth, only the respondents who were favorable to folate enriched rice, were asked to re-evaluate 
this GM rice product when the quality of an attribute would be negative. The selection of the attributes 
was based on the previously mentioned literature review (see section 1.3.1.3): taste, external 
appearance, availability, price impact; cultivation potential and environmental impact. Each of these 
variables consisted of three categories: unlikely, no difference, likely. Due to the fact that this product 
is still in a laboratory phase, these questions are hypothetical in nature.  
 
Fifth, information was gathered about WTP for FBR, which is further elaborated in chapter 4, when 
dealing with stated willingness-to-pay for FBR (see section 4.2 and 4.4.1.). 
 
The questionnaire ended with the socio-demographic profile of the respondent, based on nine 
indicators. Education, income and residence, for instance, were incorporated to take into account the 
socio-economic profile of Shanxi Province as a poor, rural province (Shanxi Province Statistical 
Bureau, 2007). Due to the close link between FBR and maternal folate deficiency, family-related 
variables were included. Because biofortified food will be produced by farmers, the farmer status 
(yes/no) was questioned. Residence was also included because rural consumers in Shanxi Province 
are more at risk and rely more on home cultivation and farming (Shanxi Province Statistical Bureau, 
2007).  
 
3.2.3. Statistical analyses 
 
Data of 944 completed questionnaires were entered and analyzed using the statistical package SPSS 
(version 15). A 5 % threshold was used as the critical significance level in all statistical analyses. In 
order to make all variables operational, recoding old and constructing new, reliable variables was 
necessary. For example, all consumer perception statements were recoded so that high scores 
indicate a positive perception. Cronbach’s alpha was used to measure the internal consistency in 
order to justify the use of an overall objective knowledge score, the statement categories of consumer 
perceptions and the overall trust scores of information channels/sources (Aaker et al., 2007). 
Furthermore, categorical variables, such as income and subjective GM food knowledge, are recoded 
into variables with less categories when more than 20 % of the cells in a crosstab had less than 5 
answers.  
 
Regarding univariate tests, the paired sample t-test was used to compare the statements (categories) 
of consumer perceptions, the level of trust in different GM food information sources/channels and the 
perceived importance of each rice attribute at purchase. With respect to the acceptance of rice 
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attributes, significant differences between the acceptance of negative attribute changes (dichotomous) 
were assessed by using the McMenar Test, which is designed for use of nominal or ordinal test 
variables (Janssens et al., 2008). 
 
On a multivariate level, a conclusive and descriptive statistical technique were selected, respectively 
multinomial logistic regression and cluster analysis. Multinomial logistic regression was employed to 
analyze the influence of a set of predictor variables by comparing the categories of a depend variable 
through a combination of binary logistic regressions (Malhotra, 2004). The entered variables fulfill the 
requirements, e.g. a categorical dependent variable and a sufficient number of cases per predictor 
variable (i.e. at least 10)(Hosmer and Lemeshow, 2000).  
By using this technique, the determinants of FBR acceptance in Shanxi Province (section 3.3.2) and 
the socio-demographic determinants of the cluster membership were explored (section 3.3.3). To 
include objective knowledge and consumer perceptions of GM food as potential factors, this 
regression only applied to consumers that have subjective knowledge of GM food (451 respondents), 
as these persons answered these questions. Due to the non-randomness of this subjective knowledge 
variable, the estimation of other investigated relationships might be disturbed or biased. By using the 
Heckman two-step procedure, this potential selection basis can be explored. Based on a probit 
analysis, the inverse mill’s ratio (lambda) was entered in the multinomial regression to control for the 
effect of subjective knowledge related factors. As the coefficient of lambda indicated that there is no 
such selection bias, the multinomial regression analysis which includes respondents with perceived 
subjective knowledge of GM food was presented. 
 
Cluster analysis was applied to identify consumer segments regarding GM food related knowledge, 
consumer perceptions and trust levels (section 3.3.3) or FBR acceptance of negative attributes 
(section 3.3.4). Hierarchical cluster analysis (Ward’s variance method, Squared Euclidean Distance 
measure of similarity) was carried out to distinguish relatively homogenous groups of respondents. 
Based on the different cluster centers, subsequent k-means clustering was applied to obtain the final 
consumer segments. Thus, by using the hierarchical clustering as input for the non-hierarchical 
subsequent K-means clustering, the differences between respondents within each segment were 
minimized, while the differences between the segments are maximized (Malhotra, 2004). This two-
stage clustering approach has been applied to other GM food segmentation studies (Arvanitoyannis 
and Krystallis, 2005; Onyango et al., 2006; Kaye-Blake et al., 2007; Zhang et al., 2010).  
Differences in cluster membership were analyzed by two statistical tests. First, the χ²-test and the 
Kruskal-Wallis test were carried out to assess the statistical significance of, respectively, nominal and 
ordinal categorical variables, such as the socio-demographic indicators and cluster membership. 
Second, cluster differences in metric variables, such as consumer perceptions, objective knowledge 
and trust scores, were tested by means of one-way ANOVA. Post Hoc Sheffe tests were performed to 
define which segments were responsible for the significant cluster differences. 
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3.3. Results 
3.3.1. Sample profile 
 
The summary statistics of the socio-demographic variables are presented in Table 11. The total 
sample of 944 respondents is considered indicative for Shanxi Province. For instance, the high poverty 
rate of this region is reflected in the asymmetric frequencies of education and income. Because the 
target group consists of those responsible for the purchase of rice, there is no respondent aged below 
20 years. Residence is controlled in order to have an equal representation of respondents living in 
rural or urban areas.  
 
Table 11 Socio-demographic characteristics of the sample (% of respondents, n=944) 
Variable  %                                         %                                                 
  Gender    Family Size  
Male  47.5 ≤2 persons  7.0 
Female 52.5 3 persons 40.8 
  Age  4 persons 29.8 
20-29 years 16.5 >4 persons 22.5 
30-39 years 29.3   Number of Children  
40-49 years 30.4 none 11.1 
50-59 years 16.7 1 child 41.7 
>59 years 7.0 2 children 31.4 
  Educationa  >2 children 15.8 
Low 71.9   Age Youngest Child  
High 28.1 none 11.1 
  Incomeb  < 3years 7.0 
Low 92.8 3-10 years 22.0 
High   7.2 >10 years 59.9 
  Farmer status    Residence  
Farmer 20.7 Rural 50.2 
Non-farmer 79.3 Urban  49.8 
 
alow: primary or secondary school; high: college or university; blow: yearly income  ¥ 40 000; high: yearly income > ¥ 40 000. 
 
Perceived or subjective knowledge of GM food (yes/no) is more or less equally divided among the 
sample: 47.8 % of the consumers are aware of GM food (Table 12). This is about 20 % lower than 
what Huang et al. (2006b) found in urban China. This might be explained by the higher public attention 
about GM food in urban areas. Furthermore, only 3.1 % assumes to have knowledge of, at least, the 
benefits or risks of GM food. The specific variables regarding the acquisition of GM food knowledge 
are further elaborated in section 3.3.3. With respect to GM rice, subjective knowledge is significantly 
lower (26.4 %) than for GM food. As the first GM rice product still needs to be commercialized in 
China, knowledge related to GM rice rather refers to information regarding the progress of 
commercialization (see section 2.5).  
 
Objective GM knowledge is even lower, with a mean score of 39.2 %. The lack of GM knowledge in 
China has been pointed out in other studies on GM food acceptance (Ho et al., 2006; Huang et al., 
2006b; Lin et al., 2006; Xi and Harris, 2006). This low score reveals significant misjudgment of 
subjective GM food knowledge, which is in accordance to the Chinese study of Li et al. (2002). Table 
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12 shows the percentage of correct answers for each objective knowledge statement. Fifty-three 
percent of the respondents answered two or less items correctly. The percentage of persons that 
answered the sixth statement correctly, which is closely related to the health benefits of our GM rice, is 
relatively high in comparison to other statements.  
 
Table 12 Subjective GM food/rice knowledge (n=944) and objective GM knowledge (n=451), evaluation of the 
objective knowledge statements, the number of correct statements and objective knowledge score (%)  
Subjective knowledge                                                                                               GM food (%)    GM rice (%) 
No I don’t know what GM food/rice is 52.2 73.6 
Yes Yes, 47.8 26.4 
 I heard of GM food, but don't know what it is 31.5 / 
 I know GM food, without details 13.1 / 
 I know GM food and its main dis/advantages 2.4 / 
 I have a profound understanding of GM food 0.7 / 
Objective knowledge statements % Correct % incorrect 
1. Genetic modification can help to make agricultural crops resistant to certain 
diseases (True) 
53.2 46.8 
2. Genetically modified bacteria are capable of cleaning oil-polluted beaches (True) 13.0 72.7 
3. The gender of a boy is decided by his father’s genetic material (True) 37.3 62.7 
4. Animal genes can in no way be transferred to plants (False) 27.5 72.5 
5. GM food contains genes but conventional food does not (False) 41.5 58.5 
6. Genetic modification can help to improve the vitamin content of food (True) 48.6 51.4 
Number of objective knowledge statements   % correct 
0-2 statements 53.7  
3-4 statements 40.1  
5-6 statements 6.2  
Objective knowledgea % correct 
Average objective knowledge score 39.2  
 
aObjective knowledge scores vary from 0 (= no true/false question correct) to 1 (= all true/false scores correct) 
 
Consumer perceptions of GM food are split into four categories (benefits, risks, safety and price 
impact). After reliability analysis (α>0.6), means are analyzed for each statement (Table 13) and each 
category of statements (Table 14). In general, consumers evaluate the four groups of GM food 
statements as slightly positive, but perceptions of GM food safety are significantly more positive.  
 
Table 13 Comparison of the evaluation of consumer perception categories, by paired sample t-tests (n = 451) 
Paired consumer 
perception categories 
Comparison of 
means 
      t  df   p 
Safety - Benefits 3.47 - 3.17   9.26 450 0.00 
Safety - Risks 3.47 - 3.18 11.29 450 0.00 
Safety - Price impact 3.47 - 3.20   6.15 450 0.00 
Benefits - Risks 3.17 - 3.18 - 0.17 450 0.87 
Benefits - Price impact 3.17 - 3.20 - 0.64 450 0.49 
Risks - Price impact 3.18 - 3.20 - 0.57 450 0.57 
Note: Consumer perceptions scores vary from 1 (= strongly disagree) to 5 (= strongly agree): high scores refer to positive 
perceptions. Bold indicates statistical significance at 0.1 %. 
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Specific statements such as health improvement (benefits), worthiness of trying (risks), labeling 
(safety) and cost reduction (price impact) are considered most positive within their statement category.  
However, GM food is often considered as a threat to biodiversity with dangerous side-effects. Related 
to FBR, consumers evaluate the health benefits of GM food as positive, while the potential of being a 
medical substitute is more considered as neutral. Their expectations of the price impact of GM food 
are slightly positive. 
 
Table 14 Consumer perception statements per consumer perception category, means and standard deviation 
(n=451) 
Consumer perception statements Mean St. dev. 
Benefits 
B1. GM food can improve the health of consumers 
B2. GM food can reduce poverty  
B3. GM food can be a good substitute for some medicines  
B4. The development of GM food should be encouraged   
B5. GM food will lower environmental pollution  
B6. GM food can prevent diseases  
B7. The quality of GM food is better than of conventional food  
 
3.45 
3.29 
3.07 
3.27 
3.18 
3.22 
3.10 
 
0.78 
0.86 
0.92 
0.86 
0.80 
0.80 
0.89 
Risks 
R1. GM food is worth trying  
R2. GM food does not pose a serious threat to biodiversity  
R3. GM food will lower the use of pesticides  
R4. GM food does not have dangerous side-effects  
 
3.53 
2.29 
3.31 
2.96 
 
0.81 
0.84 
0.77 
0.83 
Safety 
S1. The safety of GM food is carefully controlled  
S2. GM technology is an acceptable technology to use  
S3. Producing GM food is not messing around with nature  
S4. GM food should be labeled  
 
3.43 
3.44 
3.07 
3.96 
 
0.96 
0.78 
0.76 
0.83 
Price impact 
P1. GM can lower the food prices on the market  
P2. GM food can lower the costs for growing crop 
 
3.17 
3.24 
 
0.82 
0.87 
 
Note: Scores vary from 1 (= strongly disagree) to 5 (= strongly agree): high scores refer to positive perceptions. Therefore, some 
of the statements were recoded and rephrased (R2, R4 and S3). 
 
With regard to FBR acceptance, 62.2 % of the Shanxi respondents indicate that they would accept it, 
26.6 % react indifferently, while 11.2 % are reluctant. Similar results are obtained in other Chinese GM 
food studies, which underlines the general positive findings for other GM foods in China (Ho et al., 
2006; Huang et al., 2006b; Lin et al., 2006; Anand et al., 2007).  
 
3.3.2. Explaining the acceptance of folate biofortified rice 
 
The multinomial logistic regression compares the three categories of the dependent variable (FBR 
acceptance), i.e. reluctance, indifference and acceptance, through a combination of three binary 
logistic regressions. Because this statistical technique analyzes relationships between a non-metric 
dependent variable, namely consumer acceptance of FBR, and metric or dichotomous independent 
variables, some categorical socio-demographic indicators such as age (with 40 years as threshold) 
and family size (≤ or > 2 persons) are dichotomized. The age thresholds are selected so that they 
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divide the sample into two more or less equally sized groups, while family size dummy takes into 
account the presence of children (as nearly all 2 person households have no children). 
The multinomial logistic regression model to predict FBR acceptance shows a model that fits 
significantly better than the null model. The Likelihood Ratio tests in Table 15 reveal significant 
relationships between acceptance of FBR and gender, age, education level, farmer status, objective 
GM knowledge, and consumer perceptions of GM benefits and risks. Details about significant 
differences between the FBR acceptance groups are presented subsequently. 
 
Table 15 Determinants of FBR acceptance, by Multinomial Logistic Regression 
 
Likelihood ratio tests 
χ²  p 
Socio-demographic indicators   
Gender 6.90 0.03 
Age  10.61 0.01 
Family size 9.56 0.15 
Education 9.78 0.04 
Income 0.01 0.99 
Farmer/non Farmer  7.84 0.02 
Residence 1.43 0.49 
Knowledge   
Objective GM 11.74 0.00 
Subjective GM rice 3.07 0.22 
Consumer perceptions   
Benefits 5.93 0.05 
Risks 6.31 0.04 
Safety 1.53 0.45 
Price impact 0.60 0.74 
Model 102.03 0.00 
Pseudo R² (Nagelkerke) 0.25  
 
Note: Bold indicates a significant effect. To avoid multicollinearity, only one of the family related variables is included. 
 
The parameter estimates in Table 16 show the prediction of the probability that a respondent belongs 
to a category of the FBR acceptance variable, in comparison to another category of this variable, i.e. 
the reference category. The acceptance variable consist of three categories, by which three binary 
logistic comparisons are analyzed: 
(1) “acceptance” versus “reluctance” (reference category),  
(2) “acceptance” versus “indifference” (reference category), and  
(3) “indifference” versus “reluctance” (reference category).  
 
Because the socio-demographic variables are dichotomous, the parameter estimates of the binary 
comparisons refer to a specific category, expressed in parentheses in Table 16. The results support 
the scientific evidence that acceptance of GM food is mainly determined by knowledge and consumer 
perceptions (Bredahl et al., 1998; Verdurme et al., 2003b; Ganiere et al., 2006), but also by the socio-
demographic profile of a consumer (Hoban, 1998; Chen and Li, 2007). 
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Table 16 Significant determinants of FBR acceptance, by Multinomial Logistic Regression, interpretation of the 
effects, per binary logistic comparison  
 
Acceptance 
versus  
reluctancea 
Acceptance 
versus  
indifferencea 
Indifference 
versus  
reluctancea 
B p B p B p 
Socio-demographic       
Gender (male)   1.21 0.01   
Age (< 40 years) 1.75 0.00     
Education (low)   -0.71 0.03   
Farmer/non-farmer (farmer) 1.71 0.02   1.83 0.02 
Knowledge       
Objective GM   2.25 0.00 -2.19 0.03 
Consumer perceptions       
Benefits 0.83 0.03   1.01 0.02 
Risks   0.80 0.01   
 
aReference category  
 
Men and people younger than 40 years old feel more favorable towards folate enriched rice than, 
respectively, indifferent or reluctant (reference categories). While consumers with a low education 
level have a higher probability to be indifferent to FBR (than being favorable). Farmers are more likely 
to accept FBR (indifferent/yes), rather than being reluctant.  
Also the objective knowledge score is considered an important determinant of FBR acceptance. 
Consumers with substantial objective knowledge are either more accepting or rejecting FBR. In other 
words, consumers that know less about GM food are more indifferent to FBR.  
Two statement categories of consumer perceptions influence FBR acceptance, namely the 
perceptions towards the benefits and the risks of using genetic modification in food products, which 
confirms the results of different reviews on determinants of GM food acceptance (Bredahl et al., 1998; 
Verdurme and Viaene, 2001). If the consumer perceptions of GM food benefits are positive, 
respondents are significantly more likely to accept or to be indifferent to FBR. When looking at risk 
perceptions, the more positive a consumer evaluates the risks of GM food, the more likely he/she will 
accept this GM rice crop instead of being indifferent. In other words, acceptability is higher when 
Shanxi consumers have a more positive perception of the benefits of GM food and a less negative 
perception of its risks.  
Information aspects are not included in this model because of multicollinearity effect problems. 
However, from a communication point of view, these aspects deserve attention. The next section will 
focus on information aspects when determining different market segments in Shanxi Province.  
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3.3.3. Segmenting the market for folate biofortified rice 
 
Based on the GM food related variables, i.e. objective knowledge, consumer perceptions and 
information trust scores, cluster analysis identified three consumer segments in Shanxi Province: 
“enthusiasts” (14.2 %), “cautious” consumers (41.2 %) and “opponents” (44.6 %). This is in line with 
findings from other segmentation studies (Kuznesof and Ritson, 1996; Kontoleon and Yabe, 2006)(see 
Table 1, section 1.3.1.2.). The cluster names are derived from main characteristics of the three Shanxi 
consumer segments, as discussed below and illustrated in Figure 12. Based on the standardized 
cluster means of objective GM knowledge and consumer perceptions, trust in channels and sources 
providing GM food information, enthusiasts generally obtain the highest score. Only their view on the 
price impact of GM is slightly lower than the other segments. At the other extreme are the opponents, 
who have the lowest objective knowledge and the least positive perceptions. Nevertheless, their 
perception of the benefits and price impact, and their trust in information channels is more positive 
than for cautious people, while their concerns regarding safety and risks are higher. Below the 
differences are presented for each of the clustered variables, FBR acceptance, information acquisition 
(sources/channels) and socio-demographic indicators. 
 
Linking FBR acceptance with the identified consumer segments, shows that more enthusiasts are 
accepting this GM rice product, while the group of cautious consumers is more indifferent. In general, 
enthusiasts have the highest acceptance rate  (81.3 %), followed by cautious consumers (68.3 %) and 
opponents (60.2 %).  
 
   
Figure 12 Overview of cluster variables. Objective knowledge and consumer perceptions of GM food and the 
levels of trust in information channels and sources 
Note: Standardization (0 to 1) of the mean values of all variables.  
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The mean objective knowledge scores vary between 31 % for the opponents and 52 % for the 
enthusiasts, with the cautious’ score (44%) in between (Table 17). But no matter what the cluster 
membership is, the average respondent has limited knowledge of what GM food actually is (39 %). A 
closer look at the significant difference in the number of correct answers reveals that 67.7 % of the 
opponents had less than two GM food knowledge statements correct, while the enthusiasts mainly 
answered 3 to 4 items correctly and the cautious are more or less equally divided into the groups 
below 5 answers. Only 1.5 % of the opponents had (almost) all statements correct, confirming the 
groups’ limited knowledge of GM food.  
 
Table 17 Objective GM knowledge, number of correct statements (% respondents) and average score (%) per 
cluster, and significant differences, by Chi²-test and One-way ANOVA 
Correct answers Enthusiasts 
n = 64 
(14.2%) 
Opponents 
n = 201 
(41.2 %) 
Cautious 
n = 186 
(44.6%) 
Sample 
n = 451 
 
Chi²-test 
 
One-way 
ANOVA 
χ² (df) F (df) 
0-2 correct 21.9 67.7 49.5 53.7 
49.13 (4)*** 3-4 correct 67.2 30.8 40.9 40.1 
5-6 correct 10.9 1.5 9.7 6.2 
Obj. knowledge  
score a 
52 % 31 % 44 % 39 % 31.84 (450)*** 
 
Note: *** denotes statistical significance at 0.1 %. The six objective knowledge statements are described in Table 12 . 
aObjective knowledge scores vary from 0 (= no true/false question correct) to 1 (= all true/false questions correct). 
 
GM food knowledge is gathered through several information channels and sources. Audio-visual 
media, such as radio and television (39.3 %), are the information channels that are most used, 
followed by newspapers and magazines (23,7 %), the internet (23.5 %) and, to a lesser extent, oral 
tradition (8.0 %) and markets (5.5 %). A similar hierarchy is found in Chinese (Lin et al., 2006) and 
other GM food studies (Bredahl et al., 1998). However, while trust in the internet and radio are neither 
positive nor negative, consumers put less trust in advertisements and brochures (Table 20). When 
respondents receive GM food related information, they mainly depend on two sources: friends or 
relatives on the one hand, and scientists or doctors on the other. The industry or 
consumer/environmental associations are less preferred (Table 18). In other words, scientific and 
personal information dominate consumer oriented GM food information. Information sources are 
considered significantly more trustworthy than information channels, which are more or less perceived 
as neutral (paired sample t-test, p<0.001). The main sources of GM food information, informal and 
scientific sources, are also considered the most trustworthy (paired sample t-test, p<0.001). 
Consumers put also trust in their government and, although less used, in consumer oriented 
organizations. The industry, however, obtains the lowest trust score. These trust scores correspond 
with similar GM food studies (Dean and Shepherd, 2007; Costa-Font et al., 2008). 
 
Differences between the three consumer segments related to how they obtain information about GM 
food is depicted in Table 18. Due to the high number of null cells, the use of information channels is 
recoded into a dummy variable, distinguishing audio-visual information channels from the other 
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channels. The results show that significantly more opponents are using informal information channels 
to gather GM food knowledge, such as markets or oral conversations (17.4 %), while almost all 
enthusiasts (93.8 %) rely on audio-visual information channels. The level of trust in information 
channels is significantly higher in the group of enthusiasts, while the cautions take an intermediate 
position. Second, enthusiasts depend significantly less on information from consumer oriented 
organizations, while experts and personal sources are perceived as more important sources of 
opponents and cautious consumers, respectively. Regarding trust in information sources, opponents 
and cautious people have a significantly lower score than enthusiastic consumers. 
With respect to the trust in information channels and sources, the means for each cluster are 
presented in Table 19. Education is considered most trustworthy in the enthusiastic cluster, i.e. the 
segment with the highest objective knowledge. The lower trust levels of the cautious consumers are 
mainly due to their skepticism about advertisements and brochures. The information sources that 
mainly account for the high trust levels of the enthusiasts are the medical sector, the government and 
the scientific world. This is not surprising given the well established relationship between GM food 
approval and trust in GM food proponents (Siegrist et al., 2000; Frewer et al., 2003; Yee et al., 2008). 
The reluctant consumers typically have a similar trust level as the cautious consumers, but they differ 
in the way they trust the food/biotech industry (more) or the government and scientists (less).  
 
Table 18 Use of information channels/sources (% respondents), per cluster, and significant differences by Chi²-
test 
Variable Enthusiasts 
n = 64  
(14.2%) 
Opponents 
n = 201  
(41.2 %) 
Cautious 
n = 186  
(44.6%) 
Sample  
n = 451 
 
Value 
χ² (df) 
Information channels      5.95(2)* 
Audio-visual  
(Radio, television, internet,  
newspapers, magazines, books) 
93.8 82.6 88.2 86.5 
 
Markets, shops, oral conversations 6.2 17.4 11.8 13.5  
Information sources      14.29(6)* 
Personal  
(friends, relatives, neighbors) 
35.9 29.9 46.8 37.7  
Medical experts  
(doctors, scientists) 
35.9 39.3 31.2 35.5  
Industry (food, biotechnology) 20.3 20.4 11.8 16.9  
Consumer organizations,  
environmental associations 
7.8 10.4 10.2 10.0  
 
Note: * denotes statistical significance at 5 % . Bold indicates relevant findings, as referred to in the text.   
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Table 19 Consumer perceptions of trust in information channels/sources, mean and standard deviation per 
cluster, and significant differences, by one-way ANOVA 
Variable Enthusiasts 
n = 64 (14.2%) 
Opponents 
n = 201 (41.2 %) 
Cautious 
n = 186 (44.6%) 
Sample 
n = 451 
Valuea 
Mean St.dev Mean St.dev Mean St.dev Mean St.dev F 
Trust in information channels 3.32 0.5 3.13 0.6 2.88 0.5 3.05 0.5     22.55*** 
Newspaper  3.83 0.7 2.97 0.9 3.11 1.0 3.15 1.0  
Magazine 3.42 0.9 3.01 0.8 3.02 0.9 3.07 0.9  
TV  3.86 0.8 3.33 0.9 3.42 0.9 3.44 0.9  
Radio 3.17 1.1 3.16 0.8 2.83 0.9 3.03 0.9  
Internet  3.33 0.9 3.30 0.9 2.79 0.8 3.09 0.9  
Education 4.00 0.8 3.28 0.9 3.34 0.9 3.41 0.9  
Advertisement 2.55 0.9 3.03 0.9 2.18 0.7 2.61 0.9  
Brochure 2.41 1.1 3.00 0.8 2.31 0.8 2.63 0.9  
Shops 3.63 0.8 3.30 0.7 3.33 0.7 3.36 0.8  
Trust in information sources 3.94 0.4 3.49 0.4 3.47 0.4 3.55 0.4     37.95*** 
Family 3.81 1.1 3.47 0.8 4.05 0.6 3.76 0.8  
Medical 4.25 0.6 3.66 0.8 3.73 0.8 3.77 0.8  
Consumer organizations 3.95 0.7 3.47 0.7 3.43 0.7 3.52 0.7  
Environmental organizations 3.98 0.7 3.52 0.7 3.34 0.7 3.51 0.7  
Biotech industry 3.53 0.7 3.44 0.8 3.05 0.8 3.29 0.8  
Food industry 3.33 0.8 3.51 0.8 2.73 0.8 3.16 0.9  
Government 4.44 0.6 3.49 0.8 3.80 0.7 3.75 0.8  
Scientists 4.56 0.7 3.58 0.8 3.81 0.7 3.81 0.8  
 
Note: *** denotes statistical significance at 0.1 %. Trust scores vary from 1 (=distrust a lot) to 5 (= trust a lot). Bold indicates 
relevant findings, as referred to in the text. 
aThe number of degrees of freedom is 450. 
 
The cluster statements of the four perception categories differ significantly, as Table 20 illustrates. The 
enthusiasts, for instance, are more positively oriented towards the safety, the benefits and the risks of 
GM food than the other two clusters. This is consistent with the fact that those who are likely to identify 
the high benefits, are those who minimize the risks (Costa-Font and Mossialos, 2007). As a result, the 
perceptions of safety and risks of the opponents are the least positive, while cautious consumers are 
characterized by a more negative view on the benefits and the price impact. Hence, reactions of 
cautious consumers refer to the secondary conditions of GM food, while the opponents’ doubts are 
related to its primary conditions. In general, safety issues of GM food are evaluated significantly more 
positively than its price impact, benefits and risks (paired sample t-test, p<0.001).  
 
A detailed look at the various consumer perception statements, provides more insight on how these 
segments think about GM food (Table 20). Although all segments generally agree that the health of 
consumers can be improved with GM food, it is the enthusiastic segment that is optimistic towards the 
statements that are closely linked to folate biofortification, e.g. the ability of GM food to improve health 
(B1), be a substitute for medicines (B3), or prevent diseases (B6). Cautious people are more 
concerned about the potential of GM food, e.g. to reduce poverty and to be a valuable alternative to 
medicines. Regarding GM food risks, enthusiasts strongly believe that GM food will lower pesticide 
use (R3) and is worth trying (R1). Opponents have concerns about its side-effects (R4), including its 
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impact on biodiversity (R2). A similar trend is found for food safety perceptions. Compared to the 
opponents, the enthusiasts and cautious people are positively evaluating the safety control of GM food 
(S1) and (strongly) agree that GM food is an acceptable technology (S2). Nevertheless, all market 
segments confirm the need for labeling, which corresponds to China’s mandatory labeling policy 
(Huang et al., 2005a). Finally, the different price impact statements are evaluated more or less 
neutrally.  
 
Table 20 Consumer perceptions of GM food, mean and standard deviation per cluster, and significant differences, 
by One-way ANOVA 
Variable Enthusiasts 
n = 64  
(14.2%) 
Opponents 
n = 201  
(41.2 %) 
Cautious 
n = 186 
(44.6%) 
Sample 
n = 451 
(100.0 %) 
One-way 
ANOVAa 
 
Mean St.dev Mean St.dev Mean St.dev Mean St.dev F 
Benefits 3.59 0.5 3.28 0.4 2.92 0.4 3.18 0.5 67.64*** 
B1. Health improvement 4.16 0.6 3.31 0.7 3.37 0.7 3.45 0.8  
B2. Poverty reduction 2.94 1.0 3.19 0.8 2.68 0.7 2.94 0.9  
B3. Potential substitute for medicines  3.48 1.0 3.37 0.8 2.61 0.8 3.07 0.9  
B4. Encourage development   3.81 0.8 3.37 0.8 2.99 0.8 3.27 0.9  
B5. Lower environmental pollution  3.55 1.1 3.24 0.8 2.98 0.7 3.18 0.8  
B6. Disease Prevention 3.98 0.7 3.21 0.8 2.96 0.6 3.22 0.8  
B7. Better quality than regular food 3.20 0.9 3.28 0.8 2.87 0.9 3.10 0.9  
Risk 3.63 0.4 3.02 0.4 3.20 0.4 3.18 0.4 55.64*** 
R1. Worth trying  4.27 0.7 3.31 0.7 3.52 0.7 3.53 0.8  
R2. No threat to biodiversity (RC) 3.02 1.0 2.77 0.9 3.05 0.7 2.92 0.8  
R3. Lower the use of pesticides  3.77 0.8 3.27 0.7 3.20 0.7 3.31 0.7  
R4. No dangerous side-effects (RC) 3.45 1.0 2.76 0.8 3.01 0.6 2.96 0.8  
Safety 4.00 0.4 3.13 0.4 3.67 0.4 3.47 0.5 135.60*** 
S1. Carefully controlled safety 4.23 0.7 2.95 0.9 3.68 0.8 3.43 0.9  
S2. Acceptable technology    4.13 0.7 3.16 0.8 3.50 0.6 3.44 0.8  
S3. Not messing with nature (RC) 3.36 0.8 2.88 0.7 3.17 0.7 3.07 0.8  
S4. Should be labeled 4.28 0.9 3.53 0.8 4.32 0.6 3.96 0.8  
Price impact 3.01 1.0 3.33 0.6 3.13 0.7 3.20 0.7 7.07** 
P1. Lower food prices  3.08 1.1 3.30 0.7 3.06 0.8 3.17 0.8  
P2. Lower the costs to grow 2.94 1.2 3.36 0.8 3.20 0.8 3.24 0.9  
 
B, benefits; P, Price impact; R, risks; RC, recoded; S, safety 
Note: ***, ** denote statistical significance at 1 % and 0.1 %. Consumer perceptions scores vary from 1 (= strongly disagree) to 
5 (= strongly agree): high scores refer to positive perceptions.  
aThe number of degrees of freedom is 450. 
 
Multinomial logistic regression is used to compare the impact of socio-demographic indicators on 
cluster membership, a non-metric dependent variable, at multivariate level. All included socio-
demographic indicators are dummy-variables and were not entered as variables in the cluster 
analysis, unlike the other variables, which justifies the use of this technique. The multinomial logistic 
regression model which predicts cluster membership shows a model that fits significantly better than 
the null model (p<0.001), while the non-significant Goodness-of-Fit test shows that the model 
adequately fits the data (p>0.278).  
89 
 
Based on the Likelihood Ratio tests, the significant socio-demographic determinants are identified, 
namely gender, income, farmer status and residence (see Table 21). The effect of these variables can 
be interpreted by the parameter estimates of the multinomial logistic regression. First, men are likely to 
be enthusiastic consumers, while women are more likely to be in the group of cautious consumers 
(and opponents). Second, a low income level increases the odds of being in the group of opponents 
instead of belonging to one of the other two segments. Farmer status reduces the likelihood of being a 
reluctant consumer, as compared to a cautious consumer. Finally, residence is significant in 
distinguishing the cautious segment from the other two segments. Consumers that live in urban areas 
of Shanxi Province are more likely to be a member of the cautious segment. In turn, rural consumers 
have a higher probability to belong to the reluctant or enthusiastic segment.  
 
Table 21 Significant socio-demographic determinants of the consumer segments, by Multinomial Logistic 
Regression, likelihood ratio tests and parameter estimates per binary logistic comparison  
Socio-demographic 
variable (dummy)a 
Likelihood  
Ratio tests 
Enthusiasts 
versus 
opponentsb 
Enthusiasts 
versus 
cautiousb 
Cautious 
versus 
opponentsb 
   χ²   p   B   p   B   p   B   p 
Gender (male) 7.46 0.02    2.25 0.02   
Age  3.65 0.16       
Education 1.99 0.37       
Income (low) 6.09 0.05 -1.03 0.05    -0.91 0.03 
Farmer/non Farmer 
(non-farmer) 
5.67 0.05      -0.84 0.02 
Residence (urban) 11.15 0.01   -2.25 0.02   2.08 0.01 
Model 110.84 0.00       
Pseudo R² (Nagelkerke) 0.25        
 
Note: Bold indicates a significant effect. The dependent variable, cluster membership, consists of three categories or segments: 
enthusiasts, cautious and opponents. To compare all groups of the dependent variable, cluster membership, three binary 
logistic regressions are presented.  
aThe parameter estimates of the binary comparisons refer to a specific category, expressed in parentheses; bReference 
category.  
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3.3.4. Acceptance of negative attributes of folate biofortified rice 
 
3.3.4.1. Influence of negative rice attributes on folate biofortified rice acceptance  
 
In this section, the Shanxi consumers’ trade-off between the positive health attribute of FBR and 
potential negative rice attributes is analyzed. Therefore, the analysis only takes into account the 
respondents who accept FBR.  
By linking different rice attributes to the current rice purchase behavior, Table 22 gives an indication of 
the perceived importance of rice attributes when buying rice. Except for taste and health, which are 
perceived as the most important product attributes of rice purchase in Shanxi Province, the importance 
of all rice attributes differs significantly from each other (paired sample t-test, p<0.001, not shown). 
While the importance of the availability is evaluated as neutral, the cultivation potential of rice varieties 
is considered the least important. These results support a study of Kim (2009) who stated that Chinese 
consumers attach large importance to the price level of GM food products when making their purchase 
decisions28. 
 
Table 22 Perceived importance of rice attributes (n=588) 
Perceived importance of 
rice attributes at purchasea 
Rank of  
importance 
Mean St. dev. 
Taste 1 5.85 1.44 
Health  5.76 1.41 
Price 3 5.13 1.46 
External Appearance 4 4.48 1.61 
Availability   5 4.06 1.57 
Environmental impact 6 3.86 1.85 
Cultivation potential 7 2.56 1.65 
 
aMeasured on a 7-point Likert scale, ranging from 1 (= not important) to 7 (= very important) 
 
Table 23 presents consumers’ evaluation of potential negative attributes of FBR. The figures in the 
fourth column define the potential impact of each negative rice attribute on the introduction of this GM 
rice product, i.e. the potential coverage rate of this folate intervention in Shanxi Province.  
Although 62.2 % of the Shanxi consumers stated to accept FBR, negative changes of rice attributes 
could deter this acceptance rate. If the taste of this rice product is not as good as the conventional 
rice, or its impact on the environment is negative, the acceptance or the coverage rate will be 
substantially lower. The coverage rate of its introduction will be more than halved, reducing the 
acceptance rate to 28.1 % and 28.9 %, respectively, which underlines the importance of the taste and 
the environmental impact when developing (2nd generation) GM food products. Also a negative price 
impact would increase reluctance of FBR. On the contrary, changes in the cultivation potential, the 
least important rice attribute (see Table 22), or the external appearance does not make a difference for 
most of the consumers. The reduction of the initial acceptance rate of rice enriched with folate is less 
dramatic, when the cultivation potential (-12.2 %), the external appearance (-16.2 %) or the availability 
(-21.6 %) would be negatively affected. 
 
                                                 
28 WTP for FBR will be analyzed in chapter 4. 
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Table 23 Acceptance of folate biofortified rice with negative rice attributes, % of respondents, and impact on the 
initial acceptance rate, in % reduction (n = 588) 
Negative rice  
attributesa 
Acceptance of negative rice attributes Reduction of the 
initial acceptance 
rate (62.2 %) 
Remaining 
acceptance rateb Unlikely 
to accept 
Does not 
make 
a difference 
Likely to 
accept 
Taste  54.8 19.7 25.5 -34.1 28.1 
External appearance  26.0 46.3 27.7 -16.2 46.0 
Price impact  44.4 24.3 31.3 -27.7 34.5 
Availability 34.7 40.1 25.2 -21.6 40.6 
Cultivation potential  19.7 53.4 26.9 -12.2 50.0 
Environmental impact  53.6 33.3 13.1 -33.3 28.9 
 
aReduction of the initial acceptance rate, i.e. without negative attribute changes, is calculated as: (‘unlikely to accept’)*0.622; 
bThe remaining acceptance rate is calculated as: (‘does not make a difference’ + ‘likely to accept’)*0.622 
 
To test the differences in consumer’s acceptance of negative rice attributes, the six variables of Table 
23 are dichotomized. The McMenar test reveals that there is a significant difference in nearly all 
negative FBR attributes (Table 24): a lower cultivation potential of folate enhanced rice will less likely 
influence the coverage rate of FBR, followed by external appearance, availability, price impact, and 
taste and environmental impact. Only the negative changes in taste and environmental impact, i.e. the 
attributes that causes the largest reduction of the GM rice acceptance rate, are more or less equal. 
 
Table 24 Comparison of the acceptance of different negative folate biofortified rice attributes, by McMenar test 
(n=588) 
Paired acceptance of  
negative rice attributesa  
Comparison  
of meansb 
χ² 
 
   df    p 
Taste - External appearance 0.45 - 0.74 117.12 587 0.00 
Taste - Availability/accessibility 0.45 - 0.65 63.38 587 0.00 
Taste - Cultivation potential 0.45 - 0.80 139.16 587 0.00 
Taste – Price impact 0.45 - 0.56 14.82 587 0.00 
Taste - Environmental impact 0.45 - 0.46 0.14 587 0.71 
External appearance - Availability 0.74 - 0.65 11.21 587 0.00 
External appearance - Cultivation potential 0.74 - 0.80 6.58 587 0.01 
External appearance - Price impact 0.74 - 0.56 43.69 587 0.00 
External appearance - Environmental impact 0.74 - 0.46 95.29 587 0.00 
Availability - Cultivation potential 0.65 - 0.80 34.72 587 0.00 
Availability - Price impact 0.65 - 0.56 15.15 587 0.00 
Availability - Environmental impact 0.65 - 0.46 44.98 587 0.00 
Cultivation potential - Price impact 0.80 - 0.56 81.32 587 0.00 
Cultivation potential - Environmental impact 0.80 - 0.46 135.65 587 0.00 
Price impact - Environmental impact 0.56 - 0.46 11.51 587 0.01 
 
aEach variable of the acceptance of negative folate enriched rice attributes are dichotomized as follows: 0 = reject; 1 = accept; 
bAlthough the McMenar method tests the differences in binary responses of two variables, the comparison of means is 
presented, instead of the cross-tabulation for each pair. 
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3.3.4.2. Four clusters of FBR acceptance with negative rice attributes 
 
To obtain a better understanding of consumer acceptance of negative rice attributes in the high-risk 
region Shanxi Province, different segments of potential FBR consumers are identified. Through binary 
cluster analysis, reluctance (= 0) and acceptance (= 1) are compared for each negative attribute 
change. Given the consumers’ trade-off between the higher folate content and a potential negative 
product attribute, cluster analysis detected four FBR consumer segments in Shanxi Province: 
‘Traditional attribute buyers’ (17.9 %), ‘Market consciousness’ (20.2 %), ‘Intrinsic attribute buyers’ 
(27.4 %) and ‘Health seekers’ (34.5 %). Table 25 describes for each consumer segment how the 
acceptance of rice with a higher folate would change when a conventional product characteristic would 
be altered. Traditional attribute buyers are in general the most reluctant when it comes to negatively 
altered rice attributes. In other words, these consumers are significantly more favorable to FBR if it 
resembles the original rice crop. All market conscious consumers revised their opinion when 
undesirable market consequences would be involved, such as a negative price impact or a reduced 
availability compared to the conventional product. Taste is also considered as a crucial factor in their 
acceptance, which is the case in most of the consumer segments. The cluster of the “intrinsic attribute 
buyers” is significantly more represented by consumers that depend on taste and external appearance 
in order to accept folate enriched rice. Health seekers are mainly accepting it, even with negative 
changes in other attributes. Their reaction towards the additional health benefits seems to outweigh 
their perception of each undesired rice attribute. The average health seeker accepts five rice attribute 
changes of FBR, of which the negative environmental impact is the most important attribute that 
increased reluctance. 
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Table 25 Four cluster segments based on the acceptance of potential negative FBR attributes, %  of respondents 
per cluster, and significant cluster differences, by Chi²-test.  
Acceptance of negative 
rice attributes 
Traditional 
attribute 
buyersa 
n = 105  
(17.9 %) 
Market 
consciousnessa 
 
n = 119 
(20.2 %) 
Intrinsic 
attribute 
buyersa 
n = 161 
(27.4 %) 
Health 
seekersa 
 
n  = 203 
(34.5 %) 
Sample 
 
 
n = 588 
(100 %) 
Valueb 
 
 
 
 
Rice attribute       χ² 
Taste  Reject 64.8 80.7 98.1 0.0 54.8 
404.49*** 
Accept 35.2 19.3 1.9 100.0 45.2 
External 
appearance  
Reject 34.3 17.6 46.6 10.3 26.0 
69.34*** 
Accept 65.7 82.4 53.4 89.7 74.0 
Price impact  Reject 58.1 100.0 14.9 28.1 44.4 
235.64*** 
Accept 41.9 0.0 85.1 71.9 55.6 
Availability Reject 48.6 72.3 31.7    7.9 34.7 
148.14*** 
Accept 51.4 27.7 68.3 92.1 65.3 
Cultivation 
potential 
Reject 100.0 0.0 0.0 5.4 19.7 
522.30*** 
Accept 0.0 100.0 100.0 94.6 80.3 
Environmental 
impact 
Reject 67.6 55.5 55.3 43.8 53.6 
16.42*** 
Accept 32.4 44.5 44.7 56.2 46.4 
Number of 
accepted 
attributes 
 Mean 
    (st.dev) 
2.27  
(1.46) 
2.74  
(0.98) 
3.53  
(1.03) 
5.04  
(0.83) 
3.67  
(1.51) 
F 
  211.07***c 
 
 
Note: ***denotes statistical significance at 0.1 %. Bold indicates relevant findings, as referred to in the text. 
aFor each cluster, the figures of the category where the number of respondents is significantly higher than the sample 
percentage, is presented; bThe degree of freedom of the Chi²-tests is 3; cThe degrees of freedom of the One-way ANOVA test of 
the number of accepted attributes is 3; 587. 
 
Below, the main cluster differences are presented, based on socio-demographic indicators, objective 
GM knowledge and consumer perceptions of GM food (Table 26).  
Only three socio-demographic indicators (gender, famers status and residence) are significantly 
different between the four consumer segments. The market conscious group and the traditional 
buyers, i.e. the cluster segments where the number of accepted negative attributes is the lowest, are 
significantly more represented by men and rural consumers. On the contrary, slightly more women and 
urban consumers seek health or intrinsic attributes. The group of health seekers is mainly represented 
by non-farmers, while most farmers are concerned about the price impact.  
When buying rice, taste is considered a crucial factor of acceptance in the group of intrinsic attribute 
and market conscious consumers. The latter cluster, together with the traditional attribute buyers, 
attach significantly more importance to the price impact. As expected, health seekers take health 
aspects more into account when they are purchasing rice.  
With respect to consumer perceptions, there is a significant difference between the way clusters 
evaluate the benefits, the risks and the price impact of GM food. First, health seekers acknowledge the 
benefits of bringing genetic modification into food more than other groups. Second, a market 
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conscious consumer is more positively oriented towards the risks of GM food. But they are more 
concerned about the price impact of GM crops, which is in line with their high perceived importance of 
the price at rice purchase and their lower acceptance rate when FBR would imply a negative impact 
on the production costs and product price.  
 
Table 26 Significant differences of the four segments regarding the acceptance of negative FBR attributes, by 
Chi² or One-way ANOVA  
 Traditional   
attribute 
buyers 
n = 105  
(17.9 %) 
Market 
consciousness 
 
n = 119 
(20.2 %) 
Intrinsic 
attribute 
buyers 
n = 161 
(27.4 %) 
Health 
seekers 
 
n  = 203 
(34.5 %) 
Sample 
 
 
n = 588 
(100 %) 
Value 
 
Socio-demographic indicators (% respondents)                                                                                                       χ² 
Gender Female 41.9 35.3 50.9 52.7 46.8 
 11.29** 
 Male 58.1 64.7 49.1 47.3 53.2 
Farmer status  Yes 25.7 29.4 23.0 15.3 22.1 
 10.06* 
 No 74.3 70.6 77.0 84.7 77.9 
Residence Rural 58.1 63.9 51.6 48.8 54.3 
7.99* 
 Urban  41.9 36.1 48.4 51.2 45.7 
Perceived importance of rice attributes at purchase (mean, st.dev)                                                                         F 
Taste  5.50 (1.74) 6.25 (1.00) 6.19 (1.35) 5.71 (1.35) 5.85 (1.44) 9.31*** 
Price impact  5.45 (1.40) 5.35 (1.53) 4.78 (1.43) 5.11 (1.43) 5.13 (1.46) 5.86*** 
Health 5.63 (1.57) 5.77 (1.32) 5.58 (1.51) 6.08 (1.22) 5.76 (1.40) 3.17* 
Consumer perceptions (mean, st.dev) 
Benefits 3.14 (0.45) 3.11 (0.53) 3.12 (0.49) 3.34 (0.46) 3.20 (0.49) 4.78** 
Risks 3.17 (0.39) 3.41 (0.33) 3.25 (0.44) 3.15 (0.50) 3.23 (0.44) 3.95** 
Price impact 3.20 (0.58) 2.91 (0.55) 3.42 (0.76) 3.08 (0.74) 3.19 (0.72) 7.04*** 
 
Note: *, **, *** denote statistical significance at 5 %, 1 % and 0.1 %, respectively. Bold indicates relevant findings, as referred to 
in the text.   
Perceived importance scores vary from 1 (= not important) to 7 (= very important). Consumer perceptions scores vary from 1 (= 
strongly disagree) to 5 (= strongly agree): high scores refer to positive perceptions.  
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3.4. Discussion and conclusions 
 
This chapter investigated consumer’s acceptance of FBR as an intervention to address the high 
burden of folate deficiency and its adverse health outcomes, such as NTDs, in Shanxi Province in 
Northern China. The results show that Shanxi consumers generally accept this GM rice variant with 
higher folate content (62.2 %). This confirms the expectation that GM products with consumer benefits 
are (more) positively embraced by consumers (Frewer et al., 1997a; Lusk et al., 2005; De Groote and 
Kimenju, 2008; Stevens and Winter-Nelson, 2008), especially in China (Lin et al., 2004; Anand et al., 
2007). According to Li et al. (2002), the high consumer acceptance rate of GM food in China is one of 
the main factors of the strong support of the Chinese government. The large use of audio-visual 
sources for GM information acquisition might have created or reinforced the high acceptance rate of 
GM food, as the Chinese government has traditionally control over these media (Xi and Harris, 2006). 
 
Although the explained variance of our model is rather low, it does appear to be useful to explore the 
sign and impact of some of the most important determinants of GM acceptance in a high-risk region. 
As expected, FBR acceptance is determined by GM food knowledge, consumer perceptions, and the 
socio-demographic factors (Bredahl et al., 1998; Hoban, 1998; Verdurme et al., 2003b; Ganiere et al., 
2006; Chen and Li, 2007). Linking these findings with consumers’ acquisition of GM food information, 
makes it possible to formulate recommendations which deserve specific attention. 
Four socio-demographic indicators, i.e. gender, age, education and farmer status, play a role in 
influencing FBR acceptance. In line with the literature, being female (Siegrist et al., 2000; Moerbeek 
and Casimir, 2005), older (Ganiere et al., 2006; Gonzalez et al., 2009) or a non-farmer decreases the 
probability of FBR acceptance. Thus, contrary to several studies that questioned the importance of 
socio-demographic indicators to explain GM food acceptance (Bredahl et al., 1998; Li et al., 2002; 
Kontoleon and Yabe, 2006; Anand et al., 2007), these results show that it is important to take into 
account the socio-demographic profile of consumers, especially when the GM food product is targeted 
towards specific beneficiaries. Unexpectedly, women as one of the main beneficiaries of FBR are less 
favorable to this GM product than men. The lack of a significant relation between income and 
acceptance, as Wachenheim et al. (2008) and Yee et  al. (2008) observed, could be due to the 
threshold of a high income level, by which only a marginal part of the sample is not assumed to be 
poor.  
Acceptance is also determined by objective knowledge in the way that people who are indifferent to 
FBR are more likely to be those without any understanding of GM food. This contradicts the common 
positive effect of education (Hoban, 1998; Traill et al., 2004) and knowledge (Gaskel et al., 1999; 
Huang et al., 2006b; Chen and Li, 2007), and might lead one to conclude that keeping the knowledge 
levels low would lead to more indifferent people and thus, a higher coverage rate. However, FBR 
acceptance is also positively associated with consumer perceptions of the risks and benefits of GM 
food, which correspondents with the general findings (Baker and Burnham, 2001; Li et al., 2002).  
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Hence, if a promotion campaign of this potential intervention aims to influence the general acceptance 
rate of FBR, there is a need to increase knowledge about its advantages and improving consumers’ 
risk perception at the same time. 
 
As consumers with a high objective knowledge are more likely to either accept or reject the FBR, 
instead of being indifferent, the way consumers acquire GM food related knowledge is also crucial. 
Taking together the socio-demographic, consumer perceptions and information trust scores, Shanxi 
consumers with subjective GM food knowledge could be divided into an enthusiastic (14.2 %), an 
opposing (41.2 %) and a cautious group (44.6 %). The results show that both audio-visual and, 
particularly for the latter two, informal information channels, such as markets, could also play a role in 
informing consumers. Nevertheless, acceptance is likely to be hampered by sources that generally 
provide negative messages about GM food, such as consumer/environmental organizations, because 
these sources are significantly more popular with the group of opponents. The importance of experts 
in the latter might be related to the fact that anti-GM information campaigns in China are openly 
supported by several scientists and medical experts (Stone, 2011). Regarding future communication 
campaigns, it can be recommended to improve the low trust levels towards GM proponents, such as 
the government (opponents), and the industry (cautious). 
At first sight, the representation of these clusters gives the impression that the implementation of GM 
rice in Shanxi Province will not be successful as only a small group of enthusiasts will be the first to 
adopt this GM rice product. However, it is important to note that enthusiastic consumers obtain high 
scores on all investigated GM food determinants. Therefore, cautious consumers are not averse to 
GM rice, but rather less optimistic. Their doubts are mainly related to the secondary conditions of GM 
food, namely its benefits and its price impact. The opponents on the other hand, have the lowest 
objective GM knowledge score and the least optimistic perception of the primary conditions of GM 
food, i.e. safety and risks, which further supports the need for a segmented communication strategy to 
tackle folate deficiency in China. 
 
Depending on the objective of the FBR intervention, three broad groups could be targeted.  
First of all, FBR is primarily intended for women, especially women with a low income levels, in order 
to reduce the prevalence rates of NTDs as the most important negative cause of folate deficiency. 
Unfortunately, despite the fact that Shanxi women are better informed about GM food and are less 
deficient than men (see Table 6), they are less likely to enthusiastically accept GM rice than men. In 
addition, a large segment of female cautious consumers exist, to whom attention should be paid in 
order to improve to their perception of the price impact and safety aspects.  
Secondly, if raising the folate intake levels of the high-risk population is considered the main objective, 
this folate policy intervention should target the opponents, which are significantly more represented by 
people with insufficient folate intake levels, i.e. poor, rural consumers (Gao et al., 2003; Ren et al., 
2007). Thus, while women of childbearing age should be the target group of FBR when tackling the 
prevalence of NTDs, the opponents should be addressed to further ensure a widespread adoption of 
FBR and to alleviate the global burden of folate deficiency at the population level.  
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Third, another strategy is to take into account the reaction on the supply side, i.e. farmers’ acceptance, 
who are not only considered as the future producers of FBR, but who will also act as rice consumers. 
Farmers are generally more in favor of GM rice than regular consumers. Nevertheless, farmers will be 
more in favor of adopting biofortified crops when production related traits are beneficial (Hotz and 
Brown, 2004; Low et al., 2007). To attract such farmers, improved agronomic traits, such as a pest-
resistance, could be added to this folate enriched rice crop in order to improve its price impact. 
Another option is to make the biofortified staple crop royalty-free for humanitarian use, so that 
subsistence farmers can use the rice free of cost (Brewster et al., 2005). This is true for Golden Rice 
(Kowalski and Kryder, 2002)(see section 6.5.1). Nevertheless, consumer acceptance as such is often 
strong enough to convince farmers to start to adopt biofortified crops, as was successfully the case in 
Uganda (Heyd), 2007; Gonzalez et al., 2011). 
 
Because FBR is still under development, this acceptance study must be considered as an ex-ante 
evaluation of the potential coverage rate of FBR. The current product attributes could be altered due to 
folate biofortification or by adding the folate trait to a 1st or 2nd generation GM product. If the final FBR 
would imply a negative taste, environmental or price impact, the initial acceptance rate of this GM 
product in Shanxi Province would be more or less halved. As a consequence, these differences will 
negatively influence the coverage rate of this potential folate intervention in Shanxi Province Shanxi 
Province and have to be carefully considered in the further development of this rice.  
Furthermore, cluster analysis distinguished four different consumer segments regarding the 
acceptance of negative rice attributes in Shanxi Province: “Traditional attribute buyers”, “Market 
consciousness”, “Intrinsic attribute buyers”, and “Health seekers”. Whereas female and urban 
consumers are likely to be health seekers or intrinsic attribute buyers, male and rural people mainly 
belong to the other two segments. This shows that even consumers who accept the initial folate 
biofortified staple crop are a heterogeneous group when their perception of various negative changes 
of conventional rice attributes is included. On the one extreme, health seekers seem to evaluate FBR 
only by its health benefits, regardless of other altered attributes, while on the other extreme the 
traditional attribute buyers demand a GM crop that resembles its regular counterpart. In between, 
there are market conscious consumers, such as farmers whose acceptance also depends on the price 
impact or consumers who are concerned about its availability, and intrinsic attribute buyers, who might 
become reluctant when the color or taste would be different. Although folate biofortification is not 
expected to change sensory (taste, texture) and visual product attributes (Bekaert et al., 2008), 
contrary to folic acid fortified rice (Shrestha et al., 2003), this might be a problem when folate trait 
would be incorporated in MBR varieties. However, as Bouis et al. (2000) stated, color changes could 
also be an advantage from a marketing point of view. It can help to introduce and promote a product 
with a clear relation between the distinct visible trait and a higher beta-carotene content.  
 
The most important limitations in this chapter refer to the measurement of variables and data analysis. 
They can be seen as potential avenues for future research in order to validate or improve the findings 
of this consumer study. First of all, this chapter aimed to explain consumer acceptance of FBR. 
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Therefore, the influence of the different potential determinants was measured, rather than measuring 
the hierarchies of effects, e.g. through path analysis. Second, FBR acceptance was measured and 
treated as a categorical variable. Although the distinction between an indifferent and favorable 
category was useful to detect some key differences within the group of consumers that is non-averse, 
a continuous variable might improve the results. Third, it was assumed that people without any 
subjective GM food knowledge have no objective GM knowledge. As a consequence, the latter was 
dependent on the former in the survey, which reduced the sample size in some of the analyses. 
Fourth, the information acquisition variables refer to the information channels and sources that were 
used to learn about GM food knowledge. From a communication point of view, it would be interesting 
to find out which information channels and sources are preferred to obtain (more) knowledge of the  
investigated product, i.e. GM rice product with health benefits. As their prior knowledge of GM food is 
likely to be associated with 1st generation GM crops, consumer’s communication needs might be 
different when dealing with a consumer-oriented GM food product with health benefits. 
Finally, regarding the impact of negative rice attributes, future research will be needed to validate the 
findings in this chapter. One option is to include attribute changes as an information treatment in an 
experimental auction setting or to use conjoint analysis to compare different combinations of negative 
attributes. Another suggestion for future research relates to the evaluation of sensory attributes once 
the product is ready for consumption. Although it is less likely that the final FBR product will be 
characterized by taste or visual differences (Bekaert et al., 2008), these attributes might become a 
problem when the folate trait would be inserted in another GM rice crop, such as MBR. If this is the 
case, consumer sensory research, e.g. product evaluation through taste panels, might be considered 
to define the coverage of this intervention. 
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4 Willingness-to-pay for folate biofortified 
rice in Shanxi Province 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from:  
De Steur, H., Gellynck, X., Feng, S., Rutsaert, P. and W. Verbeke (2011). Determinants of 
Willingness-to-Pay for GM rice with health benefits in a high-risk region: Evidence from 
experimental auctions for folate biofortified rice in China. Submitted for publication in Food 
Quality and Preference. 
De Steur, H., Gellynck, X., Feng, S. (2011). Experimental auctions to assess the role of information on 
willingness-to-pay for second generation GM crops. The case of folate biofortified rice in a high-
risk region of China. Submitted for publication in Asian Economic Journal. 
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4.1. Introduction 
 
Because novel products, like GM foods, are often not for sale at the marketplace, it is important to 
explore their potential market demand. The so-called non-market valuation aims to elicit the economic 
value of a new, hypothetical good or product by examining how much consumers are willing to pay for 
it, in other words, what this product is worth to them. 
 
The burgeoning public concerns about risks and safety issues regarding the implementation of new 
technologies into food products led to a large body of scientific research on purchase intentions and 
WTP with regard to 1st generation GM food products (Lusk et al., 2005)29. WTP for GM food is closely 
related to the acceptance of biotechnology and differs across countries and according to the targeted 
GM food product (Costa-Font et al., 2008). European consumers are generally prepared to pay a 
premium for non-GM food products (Noussair et al., 2002), as compared to US consumers (Lusk et 
al., 2004b). Nevertheless, there is also a lot of heterogeneity within a traditional favorable or reluctant 
country. As Rousu et al. (2004a) demonstrated, many consumers in the US would like to pay a 
substantial amount to avoid GM in their products. Besides cultural differences and acceptance, WTP 
for GM food products is also explained by knowledge and consumer perceptions of GM food (Bredahl 
et al., 1998; Verdurme et al., 2003b; Ajzen, 2005; Lin et al., 2006), which are thoroughly described as 
determinants of FBR acceptance (see section 1.3.1.1); information provision (Tegene et al., 2003); the 
governmental GM food (labeling) policy (Costa-Font and Mossialos, 2007); the characteristics of the 
GM food product (Lusk et al., 2005) and methodological aspects of the economic valuation study (see 
section 4.3). Socio-demographic determinants could also play an important role (Costa-Font et al., 
2008; De Groote and Kimenju, 2008), although some studies contradict this (Lusk et al., 2001a; 
Umberger and Feuz, 2004). 
 
When examining WTP for new, controversial products, whether it is a GM food (Tegene et al., 2003; 
Rousu et al., 2005), an irradiated food (Fox et al., 2002), or an imported product (Wang and 
McCluskey, 2010), information is considered extremely important (Buhr et al., 1993; Shaw et al., 
2006). Providing positive information about the GM technology generally leads to higher WTP values 
for GM food (Tegene et al., 2003; Colson and Huffman, 2009) or a lower compensation to accept GM 
food (Jaeger et al., 2004; Liu, 2009), and vice versa. Especially if relevant health or environmental 
benefits of the GM food are mentioned, the product will more likely be accepted (Frewer et al., 1996; 
Kassardjian et al., 2005) or purchased (Jaeger et al., 2004; Lusk et al., 2004b; Hobbs et al., 2006). In 
line with these results, nutritional information about conventionally bred biofortified products increases 
a consumer’s WTP (De Groote et al., 2010). However, such favorable preferences might be 
compensated when people are informed about the involved GM technology, which is partially the case 
for Golden Rice in the Philippines (Depositario et al., 2009a), but does not hold for India (IIM, 2007). 
To date, WTP valuations of biofortified crops are scarce (Chowdhury et al., 2009). De Groote et al. 
                                                 
29 In their meta-analysis, Lusk et al. reviewed 25 peer reviewed GM food research publications with a total of 57 WTP valuations for different GM food 
products, in order to explore the effect of the value elicitation method, the research location, the product being valued, the WTA or WTP price mechanism, 
the sample characteristics and the product benefits.  
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(2011), for example, found a premium of 24 % for the yellowish conventional biofortified maize with 
higher provitamin A in Kenya, while US and Indian consumers are prepared to pay a surplus of, 
respectively, 16 % (Lusk, 2003) and 19.5 % for the transgenic Golden Rice (Deodhar et al., 2008). In 
North-East Brazil, WTP for vitamin A enriched cassava is 60 % to 70 % higher than the price of its 
regular counterpart (Gonzalez et al., 2009). 
In reality, however, positive GM information is often countered by anti-GM sources. In China, for 
instance, leading activist groups, like Greenpeace China (Greenpeace China, 2011a), or local NGOs, 
such as Utopia (Wu You Zhi Xiang) were responsible for a delay in the commercialization process of 
GM rice (Stone, 2011; Utopia, 2011)(see also section 6.5). When positive and negative information are 
simultaneously presented, two-sided information can be more persuasive as it improves the credibility 
and mitigates the need for counterarguments (Crowley and Hoyer, 1994). Regarding GM information 
treatments, previous studies have shown inconsistent findings about the direction of the impact of two-
sided information treatments about controversial food products (Fox et al., 2002). While a few 
researchers argue that positive information might dominate negative statements in specific cases 
(Rousu et al., 2004b; Colson and Huffman, 2009; Corrigan et al., 2009), the opposite is what is 
generally found in scientific literature (Fox et al., 2002; Tegene et al., 2003; Parkhurst et al., 2004; Hu 
et al., 2006). One explanation regarding the latter is that two-side information is treated as negative 
information, known as the alarmist reaction (Parkhurst et al., 2004). Some authors observed even 
more negative reactions than when negative statements are provided only (Depositario et al., 2009a). 
According to Fox et al. (2002) the dominance of negative information over positive information might 
be attributable to the loss aversion hypothesis (see section 4.3.2.1), which stimulates people to stick to 
the regular product, or the risk-averse nature of people when dealing with a decision problem. Other 
potential explanations refer to a bias in favor of ‘status quo’ alternatives (Fox et al., 2002), or a 
negativity bias (Rozin and Royzman, 2001), by which negative information is more carefully processed 
and has a bigger attractiveness (Smith and Petty, 1996). Besides the discussion surrounding the 
outcome of conflicting information, also the sequence in which people receive such information could 
influence WTP for GM food (Liu, 2009). Here, the ‘primacy’ versus ‘recency’ information order effect 
comes into play. When measuring immediate behavioral responses, such as reporting an auction-
based WTP, the last presented information (recency) is expected to dominate, unless the information 
is highly relevant to people (Buda and Zhang, 2000). 
 
Given the nature of the product being valued in this dissertation, i.e. a 2nd generation GM food product 
with tangible consumer benefits, and the positive results regarding its acceptance in China (see 
chapter 3), it can be expected that consumers would be less averse of buying this biofortified product 
than GM food of the 1st generation (Rousu et al., 2005; Han and Harrison, 2006). Therefore, the aim is 
to explore the premium for FBR, rather than its discount. In other words, instead of willingness-to-
accept compensation, a consumers’ WTP for this GM rice product with health benefits will be the topic 
of this chapter (see also section 1.3.2.1). 
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This chapter reports the results of WTP for FBR, and is dedicated to two value elicitation methods.  
The first measures the stated preference of Chinese consumers and is obtained from the standardized 
survey in Shanxi Province (in 2008; see chapter 3). Stated willingness-to-pay (sWTP) is a self-
reported construct based on a contingent valuation method (CVM) where consumers were asked what 
they are willing to pay for a GM food product (Bateman and Turner, 1993; Hanemann and Kanninen, 
1999; Pearce and Özdemiroglu, 2002; Venkatachalam, 2004; Bonti-Ankomah and Yiridoe, 2006; 
Ganiere et al., 2006; Anand et al., 2007). 
The second explores consumers’ auction-based willingness-to-pay (WTP)30 for FBR by means of 
experimental auctions in Shanxi Province. An experimental auction is a non-hypothetical value 
elicitation method, which combines the advantages of stated and revealed preference methods, in 
order to determine WTP for products or goods (see also section 1.3.2).  
Since the 1990s, experimental auctions have been extensively applied to value food characteristics 
(Lusk and Shogren, 2007)31 , with only a few of them conducted in urban China, e.g. in Beijing 
(Kachelmeier and Shehata, 1992) and Shanghai and Beijing (Wang and McCluskey, 2010). Using 
experimental methods to elicit valuations for 2nd generation GM food products is relatively new, with 
Rousu et al. (2005) being the first to explore this area. In China, two studies investigated purchase 
intentions for GM rice products in large cities: WTP for a 1st generation GM rice cookie by using 
experimental auctions (Liu, 2009) and WTP for a 2nd generation GM rice product with a higher, 
undetermined vitamin content, based on contingent valuation (Li et al., 2002). While the participants in 
the former ask for a price discount of more than 35 % to accept GM rice with undefined farmer 
benefits, the latter found that 43.9 % of the consumers are prepared to pay an average premium of   
38 % for GM rice with consumer benefits. Although the latter confirms that Chinese consumers might 
be (more) willing to purchase biofortified crops, it remains to be proven if they would be as enthusiastic 
for GM rice with higher folate content, especially in high-risk regions under challenging conditions of 
low socio-economic levels. This chapter aims to provide an answer to this question.  
Special attention is devoted to the impact of different (GM) information treatments on (zero) bidding 
behavior. Hence, an experimental auction design with 5 non-repeated information rounds was 
developed. Furthermore, the determinants of WTP for FBR are analyzed, including the effect of 
auction design characteristics. Compared to the stated preference method, the auctions were 
specifically targeted towards two groups in rural Shanxi: poor, low educated women and female 
students. These two subsamples are expected to be more responsible for the rice purchases and 
more interested in the benefits of folate, by which they are considered important beneficiaries of FBR. 
Besides a target group effect, the impact of providing folic acid supplementation as a folate substitute 
for FBR was examined. Other investigated design characteristics are related to the time and day of the 
auction, and the number of participants per auction. 
Finally, sWTP and WTP are compared with each other and with indirect, depersonalized valuations  in 
order to detect, respectively, potential hypothetical and social desirability bias (see section 1.3.2.1). 
 
                                                 
30 When referring to the auction-based valuations, the general term ‘WTP’ is used as it is expected to be the measurement that most resembles consumer’s 
true value, given the non-hypothetical nature of this method. 
31 This book contains over 50 citations of auction-based valuation studies, mainly focusing on food products.  
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In the next section, the methodology to measure the stated WTP in a standardized survey is 
described. Section 4.4.2 contains detailed information about the experimental design, including the 
rationale behind the auction mechanism, the bidding procedures and assumptions. The results section 
is split into three parts. Whereas the first part analyzes the hypothetical, stated WTP values, the 
second determines the (role of information) non-hypothetical, auction-based WTP values for FBR in 
Shanxi Province. The last results section compares the different valuation methods. The main 
conclusions, limitations and pathways for future research are described in the last section of this 
chapter.  
 
4.2. Measuring stated WTP  
4.2.1. Method 
 
The stated willingness-to-pay (sWTP) of FBR is measured in the fifth part of the 2008 consumer 
survey in Shanxi Province (see section 3.2.2)32. To assess consumer’s sWTP for this GM rice product, 
an open-ended contingent valuation approach is applied. Unlike closed-ended or dichotomous 
questions, where people have to decide whether or not to pay a specific provided premium, the 
respondents were asked to specify directly their WTP (Kealy and Turner, 1993; Balistreri et al., 2001).  
There are several arguments to underpin the selection of an open-ended format, as compared to the 
dichotomous choice approaches.  
First, this short, straightforward WTP question is a convenient method and especially appropriate 
when the participants are familiarized with the product (Mitchell and Carson, 1989).  
Second, it does not require a large sample to evaluate a range of open-ended values (Venkatachalam, 
2004). In choice experiments with Golden Rice, for instance, using dichotomous contingent valuation 
(DC-CV) complicated the design and increased the required sample size, as 6 different survey 
versions needed to be applied (Lusk, 2003).  
Third, an open-ended elicitation procedure is expected to yield systematically lower hypothetical WTP 
estimates than a discrete-choice format (Brown et al., 1996; Schulze et al., 1996; Halvorsen and 
Soelensminde, 1998; Balistreri et al., 2001) and generates values who approximate values from 
experimental auctions (Balistreri et al., 2001). In other words, the open-ended values are assumed to 
be less subject to hypothetical bias than other contingent valuation methods (Balistreri et al., 2001). 
Higher values in the DC-CV approach could be due to the presence of an anchoring bias, because 
people use the randomly proposed bid as a reference point (‘anchor’) to adjust their initial valuation 
(Langford and Bateman, 1993). Furthermore, a starting point bias occurs when the reactions in the 
second question are determined by the offered price in the starting question (Herriges and Shogren, 
1996; Ready et al., 1996).  
                                                 
32 Although the valuation method to measure indirect WTP (iWTP) is also considered a stated preference method, it is not tackled here because it is 
included in the experimental auctions. It is also assumed to be less hypothetical because it follows a non-hypothetical WTP bid from the experimental 
auctions. Therefore, the methodology regarding iWTP is discussed in the auction related section (4.3.2.2), while the respective results are discussed in the 
comparison of different valuation techniques (4.4.3). 
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Fourth, there is no risk of creating a ‘yea-saying’ bias as in DC-CV, where participants agree with the 
offered bid, no matter what value this bid represents (Brown et al., 1996; Ready et al., 1996). One 
could then argue that OE-CV determines consumers’ stated WTP rather than their acceptance of 
stated bids (Boyle et al., 1996). 
Despite these advantages, open-ended questions are still criticized because they are assumed to be 
more vulnerable to strategic bias (Mitchell and Carson, 1989; Hanemann et al., 1991; Venkatachalam, 
2004); and could be difficult to answer, especially when participants are not familiar with the market, 
by which people estimate the potential cost instead of their WTP (Hanemann and Kanninen, 1999). An 
overview of the potential biases of stated preference methods is presented in section 1.3.2.1. 
 
Based on the consumer study in chapter 3, those who are not reluctant to FBR and willing to buy this 
product were asked the following open-ended question: “Think of a situation where you can buy this 
GM rice for consumption, considering that 1 kg (or 2 Jīn)33 of conventional rice costs 3 ¥ (Yuan) on 
average, at what price would you think this product is expensive, but you would still purchase it?” Their 
stated price is then assumed to reflect the highest price they are prepared to pay for FBR. As this 
measure might be prone to criticism, e.g. consumers’ stated valuation might be not necessarily the 
same as the highest price they would actually pay, this open-ended valuation measure should be 
interpreted with caution and compared with other preferences, such as auction-based values (see 
section 4.4.3). 
A crucial precondition to elicit WTP values is the provision of unbiased, understandable information 
about the potential benefits (Hanley et al., 2006). Consumers state their sWTP based on objective GM 
information (see section 3.2.2), but without receiving any positive and negative information about GM 
food. The effect of such kind of information on WTP is further investigated in the experimental auctions 
(see section 4.4.2). If relevant, our survey-based measurement of the stated WTP complies with most 
of the 22 guidelines of contingent valuation methods, as listed by Bateman and Turner (1993). For 
example: a clear realistic scenario; consumers with experience of valuing the product; a WTP measure 
rather than using WTA (willingness-to-accept); provision of information that is not open to 
interpretation; a large, representative sample and no starting points. However, their recommendation 
to combine both open-ended and dichotomous choice approaches, to conduct additional validity tests 
and to include a control-group design to measure information and design biases is not followed 
because of practical and budgetary constraints.  
Compared to the ‘endowment’ approach in the auctions, where respondents state their highest amount 
to exchange FBR with regular rice, sWTP was based on a ‘full bidding’ approach (this distinction is 
discussed in section 4.3.2). As a consequence, our open-ended WTP values should be interpreted in 
comparison with the price of a given benchmark (Lusk and Shogren, 2007). By comparing the stated 
price estimation with the current price of regular rice in 2008, i.e. 3 ¥34, WTP for FBR is calculated as a 
continuous WTP-variable, which allows one to distinguish people who want a discount, an equal price 
or a premium. Unlike the DC-CV method (Chern and Chang, 2009), a direct price estimation based on 
                                                 
33 Jīn is the most common measure for rice bags in Shanxi and China: 1 jīn is equal to half a kilogram. 
34 The average Shanxi rice price in 2008 that is mentioned in the survey is slightly below the average price for Japonica rice in China, ca. 3.5 Yuan (National 
Bureau of Statistics of China, 2008a). For an overview of the evolution of Chinese rice prices, see Annex 3.  
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the current price of regular rice was asked, instead of presenting different price scenarios for FBR. 
Mentioning the conventional price as a benchmark before the sWTP valuation of FBR provides a 
common reference price and thereby facilitated consumers’ valuation of this novel product. 
 
4.2.2. Data analysis 
 
Data preparation and analysis was based on SPSS, version 15. Data mining reveals one important 
outlier regarding sWTP, with a value of ¥ 27. This value has been excluded from the analysis. A 5 % 
threshold was used as the critical significant level in the statistical analyses. Due to the ‘full bidding’ 
approach, the stated WTP values can be handled in two ways. On the one hand, one could focus on 
those willing to pay more (positive), an equal price (zero) or less than the regular rice (negative). On 
the other hand, one could compare those willing to pay more with those not willing to pay more. While 
the former allows negative values when ones’ stated WTP falls below the regular rice price of ¥ 3, the 
latter truncated the values at 0. To analyze sWTP and its determinants, the approach of WTP as a 
continuous variable (-∞ to ∞) was followed, in line with other WTP studies (Dickinson and Bailey, 
2002; Parkhurst et al., 2004; Hobbs et al., 2006; Chern and Chang, 2009; Wang and McCluskey, 
2010). As a 0-value is categorized as an equal price for FBR as the suggested regular rice, those who 
did not want to buy this product, i.e. 37 favorable or indifferent consumers, were not entered in this 
analysis.  
This is contrary to the experimental auctions where the latter would be identified as ‘zero bidders’, 
together with those who are not willing to be pay more (but less or an equal price). To compare sWTP 
with these auction-based WTP values, these ‘zero bids’ were distinguished from the positive WTP 
values, i.e. the values of those who are willing to pay more for FBR than for regular rice (see section 
4.4.3).  
 
Regarding the statistical analyses, the non-parametric Mann-Whitney U test was conducted to explore 
the socio-demographic differences in the stated values. Multiple, linear regression was used to 
determine the causality between the independent metric variable (sWTP) and several potential 
predictors, either dummies or continuous, interval scaled variables (Malhotra, 2004). Although several 
assumptions of linear regression were satisfied, e.g. minimum sample size (5 times the number of 
variables as a rule of thumb), absence of multicollinearity, control outliers, expected causality, 
appropriate scale of variables, independence of observations (residuals), not all assumptions were 
clearly met, e.g. normality (satisfied in histogram of standardized residuals, but not in the Shapiro-Wilk 
Test) and homoscedasticity (constant variance of residuals not fully met). Therefore, the obtained 
output should be interpreted with caution (Janssens et al., 2008). Nevertheless, as suggested by 
Chern and Chang (2009) and Wayua et al. (2009), multiple regression is an appropriate technique to 
apply to WTP valuation studies when dealing with both negative and positive values. 
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4.3. Experimental auction design, materials and data analysis 
4.3.1. Selection of the auction mechanism  
 
4.3.1.1. Overview of auction mechanisms 
 
No matter which auction mechanism is applied, experimental auctions should theoretically obtain the 
same WTP. Such WTP values are measured through a number of sealed bidding rounds, where a bid 
is assumed to reflect consumer’s true value (see section 1.3.2.1.). 
There are several auction mechanisms to obtain consumers’ price preference for a novel product (see 
Table 27). These mechanisms differ in terms of the bidding procedures, the method to select a winner, 
the number of winners and the determination of the price these winner(s) should pay, i.e. the ‘market 
price’. But what these procedures have in common is that they are all considered incentive compatible. 
According to Lusk & Shogren (2007, pp. 16-17): “An auction is said to be incentive compatible when it 
induces each bidder to submit a bid that sincerely reflects his or her value for the good. Meaning each 
bidder has a weakly dominant strategy35 to submit a bid equal to their value. I.C. auctions can be 
identified in that they separate what people say from what they pay. That is, an auction mechanism is 
incentive compatible if the market price paid by a person is independent from what he or she bids”. 
Stated differently, from a theoretical point of view, incentive compatible auctions should all yield the 
same WTP values for the auctioned good, namely the bidder’s true value. The theoretical background 
which supports the incentive compatibility of the English (Coppinger et al., 1980), BDM (Irwin et al., 
1998), random nth price (Parkhurst et al., 2004) and 2nd price auction (Vickrey, 1961) is not 
demonstrated in this PhD dissertation, except for an intuitive interpretation in footnote 36. 
 
Table 27 Incentive compatible auction mechanisms  
 English nth price Random nth 
price 
2nd price 
(Vickrey) 
BDM Collective 
auction 
Bidding procedure Sequentially offer 
ascending bids 
Simultaneously submit sealed bids 
#  winners 1 n-1 n-1 1 0 to all 0 to all 
       
Market price 
Last offered 
bid 
nth highest 
bid 
Randomly 
drawn (nth) 
2nd highest 
bid 
Randomly 
drawn 
Mean 
bid 
       
Buyer(s)  = pays 
market price 
Last (= highest) 
bidder 
If bid >  
market price 
If bid > 
market price 
Highest 
bidder 
If bid > 
market price 
∑ bids > 
∑ costs 
       
References (Coppinger et al., 
1980) 
(Shogren et al., 2001b) (Vickrey, 1961) (Becker et al., 
1964; Irwin et 
al., 1998) 
(Smith, 
1980) 
GM food related 
examples 
(Lusk et al., 
2001b) 
Depositario 
  et al., 2009a 
(Tegene et 
al., 2003) 
(Alfnes and 
Rickertsen, 
2003) 
(Rousu et 
al., 2005) 
/ 
 
BDM, Becker-Degroot-Marschak, GM, genetically modified  
Source: Lusk & Shogren (2007), except for the GM food related examples. 
                                                 
35 A key feature of incentive compatible auctions is their ability to induce a weakly dominant strategy. This means that if an auction participant pursues the 
strategy that yields a payoff, the derived utility is at least as great as in all other strategies, regardless of the bidding strategy of the other competing 
participants in the auction. 
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The English auction is commonly used in practice and is widely recognized. During this open auction, 
people continuously raise the price for an auctioned product until the point where nobody offers a 
higher bid. The participant that offered the last bid, i.e. the highest bid, wins the auction and purchases 
the product at the last rejected bid (Coppinger et al., 1980). A variant of the English auction is the 
Dutch (declining) auction, where the starting price is very high and is automatically lowered (e.g. by 
using a clock) until a bidder signals his/her WTP (Hoffman et al., 1993). In the nth and random nth price 
auctions, for example, the winning bidders (n-1) are selected by drawing (randomly) a number n, by 
which the market price is defined as the nth highest bid (Shogren et al., 2001b).  
The second price or Vickrey auction mechanism is a highly recognized auction technique. It is 
considered as a specific version of the nth price auction and uses a sealed bidding procedure to select 
only one winner at the end of the auction (Vickrey, 1961; Shogren et al., 1994; Lucking-Reiley, 2000). 
The highest bidder is the winner or buyer, and purchases the auctioned good at the amount of the 2nd 
highest bidder36.  
The collective auction goes further by summing the sealed bids and comparing the mean WTP with 
the sum of the provision costs in order to evaluate whether the group wins or not. In practice, this 
method is less implemented. A variant of the mean bid, is the ‘collective WTP’ based on group 
consensus (Rutsaert et al., 2010).  
On the other extreme, there is the Becker-Degroot-Marschak (BDM) mechanism, which uses the same 
principle as the (random) nth price auction, but on an individual basis, without the simulation of an 
active market (Becker et al., 1964).  
Except for the English and Dutch auction, the bidding procedure is closed, which means that 
participants simultaneously offer a sealed bid. 
 
4.3.1.2. Second price (Vickrey) auction mechanism 
 
Several economists examined this hypothesis in practice by confronting the second price auction with 
other widely used auction mechanisms, such as the BDM (Noussair et al., 2004), the random nth price 
(Shogren et al., 2001a), or both (Lusk and Rousu, 2006), or the BDM, the random nth price and the 
English auction (Lusk et al., 2004a). Based on their findings, multiple reasons can be cited for 
selecting the 2nd price Vickrey auction mechanism to elicit WTP for FBR in Shanxi Province. These 
arguments are mainly associated with the research location, i.e. a poor, rural region; the auctioned 
product, i.e. 2nd generation GM staple crop with consumer benefits; and the sample characteristics, i.e. 
rice consuming women of childbearing age.  
 
                                                 
36 To explain the theoretical rationale behind the incentive compatibility of 2nd price auctions, a mere, intuitive interpretation of this theoretical predication will 
be provided, based on Lusk & Shogren (2007). If the Vickrey auction is incentive compatible, bidding the true value for an auctioned good should be the 
weakly dominant bidding strategy. This can be illustrated when looking at deviating bidders. Compared to the obtained utility of true value bidders, the utility 
of bidders that state an amount that diverges from their true value could be equal, but could also be lower. It is the latter finding that justifies the use of 2nd 
price auctions. For instance, if a participant bids lower than his true value (under-bidding), he could lose the opportunity of buying the auctioned product for 
a price he would be willing to pay. On the other hand, a participant that decides to overbid may have to buy the auctioned good for a price that is higher than 
his true value, which is the case when the 2nd highest bid exceeds his true value. Thus, because the derived level of utility of bidding a true value is at least 
as high as in other bidding strategies, such as over- and underbidding, true value bidding behavior is the weakly dominant strategy. 
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First of all, low educated, poor participants can relatively easily understand the 2nd price auction (Lusk 
and Shogren, 2007; Wayua et al., 2009), which facilitates its implementation in regions like Shanxi 
Province, which are characterized by low socio-economic levels.  
Second, this mechanism is recommended when the participants have valuations near the market 
price, the so-called on-margin bidders, whereas the random nth price auction is more appropriate when 
dealing with off-margin valuations (Shogren et al., 2001b; Lusk and Rousu, 2006). As the women in 
Shanxi are mainly responsible for the food purchases in their household, it can be assumed that they 
will have a good view on the current rice prices. Besides, due their low socio-economic situation, they 
are expected to be price sensitive (Kim, 2009) and will more actively respond to a food valuation 
experiment (Rutsaert et al., 2009).  
Third, unlike the BDM, the 2nd price mechanism puts a higher cost on overbidding behavior (Lusk and 
Shogren, 2007). Reducing the incentives to overbid is important, as it can be expected that the 
deviating behavior of consumers in an auction with a relatively inexpensive good is to overbid, which 
could be considered as a more socially desirable action.  
Fourth, the obtained 2nd price auction bids are more accurate than in the BDM (Noussair et al., 2004). 
Especially the WTP of high value bidders will be more likely to correspond with true values (Lusk and 
Shogren, 2007). In our auctions, values are expected to be high, given the selection of the sample in 
favor of involved participants, namely rice consuming women of childbearing age from a folate 
deficient region. 
 
Although the WTP values in our auctions should not differ when other incentive compatible price-
discovery techniques are applied, the results of the Vickrey auction mechanism are sometimes prone 
to criticism. According to Rutström (1998), the 2nd price auctions generate higher mean bids than the 
values of the BDM and English auctions, which is in line with the postulated critique that the Vickrey 
auction encourages overbidding (Kagel et al., 1987; Bernard, 2005). Other studies countered this 
criticism, though (Lucking-Reiley, 2000; Shogren et al., 2001b; Parkhurst et al., 2004), at least for the 
initial bidding round (Lusk et al., 2004a). Some authors reported even lower mean bids, indicating 
potential underbidding (Hong and Nishimura, 2003; Noussair et al., 2004). Another shortcoming refers 
to the risk of low value bidders to deviate from their true value in multiple repeated bidding rounds 
(Lusk et al., 2004a). In our auctions this potential problem is addressed by differentiating the provided 
information in each additional bidding round, instead of using repeated rounds. 
 
Despite this criticism, there are additional reasons not to implement one of the other auction 
mechanisms, given the nature of this study.  
First, the open nature of the English auction increases the risk of affiliated bids. Bidder affiliation or 
interdependent bids in an auction is the phenomenon where a high value bidder influences the 
possibility that his competitors will be influenced and increase their values (List and Shogren, 1999). 
Although bid affiliation could also occur in 2nd price auctions, making this mechanism incentive 
incompatible (McAfee and McMillan, 1987; Harrison et al., 2004), our auction design addresses these 
issues. For example, bid prices are not posted (see section 4.3.2).  
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Second, the random nth price auction stimulates competition and generates better results for low value 
bidders (Shogren et al., 2001b; Lusk and Rousu, 2006), but appears to cause difficulties both for the 
participants to understand and the research administrator to manage (Lusk and Shogren, 2007).  
Third, the BDM has proved its usefulness to efficiently conduct WTP auctions in field settings (Lusk et 
al., 2001a) or developing regions (De Groote et al., 2011), and reduces the risk of a group competition 
effect where people just bid to win, known as the top-dog effect (Corrigan and Rousu, 2006a), but the 
absence of a market environment still outweighs these benefits (Shogren et al., 2001a). 
 
4.3.2. Bidding procedures 
 
This section describes the characteristics of the bidding procedures in the 2nd price rice auctions in 
relation to scientific literature. The experimental auctions followed a self-reported sealed-bid 
endowment approach, with multiple information/bidding rounds and the possibility of bidding on an 
alternative product in half of the auctions. In addition to the general personalized valuation approach 
throughout the auction process, an indirect, depersonalized valuation component is incorporated in the 
3rd round to explore social desirability.  
 
4.3.2.1. Bidding method  
 
One of the most important choices an auctioneer needs to make is the bidding method of his auction. 
Basically there are two types of bidding strategies, endowment versus full bidding, which are 
juxtaposed in Table 28. In the full bidding procedure, auction participants bid the total amount they 
think one or more simultaneously auctioned products are worth. This approach is in line with the 
applied stated preference method in section 4.2.1. The endowment bidding strategy requires people to 
bid the amount they are prepared to pay to exchange an initial given conventional product with the 
novel, auctioned product.  
  
The Vickrey auctions on FBR were based on the endowment approach. Proponents of this method 
mainly refer to the directly obtained WTP values as the most important advantage over full bidding 
(Hoffman et al., 1993). Through the process of upgrading, consumers’ endowed bids represent their 
valuation of the difference between the conventional and the auctioned good. Another advantage is 
the possibility of obliging winners to consume the auctioned product, while others have to consume the 
endowed good, which increases the participants’ involvement (Shogren et al., 1994). A third important 
benefit relates to the fee in order to reward participants for their participants. By using the endowed 
bidding strategy, the endowed product can be used as (a part of) the participant fee and could thereby 
mitigate the effect of high monetary participant fees (Rutström, 1998; Loureiro et al., 2003; Cherry et 
al., 2004). According to Rutström (1998), the endowed product should be of low(er) quality, which can 
then be upgraded with the attributes of the auctioned one. Finally, due to the exchange procedure, the 
WTP values in endowed bidding are expected to be less influenced by external market price 
information (Corrigan, 2005). 
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The endowment procedure is criticized by advocates of full bidding (Corrigan and Rousu, 2006a; 
Colson and Huffman, 2009) and should be implemented with caution. First of all, endowing 
participants with a good could reduce the WTP values as they might become attached to the endowed 
product, just because they own this good. This is the risk of ‘loss aversion’ hypothesis, a phenomenon 
that occurs when valuations are ‘reference-dependent’, i.e. dependent on the endowed product 
(Tversky and Kahneman, 1991). As Lusk et al. (2004a) observed, the risk of loss aversion in 2nd price 
auctions becomes a major concern after conducting multiple similar rounds and is, thus, less relevant 
for the non-repeated FBR information rounds. Furthermore, endowing products could cause a 
‘reciprocal obligation effect’, by which consumers are bidding higher to reward the auctioneer for their 
endowment (Corrigan and Rousu, 2006a). In our auctions, we attempt to address this by providing a 
separate part of the participant fee (¥ 5) at the start of the auction, which could be used to bid on the 
auctioned products.  
 
In our rice auctions, regular rice was endowed in order to measure the premium a consumer is willing 
to pay for FBR. In auction literature, however, GM food studies mainly determined the premium for a 
GM-free product or the compensation to sell a regular for a GM product (Lusk et al., 2001b; Jaeger et 
al., 2004; Li et al., 2004; Lusk et al., 2004b; Lusk et al., 2005; Costa-Font et al., 2008). Contrary to our 
design, these auctions solely focused on GM food products with modified agronomic traits in typically 
reluctant (developed) countries. Given the clear health benefits of FBR to the study population, and 
the relatively high acceptance rates of GM food (Huang et al., 2006b), GM rice (Li et al., 2002) and 
FBR in China (see chapter 3), regular rice is assumed to be an ‘inferior product’ compared to FBR. 
Nevertheless, regular rice might become ‘superior’ when the use of GM technology is negatively 
evaluated, i.e. in bidding round 3. 
 
Table 28 Main characteristics of the endowment versus full bidding procedure in 2nd price auctions 
 Endowment Full Bidding 
Basic principlea Bid to upgrade from a conventional 
product to a novel product 
Bid on both the conventional  
and novel product 
Obtained valueb Marginal value directly  
reflects WTP  
No direct comparison of the  
values between the products 
Consumption requirementc Yes, if necessary No 
Risk of loss aversiond Yes (if greater value attached to 
endowed product) 
No 
Risk of reciprocal obligatione Yes No 
Alternative participant feef Yes, endowed product used 
as (partial) participant fees 
No  
Bidding behaviora,g Forced bids if people consider the 
endowed product as inferior 
People only bid true value if it is  
lower than actual value (market price)  
 
aLusk & Shogren (2007); bHoffman et al. (1993); cShogren et al. (1994); dLusk et al. (2004a) and Tversky and Kahneman (1991); 
eCorrigan and Rousu (2006a); fLusk et al. (2001a); gCorrigan (2005) 
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4.3.2.2. Direct, indirect and negative valuation  
 
Direct valuations 
The general bidding rule of the WTP measure, where bids can range between 0 (‘no WTP’) to ∞, was 
applied. As in nearly all experimental auctions, consumers’ WTP was obtained through their own, 
direct valuation, i.e. self-reported bids. Therefore, participants bid by stating the highest amount they 
are willing to pay to exchange the endowed product (regular rice) with the auctioned product (FBR).  
 
Indirect valuations and social-desirability bias 
Although direct, self-reported statements are the most commonly used valuations in experimental 
auctions, the nature of such values may lead to social desirability bias (SDB). Social desirability is a 
social psychological phenomenon defined as “a tendency of individuals to manage social interactions 
by projecting favorable images of themselves, thereby maximizing conformity to others and minimizing 
the danger of receiving negative evaluations from them” (Johnson and Van De Vijver, 2002, p. 196).  
Despite evidence of the prevalence of SDB when using self-reporting or self-administered research 
methods (Fisher, 1993; King and Bruner, 2000; Johnson and Van De Vijver, 2002; Leggett et al., 
2003; Lusk and Norwood, 2006) and hypothetical value elicitation methods (Leggett et al., 2003; Lusk 
and Norwood, 2009; Olynk et al., 2010), non-hypothetical value elicitation studies are seldom the 
subject of social desirability bias research. Nevertheless, social desirability could also bias 
experimental auctions, when higher WTP values reflect bidders’ tendency to make a good impression 
on the auctioneer. This could be of major concern in laboratory based auctions, as scrutinizing 
peoples’ bidding behavior in a controlled environment could create a Hawthorne effect37 (Shogren et 
al., 1999; Levitt and List, 2005), especially when the auctioned good may involve negative reactions 
and the targeted audience is female (Lusk and Norwood, 2006). As these conditions were present in 
our ‘laboratory’ based auctions, prudence is in order.  
 
In an attempt to reduce social desirability beforehand, the following precautions were taken:  
(1) reducing the incentives to overbid as a SDB, by using the 2nd price auction mechanism to penalize 
overbidding more than underbidding (see section 4.3.2.1);  
(2) simplification of the auction procedure by using vulgarized words, removing difficult questions, 
extending the amount of training and emphasizing the weakly dominant strategy to obtain true values;  
(3) making people at ease, e.g. by starting the auction with the easiest part of the survey;  
(4) reducing the bidders’ need to please the auctioneer for the incentives, by separating the participant 
fee (after the auction rounds) and the amount of money to bid (before the auction rounds). In that way, 
bidders are less prone to reciprocal obligation (Lusk and Shogren, 2007), which can be seen as an act 
of social desirability where conformity is triggered by the high participant fee.  
(5) ensuring anonymity, through the use of participant ID codes;  
(6) measuring SDB. 
 
                                                 
37 The classic Hawthorne effect states that participants in an experiment are influenced by their participation in the research itself (see for instance,(Levitt 
and List, 2009). 
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There are basically two ways to measure SDB in value elicitation research.  
One option is to include one of many social desirability scales (SDC), which are originally developed 
for psychological ends. Among the most employed measurements are the Marlowe-Crowne SDC (M-
CSDS, 33 items) and its short-item variants (Crowne and Marlowe, 1960; Ray, 1984; Hays et al., 
1989; Fleming and Zizzo, 2011) and the Eysinck Lie-Scale (EPQ-L) and its short-item variants 
(Eysenck et al., 1985; Lajunen and Scherler, 1999).  
A second approach uses indirect questioning or bidding as a way to depersonalize the personal 
character of the self-reported bids. Therefore, one could ask respondents to estimate what others think 
an auctioned product is worth more than the regular counterpart (Fisher, 1993; Lusk and Norwood, 
2006).  
Both measurements were tested and evaluated during the pilot trials. But as the former was more 
likely to provoke confusion, e.g. because people question the relevance of such questions in a rice 
auction; and to generate a high non-response rate, due to the awareness of being subject to a lie-test, 
only an indirect valuation question was included after the third bidding round (see survey design, 
section 4.3.5). Rather than using an indirect valuation bidding procedure, an indirect valuation stated 
preference question (iWTP) was included in the survey that accompanied the direct valuation bids of 
the auction. By doing so, it is possible to compare both direct and indirect valuations, which might 
reveal potential SDB and validate the direct auction values. 
 
Negative valuations  
An important drawback of using WTP measurement is the fact that one cannot distinguish if someone 
bid zero because she is reluctant or because she is indifferent (Jaeger et al., 2004). A negative value 
approach makes it possible to further analyze why people bid zero: because they refuse to buy the 
product or because they need an incentive (discount) to purchase it. 
Contrary to the general bidding rule, i.e. values truncated at zero, some authors introduced negative 
bids in their Vickrey auction to distinguish indifferent from reluctant people. Broadening the bidding 
rule to allow for negative bidding is relatively new in auction literature (Dickinson and Bailey, 2002; 
Parkhurst et al., 2004; Hobbs et al., 2006; Chern and Chang, 2009; Wang and McCluskey, 2010) and 
could be particularly relevant when auctioning controversial goods (Parkhurst et al., 2004), such as 
GM food products. 
Here, negative bids were allowed for those who bid zero in one certain bidding round of our auction, 
specifically when information about the GM technology is provided (round 3, see section 4.3.4). In 
comparison with previous negative valuation literature, there was an additional bidding option for zero 
bidders in the GM bidding round. By excluding negative bidding from the actual auction rounds, we 
can avoid large negative bids that were submitted in order to increase the monetary benefits.   
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4.3.2.3. Bidding procedures 
 
Bidding procedures differ in terms of the openness of submitting bids (sealed versus orally), the type 
of bidding rounds (repeated rounds versus information rounds, selection of binding round), the number 
of binding auction rounds and the provision of price information (benchmark price versus posted 
prices). The application of each aspect will be shortly discussed in relation to our auction design.  
 
Sealed bids  
Although organizing the 2nd price auctions orally might be valuable to include illiterate people (Wayua 
et al., 2009), the original sealed-bid approach of the Vickrey auction was maintained because it 
reduces the potential risk of bidder affiliation (Jaeger and Harker, 2005).  
 
Information rounds 
The rice auctions consisted of a within-subject design with 5 non-repeated information rounds. This 
makes it possible to measure the effect of additional information treatments on a participants’ WTP 
while controlling for other factors, which is widely done in (GM) food auctions (Noussair et al., 2002; 
Tegene et al., 2003; Jaeger et al., 2004; Hu et al., 2006; Hellyer, 2010; Wang and McCluskey, 2010). 
The innovative approach in our auctions is to capture the effect of different FBR attributes by assigning 
them to different information rounds (see section 4.3.4).  
Although repeated bidding rounds have an important advantage over non-repeated counterpart in that 
they allow the consumers to further learn the procedures of the auction mechanism, several authors 
lend support for a design with non-repeated information rounds (Alfnes and Rickertsen, 2003; Harrison 
et al., 2004; Corrigan and Rousu, 2006b), if extensive training (Drichoutis et al., 2010) and single 
binding is incorporated (see below). 
 
Single binding approach 
An auction with multiple bidding rounds requires a single binding approach to avoid the situation of 
people bidding less on sequential bidding rounds, due to diminished marginal utility or reduced 
demand (Jaeger and Harker, 2005). If a participant won the first round, and had to buy the product, 
she would probably bid lower in the following rounds as the extra utility she will derive from winning the 
same product would be lower. The same holds true for bidding on multiple products.  
Therefore, only one round (and one product in the case of the two-product auctions, see section 4.3.3) 
was randomly selected as binding after the last auction round. In that way, a participant had an equal 
chance to win each round/product, and was informed prior to the first round that the winner will only 
have to buy a single product from the selected round. As a consequence, participants were expected 
to bid honestly in each round (Hobbs et al., 2006) and should behave in the same way as when 
several separate auctions with one single round would have been conducted (Roosen et al., 1998). 
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Benchmark price and price posting 
There is a lot of discussion whether a benchmark price should be provided or not (Harrison et al., 
2004; Bernard and He, 2010). According to Drichoutis et al. (2008) all that can be surmised is that 
there is likely to be an effect of posted prices on bid values. In the rice auctions, only the benchmark 
price of the endowed rice product was posted during the auctions, similarly to other rice auctions in 
developing countries (Corrigan et al., 2009; Rutsaert et al., 2010). In that way, all participants had 
common knowledge of the quality of the auctioned rice product. In line with Harrison et al. (2004), the 
bids of the (winning) participants were not revealed during the auction. This reduces the risk of bidder 
affiliation (Corrigan and Rousu, 2006b), which is likely to occur in auctions with novel, unfamiliar 
goods, such as GM food (List and Shogren, 1999). Nonetheless, the problem of affiliated bids and 
posting prices is mainly associated with the use of repeated rather than information bidding rounds 
(List and Shogren, 1999).  
Avoiding price feedback is further supported by the fact that low value bidders will be highly affected 
by high posted prices, reducing their engagement (Lusk and Shogren, 2007), by which all bids 
converge with the posted winning price (Nunes and Boatwright, 2004). 
 
4.3.3. Study design and participants 
 
When designing the study, an important organizational decision needs to be made: the setting of the 
auction. Recently, the location of experimental auctions tends to shift more and more from the 
laboratory to the field, such as a supermarket (Harrison and List, 2004; Rousu et al., 2005; Knight et 
al., 2007; Corrigan and Rousu, 2008). When comparing both, laboratory auctions typically generate 
higher bids than experiments in a field or retail setting (Shogren et al., 1999; Lusk and Fox, 2003). 
Proponents of the latter question laboratory auctions for the increased risk of social desirability (see 
section 4.3.2.2), the lack of alternative options and real market influences, the more homogenous 
nature of the sample (Rousu et al., 2005) and the requirement of higher participant fees (Lusk et al., 
2001a). Still, laboratory auctions have great merit in that the experimenter can control the setting and 
separately measure the effect of potential, selected determinants on consumers’ bidding behavior. 
Therefore, the rice auctions were organized in a laboratory setting.  
 
Table 29 summarizes the main characteristics of the implemented experimental auction design to elicit 
consumer’s WTP for FBR. The auction design was developed, adjusted and refined during two pilot 
auctions that were held with students in Nanjing Agricultural University, Jiangsu Province. In total, 14 
auction sessions with 252 women of childbearing age were held in Taigu, a rural county of Shanxi 
Province in April 2011. 
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Table 29 Design of the experimental auctions in Shanxi Province 
Target group Auction  
location 
Auctioned  
product(s) 
Timing  Number of 
auctions 
Participants 
per auction 
Total 
participants 
Female students  
= student sample 
School  FBR Morning 1 20 20 
 Afternoon 1 20 20 
 Evening  1 20 20 
FBR + FAR Afternoon 1 20 20 
 Evening  2 20 40 
 ALL Total 6 20 120 
Women of cba 
= non-student 
sample 
Auction room  
near market 
FBR Morning 2 9; 19 28 
 Afternoon 1 19 19 
 Evening  1 19 19 
FBR + FAR Morning 1 16 16 
 Afternoon 2 15;16 31 
 Evening  1 19 19 
 ALL Total 8 16.5 132 
Women of cba  TOTAL Total 14 18 252 
 
cba, childbearing age; FBR, folate biofortified rice; FAR, folic acid pills + rice 
 
Two different auction types can be distinguished, depending on the number of products that were 
involved in the auction.  
In all auctions the endowed product was a regular rice bag of 1 kg (2 jīn), which is available in the 
market at about 5.2 Yuan or 0.8 dollar in 2011. This was the most commonly bought rice bag and 
represents the second lowest quality (see also Figure 14). By using a low quality rice bag to elicit the 
value for the folate trait, the risk of a loss aversion hypothesis is further reduced and the WTP 
measure can be applied. In the first type of auctions, only FBR was auctioned. As this GM rice product 
is not ready for commercialization, and given the assumption that FBR only differs in the folate trait, a 
similar rice bag was used as a GM rice bag. However, in our auctions, we claimed that it was FBR so 
that people actually bid on a product of which they think is genetically modified (see section 4.3.4).  
In the second auction type, however, folic acid supplements were attached to a regular rice bag (FAR) 
and sold next to the FBR. In this way, one of the most important means to increase folate intake levels 
is brought into the auction. Hence, we partly address the need to include substitutes as an auction 
design effect in GM food auctions, as acknowledged by Kassardjian et al. (2005) and Corrigan et al. 
(2005; 2009). To measure the effect of this substitute on WTP for FBR, only half of the participants 
could bid on the two folate products. 
  
Based on the research location, two target groups are distinguished.  
In an auction room in Shanxi Agricultural University, 120 female Shanxi students (18 - 24 year) took 
part in 6 school based auctions. Due to the involvement of the local University staff, it was possible to 
recruit 20 participants per auction. This ‘student sample’ represents the future generation of pregnant 
women. Another 8 auctions were targeted towards Shanxi women of childbearing age (‘non-student 
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sample’), i.e. 132 participants. Here, the auction room was closely situated to a small vegetable 
market and the largest supermarket of Taigu county.   
 
Together, the total sample consists of 252 women of childbearing age. According to Liu (2009), 
auction samples typically vary between 100 and 200 participants, which supports our sample size. The 
size of the two subsamples is considered valuable to measure the effect of the target group and the 
auction type (FAR versus FBR). Due to practical constraints regarding the recruitment of the non-
student sample, the assumption of a fixed set of bidders per auction was not satisfied. Moreover, the 
average number of participants per auction, 18 women, might be considered high compared to a 
common auction size of 10 people. Umberger and Feuz (2004), for instance, discovered a positive 
relation between auction size and the market price. A higher auction size decreases the expected cost 
of deviating from truthful bidding, because it lowers the probability of winning and experiencing 
monetary consequences. Given the limited evidence of negative influences of increasing the auction 
size, and the incentive compatibility of 2nd price auctions, the auction size is expected to be of less 
primordial importance than, for instance, the amount of training these participants receive.  
 
The auctions were held on different days of the week. As auctions during working hours may exhibit a 
sampling bias, leading to higher rates of unemployed people (Wang and McCluskey, 2010), weekend 
and evening auctions were included. Also the timing of the auctions differed, which increases the 
chance of a time-of-the-day effect (Hoffman et al., 1993). Previous auctions with staple crops in 
developing countries pointed out the existence of higher WTP values in the morning (Rutsaert et al., 
2009; De Groote et al., 2010).  
 
The effect of each of the above mentioned auction design characteristics, i.e. target group (student 
versus non-student sample), auction type (FBR versus FBR+FAR), auction size and the timing (time, 
day), is examined in the analysis. 
 
4.3.4. Auction design  
 
Figure 13 gives an overview of the different steps of the experimental auctions, from the recruitment of 
the participants to the debriefing stage.  
Hereunder, each of the auction events will be discussed in the order of occurrence38.  
                                                 
38 For a detailed overview of the whole procedure of the experimental auctions, reference is made to the “FBR auction manual – guide for the Chinese 
researcher”, which was developed to further assist the experimental auctioneers during the auctions in Shanxi Province. This guide is available at:  
http://users.ugent.be/~hdesteur/Auction_guide/    
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Figure 13 Sequence of steps in the experimental auctions in Shanxi Province 
FAR, folic acid pills + rice; FBR, folate biofortified rice; GM, genetic modification; NTD, neural-tube defect; RNI, recommended nutrient intake; pt., Part  
aThe survey consisted of four parts, each related to a specific bidding round: 
- Part A: socio-demographic information and knowledge of folate – before the start of the experiment; 
- Part B: folate related questions (knowledge of benefits, of a women who delivered an NTD, of the National birth defect program, use of folic acid pills – before round 2; 
- Part C: GM food objective knowledge and acceptance of GM food – before round 3; 
- Part D: indirect valuation (estimated WTP of the average Shanxi women) – after round 3 
bIn half of the auctions, rice with free folic acid supplements is provided as a substitute. All information treatments in these 2-product auctions are similar, except for the 3rd and 4th auction round, 
where the non-GM nature of FAR is specifically mentioned. 
cIn the FBR + FAR auctions, a final question was added to the last bidding slip in order to determine consumers’ final product preference.  
STEP 4. Rice auctions 
 
Bid 1+ survey pt. Ba 
 
 
Folate benefits: 
 
reduces the risk of: 
 
- pregnant women: 
NTDs and stillbirths  
- heart and cardio-
vascular diseases 
- Alzheimer, anemia  
 
improves the overall 
resistance to diseases 
Bid 2 + survey pt. Ca 
 
 
 
 
 
GM technology: 
 
FBR is made using 
genetic modification 
(GM) 
 
Provision of GM  
food definition  
 
FAR is not made  
using GM technologyb 
 
 Bid 3 + survey pt. Da 
 
 
 
 
 
 
 GM information: 
 
randomly distributed 
GM information sheets 
 
- positive   
- negative   
- objective   
- positive + negative   
- negative + positive   
- all   
(see Table 30) 
 
Shanxi situation: 
 
- folate deficiency rate 
- burden of folate 
deficiency 
- potential health 
impact of FBR 
 
Auction round 1 
 
 
Auction round 2 
 
 
Auction round 3 
 
 
Auction round 4 
 
 
Auction round 5 
 
 
Bid 4 
 
 
 
 
 
Folate content: 
 
Same taste, appearance, 
… as regular rice  
 
40 times more folate 
 
Regular portion 
allows to achieve the 
RNI of folate 
STEP 2.  
Arrival & Introduction 
 
- consent form & ID  
- explanation procedures 
- survey pt. Aa 
 
STEP 3.  
Training & Practice 
 
- gas cooker example 
- quiz with candy bar  
- chocolate auction trial 
- announcement winner 
STEP 5.  
Debriefing & closing 
 
- selection buyer 
- revealing the truth  
- participant fee  
- free rice bag 
Bid 5c 
 
 
 
 
 
STEP 1. Recruitment 
 
- recruitment form  
- participant conditions 
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Step 1. Recruitment 
 
The participants were required to fulfill the following five criteria: female, of childbearing age, 
consuming and buying rice, living in Shanxi Province and capable of reading and writing. As a 
consequence, no illiterate consumers participated in the auctions. Although this might be interesting 
from a health intervention point of view, it would require oral bidding and an interviewing approach, 
which would have impeded auction procedures, such as sealed bidding (Wayua et al., 2009). 
Participants were recruited by distributing a recruitment form with a schedule of the upcoming auction 
hours. To make sure that not only those who are interested in the study are taking part in the 
experimental auction, participants did not receive specific indications as to the nature (GM, folate,…), 
objective (WTP) and aim of the experimental auctions at the time of recruitment. Potential participants 
are asked to participate in a “consumer experiment with rice”, organized on behalf of Nanjing 
Agricultural University and Shanxi Agricultural University. As people could react differently when they 
would be aware of the involvement of the foreign institute, Ghent University was never mentioned and 
their staff was not physically present during the auctions. To attract the participants, they were also 
informed about the monetary and material incentives, and the maximum duration of the study.  
 
Step 2. Arrival and introduction 
 
Upon arrival at the auction room, each participant was seated and received an informed consent form; 
a specific participant ID, to track her questionnaire and bidding slips; and the first part of the 
questionnaire (part A), which contains information about her socio-demographic profile and knowledge 
of folic acid. When all participants passed on their documents to one of the organizers, a short 
introduction of the partners and the purpose of the session was given, followed by a brief overview of 
the different steps and a summary of the general rules of the auction, including a reminder of the 
confidentiality and anonymity. People were asked not to talk during the session unless told otherwise.  
 
Step 3. Training and Practice 
 
Extensive training, learning through interaction and practice, is considered extremely important to 
avoid confusion and misunderstanding about the auction mechanism and its weakly dominant strategy 
(Brown, 2005; Plott and Zeiler, 2005; Drichoutis et al., 2010).  
Before starting the training and the trial session, people learned the procedures of the 2nd price auction 
mechanism: what is an auction; what do you have to bid (i.e. the highest amount you are truly 
prepared to pay to exchange the conventional product, initially given to you, with an alternative 
auctioned product”); what can you bid (i.e. between 0 and ∞); who has to buy the product (i.e. highest 
bidder in randomly selected round); at what price (i.e. 2nd highest bid) and why to bid honestly (“If you 
bid more than you actually value the product, and you win, you may have to pay more than you think 
it’s worth. On the contrary, if you bid less than your true value, the product might be sold to another 
participant for a price you would have actually wanted to pay”).   
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The training session consisted of two examples, one with a non-food (gas cooker39) and one with a 
food product (candy bar). Hypothetical, numerical bids were shown to illustrate the 2nd price auction 
mechanism. Afterwards, a small quiz was organized to find out if people understand the auction 
mechanism procedures. In the ‘two products’ auctions, the examples were extended to contain two 
auctioned products. 
After the training, a real-money practice round with chocolate is conducted to further familiarize with 
the procedures. To reduce the impact of the trial auction and the improve the learning process, the 
endowed product was cheap, small and well known (Jaeger and Harker, 2005; Liu, 2009; Hellyer, 
2010; Rutsaert et al., 2010). Each participant was given a small regular milk chocolate bar of ¥ 2, 
which was then considered their own chocolate bar, and a trial bidding slip. While the trial in the FBR 
auctions consisted of two rounds with a bigger, dark chocolate bar, two big chocolate bars (black 
versus hazelnut) were auctioned in the FBR+FAR trials.  
 
Step 4. Rice auctions: FBR versus FBR+FAR auctions 
 
Before the rice auction actually started, the general rules were presented once again, e.g. anonymity 
and confidentiality, best strategy, possibility of zero bids, and the selection of buyer. From this point 
on, all communication was prohibited.  
Besides a regular rice bag of 1 kg or ¥ 5.2 (i.e. benchmark price), participants received a bidding slip 
and ¥ 5 as a budget, which could be used to bid on the product(s)40. Regardless of the number of 
auctioned products, five auction rounds were run in the same order, alternated with different parts of 
the questionnaire (see section 4.3.2.3). Each round contained new information about FBR and/or 
FAR, by which participants could adjust or maintain their previous bid. 
 
Below, the different information rounds are described in more detail. Unless otherwise mentioned, the 
information refers to both products in the FBR + FAR auctions. To facilitate consumers’ evaluation 
throughout the rice auctions, the word use was simplified and consequently used, as Tegene et al. 
(2003) suggests. Words, like micronutrients (round 1), biotechnology or genetic engineering (round 3), 
NTDs (round 5), were replaced by more vulgarized or common concepts. 
 
In the first information round, the improved vitamin content of the product was mentioned. Regarding 
FBR, the only difference with the rice bag is its increased folate content, i.e. about 40 times more than 
in the endowed regular rice bag. Participants were informed that it is exactly the same rice bag, except 
for this folate content. All other rice attributes, such as taste, appearance and cooking quality, are 
assumed to be similar. Although the attribute changes are not fully mapped yet (see section 1.3.1.3), 
these assumptions were needed in order to measure the effect of the folate trait.  
                                                 
39 The gas cooker example was chosen as it reflects a common exchange practice in Shanxi Province. New gas cookers are sold door-to-door, where 
people can decide whether they want to pay to upgrade their old gas cooker. 
40 Analogues to the chocolate trial round of the FBR+FAR auctions, the auctioned rice products were presented by a randomly assigned three-digit code. 
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In the case of the rice bag with folic acid pills, seven supplements were attached to a regular rice 
bag41. In this way, the folate content is exactly the same as in FBR, i.e. approximately 40 times higher 
than in the regular rice bag42. By consuming a regular FBR portion or a folic acid pill, one could 
achieve the daily recommended folate intake, which would not be possible with the regular rice bag. 
After reporting their WTP, the consumers received part B of the questionnaire. This part measured the 
knowledge related to folate benefits, and preceded round 2. 
 
The second information round provided the participants with information about the benefits of the 
higher folate content of the auctioned product(s): “Consuming this product (and achieving the daily 
recommended folate intake level) is good for the health of women, because it drastically reduces the 
risk of pregnant women to deliver a baby with a (neural-tube) birth defect, such as spina bifida (split 
spine or open back) or a still birth43. Consuming your regular rice product likely will not protect you 
against having a baby with a birth defect. It also reduces the risk of anemia (lack of oxygen in the 
blood), certain cancers, Alzheimer, coronary and cardiovascular diseases. In addition consuming more 
folate also improves the overall resistance to diseases”. People were then asked if this information 
changed their WTP. If so, they could report a different value, if not, they could indicate the same bid. 
This strategy was consequently followed throughout the auction process. After this round, part C of the 
survey was distributed to measure consumers’ knowledge and acceptance of GM food.  
 
The third information round is considered as the key bidding round. Because this round only mentions 
the GM nature of FBR, it is considered as the GM-round, i.e. the round where people evaluate this 
technology based on their prior believes, without the influence of additional GM related information 
(round 4). Half of the participants also learned about the folic acid pills as a non GM substitute, which 
might affect FBR bids, as Jaeger and Harker (2005) have shown. As the next round will be used to 
provide the participants with GM food information, only a general definition of GM food is mentioned 
here: “GM food is food of which the genetic material has been modified by technology in order to 
introduce new characteristics from plants or animals to other kinds of plants or animals. By doing so, 
the food will be changed in shape, nutritional or consuming quality, and other aspects” (derived 
from(FAO, 2004a; Lusk et al., 2004b; HGP, 2008; Bansal et al., 2010). Although results could be 
influenced when consumers would be informed about the specific characteristics of the transgenic 
technology that has been applied (Jaeger and Harker, 2005; Colson and Huffman, 2009; Novotorova 
and Mazzocco, 2009), only a general GM food definition was provided to reduce the complexity of this 
auction round. 
As this is the last round were all participants receive similar information about FBR, an additional 
bidding slip was given to those who bid zero in this round, i.e. who did not want to pay for FBR. 
Hereby, they were asked if – and how much - they would be willing to buy FBR if the price would be 
                                                 
41 Although there is a clear difference between folic acid and folate (see section 2.3), Mandarin uses a common character for both, which avoids the need to 
clarify this technical difference between folic acid supplements and folate enriched rice to the participants. 
42 A regular rice bag of 1 kg contains 80 µg of folate, while a FBR bag of the same size contains approximately 3 000 µg (see section 2.4.4.2). To be able to 
compare this with FAR, we attached 7 folic acid pills to the bag (2 800 µg). Although the actual folate content between FBR and FAR slightly differs, we only 
mentioned that both products contain about 40 times more folate as the regular rice bag. Therefore, emphasis was put on the achievement of the 
recommended daily folate intake (RNI), rather than the specific folate concentrations. 
43 A drawn picture of neural-tube defects was shown (see Figure 9 in Chapter 2). 
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lower than the regular rice bag. Stated differently, the zero bidders in the 3rd round had the opportunity 
to bid a negative value (see section 4.3.2.2). Here, our approach differs from the study of Parkhurst et 
al. (2004) who incorporated negative values in the bidding procedure itself.  
After this round, people were asked to fill in the last part of the questionnaire, which deals with indirect 
valuation to determine consumers’ stated WTP of the average female consumer in Shanxi Province 
(see section 4.3.2.2 and 4.3.5).  
 
In the fourth information round, each participant received one out of six information sheets which 
contain several statements about genetic modification: positive, negative, positive + negative, negative 
+ positive, objective, all. As Table 30 shows, the different information treatments were equally divided 
between the participants of the FBR and FBR+FAR auctions on the one hand, and two target groups 
on the other.  
While the positive GM information sheet mainly represents the view of the agricultural biotechnology 
industry and supporting organizations like ISAAA, the negative GM information is based on statements 
from the world leading environmental organization, i.e. Greenpeace (2011a), and the only major anti-
biotech NGO in China, i.e. Utopia (2011). Third information was mainly derived from a study of 
Tegene et al. (2003) where the so-called objective, verifiable third party GM information had a 
significant positive impact on the opinion of reluctant US consumers.  
When developing these sheets, special attention was paid to the relevance for the reader, as this 
positively influences their understanding and valuation (Jaeger et al., 2004). For example, each 
information forms contained a statement that refers to the Chinese context. The focus of the 
statements was also broadened to GM food in general, including 1st and 2nd generation GM, as both 
the environmental and health benefits are expected to have a significant impact on consumers’ WTP 
(Frewer et al., 1996; Jaeger et al., 2004; Lusk et al., 2004b; Kassardjian et al., 2005).  
The inclusion of these combined treatments makes it possible to assess whether negative information 
is dominating in two-sided GM information, as Tegene et al. (2003), Hu et al. (2006) and Depositario 
et al. (2009a) found, or whether positive information prevails, in line with other GM food valuation 
studies (Rousu et al., 2004b; Colson and Huffman, 2009; Corrigan et al., 2009). As a consequence, 
also the order of conflicting GM information, i.e. the presence of primacy or recency information order 
effects, could be examined. Therefore, the two-sided information treatment was assigned to twice the 
amount of participants who received another information sheet.  
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Table 30 GM information sheets, per auction type and location, and GM information descriptions. 
Information sheet FBR auctions FBR + FAR auctions Total  
 Student 
sample 
Non-student 
sample  
Student 
sample 
Non-student 
sample 
Positive  10 11 10 11 42 
Negative 10 11 10 11 42 
Positive + negative 10 11 10 11 42 
Negative + positive 10 11 10 11 42 
Objective 10 11 10 11 42 
All (positive + negative + objective) 10 11 10 11 42 
Total 60 66 60 66 252 
GM Food information descriptionsa 
1. Agricultural Biotech Industry view on GM (positive information) 
GM FOOD … 
… is one of the greatest discoveries in agriculture and could lower farmer costs and food prices, e.g. by 
developing crops that are resistant to diseases and drought; 
… could be one of the most environmentally helpful discoveries ever, e.g. by reducing the use of chemical 
insecticides by more than 50 % 
… products, like GM rice, are safe according to the China’s Ministry of Agriculture 
Source: Leading GM food developing companies and research institutes 
2. Environmental Group view on GM (negative information) 
GM FOOD … 
… is very dangerous because unknown adverse effects could be catastrophic; 
… could pose major health problems, such as the development of new allergens; 
… could harm bio-diversity and disturb the eco-system, e.g. some insects developed tolerance towards 
insect-resistant GM crops; 
… is already illegally sold in China without approval of its safety; 
Source: Greenpeace, an international leading environmental group 
3. Independent view on GM (objective information) 
GM FOOD … 
… is a technology where genes are transferred across plants or animals, a process that would not 
otherwise occur;  
…  with improved vitamin content is currently not commercialized in China;  
… has a largely unknown impact on the environment. 
… are produced by businesses that seek profits 
Source: Parties with no financial stake in GM foods. 
FBR, folate biofortified rice; FAR, folic acid pills + rice; GM, genetically modified 
aadapted from different pro-, anti-, and objective GM stakeholders (Tegene et al., 2003; Huffman et al., 2004; Lusk et al., 2004b; 
Huffman et al., 2007; Rousu et al., 2007; Greenpeace India, 2008; Colson and Huffman, 2009; James, 2009a; Waltz, 2010; 
Greenpeace China, 2011b). 
 
Whereas the previous auction rounds focused on product-related information, such as the folate 
content (round 1), the health benefits (round 2), the production method (round 3) and information 
about the production method (round 4), the fifth information round introduced an information treatment 
related to the participants’ residence, Shanxi Province.  
This information treatment revealed the link between the folate benefits of the auctioned product(s) 
and the current situation in Shanxi Province: “Of all Chinese Provinces, Shanxi Province could 
especially benefit from consuming more folate, either by consuming folate enriched GM rice, or rice 
sold together with folic acid pills, instead of regular rice. The current daily folate consumption of Shanxi 
women is far below the daily recommendations. About 40 % of Shanxi pregnant women are assumed 
to be folate deficient, the highest number in China, and one of the highest in the world. Due to their 
low folate intake, Shanxi women deliver every year one of the highest numbers of (neural-tube) birth 
defects, like spina bifida, in the world. About 1-2 out of 100 births in Shanxi Province are characterized 
by a birth defect, which may have been prevented if their mothers had been consuming more folate” 
(adapted from section 2.3.2.1 and 2.3.3). As participants could feel uncomfortable when learning 
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about the low, ‘unhealthy’ folate intake levels of women in this province, this issue is touched as the 
last auction round.  
In the FBR+FAR auctions, the last bid is followed by a short question to determine which of the two 
auctioned products a participant would prefer if both would be available in the store. Such a product 
comparison is also used in contingent valuation methods with other biofortified products (Corrigan et 
al., 2009). After this round, a binding round and/or product, and a buyer was selected. However, in the 
case where FBR was selected as binding, debriefing was required (step 5). 
 
Step 5. Debriefing and closing 
 
No matter which auctioned product was selected as binding, the participants were informed about the 
purpose of the study and, more important, the truth behind the auctioned GM rice product. As our 
product is far from commercialized, we could not sell this product for real when it was selected as 
binding. As participants needed to believe that they were really bidding on a GM rice product with  
high folate content, in order to maintain the non-hypothetical character of the study, they were 
informed that it was necessary to claim that the auctioned product was genetically modified. When this 
product was selected as binding, the exchange was ultimately cancelled. When the FAR bag was 
selected, the exchange and payment took place. This procedure follows Kassardjian et al. (2005).  
Another important debriefing issue is to mention that it is fairly important that participants could not 
communicate with others about the objectives and the true meaning of the experiment. People who 
enter an auction room with knowledge of the true nature of the auctioned GM product would bid 
significantly different than others. To reduce this risk all auctions were conducted in a short time (i.e. 6 
days) at two different locations (i.e. auction room in school and close to the market place).  
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4.3.5. Auction survey  
 
The auction questionnaire consisted of four parts, which were administered in between auction rounds 
(see Figure 13, section 4.3.4). This novel approach of conducting auction surveys requires that the 
experimental auctioneer carefully controls the immediacy of the answers so that a participant is not 
aware of future information treatments.  
This section describes the content of each survey part in the order of occurrence. Some of the 
questions refer to the survey on FBR acceptance in 2008, which is elaborated in chapter 3. 
 
Part A was distributed at the start of the auction and dealt with the socio-demographic profile of the 
female rice consumers. According to the review of Lusk et al. (2005), sample characteristics are 
largely responsible for differences in WTP values between GM food studies. Due to the complexity of 
the auctions, these questions were used to make the participant at ease. The following items are 
adopted from the 2008 survey (see section 3.2.2): age, education, income, farmer family44  and 
residence. As this study is conducted in a poor, rural Chinese region and particularly targets women 
versus students of childbearing age, socio-demographic indicators (e.g. age and education) are 
biased. Furthermore, a yes/no question measured if women were responsible for the rice purchases in 
their household. Knowledge of folate was measured by giving three potential definitions and asking 
participants to pick the one they believed to be correct. 
 
The folate and folic acid related questions of Part B followed the 1st bidding round. First, to see 
whether participants have knowledge of the folate benefits, three alternative options were provided, of 
which only one is correct. Second, two questions referred to the past use and the current intake of folic 
acid pills. The former consists of 5 answer categories (no, never; no, I don’t know; yes, ever; yes, at 
least 2 months before pregnancy; yes, during pregnancy), of which the latter two categories indicate if 
they correctly use it. Current folic acid use (yes/no) is divided into two positive answers, depending if 
they received the supplements for free or not. Knowledge about the Chinese National Program to 
reduce birth defects (see section 2.4.1.2) is expected to be associated with free folic acid supplement 
use. Finally, involvement in the topic is further reflected in the question: “Do you know a woman who 
delivered a baby with a birth defect ?” (no; yes; yes, myself). 
 
Part C precedes the GM related information of the 3rd auction round and, therefore, measures 
consumers’ objective knowledge of GM food, as described in section 3.2.2. The variable GM food 
acceptance is similar to the FBR acceptance construct in the 2008 survey, but refers to the broader 
term of GM food.  
 
Part D of the survey was situated between round 3 and 4 and encompassed indirect valuation to 
measure social desirability bias (see section 4.3.2.2). Indirect or depersonalized stated WTP (iWTP) 
was measured by included the following question after the third bidding round: “Do you think the 
                                                 
44 Compared to the consumer survey in chapter 3, I broadened the farmer related variable to consumers that are living in a household with farming activities, 
rather than being the farmer. 
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average female rice consumer in Shanxi would be willing to pay more to exchange her bag of rice with 
a GM rice bag with higher folate content (and more health benefits)?”. According to their answer, 
people could indicate how much the average Shanxi woman is willing to pay more to exchange her 
product. Although optimal indirect valuation would require attachment of monetary consequences to 
consumer bids, we decided to include this item in the questionnaire, rather than using it as a standard 
bidding procedure throughout the auctions. As such, iWTp must be considered as a stated value.  
 
4.3.6. Data analysis 
 
The data preparation was based on SPSS, version 18. First, some of the variables, such as folic acid 
use, income and education, needed to be recoded into dummy variables in order to be included in 
multivariate data analyses. Second, the objective GM knowledge score was operationalized as in the 
consumer acceptance study (see section 3.2.2).  Third, extreme outliers which might be an indication 
of heavy auction fever are explored. There was only one participant, of which the data needed to be 
removed due to extremely high bids.  
Because the WTP values were not normally distributed, but left-skewed, non-parametric tests were 
required. The Mann-Whitney U test and the Kruskall-Wallis test were applied as the non-parametric 
equivalent of one-way ANOVA to identify significant WTP differences between, respectively, two (e.g. 
number of auctioned products, target group) or more (e.g. auction timing, GM food acceptance) 
grouping variables. To test whether bids differ between two or more information rounds, the Wilcoxon 
(matched-pairs) signed-rank test (two) and the Friedman test (more) were selected45. Chi2-test was 
applied to analyze differences between categorical variables.  
 
Given the typically left censored distribution of mean bids in experimental auctions, with a large 
proportion of bids close or equal to zero, the Tobit regression (Tobin, 1958) or the double-hurdle 
model (Cragg, 1971) are considered as appropriate multivariate techniques to analyze the factors that 
influence WTP for FBR. By using STATA (version 10), the double-hurdle method was utilized because 
it addresses the need to distinguish the participation from the consumption decision process (Haines 
et al., 1988). The double-hurdle is based on a probit model to determine whether participants want to 
bid or not (first hurdle; participation effect), followed by a truncated regression model to explain the 
amount of those who actually bid (second hurdle; consumption effect), i.e. when bids are truncated at 
zero. All entered predictors are either continuous or (recoded into) dichotomous variables. A 10 % 
threshold was used as the least critical level of significance in the double hurdle estimates, which is 
common in WTP valuation studies (e.g.(Lusk et al., 2001a; Maynard et al., 2004; Han and Harrison, 
2006; Froehlich et al., 2009). 
  
                                                 
45 The sign test is similar to the Wilcoxon signed rank test, but the latter is used as it assumed to be more powerful (Roosen et al., 1998). 
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4.4. Results and discussion 
4.4.1. Stated willingness-to-pay for folate biofortified rice (sWTP) 
 
4.4.1.1. Stated WTP for folate biofortified rice 
 
The average price consumers stated to be willing to pay (sWTP) for 1 kg of FBR in 2008 is ¥ 5.15 (or 
US$ 0.8). This is significantly higher than the average price of 1 kg conventional rice, i.e. ¥ 3. Similar 
positive results are obtained in other GM food CV studies in China (Li et al., 2002; Lin et al., 2006).  
As mentioned in the methodology section, sWTP is a continuous variable, based on the valuation of 
consumers that are not resistant to FBR. By using the Mann-Whitney U-test a significant difference 
(p<0.03) is found between the sWTP of favorable and indifferent consumers, with the former (¥ 2.25) 
more willing to pay for FBR than the latter (¥ 1.91). Comparison of these self-reported WTP values 
with the conventional rice price demonstrates that 94.1 % of these respondents want to pay a 
premium (¥ 2.32 on average), while 5.9 % do not accept a higher price, of which 51.1 % asks for a 
discount, ranging from ¥ -0.1 to ¥ -2.0. About 37 persons were excluded from the analysis, as these 
persons are not willing to buy FBR (‘zero bidders’). The high number of people that are prepared to 
pay a premium could be an indication of hypothetical bias.  
Table 31 presents sWTP as a continuous, a truncated or a positive value. The lower, truncated mean 
sWTP value (¥ 2.09) includes the ‘zero bids’ and is compared with the auction values in section 4.4.3.  
 
Table 31 Stated willingness-to-pay  
WTP value n Mean Std. dev. 
sWTP (continuousa) 801 2.15 2.09 
sWTP ≥ 0b 838 2.09 2.06 
sWTP > 0 754 2.32 2.04 
 
Note: 1 ¥ is about US$ 0.15.  
aIncluding negative values. Zero values refer to an indifferent valuation, while those who did not want to pay are excluded; 
bPositive values and ‘zero bidders’, i.e. those who did not want to pay more for FBR.  
 
Because the multiple regression analysis in the next section only includes consumers with subjective 
GM food knowledge, the table below presents the socio-demographic differences in mean sWTP of all 
indifferent and favorable rice consumers. The valuation differences reveal that, within this group, 
women, members of a small family, respondents with a high income or education level and rural 
consumers stated a higher sWTP value.  
 
Table 32 Significant sWTP differences per socio-demographic variable, by Mann-Whitney U test (n=801) 
Variable Categories Mean sWTP p 
Gender Male 1.79 0.00 
 Female 2.49  
Family size <2 persons 2.85 0.01 
 >2 persons 2.11  
Education Low 2.00 0.01 
 High 2.54  
Income Low 2.08 0.00 
 High 3.08  
Residence Urban 2.51 0.00 
 Rural  1.76  
 
Note: sWTP refers to the continuous values as shown in Table 31. 1 ¥ is about US$ 0.15.  
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4.4.1.2. Explaining stated WTP for folate biofortified rice 
 
Multiple regression analysis focuses on those with subjective knowledge in order to identify the 
influence of key concepts of FBR acceptance (see also Figure 2, section 1.3) on sWTP. The model 
(R²: 0.2) shows that age, the importance of health in rice purchase and the GM risk perception have a 
significant positive influence, while family size, residence, subjective GM rice knowledge and 
perceptions of the price impact negatively affects the stated preference (Table 33). The importance of 
each factor is reflected in the size of the standardized coefficients.  
When looking at the socio-demographic profile, living in a rural area, being older than 40 years and 
having a small family increases sWTP. Despite the higher relevance of FBR to women, gender is not 
significant. This might be due to the fact that valuations of women are generally lower than of men 
(Feuz et al., 2004) or because men are less involved in rice purchases and, thus, have limited price 
awareness. Unlike previous research (Kinsey, 1997; 2008), positive income effects on WTP are not 
observed, at least not in the general sample of indifferent and favorable consumers.  
Furthermore, if consumers attach large importance to the health characteristics of rice when 
purchasing it, sWTP for FBR will be higher.  
In line with the acceptance study (chapter 3), there is no one-sided positive effect of objective GM 
knowledge. Instead, stated knowledge about GM rice negatively influences the stated preference. 
With respect to consumer perceptions, people stated higher WTP values when they are less 
concerned about the GM risks. Stated WTP for FBR is lower when people have better expectations of 
its price impact. Although the respondents were explicitly told not to, this relationship shows that some 
consumers might have linked their price expectations to their valuations, which is an important 
criticism of hypothetical (open-ended) valuation (Schkade and Payne, 1994; Lusk and Shogren, 2007). 
The insignificance of acceptance is most likely due to the sample of analysis, which does not contain 
reluctant consumers.  
 
The explained variance of the model increases to 50 % when farmers are analyzed separately. For 
this particular group, sWTP is influenced by education, income and residence. Rural farmers with a 
low income and education level are less willing to purchase. These findings indicate that prosperous 
farmers would (or state to) be more interested in cultivating this GM rice. This lends support for the 
need to attract poor subsistence, rural farmers with more competitive prices (e.g. royalty-free policy; 
Brewster et al., 2005). The significant determinants of the non-farmers sample mainly correspond with 
those of the total sample. 
 
It is important to note that this model is based on continuous WTP values, i.e. without zero bids. As a 
consequence, the results should be carefully interpreted and should not be compared with the 
regression model of the auction-based WTP values (see section 4.4.2.4). For this reason, the main 
focus in this chapter and in the respective research question (RQ4A) will be on the auctions.  
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Table 33 Determinants of sWTP for FBR, by multiple linear regression, split up between farmers and non-farmers   
 
All Farmers Non-farmers 
β p β p β p 
Socio-demographic        
Gender -0.11 0.38 0.02 0.90 -0.09 0.44 
Age 0.12 0.04 0.14 0.22 0.14 0.03 
Family size -0.13 0.02 -0.11 0.27 -0.13 0.02 
Education -0.05 0.46 0.25 0.02 -0.04 0.52 
Income 0.03 0.60 0.46 0.00 -0.03 0.61 
Farmer family 0.01 0.94 NA NA NA NA 
Residence -0.27 0.04 -0.33 0.04 -0.23 0.07 
Perceived importance of rice attributes 
Health 0.14 0.01 0.13 0.24 0.10 0.09 
Knowledge       
Objective GM 0.07 0.21 0.08 0.52 0.06 0.38 
Subjective GM rice -0.10 0.05 0.02 0.89 -0.11 0.05 
Consumer perceptions       
Benefits 0.02 0.77 0.08 0.44 -0.01 0.87 
Risks 0.11 0.04 0.01 0.91 0.17 0.01 
Safety 0.05 0.38 -0.16 0.21 0.07 0.27 
Price impact -0.16 0.00 -0.01 0.91 -0.16 0.01 
Acceptance (versus indifference) 
FBR -0.01 0.92 0.01 0.90 0.02 0.76 
R² 0.21  0.50  0.15  
 
NA, not applicable 
Note: This regression refers to the continuous sWTP variable, as shown in Table 31. To include the knowledge and consumer 
perception variables, only indifferent and favorable consumers with GM food knowledge are included (n=375). All socio-
demographic variables are dummy coded, similar to the multinomial regression analysis in Table 15 (section 3.3.2). 
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4.4.2. Auction-based willingness-to-pay for folate biofortified rice 
(WTP) 
 
The results of the experimental auctions in Shanxi Province are presented in seven different 
subsections. First, the sample descriptive statistics (section 4.4.2.1) and a summary of the bids are 
given (section 4.4.2.2), with a particular focus on the third key round (section 4.4.2.3). The 
determinants of WTP for FBR are mapped in section 4.4.2.4. Section 4.4.2.5 describes the role of the 
different information treatments, while section 4.4.2.6 further explores what information drives people 
to stop bidding (zero bidding behavior).  
 
4.4.2.1. Sample descriptive statistics 
 
The characteristics of the sample are presented according to the target group (Table 34). The 
inclusion of a student subsample imposed limitations with respect to the representativeness of the 
Shanxi population. First, students are highly educated, young women without earnings who are 
seldom in charge of the rice purchase. On the contrary, low education and income levels are 
dominating in the non-student sample, which reflects the current socio-economic situation in Shanxi 
Province. Second, conducting auctions in a rural county led to a higher share of farming families and 
rural consumers, as compared to the province-wide sample in the consumer survey in chapter 3.  
One needs to take into account these target group-based biases. Therefore, a ‘target group’ variable 
was included in the multivariate analysis as an indicator for different socio-demographic differences. 
Hence, when there is a significant target group effect, this will be very much attributable to the distinct 
socio-demographic profile of the two target groups.  
 
The general target group, i.e. women of childbearing age, are better informed about folic acid, its 
benefits and the national birth defect program. This might be due to their age and their history of a 
pregnancy. The use of folic acid is relatively low among this group. Respectively 12.5 % and 22 % of 
the student and non-student sample have ever used folic acid. Current use is lower, but this is likely 
due to low number of pregnant women46. Moreover, only four participants indicated that they used it 
before and during pregnancy, which might be a partial explanation for the low effectiveness of folic 
acid supplementation programs in Shanxi Province (see section 2.4.1.1).  
A large proportion of the sample is aware of a woman who delivered a baby with a birth defect      
(41.3 %), of which three participants delivered a birth defect themselves. Especially in the student 
auctions the knowledge of NTD affected pregnancies is high, which confirms the high prevalence of 
NTDs in Shanxi Province. As expected, knowledge of the birth defect program is significantly related 
with knowing folic acid (χ2≡22.38(2), p<0.001) and its benefits (χ2≡29.81(2), p<0.001), and the use of 
folic acid supplements (χ2≡22.61(2), p<0.001).  
The objective GM knowledge score is significantly higher in the student sample (67 %) than in the 
non-student sample (35 %), of which the latter is consistent with the consumer survey in 2008 (39 %; 
see section 3.3.1).  
                                                 
46 Only 3 participants were pregnant at the time of the auctions. 
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Finally, the GM food acceptance rate of the general target group is almost twice as large as in the 
student sample. Nevertheless, the GM food acceptance rate in this 2011 study, with 78 % of the total 
sample not being reluctant, supports the optimistic view of Shanxi consumers in 2008.  
 
Table 34 Socio-demographic and auction-related variables, per target group 
 Student  
sample  
Non-student 
sample 
Total  
sample 
Variable - continuous mean st.dev   mean st.dev mean st.dev 
Socio-demographic indicators     
Age   20.86 1.29    39.44 9.76   30.41   11.67 
Knowledge       
Objective GM  0.67 0.17 0.35 0.25 0.50 0.27 
Variable Categories n % n % n % 
Socio-demographic indicators     
Educationa  Low 0 0 101 76.5 101 40.1 
 High  120 100.0 31 23.5 151 59.9 
Incomeb Low NA NA 124 93.8 124 93.8 
 High 0 0 8 6.2 8   6.2 
Farmer familyc           Yes 48 40.0 55 41.7 103 40.9 
 No 72 60.0 77 58.3 149 59.1 
Residence Urban 30 25.0 13 9.8 43 17.1 
 Rural  90 75.0 119 90.2 209 82.9 
Rice purchased           No 113 94.2 19 14.4 132 52.4 
 Yes 7 5.8 113 85.6 120 47.6 
Knowledge        
Folic acid No  89 74.2 84 65.2 173 69.2 
 Yes 31 25.8 46 34.8 77 30.8 
Folate benefits No  99 82.5 95 72.0 194 77.0 
 Yes 21 17.5 37 28.0 58 23.0 
NTD womene  No  77 64.2 71 53.8 148 58.7 
 Yes 43 35.8 61 46.2 104 41.3 
Birth defect program No  82 68.3 71 53.8 153 60.7 
 Not sure 26 21.7 23 17.4 49 19.4 
 Yes 12 10.0 38 28.8 50 19.8 
Folic acid usef        
(Ever) use No  105 87.5 103 78.0 208 82.5 
 Yes 15 12.5 29 22.0 44 17.5 
Current use No  105 87.5 115 87.1 220 87.3 
 Yes 11 9.2 9 6.8 20    7.9 
Yes, for free 4 3.3 8 6.1 12    4.8 
Acceptance  
GM food  
No 28 23.3 28 21.2 56 22.2 
Indifferent 67 55.8 54 40.9 121 48.0 
 Yes 25 20.8 50 37.9 75 29.8 
 
cba, childbearing age; NA, not applicable 
aLow: primary or secondary school; high: college or above; bThe threshold for the income variable is a yearly income of ¥ 40 000 
(about 6 152 US$); cFarmer family’ refers to being a member of a farming household; dDummy variable indicating whether the 
respondent is responsible for the rice purchases in her household; eAwareness of a women who delivered a baby with an NTD; 
fPast or current use of folic acid supplements. 
 
 
4.4.2.2. Overview of the bids regarding WTP for FBR and FAR 
 
Table 35 summarizes the main results of the bidding process during the experimental auctions. 
Although this section focuses on the total average WTP values, the average WTP values without zero 
bids are also presented. The data does not reveal extreme outliers, which reduces the probability of 
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auction fever. This phenomenon occurs when the auction conditions drive participants to bid high only 
because they want to win. 
 
Table 35 Overview of average bids, standard deviations, zero bids, per auction type and per auction round 
 Round 1 Round 2 Round 3 Round 4 Round 5 
 FBR FAR FBR FAR  FBR FAR FBR FAR FBR FAR 
Student sample           
N 119 60 119 60 119 60 119 60 119 60 
Average bid (in ¥) 1.22 0.56 1.71 0.80 1.34 0.93 0.70 0.87 1.22 1.35 
Std. deviation 1.06 0.98 1.40 1.20 1.48 1.27 0.92 1.10 1.20 1.37 
Zero bids (#) 12 31 7 18 27 15 48 12 29 4 
Zero bids (%) 10.00 51.67 5.83 30.00 22.50 25.00 40.00 20.00 24.17 6.67 
Av. bid w/o zero bids (in ¥) 1.36 1.17 1.82 1.15 1.74 1.23 1.18 1.09 1.61 1.44 
Std. deviation 1.04 1.15 1.38 1.29 1.47 1.33 0.93 1.13 1.12 1.36 
Non-student sample           
n  132 66 132 66 132 66 132 66 132 66 
Average bid (in ¥) 1.59 0.97 2.23 1.17 2.08 0.94 1.43 0.97 2.09 1.21 
Std. deviation 1.56 1.58 1.82 1.40 1.93 1.35 1.65 1.16 1.88 1.42 
Zero bids (#) 15 30 5 19 17 27 37 21 11 13 
Zero bids (%) 11.36 45.45 3.79 28.79 12.88 40.91 28.03 31.82 8.33 19.70 
Av. bid w/o zero bids (in ¥) 1.79 1.79 2.32 1.64 2.39 1.60 1.99 1.31 2.28 1.51 
Std. deviation 1.54 1.77 1.80 1.41 1.88 1.43 1.64 1.19 1.85 1.44 
Total sample           
n 251 126 251 126 251 126 251 126 251 126 
Average bid (in ¥) 1.42 0.78 1.99 0.99 1.73 0.94 1.09 0.88 1.67 1.28 
Std. deviation 1.36 1.34 1.65 1.32 1.77 1.31 1.40 1.13 1.65 1.39 
Zero bids (#) 27 61 12 37 44 42 85 33 40 17 
Zero bids (%) 10.71 48.41 4.76 29.37 17.46 33.33 33.73 26.19 15.87 13.49 
Av. bid w/o zero bids (in ¥) 1.58 1.51 2.09 1.41 2.10 1.40 1.64 1.20 1.99 1.48 
Std. deviation 1.34 1.55 1.63 1.37 1.74 1.38 1.43 1.16 1.61 1.39 
FAR, folic acid pills + rice; FBR, folate biofortified rice; w/o, without 
Note: 1 ¥ is about US$ 0.15 Bold indicates values of the key auction round regarding FBR. 
 
The Mann-Whitney U test reveals significant differences between the two target groups in all FBR 
bidding rounds, but not for the FAR bids. Except for the first round, all mean FBR bids are significantly 
lower in the group of female students as compared to the non-student sample. The contradiction with 
the general assumption that student and non-student samples generate similar valuations (Lusk et al., 
2005; Depositario et al., 2009b) is only reflected in the FBR bids. This leads to the conclusion that 
besides the socio-demographic characteristics of the two target groups, also the controversial nature 
of an auctioned good account for inter-group variations.  
 
Other design characteristics that could account for bidding differences are the size, the timing, the day 
of the auction and the number of auctioned products. Regarding the auction size it is important to 
notice that only the number of participants in the student auctions could be controlled. Both the 
smallest (n=9) and the largest auction size (n=20) generated the lowest bids. As there is only a clear 
auction size difference for the FBR bids in round 4, where the group size of 16 participants has a 
significantly higher score (p<0.001), other factors are assumed to be more important in differentiating 
the sample. With respect to the time and the day, no significant bid differences were found. Unlike 
previous research (Rutsaert et al., 2009; De Groote et al., 2010), bidding behavior does not differ 
significantly between morning, afternoon or evening sessions, nor between auctions on weekdays 
versus weekends. Regarding the latter, only the 5th round is remarkably higher in the weekend, but the 
significance disappears when analyzing the target groups separately.  
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Another important finding is that, contrary to our expectations, bids are no less different when a folate 
substitute was offered. In every auction round, even in the 3rd auction round, having the option to bid 
on FAR did not result in a significant lower WTP for FBR.  
Looking at the FAR bids of the third information round, only students increased their bid when lowering 
their FBR value. However, students who lacked the possibility to bid on the substitute reduced their 
WTP for FBR in the same way. Even more surprising is the fact that the general target group also 
lowered their FAR bids in the third round, which confirms the unattractiveness of FAR as a substitute. 
Compared to the compliance of taking pills, the convenience of folate incorporated in FBR seems to 
outweigh the absence of GM technology in FAR. Thus, it seems that FAR might be more successful 
for the future generation of mothers, but it is not likely to affect their valuation of folate enriched rice, 
which is lowered in the 3rd round, regardless of having a GM-free option.  
 
At the end of the FBR + FAR auctions, i.e. in half of the auctions, the female rice consumers were 
asked to state their preference when both products would be available in the market. As such, 
consumers’ preference reflects an ‘informed’ choice.  
In general, 61.6 % of the sample prefers FBR over FAR47. The preference differs according to the 
target group (χ2≡22.76(1), p<0.001). While the majority of participants in the non-student auctions are 
in favor of the GM rice variant (81.5 %), the preference of the female students is more oriented 
towards FAR (60 %). It is important to note that this does not mean that students do not want to buy 
FBR, but they generally prefer FAR over FBR, regardless of their value for FBR. 
In nearly all cases, the product with the highest value is preferred. This is important, as it shows that 
the submitted WTP bids represent the valuation of the consumers, rather than their evaluation of the 
(preferred) cost of the auctioned product. Measuring product preference at the end of the auctions can 
be considered an additional tool to validate the bidding procedures and to examine whether 
consumers understand the purpose of bidding. For instance, if a participant expects that her response 
will influence the future price of a product, as Lusk (2007) states, she would probably prefer the 
product with the lowest value.  
  
4.4.2.3. WTP for folate biofortified rice 
 
The third round is considered the key auction round. Here, women bid on FBR with knowledge of the 
nutritional content (round 1), the health benefits (round 2) and the applied GM technology (round 3). 
This is also the last common information round and precedes the GM information treatment (round 4). 
In general, female Shanxi rice consumers are willing to pay 1.73 ¥ (US$ 0.27) more for 1 kg of this GM 
rice variant (see Table 35). Although the premium of 33.7 % appears to be high, similar premiums are 
reported for other biofortified crops in developing countries, such as maize in Kenya (24 %, De Groote 
et al., 2011), rice in India (19.5 %, Deodhar et al., 2008), the Philippines (40.0 %, Depositario, et al., 
2009), and China (38.0 %, Li et al., 2002). Some studies found even higher premiums, e.g. for 
                                                 
47 Another indication of the substantial market demand for FBR is the feedback after the auction. For example, respondent 160, among many other 
participants, asked the auctioneer: “When will this kind of folate rice actually be available, because I want to buy it.” (translated from Chinese) 
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cassava in North-East Brazil (up to 60-70 %, Gonzalez et al., 2009). Nevertheless, one should be 
careful to draw conclusions by comparing premiums from different biofortification studies, as they 
differ in terms of the auctioned products, the targeted audience, the information treatment and 
research location. For example, endowing consumers with a rice product of a higher quality or 
increasing the rice bag weight would not necessarily lead to the same premium or value increase. The 
loss-aversion hypothesis (Tversky and Kahneman, 1991), for example, might reduce consumers’ 
attractiveness to exchange their endowed rice. 
 
Because the size of the premium share is dependent on the volume and the price of the endowed 
product, it is also interesting to look at the absolute increases. When adding this premium price to the 
price of the endowed, regular rice bag (¥ 5.2), FBR is worth ¥ 6.9 per kg. Figure 14 shows how this 
premium is ranked among the ‘currently’ available rice products in Shanxi Province. It illustrates how 
FBR, initially interpreted as a low quality (Q2) product with enhanced folate content, is valued as equal 
to the Q3 rice. In other words, folate biofortification raises the quality of a rice product to the next 
quality level. In this way, the premium is likely to be an indication for price-awareness of Chinese 
consumers (Kim, 2009) 48  and the rising demand for food quality in China, even in low income 
households (Wang and McCluskey, 2010), rather than a prove of auction fever.  
 
 
Figure 14 Benchmarking FBR within the range of market prices for rice in Shanxi Province, in ¥ per kg 
Note: Regular rice prices refer to the Taigu retail market in April 2011. Qx indicates the quality level of the regular rice products. 
Except for the enhanced folate content, FBR is similar as Q2, i.e. the endowed product. 1 ¥ is about US$ 0.15 
 
While the FBR bids are significantly higher in the non-student sample, i.e. 0.74 ¥ higher, the number of 
zero bidders is higher in the student auctions. Stated differently, the students more strongly oppose 
GM rice with folate related health benefits than the general Shanxi consumer, with a non-WTP share 
of 22.5 % and 12.9 %, respectively. This is in line with WTP research on vitamin enriched GM rice in 
China and Golden rice in India, where respectively 81.3 % (Li et al., 2002) and 70 % (IIM, 2007) were 
not reluctant to GM rice. The relatively low number of zero bids might be attributed to the recruitment 
conditions, by which the primary target group of FBR participate in the auctions. The difference 
                                                 
48 In round 2 participant 147 state it as follows: “Even though this rice is very healthy, I consider rice as a main food product in our daily life, so I don’t bid too 
high” (translated from Chinese). 
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between the two subsamples might be also attributed to the lower involvement of students, which is 
expected to lower the bids (Fox, 1995). 
 
The value of rice with free folic acid pills (0.94 ¥) is lower than for FBR, regardless of the target group. 
As stated before, including FAR did not influence the FBR bids, even when people are informed about 
the non-GM nature of the former. Nevertheless, looking at the zero bids reveals an important 
discrepancy between the two subsamples. While the share of zero bids for FBR and FAR are more or 
less similar in the student sample, the FAR zero bidders dominate the non-student sample. Thus, the 
valuation of FBR is significantly lower for students, which is also reflected in the bigger opposition. 
Therefore, when the zero bids would not be taken into consideration, FBR and FAR values are slightly 
converging in the total sample.  
One shortcoming of auction data is the lack of information on the factors that influence the bidding 
behavior. High bids could be due to the extensive training (Drichoutis et al., 2010), the positive 
information rounds about the high nutritional content, the similarities with regular rice (round 1) and the 
potential health benefits (round 2), the high involvement of the participant target groups, the general 
acceptance of the auctioned product and other personal characteristics. The inclusion of an auction 
survey which measures socio-demographic and auction design characteristics is an important step to 
discover the determinants. In the next section, the influence of the most relevant survey variables will 
be examined. 
 
4.4.2.4. Determinants of WTP for FBR  
 
In this section, the determinants of WTP for FBR in the first three rounds are analyzed, as these are 
the common information rounds. Based on the double hurdle model, the factors that influence the 
probability of bidding and the level of the bids are examined.  The variable ‘target group’ is included to 
take into account the socio-demographic differences that characterize the two samples, such as 
education, age and the responsibility of rice purchases. As the objective of this study is to analyze 
WTP for FBR in a poor, rural high-risk region, income is generally low and with insufficient variation, 
by which it cannot be entered in the analysis. Only farmer family and residence are well distributed to 
be included. As several variables were highly correlated, e.g. folic acid use versus current folic acid 
use, the most relevant variable was selected to avoid multicollinearity. 
 
The results of the double-hurdle model per information round (1-3) are presented in Table 36. The 
insignificant effect of auction type, i.e. offering FAR or not, is confirmed throughout the bidding rounds, 
which justifies our choice to analyze both types together. Having the option to bid on FAR does not 
significantly lower the FBR values. Therefore, one could argue that either the folic acid supplements 
are not attractive enough to compensate for potential negative perceptions of GM technology, or GM 
technology is not seen as unattractive enough to outweigh the perceived benefits. 
 
In the first two rounds, where information about folate and its benefits is provided, FBR is presented as 
if it were a conventionally bred biofortified crop. No significant effects are found in the first hurdle 
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during the first two rounds. It seems that the one-sided positive information about the consumer 
benefits is warmly embraced by most of the consumers. This is in line with the positive WTP values for 
conventional biofortified crops, as observed by De Groote et al. (2011). Regarding the level of the 
bids, a target group effect comes into play, with the general target group bidding higher than the 
female students.  
Furthermore, knowledge of the folate benefits increases the level of WTP values, but only in the 
second round. When the experimenter informed participants about these benefits, this appears to 
confirm their initial knowledge by which they bid significantly higher. This supports the presence of a 
confirmation (Schulz-Hardt et al., 2000; Jonas et al., 2001) or congeniality bias (Hart et al., 2009), by 
which information that is consistent with preconceptions is preferred. Such a prior nutritional 
knowledge effect was not found in other valuation studies on biofortified crops (De Groote et al., 2011) 
but does seem to be an important success factor in Asian nutrition interventions (Hardjanti, 2005). 
However, nutritional knowledge does not influence the purchase decision as such. Other variables, 
such as residence, farmer family, current use of folic acid supplements or awareness of a woman with 
a NTD-affected pregnancy are insignificant. 
 
Both hurdles of the GM related third round demonstrate an important target group effect. The general 
target group of women who are of childbearing age, represented in the non-student auctions, have a 
significantly higher probability of bidding and are prepared to pay more than the female students. The 
dummy variable ‘GM food acceptance’ is the most important effect of the model. It positively 
influences the probability of paying for FBR and the amount that is submitted. In other words, people 
who are not resistant to GM food are more willing to pay (more) for FBR. These effects correspond 
with findings from several valuation studies that investigated determinants of WTP for GM food 
(Bredahl et al., 1998; Verdurme et al., 2003b; Lin et al., 2006; Costa-Font et al., 2008), including the 
amount of WTP (Kassardjian et al., 2005; Lusk et al., 2005; Colson and Huffman, 2009).  
Furthermore, the positive impact of objective GM knowledge on WTP is only significant in the first 
hurdle, i.e. higher objective knowledge associates with a higher probability of participation. When 
monetary consequences are attached to stated preferences for a controversial GM product, being less 
correctly informed about the GM technology leads to a higher chance of zero bidding, i.e. reluctance. 
Compared to the FBR acceptance study in chapter 3, where high objective GM knowledge was related 
to either FBR acceptance or reluctance, rather than indifference, these results highlight the importance 
of GM food knowledge when making a purchase decision regarding GM food (House et al., 2004). 
Although not investigated here, more positive GM food consumer perceptions could provide an 
answer to this discrepancy.  
 
Although there is no direct evidence that socio-demographic characteristics influence WTP values - 
which has also been postulated by other researchers (Umberger and Feuz, 2004) - the significant 
effect of the ‘target group’ variable is very likely to have acted as a proxy of socio-demographic 
influences. Being higher educated (House et al., 2004), younger (see Table 33), less responsible for 
rice purchases and less involved are likely to account for such target group differences. With respect 
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to the general low income levels in the non-student sample, the results show that even poor 
consumers are prepared to pay for quality, a finding that has been confirmed in other food auction 
studies in developing countries (Gonzalez et al., 2009; Wayua et al., 2009; Demont et al., 2011; 
Rutsaert et al., 2011). 
 
Table 36 Determinants of WTP for FBR, double hurdle estimations, per information round (1-3) 
Round 1 1st hurdle   2nd hurdle   
 coefficient  st. error     p coefficient st. error     p 
Target groupa -0.094 0.220 0.668      1.511* 0.851 0.076 
Auction typeb 0.290 0.218 0.183 0.812 0.748 0.277 
Farmer family 0.260 0.227 0.252 -0.666 0.746 0.372 
Residence 0.223 0.295 0.225 0.967 1.147 0.399 
Folate benefits 0.098 0.270 0.717 1.300 0.849 0.127 
Constant 0.549 0.497 0.269 -3.096 2.533 0.222 
Sigmac    2.613 0.473 <0.001 
Log likelihood -83.698   -317.045   
n 251   224   
Round 2 1st hurdle   2nd hurdle   
 coefficient  st. error     p coefficient st. error     p 
Target groupa 0.191 0.286 0.504      1.260* 0.666 0.059 
Auction typeb 0.006 0.282 0.982 -0.612 0.605 0.312 
Farmer family 0.004 0.295 0.989 -0.207 0.619 0.738 
Residence 0.011 0.389 0.978 0.073 0.868 0.933 
Folate benefits 0.508 0.442 0.250      1.460** 0.706 0.039 
Current folic acid use  -0.483 0.358 0.177 0.266 0.896 0.766 
Knowledge NTDwomen 0.154 0.299 0.606 -0.130 0.609 0.831 
Constant 1.501 0.657 0.022 -0.689 1.668 0.680 
Sigmac    2.689 0.355 <0.001 
Log likelihood -46.107   -400.145   
n 251   239   
Round 3 1st hurdle   2nd hurdle   
 coefficient  st. error     p coefficient st. error     p 
Target groupa     0.633**   0.263 0.016      2.503** 1.198 0.037 
Auction typeb 0.119 0.201 0.554 -0.252 0.819 0.758 
Farmer family 0.218 0.218 0.317 0.759 0.898 0.398 
Residence 0.107 0.271 0.693 -0.231 1.179 0.845 
Objective GM knowledge      0.784* 0.468 0.094  0.156 1.868 0.933 
GM acceptanced    1.008*** 0.223 0.001      3.357** 1.592 0.035 
Constant 0.044 0.541 0.935 -3.269 2.862 0.253 
Sigmac    3.122 0.518 <0.001 
Log likelihood -102.162   -348.515   
n 251   207   
 
Note: *, **, *** denote statistical significance at 10 %, 5 % and 1 %, respectively. Except for objective GM knowledge, all 
variables are dummy variables (see Table 34). First hurdle = participation model, based on probit regression. Second hurdle 
=consumption model, based on truncated regression. 
a’0’ = student-sample, ‘1’ = non-student sample; b’0’ = one auctioned product (FBR), ‘1’ = two auctioned products (FBR and 
FAR). cSigma is the error variance. dAcceptance of GM food is dichotomized: ‘0’ = indifferent or favorable, ‘2’ = reluctant. Other 
contrasts were excluded due to insignificance. 
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4.4.2.5. The role of information 
 
This section analyzes the influence of information on the valuation of FBR alone, and compared with 
FAR. Except for the 4th auction round, where six GM information treatments are randomly distributed, 
each round consists of one common information treatment, as shown in Table 30. As each participant  
received all information treatments in the same order, the valuation of new information has to be 
perceived as the consumers’ trade-off between the latest information and the preceding information 
treatment(s). By doing so, one cannot interpret the valuation of the GM trait of FBR as an isolated 
information trait, but as an additional characteristic of the auctioned product. This resembles actual 
market behavior, where consumers’ purchase intensions for GM food are determined by their 
evaluation of the different product attributes (Ganiere et al., 2006). 
In order to analyze the effect of the five information rounds, the non-parametric Friedman test for 
repeated measures is applied. Table 37 marks significant differences between the different bidding 
rounds, regardless of the target group or the auctioned product. To analyze the effect of subsequent 
bids and capture the specific information round effects, the Wilcoxon signed-ranked test was used. As 
the null-hypothesis of this test focuses on the median of the paired differences, the median values are 
also presented. Not surprisingly, the FBR bids significantly differ after each information round, while 
consumers’ bids were significantly different for FAR bids only after they received non-GM information.  
 
Table 37 Significant average WTP differences between subsequent information rounds, per auctioned product 
and target group 
Friedman test  FBR (n=251) FAR (n=126) 
  χ2 df  p χ2 df   p 
Student sample  123.15 4  0.00 77.49 4   0.00 
Non-student sample  83.90 4  0.00 22.25 4   0.00 
Total   185.20 4  0.00 83.20 4   0.00 
Wilcoxon   
signed-rank test 
Information  
effect 
Δ Δ 
st.dev p 
Δ Δ 
st.dev p 
mean median mean median 
Student sample          
WTPR2 - WTPR1 Folate benefits 0.49 0.4 0.92 0.00 0.24 0.5 0.52 0.00 
WTPR3 - WTPR2 GM technology -0.37 -0.4 0.89 0.00 0.12 0.0 0.58 0.11 
WTPR4 - WTPR3 GM informationa -0.64 -0.6 1.24 0.00 -0.06 0.0 0.72 0.95 
WTPR5 - WTPR4 Regional situation 0.51 0.6 0.84 0.00 0.48 0.5 0.69 0.00 
Non-student sample          
WTPR2 - WTPR1 Folate benefits 0.65 1.0 1.37 0.00 0.19 0.5 1.04 0.00 
WTPR3 - WTPR2 GM technology -0.16 -0.2 1.43 0.84 -0.22 -0.3 1.07 0.20 
WTPR4 - WTPR3 GM informationa -0.65 -0.8 1.60 0.00 -0.05 0.0 1.03 0.58 
WTPR5 - WTPR4 Regional situation 0.66 0.9 1.17 0.00 0.32 0.4 0.83 0.00 
Total          
WTPR2 - WTPR1 Folate benefits 0.57 0.5 1.18 0.00 0.21 0.3 0.83 0.00 
WTPR3 - WTPR2 GM technology -0.26 -0.2 1.21 0.00 -0.06 0.0 0.89 0.86 
WTPR4 - WTPR3 GM informationa -0.64 -0.8 1.44 0.00 -0.05 0.0 0.89 0.57 
WTPR5 - WTPR4 Regional situation 0.59 0.8 1.03 0.00 0.39 0.5 0.77 0.00 
 
FAR, folic acid pills + rice; FBR, folate biofortified rice; R, Round; WTP, willingness-to-pay 
Note: 1 ¥ is about US$ 0.15 
aAggregated information effect, based on six different information treatments. Specific GM information effects are described in 
Table 38. 
 
 
 
139 
 
Round 1 and 2: Folate related information 
As expected, the provision of information about the higher folate content in FBR (round 1) led to 
substantial WTP values, which are significantly increased when participants learned about the health 
benefits of an improved folate intake level (round 2). A similar trend is observed for FAR, but the 2nd 
round increase is less pronounced.  
 
Round 3: GM technology 
Regarding the GM related rounds, only FBR bids are affected when participants are informed about 
the GM technology in FBR and after the GM information treatment (see also Figure 15). The WTP 
difference between the 2nd and 3rd round can be perceived as the difference in WTP for conventional 
versus transgenic biofortified rice. The results show that bids are lowered in the student sample, but 
did not change significantly in the general target group. Thus, women of childbearing age are not only 
willing to pay more for the folate benefits, but seem to be less concerned about the GM nature of FBR.  
The evaluation of GM technology in FBR in the non-student auctions is not as controversial as what 
might have been expected. This might be caused by the high acceptance rate of GM food (see 
previous section). Reluctant consumers bid on average ¥ 0.92, while the premium of indifferent and 
favorable consumers amounts ¥ 1.71 and ¥ 2.37, respectively (Kruskall-Wallis test, p<0.001). 
However, it is striking that about 60 % of those who state to reject GM food are still bidding in round 3, 
though their bids are lower. This shows that the provision of positive health information can 
compensate for the negative perception of GM technology in food. On the contrary, approximately    
11 % of the participants who claimed to accept GM food, bid zero.  
 
Round 4: GM information 
When consumers are provided with specific GM information, FBR bids are again lowered. As a 
consequence, the FAR bids in the student sample were higher than the FBR values (and zero bidding 
is lower). But this is mainly because they lowered their FBR bids, rather than increasing their FAR 
bids.  
The overall average WTP difference in round 4 tends to be negative (Table 37). A distinction should 
be made according to the different GM information treatments. Table 38 and Figure 15 illustrates how 
the WTP values of FBR in the ‘non-common’ fourth round are affected by the type of GM information. 
Due to the high number of information sheets, the two subsamples are taken together. Despite the fact 
that the participants’ 5th bid is based on the acquisition of different GM information, no significant 4th 
round effect could be observed in these valuations.  
Furthermore, FAR values do not significantly differ according to the provided GM food information 
(Kruskall-Wallis test, p=0.605), even in the student auctions (Kruskall-Wallis test, p=0.279), which 
further supports the low attractiveness of FAR as an alternative to FBR. Nevertheless, the FAR values 
are higher, but not significant, when negative and objective information is provided, either alone or 
together.  
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Table 38 Significant GM information effects, per information treatment, by Wilcoxon signed-rank test  
GM information  
effect 
Descriptives  Wilcoxon signed-rank test 
n   mean   st.dev 
% 
zero bids 
 Δ 
   mean 
Δ 
median 
st.dev 
Positive  41 1.59 1.52 17.1  0.14 0.5 1.54 
Negative 42 0.53 1.03 61.9  -1.28 -1.0 1.69 
Positive + negative 42 1.36 1.82 28.6  -0.25 -0.7 1.10 
Negative + positive 42 0.89 0.96 31.0  -0.67 -0.9 1.09 
Objective 42 1.30 1.55 28.6  -0.98 -0.7 1.33 
All 42 0.87 1.11 25.7  -0.79 -0.6 1.40 
 
GM, genetic modification 
Note: Figures in bold indicate information effects significant at 0.001. GM information effect = WTPR4 - WTPR3. 
 
When evaluating how respondents adjusted their WTP for FBR after the specific GM information 
treatment, the Kruskall-Wallis test reveals a significant difference between the information treatments 
at 0.1 %. The decrease or increase in WTP is most pronounced when, respectively, one-sided 
negative or positive GM information is provided. Somewhat surprising, the objective information 
treatment is ranked 2nd when looking at the WTP reductions. This might be due to difficulties in 
understanding, e.g. ‘gene transfer’ GM definition; the negative connotation surrounding the economic 
impact, e.g. profit-seeking businesses; or the relevance of the biofortification statement, e.g. GM food 
with improved vitamin content is not commercialized in China (see Table 30). The average WTP 
difference of the ‘all’ and ‘negative + positive’ information group approximate the general 4th round 
effect. Contrary to Tegene et al. (2003), both positive and objective GM information in the ‘all’ 
treatment only slightly weakened the effect of the negative statements, further supporting consumers’ 
negative perception of the objective GM information treatment. In the ‘positive + negative’ treatment, 
the downward adjustment is substantially smaller. This lends partial support for the primacy effect, 
which is observed when the information is highly relevant to the consumer (Buda and Zhang, 2000). 
Nevertheless, negative information still dominates in each conflicting information treatment, which 
confirms the general findings in literature (Fox et al., 2002; Tegene et al., 2003; Parkhurst et al., 2004; 
Hu et al., 2006). Although the provision of negative information alone resulted in the least favorable 
valuations, contrary to other GM food (Corrigan et al., 2009) and GM rice auctions (Depositario et al., 
2009a), the participants with conflicting information seem to be also prone to an alarmist reaction. Our 
findings suggest that this hypothesis is not only applicable to two-sided (positive and negative, or vice 
versa) information, as Parkhurst et al. (2004) discovered, but also to the combined treatment (all = 
positive + negative + objective). 
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Figure 15 Significant mean WTP differences between subsequent bidding rounds and per GM information 
treatment in round 4, in ¥ 
R1: nutritional information; R2: health benefits; R3: GM technology, R4: GM information, R5: situation in Shanxi Province 
Note: 1 ¥ is about US$ 0.15. Here, a GM information effect refers to the impact of the different treatments on the mean WTP in 
the 3rd round.  
 
The acceptance of GM food could play a role to mitigate or reinforce the effect of the provided 
information. Overall, the more positive a participant is oriented towards GM food, the higher she will 
bid for FBR in the 4th round (Kruskall-Wallis test, p<0.001). Except for the one-sided positive 
information, where WTP values do not differ according to consumers’ approval of GM food, all other 
information sheets generate higher bids for favorable consumers. The difference is most pronounced 
for objective and one-sided negative information.  
However, to investigate the GM information effect, it is important to investigate the bid differences 
between round 4 and 3, rather than the absolute WTP values. In correspondence with Lusk et al. 
(2004b), favorable consumers are generally more susceptible to the provision of GM information 
(Kruskall-Wallis test, p<0.01). Upon reading the GM information, favorable consumers adapt their 3rd 
bid by drastically lowering their valuation, especially in the case of negative and objective information 
(Kruskall-Wallis test, p<0.05). Indifferent consumers behave similarly, by reducing their WTP, but to a 
lesser extent (Kruskall-Wallis test, p<0.05). People opposed to GM food are sensitive to positive 
information when it is provided alone or prior to negative information (positive + negative). The latter 
conclusion further supports the presence of a primacy effect. In all other cases, the negative 
information reinforced their attitude, by which they further reduced their initially low WTP values. 
Again, a confirmation bias might be responsible for activating the alarmist reaction of reluctant 
consumers.  
Thus, consumer’s GM food attitude is triggered when receiving GM food information, in line with 
attitude theory (Fazio et al., 1982), but it appears to be not strong enough to counter information that is 
opposed their acceptance. These findings are consistent with GM food studies of Colson and Huffman 
(2009) and Frewer et al. (2000). For example, reluctant bidders stop bidding when they received only 
negative information, but not when they also read positive statements. Providing positive or negative 
information alone drives most consumers towards, respectively, higher or lower bids. Thus, our study 
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shows that one-sided information may be as persuasive as conflicting information treatments, which 
contradicts findings from Crowley and Hoyer (1994).  
 
Round 5: Shanxi situation 
In the fifth auction round people are confronted with the current situation in Shanxi Province regarding 
folate deficiency and NTDs. Whereas the FBR values are decreased in the GM related rounds, 
consumers generally react positively on this information by increasing their bid to a level that 
approximates the 2nd round values. Most of them either kept their previously submitted bid (33.1 %) or 
increased it (60.6 %). When the zero bidders are excluded, only 7.1 % reduced their bids, while     
20.9 % maintained and 72.0 % raised the bid. Together with the fact that only 4 respondents turned 
their previous bid into zero, this provides a strong rejection of the hypothesis that many people would 
feel uncomfortable when they are informed about the problematic situation in their own province. The 
insignificant difference between WTP for FBR in the 3rd and 5th round indicates that the FBR bids 
recover from the reduction associated with round 4 (see also Table 35). As the FAR bids are not 
affected by GM information, the valuation of this product increases to its highest level, but still below 
the respective FBR value. 
 
4.4.2.6. Zero-bidding behavior 
 
This section examines the role of information on zero bidding, i.e. when people are not willing to 
purchase the auctioned product in certain rounds. Consistent zero bidding for FBR and FAR occurs in 
0.02 % and 0.10 % of the sample, respectively. In the first two rounds, the number of zero bidders is 
higher for FAR (see Table 35). This shows a preference for FBR when auctioned together with FAR. 
When comparing the impact of GM technology (round 3) on zero bidding, a target group effect is 
shown for FAR. While FBR zero bidders are increased in both target groups, FAR zero bidding is only 
lowered in the students’ sample. This is due to the higher GM food acceptance rate and the 
preference for FBR in the non-student sample. As a consequence, an opposite zero bidding pattern is 
observed after 5 auction rounds. 
 
New zero bidders 
Although the number of zero bids provides insight in the opposition towards both auctioned products, it 
does not reveal the information where a participant starts to bid zero. Figure 16 compares the new and 
the total number of zero bidders in each round. A ‘new zero bidder’ in round x is defined as a 
participant who starts to bid zero after she received the information treatment of this round.  
In round 1 the number of new zero bidders equals the total number of zero bids. Reasons for zero 
bidding in this folate round might be related to the concerns regarding the high folate content or the 
reluctance or inconvenience of taking pills49. As expected, during the GM related information rounds, 
                                                 
49 Examples of comments that were written on the bidding slip support this statement: Respondent 147: “40 times more folate in our rice than regular rice is 
too much, I am afraid that it will have some negative effects to our health”; Respondent 71: “I don’t want to take vitamin pills”; Respondent 114: The pills are 
not very convenient compared to folate in the rice” (translated from Chinese). 
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the number of people that change their positive WTP into a zero bid is the highest50. Zero bids in the 
2nd and 5th round are mainly submitted by participants who bid zero in the previous round.  
 
(a)  (b)  
Figure 16 Zero bidders and new zero bidders regarding (a) FBR and (b) FAR, in number of participants. 
 
Figure 17 focuses on the relationship between the number of zero bidders and the different GM 
information treatments. While zero bidding is most popular in the negative GM information treatment, 
the opposite is seen when only positive information about GM is given. Conflicting information 
treatments have more or less an equal share of new zero bidders. 
 
 
Figure 17 Zero bidding behavior for FBR after the GM information treatment, in number of participants 
 
Negative valuations 
Participants that were not willing to bid for FBR or FAR in the third round received an additional form 
to evaluate whether they would accept it if the price would be lower. Even though negative values are 
not incorporated in the auction process and are, strictly speaking, hypothetical, they help to gain 
insight in the motives behind zero bidding behavior. Out of 44 FBR zero bidders, only 22.7 % are 
consistent in their reluctance and are not willing to buy FBR, even if there would be a discount. The 
                                                 
50 Reasons for zero bidding in the third round include, for example: Respondent: 21: “I don’t want to buy GM rice with more folate in it, because we have 
another way to consume folate”. Respondent 55: “Until now, we don’t know whether the advantage of GM food is bigger than its disadvantage, or vice 
versa, so I put my own health first.”; Respondent 232: “I believe there is no reason to think that this kind of food is safe, so I will not buy it, no matter what 
the price is” ( translated from Chinese). 
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other participants claim to accept FBR if it would be cheaper, i.e. between ¥ 0.2 to ¥ 2.0. These figures 
are comparable with another Chinese GM rice study (Li et al., 2002).  
In the case of the non-GM FAR, only 7.3 % of the zero bidders are not susceptible to a discount. This 
demonstrates that a large part of the zero bidders considers the additional free folic acid supplements 
not to be of more value than regular rice, but will not be averse of buying it when the price would be 
more competitive, i.e. on average ¥ 0.57 lower.  
Comparison of both products shows that awareness of the GM technology causes more people to 
maintain their initial FBR zero bids, but not as much as would have been expected. 
 
4.4.3. Comparing stated (sWTP), auction-based (WTP) and indirect 
valuations (iWTP) 
 
This section compares the auction valuations with indirect or direct, stated valuations. Therefore, the 
latter refers to the same target groups as in the auctions (Table 39).  
 
Table 39 Comparison between WTP, iWTP and sWTP, zero bidders, mean average bids and standard deviation, 
per target group 
WTP value WTPb iWTPc sWTPd Δ  
WTP -  
iWTP 
Δ  
WTP -  
sWTPe 
Δ  
iWTP -  
sWTPf 
Source  Auctions  Auction survey Cons. survey 
 Mean  st. dev  Mean  st. dev  Mean  st. dev  
Student samplea      
N 119 119 81 NA NA NA 
Zero bids (%) 22.50 27.73 6.17 -5.23 16.33 21.56 
Average bid (in ¥) 1.34 1.48 0.97 1.45 2.85 3.43 0.37 -1.51 -1.88 
   w/o zero bids (in ¥) 1.74 1.47 1.33 1.56 3.04 3.46 0.41 -1.30 -1.71 
Non-student sample      
n  132 127 354 NA NA NA 
Zero bids (%) 12.88 19.69 12.43 -6.81 0.45 7.26 
Average bid (in ¥) 2.08 1.93 1.19 1.37 2.34 2.32 0.89 -0.26 -1.15 
   w/o zero bids (in ¥) 2.39 1.88 1.48 1.27 2.67 2.30 0.91 -0.28 -1.19 
All women      
N 251 246 435 NA NA NA 
Zero bids (%) 17.46 23.58 11.26 -6.12 6.20 12.32 
Average bid (in ¥) 1.73 1.77 1.08 1.37 2.43 2.57 0.65 -0.70 -1.35 
   w/o zero bids (in ¥) 2.10 1.74 1.41 1.41 2.74 2.57 0.69 -0.64 -1.33 
 
cba, childbearing age; FAR, folic acid pills + rice; FBR, folate biofortified rice; NA, not applicable; w/o, without 
Note: 1 ¥ is about US$ 0.15  
aDue to the use of age categories in the 2008 consumer survey, the student sample regarding sWTP is aged below 29 years 
(compared to 24 years in the student auctions); bAuction-based WTP as derived from the bidding slip in the 3rd auction round; 
cConsumers’ estimation of WTP for FBR of the average Shanxi women; dBased on the 2008 consumer survey in Shanxi 
Province (see section 3.2.2). Average sWTP bids are truncated at zero (see Table 31); eLarge differences indicate a potential 
hypothetical bias; fLarge differences indicate a potential social desirability bias. 
 
Hypothetical bias 
The non-hypothetical auction-based values are used to evaluate potential hypothetical bias in sWTP 
valuations. In correspondence with the literature, the average stated values for FBR are 40.5 % higher 
than the average auction-based values, which might indicate the existence of a hypothetical bias in 
the former. One could argue that the differences between the hypothetical versus non-hypothetical 
bids, ¥ 0.7 on average, are not large enough to underpin this, especially in the case of the general 
target group (¥ -0.4). Indeed, several authors found that open-ended contingent valuation is less prone 
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to hypothetical bias than other types (Brown et al., 1996; Balistreri et al., 2001). But when looking at 
the zero bidding behavior in the consumer survey, the number of zero bidders in the student sample     
(6.2 %) is remarkably lower than in the respective target group of the auctions (22.5 %). This 
demonstrates that a hypothetical bias is likely to occur when students are stating their preference for 
FBR. Although the (zero) bid differences are less pronounced in the non-student sample, it does not 
imply the absence of hypothetical bias. It is more likely that the generally high values in the auctions 
are responsible for the relatively small gap between direct and indirect valuations in this target group, 
which would mask hypothetical bias.  
 
 
Several reasons can be cited for the high values in the auctions.  
First, the more comprehensive information rounds in the experimental auctions, e.g. information of 
folate benefits by providing a picture of NTDs, are likely to increase the WTP values. Starting with 
positive information might have created an optimistic bias, by which consumers reduce their risk 
perceptions and become overly optimistic (Weinstein, 1980; Lee and Job, 1995). Second, the high 
involvement of the female sample in an experiment with a good that is beneficial to the respondents 
could have further increased WTP values and converged direct and indirect values. In addition, some 
authors found that women generally bid higher than men (Lusk et al., 2004a), although others 
disagreed (Feuz et al., 2004). Fourth, as mentioned in section 4.4.2.3, the extensive trial sessions are 
expected to raise WTP values (Drichoutis et al., 2010). Fifth, the consumer survey (sWTP) and 
auctions (WTP) are conducted in 2008 and 2011, respectively. Therefore, the 2009 approval of GM 
rice in China (Waltz, 2010) and the provincial initiatives regarding the national birth defect program in 
2009 (Chinese Ministry of Health, 2001) could have raised awareness and valuations of the auction 
participants. The data collection might be also affect by the increased price of rice since 2008 (see 
Annex 3), by which the price for 1 kg rice in Shanxi was ¥ 2.2 higher in 2011 (National Bureau of 
Statistics of China, 2011a). Although the WTP values are compared with the current benchmark price 
of regular rice, and interpreted as the price of a product is worth more, the higher prices might have 
influenced the typically price-sensitive Chinese consumer (Kim, 2009). Sixth, the measurement of 
WTP could also play a role. While the survey participants were asked to state their full sWTP, the 
auction participants were subject to an endowment approach. Furthermore, the selection of the target 
groups in the stated valuation method is based on age categories, by which the age range of the 
sWTP student sample is larger than in the auctions. Finally, social desirability bias (SDB) and auction 
fever in experimental auctions could lead to overstated WTP values. 
 
Social desirability bias 
Social desirability can be explored by juxtaposing the WTP and iWTP values for FBR in the 3rd auction 
round. Indirect values are expected to avoid or, at least, reduce SDB because this method 
depersonalizes the valuation exercise in an auction setting. Although this indirect WTP measure is 
based on a survey-based stated preference method (see section 4.3.5) and does not impose 
monetary consequences, the risk of hypothetical bias might be lower due to its inclusion in a non-
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hypothetical experiment which simulates a market environment. Indirect valuation is also useful to 
provide insight in the presence of auction fever, i.e. high valuation driven by competitive behavior. 
Table 39 shows that consumers’ estimation of the WTP of the average Shanxi women is ¥ 0.65 lower 
than their auction-based valuation of FBR. But even in the general target group the price difference is 
still below 1 ¥, which makes it hard to support high bidding behavior as an act of SDB or due to 
auction fever.  
Due to the lower average WTP values in the student auctions, one would have expected that their 
indirect valuation would converge with the valuations of the non-student sample, which represents the 
average Shanxi female rice consumer, leading to a smaller direct-indirect WTP gap. Instead, a 
discrepancy is found between both target groups. This might be explained by a social phenomenon 
where people tend to believe that their own behavior is no different than that from others, i.e. ‘the false 
consensus effect’ (Ross and House, 1977), which could be reinforced by the timing of the indirect 
valuation, i.e. immediately after their WTP bid. Indeed, there is a correlation between ones’ direct and 
indirect valuation (p<0.01). Even 22.4 % of the total sample did not change the value of their bid. 
However, when zero bidders are removed, this percentage drops to 6.9 % of the sample. Most of the 
people (62.2 %) decreased their direct bids, while 15.4 % increased their bids. As for the direction of 
both valuation methods, a similar tendency is observed. On the one hand, half of the zero bidders 
(16.7 %) turned their direct zero bid into a positive, indirect bid. On the other hand, 24.3 % of those 
who valued FBR positively think the average Shanxi women would not be prepared to pay for this 
product, and submitted a zero bid. In total, 41 % of the respondents expect that the average Shanxi 
woman would deviate from her own bids. This reduces the likelihood of a general false consensus 
effect. Another explanation could be that female students are less experienced to estimate the 
valuation of the average Shanxi consumer. This could be due to their lower familiarity with rice prices 
and because they are less responsible for rice purchases (see section 4.4.2.1). 
 
4.5. Conclusions 
 
This chapter investigates WTP for FBR as a GM rice product with health benefits. By means of a 
standardized survey and experimental auctions in Shanxi Province, respectively stated (sWTP) and 
auction-based values (WTP), as well as indirect valuations (iWTP) are determined. As the latter is 
mainly used to explore SDB and validate the WTP bids in the experimental auctions, the focus in this 
chapter is on the hypothetical and non-hypothetical direct value elicitation methods. Although these 
two preference methods are clearly distinct from each other, they demonstrate that a large part of 
Shanxi consumers is willing to pay for FBR. When looking at women of childbearing age, the premium 
for FBR is valued between ¥ 1.73 (WTP) and ¥ 2.43 (sWTP). The number of zero bidders varies 
between 17.5 % and 11.4 %, respectively. These positive results are further supported when FBR is 
auctioned together with FAR as a folate substitute. About 61.6 % of the sample prefers FBR over 
FAR, regardless of their valuation of the latter. Although 39.4 % of consumers prefer FAR at the end of 
the auction, only 15.9 % are averse to FBR. These results confirm the supportive consumer valuations 
for GM food (Curtis et al., 2004; Hu et al., 2006), GM rice with agronomic (Liu, 2009) and nutritional 
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benefits (Li et al., 2002) in China. It also underpins the supportive consumer reactions to FBR, as 
determined in chapter 3. Although FAR is generally evaluated as an unattractive product, it might be 
used as a complementary option for FBR when aiming to attract the future generation of mothers, i.e. 
young, female students of childbearing age. 
 
When comparing the stated and auction-based values, the zero bidding behavior reveals potential 
hypothetical bias in the female student sample. In this target group, the number of zero bids is about 
16.3 % higher when the students elicit their value through experimental auctions. But whether one 
assigns a hypothetical bias to the sWTP results or not, several findings advocate for use of the 
auction-based values. First, the auction values are validated through indirect valuation, as there is a 
minor chance of SDB. Second, the preference question in the ‘two-product” auctions shows that 
people prefer the product with the highest value. Third, the investigated auction design characteristics, 
such as the auction size, time (morning, afternoon or evening) and day (weekend or weekday) of the 
auction, and the availability of folate substitute, did not reveal significant differences in WTP. The 
exception to this was the target group effect, which indicated that female students were less 
supportive of FBR than the general group of women. The latter reacted more positively towards FBR, 
but not towards FAR. This contradicts previous auction literature that found no differences between 
student and non-student samples (Lusk et al., 2005; Depositario et al., 2009b).  
 
The effect of the socio-demographic profile could be examined in both valuation methods. Being old, 
having a small family and living in an urban area significantly increased consumers’ stated WTP for 
FBR. The lower sWTP values of poor, low educated, rural farmers is an important finding, which 
needs to be further explored in order to detect the reasons they attach to their bidding behavior.  
In the experimental auctions, the significant target group effect indirectly demonstrated that socio-
demographic indicators, i.e. age and education, might influence the amount one is willing to pay for 
the increased folate content and, when GM information is provided, determine the purchase decision. 
However, the high acceptance rate of GM food in the non-student sample is more likely responsible 
for this discrepancy in bidding behavior. Students are also expected to be less involved, either 
because they are not concerned with pregnancy issues, or because they are not responsible for the 
rice purchases in their household. 
 
The auction study also revealed important information effects that can be taken into account when 
developing a communication strategy or a promotion campaign for biofortified crops. 
First, auctioning FBR as if it would be conventionally bred - although this is less likely to occur (see 
section 2.4.4.2) - shows that improving nutritional knowledge is important to increase WTP and, in line 
with confirmation bias, the effect of nutritional information on WTP for conventionally bred crops.  
Second, mentioning the GM technology does not necessarily decrease consumers’ valuation, even if a 
non-GM substitute is available. However, when specific information about GM is distributed, bids are 
significantly altered. When consumers have to deal with conflicting information, which is likely to be 
the case in reality, they seem to be subject to an alarmist reaction and a small primacy effect, by 
148 
 
which negative information largely prevails, unless positive information is presented prior to the 
negative statements.  
Third, even more important is that favorable consumers are more susceptible to information that does 
not align with their approval of GM food. On the contrary, reluctant consumers are reinforcing their 
initial attitude when learning about negative statements of GM. This demonstrates that it will be hard to 
convince the latter through an information campaign, if it will be countered by opposite information. 
Moreover, such a situation could discourage those that are not averse of GM food, which is exactly 
what happened when the commercialization of Bt rice in China was put on hold (see section 6.5). 
Therefore, to extend the coverage rate of biofortification interventions, it is recommended to focus on 
improving the consumers’ acceptance of GM (biofortified) food. GM food related knowledge and 
consumer perceptions are key factors to realize this, as chapter 3 has shown.  
Another important finding is the positive effect of information about the current situation and the 
potential for FBR in Shanxi Province. Apparently, it further increases the involvement and awareness 
of the need to consume folate and has the potential to reduce negative GM information effects. 
Similarly, the effect of GM information might be attributed to the inclusion of country-specific 
statements.  
 
 
Because the comprehensive methodology section of this chapter discusses the bottlenecks of the 
stated preference method (e.g. open-ended valuation and hypothetical bias) and the rice auction 
design (e.g. controlled laboratory setting and the Hawthorne effect, endowment and the loss aversion 
hypothesis), the emphasis is put on the recommendations for future research.  
Besides its hypothetical nature, the main limitation and criticism of our open-ended WTP values is the 
assumption that consumers are capable of making a precise estimation of their value for FBR and do 
not feel forced to give a social desirable answer. Therefore, it might be interesting to use an interval 
approach, where consumers indicate a range of WTP values (Håkansson, 2008), rather than asking 
for a fixed WTP estimation, in order to overcome these limitations of open-ended questions. 
 
Like every other valuation method, our experimental auction design is built upon methodological 
choices, which necessarily involve limitations. Future auction research can improve and validate our 
results in several ways, e.g. by exploring how these poor, low educated consumers react to another 
auction mechanism, such as the Becker-Degroot-Marschak (BDM) approach, which is also deemed 
appropriate in poor, rural areas (De Groote et al., 2011), by investigating the influence of the order of 
information rounds and its relation with optimism bias, price feedback, additional outside options 
(Cherry et al., 2004), or a consumption requirement of the purchased product (Corrigan and Rousu, 
2006a). Regarding the latter, for example, previous research emphasized the importance of a 
(hypothetical) after-auction consumption requirement to stimulate truthful bidding behavior for a GM 
product (Fox et al., 1995). 
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As the experimental auctions solely focused on the consumer side, on women of childbearing age in 
particular, future research is needed to measure how much rice farmers’ are willing to pay for FBR 
seeds among other seeds in order to investigate the potential demand on the supply side, i.e. the 
potential adoption rate of FBR. The stated preferences of such farmers is a first indication that poor, 
low educated, rural farmers are less willing to pay for FBR.  
Furthermore, the insignificant auction type effect showed that selling folic acid supplements together 
with rice was not as successful as might have been expected. Although young women do not consider 
it as unattractive, it is seldom seen as a valid alternative when looking for a non-GM substitute. This is 
an important finding which helps to explain the ineffectiveness of folic acid supplementation programs 
(see section 2.4.1.2). Future research should take this into account and try to discover why folic acid 
supplements are not perceived as an attractive product. Convenience and compliance may be 
responsible for this negative perception, as put forward during the auction feedback.  
It might be also interesting to determine the impact of different folate levels on WTP. This study, for 
instance, investigated consumers’ valuation of a rice bag that contains 40 times more folate than in 
regular rice. There might be a folate threshold which drastically improves consumers’ WTP. In 
addition, the effect of adding other micronutrients, or informing about improved agronomic traits, could 
be investigated in order to define consumers’ preference for an improved folate content as one of 
many stacked traits in GM rice. Another novel approach in WTP studies is to combine quantity (‘how 
many’) and quality (‘how much’), instead of focusing only on the latter. By doing so, one could 
determine the market demand for different prices, as Corrigan et al. (2009) successfully demonstrated.  
When FBR would be ready for consumption, future research could introduce a taste session in a 
specific auction round in order to evaluate the sensory aspects of this product. Such product attributes 
may influence consumers’ acceptance and WTP, as shown in food auctions (Hobbs et al., 2006; 
Rutsaert et al., 2009; Hellyer, 2010)(see also section 3.3.4).  
Also the way that information is provided could be improved and further explored. For example, the 
effect of uncensored photos of NTDs could further persuade female participants, either in a negative 
(too much confrontation), but most likely in a positive way (more involvement). Reference can be 
made to the effective current tobacco labeling regulations in China, which requires tobacco companies 
to include uncensored pictures (Fong et al., 2010). The results showed that ‘picture’ warnings are 
significantly more effective than ‘text’ warnings. As a consequence, also the GM information in the 4th 
round might become more effective and realistic if pictures, a newspaper lay-out or labels would be 
used (Ennekinga et al., 2007). Given that GM food labeling is mandatory in China, analyzing the 
effects of GM food labels instead of information could gain insight on how to bring biofortified crops 
most effectively into the market. In this respect, the efforts of De Groote et al. (2010), who simulated 
radio messages, are worth mentioning. With respect to Shanxi Province, such trustworthy audio-visual 
information channels (see section 3.3.3) could be also applied to the regional information about the 
current situation regarding NTDs and folate deficiency. Organizing a discussion information round 
about GM food is another example, suggested by Lusk et al. (2004b). Given that Asian consumers are 
typically more acquainted with negotiable prices, one could also introduce a collective bidding process 
or an individual auction which allows negotiation, such as the BDM. 
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5.1. Introduction and objectives 
 
Folate biofortification and multi-biofortification of the world’s major staple crop is expected to have a 
large impact on micronutrient deficiency related health problems, especially in a rice consuming 
country like China. This chapter estimates the potential health impacts of the introduction of FBR and 
MBR in China, by applying the Disability-Adjusted Life Year (DALY) framework (Murray and Lopez, 
1996; Tan-Torres Edejer et al., 2003)(see section 1.3.2.2).  
Although the DALY framework has been criticized in the past (Anand and Hanson, 1998; Lyttkens, 
2003)(see also section 5.2), it is increasingly used as a method in health impact studies of 2nd 
generation GM products or biofortified crops (Stein et al., 2005b; Horton, 2006; Meenakshi et al., 
2007; Fan et al., 2009). Previous impact studies evaluated the health effects of biofortified crops, such 
as iron fortified beans (Suárez, 2010) and provitamin A enriched crops, e.g. Golden Rice 
(Zimmermann and Qaim, 2004), cassava roots (Manyong, 2004) or sweet potatoes (Fan et al., 2009), 
in developing countries like Bangladesh, Philippines, Nigeria or India.  
 
China is a relatively new area to evaluate biofortified staple crops (Ma et al., 2007; Fan et al., 2009). 
Due to the regional differences in folate intake, rice consumption and NTD prevalence, the health 
impact of FBR is assessed for both northern and southern provinces, at regional and administrative 
divisional level. Furthermore, as previous studies refer to crops biofortified only with single 
micronutrients, and poor people often suffer from multiple micronutrient deficiencies, a country-wide 
ex-ante analysis of the potential health benefits of rice multi-biofortification (MBR) in China is carried 
out. This study evaluates the effect of enriching rice with folate and the three main micronutrients, i.e. 
zinc, iron and vitamin A.  
 
Figure 18 gives an overview of the application of the DALY framework to determine the health benefits 
of the potential introduction of FBR and MBR in China. Hereby, the health gap between a situation 
with and without biofortification is assessed (Figure 18). In a first step, the number of DALYs that are 
currently lost due to folate and other micronutrient deficiencies are assessed. This is the status quo 
without biofortification (current burden). The second step measures the number of DALYs that would 
still be lost when FBR or MBR is implemented. By comparing the number of DALYs lost with and 
without biofortification, the health benefits can be estimated and measured in terms of DALYs saved. 
This requires additional data and assumptions, as shown in Figure 18. The main concepts are further 
elaborated in section 5.2. 
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Figure 18 Application of the DALY framework to assess the potential health benefits of folate biofortified and 
multi-biofortified rice 
DALY, disability-adjusted life year; FD, folate deficiency; ID, iron deficiency; NTD, neural-tube defects; VAD, vitamin A 
deficiency; ZD, zinc deficiency 
Source: Own illustration, based on Zimmermann and Qaim (2004) and Stein et al. (2005b). 
  
To evaluate the estimated health impact of FBR and MBR in China, the number of DALYs saved is 
compared with the costs to introduce these interventions. There is a lot of evidence that a well-
designed, well-targeted policy intervention to tackle micronutrient malnutrition could be cost-effective 
(FAO, 2004b; Klemm et al., 2009; Micronutrient Initiative, 2009; CC, 2011), whether it is based on 
biofortification (Meenakshi et al., 2007; Meenakshi, 2008a), supplementation (Baltussen et al., 2004; 
Fiedler et al., 2008), fortification (Wallich et al., 2001; Horton, 2006; Fiedler et al., 2008) and - although 
less explored (Ruel, 2001), food diversification (FAO/ILSI, 1997; Thompson and Amoroso, 2010). 
When comparing supplementation and fortification programs of main micronutrients, the latter seem to 
be generally the most cost-effective strategy, due to their lower annual costs, while the health impacts 
of the former intervention is often more positive (World Bank, 1994; Mason et al., 1999; Mannar, 2001; 
WHO, 2002). However, when looking at the (recurring) costs of the biofortification strategy, this 
intervention has the potential to be more cost-effective than the currently available interventions 
(Stein, 2006; Meenakshi et al., 2007).  
Section 5.4.3 of this chapter is devoted to the cost-effectiveness of FBR and MBR in China. Besides 
the use of a widely accepted threshold to evaluate micronutrient interventions, the costs and benefits 
are also compared with the results from studies on different biofortified products in various regions. In 
addition, specific attention is paid to the potential of other folate interventions in China and the 
comparison between Shanxi Province and another high-risk region of folate deficiency, i.e. the Indian 
Balrampur District. The sensitivity analysis focuses on the effect of different DALY parameters on the 
health impact analysis in Shanxi Province, and the impact of the applied technology in MBR (see 
section 5.4.5).  
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► maternal mortality 
 
 
 
 
 
 
 
 
 
 
 
 
see Table 3-4  
 
 
Functional outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health impact 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
154 
 
5.2. The Disability-Adjusted Life Year framework  
 
The Disability-Adjusted Life Year approach is used to quantify the burden of folate deficiency or multi-
micronutritional deficiency as a single index, i.e. the number of DALYs lost (Murray and Lopez, 1996; 
Tan-Torres Edejer et al., 2003). This number equals the sum of the “Years Lived with Disability” (YLD) 
and “Years of Life Lost” (YLL), which represent, respectively, disability-weighted morbidity and cause-
specific mortality due to the micronutrient deficiency (see also section 1.3.3). The DALY formula that is 
used to estimate both the death and disease condition resulting from micronutrient malnutrition, 
including folate deficiency, is expressed as:  
 
DALYslost = YLD + YLL =  ∑ TjIijDij (
1−e
−rdij
r
) +  ∑ TjMj (
1−e
−rLj
r
)jj   
         Source: adapted from Murray and Lopez (1996) 
 
The input parameters of the formula are: the total number of people in target group j (Tj), the mortality 
rate associated with the micronutrient deficiency in target group j (Mj), the incidence rate of functional 
outcome i in target group j (Iij), the disability weight for functional outcome i in target group j (Dij), the 
duration of functional outcome i in target group j (dij), the average remaining life expectancy for target 
group j (Lj)51 and the discount rate for future life years (r).  
 
Although this framework is widely recognized as one of the most important tools to measure the 
current health gap and the potential impact of health interventions, it has been criticized on different 
conceptual and ethical issues (Anand and Hanson, 1997; Murray and Acharya, 1997; Arnesen and 
Kapiriri, 2004). Given the specific application of the DALY approach in this PhD dissertation, only the 
three most relevant issues will be tackled.  
First, an age-weighting component as used in the initial GBD study (Murray and Lopez, 1996) poses 
an ethical problem: a higher preference for - and a higher health impact when - saving young adult 
lives instead of those of children or the elderly (Musgrove, 2000). Although valuable socio-emotional 
reasons could be attributed to these weights, Lyttkens (2003) compares such a value statement with 
opening Pandora’s Box. Instead of using different age-weighting factors in a sensitivity analysis, as 
done by Murray (1996), I avoid this ethical discussion by removing any age-weighting factor in our 
analyses, following other health impact studies on biofortified crops (Stein et al., 2005b).  
Second, the use of the disability weights is one of the most controversial aspects of the DALY 
approach (Paalman et al., 1998; Anand et al., 2007). Both the applied methodology to determine the 
disability weights (Lyttkens, 2003) and their socio-cultural applicability are questioned (Allotey et al., 
2003). Anand and Hanson (1997), for instance, disapprove the disability scores because they are 
based on the subjective opinion of an expert panel, while others criticize the DALY approach for its 
lack to adequately include suffering, pain and conditions worse than death (Paalman et al., 1998). 
Another highly criticized issue when measuring DALYs refers to the use of a discount rate.  
                                                 
51 Because tackling a single micronutrient deficiency is not expected to improve the average life expectancy, Chinese life expectancy rates are used. This 
differs from the initial GBD study (Murray and Lopez, 1996), where the maximum biological life expectancy is used, because the GBD affects the life 
expectancy. The need to use regional life expectancy rates when analyzing developing regions is further supported by Musgrove & Fox-Rushby (2006). 
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Discounting attaches a higher value to a saved life today than to saving one in later years. As such, it 
promotes early investment by increasing the benefits of the present generation at the expense of the 
next generations (Murray and Acharya, 1997). For example, applying a discount rate of 3 % to future 
benefits would imply that saving a healthy year this year is, respectively, 14 % or 52 % more worth 
than a healthy year that is saved 5 or 25 years from now on. By doing so, discounting aims to avoid 
excessive sacrifice by the current generation, rather than to claim that future health is less worth. 
Without discounting, the number of DALYs lost before and after biofortification will be also bigger. The 
need for discounting has been justified by three underlying motives: (1) there is a general tendency to 
prefer present over future benefits; (2) there is uncertainty whether a person or an intervention could 
not take advantage of future benefits, for example due to death or a technology that lost its value, 
respectively; and (3) the diminished marginal utility (see also section 4.3.2) (Bowie et al., 1997; Tan-
Torres Edejer et al., 2003). When applied to cost-effectiveness analyses (CEA), both benefits and 
costs have to be discounted to avoid that funds can be invested to generate higher benefits in the 
future and health interventions can be postponed (Musgrove, 2000). Because most criticism refers to 
the level of the discount rate (Brouwer et al., 2005), rather than to the use of a discount rate as such, 
the standard discount rate in widely recognized disease burden and health impact studies, i.e. 3 % 
(Murray and Lopez, 1996; WHO, 2000, 2002; Zimmermann and Qaim, 2004; Evans et al., 2005; Stein 
et al., 2005b; Musgrove and Fox-Rushby, 2006), has been applied throughout this chapter.  
 
With respect to the burden of folate deficiency, only NTDs caused by folate deficiency could be 
included as functional outcomes in the DALY formula. This is because the relationship of folate 
deficiency and other functional outcomes is not clearly defined (see section 2.3.3). The three main 
NTD types, i.e. spina bifida, encephalocele (also known as cranium bifidum) and anencephaly, in 
particular those NTDs that are attributable to folate deficiency, are considered as functional outcomes 
in this study. The target groups referring to these NTDs are births, both fatal and non-fatal, as those 
will be directly influenced by their mother’s biofortified diet. The functional outcomes related to these 
target groups are split into a non-fatal (morbidity) and fatal (mortality) component. While the latter is 
determined by abortions and stillbirths, the former consists of live births suffering from spina bifida or 
encephalocele. The third NTD type, anencephaly, results in death before or shortly after birth and is 
considered as a part of the mortality component (Mathers et al., 1999; Access Economics, 2006). The 
values of the input parameters of the DALY framework are further described in the next sessions.  
 
5.2.1. Assessing the current burden  
 
5.2.1.1. Data and assumptions to measure the current burden of folate deficiency in China 
 
China holds the first position in the world ranking of NTDs (see Figure 10), the most important 
functional outcome of (maternal) folate deficiency. This section further explores the number of NTDs in 
China, its 31 administrative areas and 4 regions52.  
                                                 
52 For a map of the administrative areas/regions, see Figure 24 (Annex 1). 
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Table 40 presents the most relevant demographic statistics to calculate the total number of NTDs 
according to its main type: spina bifida, anencephaly or encephalocele. In 2007, China is 
characterized by a total population of 1.3 billion people and, based on a birth rate of 11.2 births per     
1 000 population, approximately 14 million births. As no recent regional life expectancy rates are 
available, the life expectancy of these births, 71.24 years for China, refers to the year 2000 (National 
Bureau of Statistics of China, 2008c). The regional NTD prevalence rates are expressed per 10 000 
births and refer to NTD affected pregnancies within the period 1996 to 2000 (Dai et al., 2002). These 
rates are then used as approximate incidence rates. In Figure 19, a geographical presentation of the 
NTD prevalence rates per administrative area is shown.  
 
Table 40 Demographic profile of China, total population, birth rate, total births and life expectancy at birth, and 
NTD prevalence rates per functional outcome, per administrative area and region 
Administrative 
area/ Region 
Populationa  Births  NTD rated  
(x 1 000 
persons) Rateb Total Life exp.c Anenc. Spina  Enceph. Total 
NORTH 556 299 10.8 6 028 946 73.19 7.3 10.2 2.4 19.9 
Northeast 458 688 10.4 4 761 446 73.59 6.6 10.3 2.3 19.2 
Beijing  16 171 8.3 134 544 76.10 2.3 5.8 1.4 9.6 
Tianjin  10 996 7.9 86 975 74.91 3.7 10.3 2.2 16.2 
Hebei  70 557 13.3 940 520 72.54 5.1 9.2 2.6 16.9 
Shanxi  34 521 11.3 390 089 71.65 27.2 27.2 6.6 60.9 
Inner Mongolia  24 518 10.2 250 327 69.87 17.0 11.8 3.2 32.0 
Liaoning  43 686 6.9 300 993 73.34 4.3 11.0 1.6 16.9 
Jilin  27 852 7.6 210 284 73.10 5.0 8.2 0.9 14.0 
Heilongjiang 39 103 7.9 308 134 72.37 4.6 5.2 1.3 11.1 
Shandong  95 218 11.1 1 057 870 78.14 1.6 6.8 1.3 9.7 
Henan  96 067 11.3 1 081 711 73.91 5.1 12.4 3.3 20.8 
Northwest 97 611 13.0 1 267 500 72.39 9.4 9.9 2.9 22.2 
Shaanxi  38 203 10.2 390 056 74.70 12.3 14.5 5.8 32.6 
Gansu  26 656 13.1 350 254 71.85 11.7 12.2 2.6 26.5 
Qinghai 5 606 14.9 83 691 72.55 6.6 6.6 2.0 15.3 
Ningxia  6 178 14.8 91 431 68.95 9.2 10.1 1.8 21.1 
Xinjiang  20 969 16.8 352 068 73.92 5.9 4.8 2.5 13.3 
SOUTH 764 524 11.4 8 741 811 69.42 2.7 2.2 0.8 5.8 
Southeast 565 087 11.5 6 524 892 69.96 2.7 2.1 0.8 5.6 
Shanghai  18 564 9.1 168 380 71.54 0.7 0.8 0.4 1.8 
Jiangsu 77 226 9.4 723 603 71.08 1.5 2.0 0.4 3.9 
Zhejiang 50 938 10.4 528 734 70.66 2.6 2.8 0.3 5.7 
Anhui 62 497 12.8 796 833 73.27 5.3 4.0 1.6 10.8 
Fujian  36,393 11.9 433 081 71.29 4.3 1.5 1.2 6.9 
Jiangxi  44 383 13.9 615 153 72.92 2.2 2.5 1.1 5.8 
Hubei  58 231 9.2 535 144 71.73 2.9 2.0 1.3 6.2 
Hunan 64 869 12.0 775 832 71.20 2.6 3.8 1.1 7.4 
Guangdong  95 166 12.0 1 138 180 65.96 2.5 2.1 1.0 5.6 
Guangxi  48 269 14.2 684 936 65.49 5.1 0.7 0.5 6.2 
Hainan  8 551 14.6 125 017 64.37 2.7 1.0 0.2 3.9 
Southwest 199 437 11.1 2 216 919 68.23 2.8 2.7 1.0 6.6 
Sichuan  83 557 9.2 769 557 70.07 1.8 1.5 1.1 4.4 
Guizhou  38 430 13.3 510 350 67.47 4.3 6.9 0.7 11.9 
Yunnan  45 854 13.1 599 776 66.03 1.8 1.0 1.0 3.8 
Tibet 2 874 16.4 47 141 70.17 3.6 3.6 0.0 7.3 
Chongqing  28 722 10.1 290 094 67.41 4.0 2.0 1.6 7.6 
CHINA 1 320 823 11.2 14 770 757 71.24 4.7 5.8 1.7 12.2 
 
aPopulation figures of 2007 are based on the 2008 China Statistical Yearbook (2008c); bBirth rates are expressed per 1 000 
population in 2007, derived from the 2008 China Statistical Yearbook (2008c); cRegional life expectancy at birth in 2000, in 
years (National Bureau of Statistics of China, 2008c); dNTD prevalence rates (1996 – 2000) are expressed per 10 000 births, 
based on a study of Dai et al. (2002).  
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The number of neural-tube defects in China 
Based on the population, the birth rate and the NTD prevalence rate (Table 40), the total number of 
NTDs can be calculated for each administrative area (not presented). To define the number of NTDs 
per functional outcome, reference is made to the composition of NTDs in the study of Li et al. (2006), 
where NTDs were ascertained from live births, still births and induced abortions in Shanxi Province53. 
According to this Chinese study, 31 % of all NTDs are considered to be abortions, while live births and 
stillbirths account for 40.09 % and 28.91 % of all NTDs, respectively. These figures are in line with 
older studies in China (Moore et al., 1997). Within the group of NTD live births, the number of cases of 
spina bifida and encephalocele is determined by the proportion of their prevalence rate and the total 
NTD prevalence rate. Though some studies explored the occurrence of multiple NTDs (Tamura and 
Picciano, 2006; Gu et al., 2007), in which newborns are affected by several malformations, such 
double counts are not included. 
 
Each year, a total of 18 020 pregnancies is affected with an NTD in China, most of them with a fatal 
result (De Steur et al. 2010a). It is important to notice that this total NTD figure refers to all NTDs, i.e. 
NTDs caused by folate deficiency or other factors, such as genetic or environmental factors (Sever, 
1995), except for spontaneous NTD related abortions. Although there is evidence on the positive 
relationship between a history of spontaneous abortions and an increased prevalence of NTDs 
(Todoroff and Shaw, 2000), the number of spontaneous NTD related abortions is not included due to 
data constraints. If information on the number of NTDs that result in a spontaneous termination was 
available, the number of NTDs in China would be higher. 
When comparing Chinese regions, the NTD prevalence rate is a more appropriate indicator than the 
total number of NTDs. Although Shanxi Province, situated in the Northeast, obtains the highest NTD 
prevalence rate (60.9), Northwest China is considered the most problematic Chinese region, with 22.2 
NTDs per 10 000 births. The significant difference between Northern and Southern China is shown in 
both the NTD prevalence rate and the total number of NTDs (see Figure 19). While 31 % of all NTD 
affected pregnancies occur in Southern China, its northern counterpart accounts for more than two 
thirds of all Chinese NTDs (see De Steur et al. 2010a). 
 
 
 
 
 
 
 
 
 
 
                                                 
53 While abortions are considered as a voluntary or spontaneous termination of a pregnancy, stillbirths are defined as births of a baby with no signs of life 
(WHO, 2001a). Due to a lack of data on spontaneous abortions, only voluntary (induced) NTD abortions are calculated.  
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Figure 19 NTD prevalence rates in China, per administrative region (1996-2000), in the number of NTDs 
expressed per 10 000 births 
Source: Own illustration, based on Table 40 and Dai et al. (2002) 
 
The number of neural-tube defects caused by folate deficiency in China 
Although the total number of NTDs is generally acknowledged as the indicator of the magnitude of 
folate deficiency (see section 2.3.3), only a part of these NTDs are attributable to the suboptimal 
intake of this micronutrient. As there is a lack of data on the attribution of folate deficiency to other 
functional outcomes, NTDs caused by folate deficiency are the only functional outcomes of folate 
deficiency that will be included in the DALY framework. This implies an underestimation of the global 
burden of folate deficiency. Nevertheless, as NTDs are not only considered as the main adverse 
health outcome of folate deficiency, but also as the world’s major congenital malformation, the number 
of NTDs caused by folate deficiency is a valuable indicator to measure its current burden. Due to the 
lack of data on the attribution of folate deficiency to NTDs in each administrative area, two regional 
attribution levels are used to determine this number: 40 % in Southern and 85 % in Northern provinces 
(Berry et al., 1999)(see also section 2.3.3). 
Based on these regional attribution levels and the total number of NTDs, the number of NTDs caused 
by folate deficiency is calculated (Table 41). The use of different attribution levels further demonstrate 
the discrepancy between Northern and Southern China. No less than 83 % of all these NTD affected 
pregnancies in China occur in the north, and in particular, in the northwest. Even more striking is the 
number of the NTDs in Shanxi Province, which is almost as high as the whole southern part. With 
respect to the different functional outcomes, almost 60 % of the NTDs has a fatal outcome. If the NTD 
results in a live birth, malformations in the back (i.e. spina bifida) are the most frequent outcome.  
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Table 41 Neural-tube defects caused by folate deficiency in China, per functional outcome, per administrative 
area and region 
Region/  
Administrative  
area 
Non-Fatal Fatal    Total 
   Spina Enceph. Total   Abort. Stillb. Total  
NORTH 3 363 877 4 240 3 279 3 058 6 336 10 576 
Northeast 2 599 624 3 223 2 492 2 324 4 816 8 038 
Beijing  35 9 44 34 32 66 110 
Tianjin  40 8 48 37 35 72 120 
Hebei  424 119 543 420 392 812 1 355 
Shanxi  652 158 809 626 584 1 209 2 019 
Inner Mongolia  215 58 273 211 197 407 680 
Liaoning  151 22 173 134 125 259 433 
Jilin  91 9 101 78 73 150 251 
Heilongjiang 93 23 117 90 84 175 291 
Shandong  293 55 348 269 251 520 868 
Henan  604 162 766 593 553 1 145 1 912 
Northwest 765 253 1 018 787 734 1 521 2 538 
Shaanxi  310 123 433 335 312 647 1 080 
Gansu  261 55 316 244 228 472 788 
Qinghai 33 10 44 34 32 65 109 
Ningxia  56 10 66 51 47 98 164 
Xinjiang  105 55 159 123 115 238 397 
SOUTH 634 261 894 692 645 1 337 2 231 
Southeast 470 195 666 515 480 995 1 660 
Shanghai  3 2 5 4 4 7 12 
Jiangsu 38 7 45 35 33 68 113 
Zhejiang 43 5 48 37 35 72 121 
Anhui 99 39 138 107 100 206 345 
Fujian  27 21 48 37 35 72 120 
Jiangxi  40 18 57 44 41 85 143 
Hubei  32 21 53 41 38 79 132 
Hunan 72 20 92 71 67 138 230 
Guangdong  68 34 102 79 74 152 255 
Guangxi  41 27 68 53 49 102 171 
Hainan  6 1 8 6 6 12 19 
Southwest 163 65 229 177 165 342 571 
Sichuan  32 22 54 42 39 81 135 
Guizhou  88 10 98 75 70 146 243 
Yunnan  18 18 36 28 26 54 90 
Tibet 6 0 6 4 4 8 14 
Chongqing  20 15 35 27 25 53 88 
CHINA 3 997 1 137 5 134 3 970 3 703 7 673 12 807 
Note: These figures are determined by the total number of NTDs (see De Steur et al. 2010a) and the attribution level of folate 
deficiency to NTDs in Northern (85 %) and Southern China (40 %). 
 
Input parameters of the DALY formula to measure the current burden of folate deficiency in China 
The table below summarizes all input parameters that are included in the DALY formula. The 
combined input parameters TjIij and TjMj refer to, respectively, the non-fatal and fatal functional 
outcomes of NTDs caused by folate deficiency, which are also shown in Table 41. The disability 
weights of the functional outcomes (Dij) differ according to the level of severity or disability, and range 
from 0 (‘healthy’) to 1 (‘death’) (Murray and Lopez, 1996). The average remaining life expectancy (Lj) 
of stillbirths and abortions refers to the average life expectancy at birth (see Table 40, column 5). The 
duration of a non-fatal NTD (dij) is assumed to be permanent, by which dij equals Lj. Based on the 
global burden of disease study of Mathers et al. (1999), a disability weight of 0.593 and 0.52 is 
attributed to spina bifida and encephalocele, respectively. The discount rate for future life years (r) 
amounts to 3 percent, as this is the widely acknowledged standard rate in health impact analyses 
(Evans et al., 2005). 
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Table 42 Overview of the input parameters of the DALY formula, applied to folate deficiency in China  
Functional outcome TjIij TjMj Dij Lj=dij r 
Morbidity      
Spina bifida Table 41, column 2 NA 0.593 
Table 40, column 5  3 % 
Encephalocele Table 41, column 3 NA 0.520 
Mortality      
Stillbirths NA Table 41, column 6 NA 
Table 40, column 5  3 % 
Abortions NA Table 41, column 5 NA 
dij, the duration of functional outcome i in target group j; Dij, the disability weight for functional outcome i in target group j; Iij, 
incidence rate of functional outcome i in target group j; Lj, the average remaining life expectancy for target group j; Mj, the 
mortality rate associated with the deficiency in target group j; NA, not applicable; r, discount rate for future life years; Tj, total 
number of people in target group j.  
 
 
5.2.1.2. Data and assumptions to measure the current burden of vitamin A, iron and zinc 
deficiency in China 
 
Table 43 summarizes the parameter values for all included functional outcomes of micronutrient 
malnutrition in China, applied to the relevant target group and split up between fatal and non-fatal 
results. All data sources and calculation methods are provided in the table footnotes. Functional 
outcomes on which there is robust evidence on the attribution level (AL) of one of the four deficiencies 
are included. In the case of folate deficiency, for instance, there is evidence on its causal relationship 
with NTDs, but conclusive data on its potential association with anemia and other adverse health 
outcomes is lacking. Furthermore, as the incidence of functional outcomes is not always available, 
prevalence rates are transformed into incidence rates. 
 
The data on folate deficiency refer to the national figures of the previous section and are only 
presented for the sake of completeness.  
Vitamin A deficiency primarily affects children under 5 through measles, blindness and corneal 
scarring, with an attribution level of 10 %, and is responsible for all nightblindness in children and 
pregnant women. The vitamin A related functional outcomes also differ in duration, with a relatively 
short period of nightblindness compared to permanent outcomes, such as corneal scarring and 
blindness. The biggest problem of vitamin A deficiency, however, is its association with child mortality. 
West et al. (2010) found that between 23 % and 34 % of childhood mortality in Sub-Saharan Africa 
and Southern Asia is attributable to vitamin A deficiency. As a conservative assumption, the lower 
value of 23% is applied here. 
Zinc deficiency is also associated with child mortality, but the AL of 4% is much lower (Jones et al., 
2003). Other adverse functional outcomes of zinc deficiency include stunting and infectious diseases 
such as diarrhea and pneumonia. Incidence rates of diarrhea and pneumonia among children refer to 
infants and children between 1-5 years of age. 
The DALY parameters to estimate the burden of iron deficiency (ID) are derived from Chinese iron 
deficiency anemia (IDA) data for four target groups and two groups of functional outcomes, namely 
impaired physical activity and impaired mental development. Mild IDA is excluded due to the uncertain 
link with functional outcomes.  
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Through IDA related fatal pregnancies, IDA mortality affects mothers, newborns and, due to the lack of 
breastfeeding, children. Maternal IDA related deaths occur in 5% of all fatal pregnancies (Stein et al., 
2005b). Thirty percent of these fatal pregnancies lead to stillbirth, while 9.1% of the surviving births die 
because they could not be breastfed (Jones et al., 2003).   
Common parameters of the DALY formula, such as the disability weights and the remaining life 
expectancies are derived from the Global Burden of Disease (GBD) study (Murray and Lopez, 1996) 
and the Chinese WHO life tables (WHO, 2008b). As in the previous section, a discount rate of 3 % is 
applied. 
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Table 43 Input parameters of the DALY framework to measure the current burden of micronutrient malnutrition (folate, vitamin A, zinc, iron) in China, non-fatal and fatal 
functional outcomes per micronutrient deficiency. 
FOLATE Demographic indicators All causes FD 
           
Non-fatal 
outcomes 
Target 
groups 
Population 
size (Tj)a 
Prevalence 
rate 
Incidence 
rateb 
AL  
FD (%)c 
Incidence 
rate (Iij)b 
Tj Iij 
 
Disability 
weight (Dij)d 
Av. age  
of onset 
Duration (dij)e 
 
spina bifida births 14 770 757 / 3.81 71.07 2.71 3 997.18      0.593 0 73.8  
encephalocele births 14 770 757 / 1.08 71.07 0.77 1 137.26      0.52 0 73.8  
Fatal 
outcomes    
Mortality 
rateb  
Mortality 
rate (Mj)b 
TjMj 
  
Av. age  
of death 
Av. remaining  
life exp. (Lj)e 
abortions births 14 770 757 / 3.78 71.07 2.69 3 970.26 (1.00) 0 73.8  
stillbirths births 14 770 757 / 3.53 71.07 2.51 3 702.59 (1.00) 0 73.8  
VITAMIN A Demographic indicators All causes VAD 
           
Non-fatal 
outcomes 
Target 
groups 
Population 
size (Tj)a 
Prevalence 
rate 
Incidence 
rate  
AL  
VAD (%) 
Incidence 
rate (Iij) 
Tj Iij 
 
Disability 
weight (Dij)d 
Av. age  
of onset 
Duration (dij) 
 
measles children < 5 yrs 85 803 286 1.98f     72.09j 10m      7.21 6 185.34        0.35 / 0.03 (10 days) 
measles w complic. children < 5 yrs 85 803 286 1.98f     36.04j 10m      3.60 3 092.67 0.7 / 0.05 (20 days) 
nightblindness children < 5 yrs 85 803 286 0.10 %g       0.10 %j 100m       0.10 85 803.29        0.05 / 1  
corneal scarring children < 5 yrs 85 803 286 0.10 %g 0.02 %k       10n  0.002 1 716.07 0.2 1 74.20e 
blindness children < 5 yrs 85 803 286 0.20 %h 0.04 %k       10n  0.004 3 432.00 0.5 1 74.20e 
nightblindness pregnant women 14 770 757 4.20 %i     10.08 %j 100m    10.08 148 889.23 0.1 / 0.42 yr (5 months) 
Fatal 
outcomes    
Mortality 
rate   
Mortality 
rate (Mj) 
TjMj 
  
Av. age  
of death 
Av. remaining  
life exp. (Lj)e 
mortality  children < 5 85 803 286     / 19l 23o 4.37 64 548.21 (1.00) 1 74.20 
ZINC Demographic indicators All causes ZD 
           
Non-fatal 
outcomes 
Target 
groups 
Population 
size (Tj)a 
Prevalence 
ratep 
Incidence 
rateq  
AL  
ZD (%) 
Incidence 
rate (Iij)q 
Tj Iij 
 
Disability 
weight (Dij)d 
Av. age  
of onset Duration (dij) 
diarrhea infants  17 170 674 13.18 16.04j 18r 2.88 49 574 312   0.2 / 0.008 (3 days) 
pneumonia infants  17 170 674 22.58 20.61j 41r 8.45 145 074 849   0.3 / 0.011 (4 days) 
stunting infants  17 170 674 / 5.95      100 5.95 1 021 655  0.0001 0.5 73.8e 
diarrhea children (1-5 yrs) 68 682 698 8.70 7.94j 18r 1.43 98 145 858   0.15 / 0.011 (4 days) 
pneumonia children (1-5 yrs) 68 682 698 23.00 20.99j 41r 8.61 591 006 029  0.2 / 0.011 (4 days) 
Fatal 
outcomes    
Mortality 
rate  
Mortality 
rate (Mj) 
TjMj 
  
Av. age  
of death 
Av. remaining  
life exp. (Lj)e 
increased mortality infants  17 170 674 / 17l 4s 0.68 10 044.12 (1.00) 0.67  74.1 
increased mortality children (1-4 yrs) 51 512 023 / 19l 4s 0.76 11 225.78 (1.00) 2.00 73.2 
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Table 43 (continued) 
IRON Demographic indicators All IDA types IDA types 
           
Non-fatal 
outcomes 
Target 
groups 
Population 
size (Tj)a 
Prevalence 
rate 
Incidence 
ratek 
AL IDA types 
(%)w 
Incidence 
rate (Iij) 
Tj Iij 
 
Disability 
weight (Dij)d 
Av. age  
of onsetg 
Duration (dij) 
 
impaired physical activity           
moderate children < 5 85 853 372 
8.00t 1.33 
0.562 0.75 643 327.94 0.11 0.5 4.50 
severe children < 5 85 853 372 0.038 0.05 43 499.04         0.087 0.5 4.50 
moderate children 6-14 150 231 072 
17.94u 1.99 
0.562 1.12 1 682 499.54 0.11 6 8.00 
severe children 6-14 150 231 072 0.038 0.08 113 763.31         0.087 6 8.00 
moderate men 15+ 487 312 627 
9.52u 0.16 
0.562 0.09 448 750.35 0.11 15 58.70e 
severe men 15+ 487 312 627 0.038 0.01 30 342.55 0.09 15 58.70e 
moderate women 15+ 473 856 262 
16.92u 0.27 
0.562 0.15 730 078.87 0.11 15 62.90e 
severe women 15+ 473 856 262 0.038 0.01 49 364.76 0.09 15 62.90e 
impaired mental development          
moderate children < 5 85 853 372 
8.00t 1.33 
0.562 0.75 643 327.94         0.006 5 70.40e 
severe children < 5 85 853 372 0.038 0.05 43 499.04         0.024 5 70.40e 
Fatal 
outcomes    
Mortality 
rate 
AL IDA 
(%) 
Mortality 
rate (Mj)v 
TjMj 
  
Av. age  
of death 
Av. remaining  
life exp. (Lj)e 
maternal mortality births 14 770 757 / 41.3v 5    2.07 305.02 (1.00)      27z 52.1 
stillbirths fatal pregnancies 14 770 757 / / /    0.06x 91.50 (1.00) 0 73.8 
child mortality fatal pregnancies 14 770 757 / 19.0l /    0.00099y 0.15 (1.00) 1 74.2 
 
AL= attribution level; FD = folate deficiency; IDA = iron deficiency anemia; VAD = vitamin A deficiency; ZD = zinc deficiency 
Note: Input parameters are based on Stein et al. (2005b), unless otherwise stated. The discount rate (r) is set at 3 %. 
 
aNational Bureau of Statistics of China (2008c). The number of pregnant women is derived from the number of reported births. This figure is both an under- or overestimation, because this figure 
does not take into account the non-reported births and the share of women that are pregnant of a twin or triplet, respectively; bExpressed per 10 000 births. The share of the different non-fatal and 
fatal outcomes is derived from Dai et al. (2002) and Li et al. (2006), respectively: spina bifida (31.21 %), encephalocele (8.88 %), abortions (31 %) and stillbirths (28.91 %); cThe percentage of NTDs 
that is attributable to folate deficiency is based on the Chinese national attribution level of 71.07 % (see Table 40); dDisability weights of the Global Burden of Disease study, as defined by Murray 
and Lopez (1996); eThe remaining life expectancy at different ages are based on the Chinese WHO life tables in 2008 (WHO, 2008b); f The total prevalence of measles in children below 5 years is 
3.95 per 100 000 children (Hao et al., 2010). An estimated 50 % of these cases involve complications (Stein et al., 2008b); gBased on a large-scale nationwide survey on vitamin A deficiency (Lin et 
al., 2002; Jingxiong et al., 2006; WHO, 2009b); hOwn calculations, based on Chinese estimates of childhood blindness (WHO, 1999) and applied on the most recent figure of the blind population in 
China, i.e. 6.6 million (CDPF, 2006). iWHO Global Database on Vitamin A Deficiency (WHO, 2009b); jThe incidence rate of a temporary functional outcome is based on the formula: ‘prevalence 
rate’/‘duration of the disease’ (Stein et al., 2005b); kThe incidence rate of a permanent functional outcome is based on the formula: ‘prevalence rate'*‘size 1st age cohort’/‘size target group’ (Stein et 
al., 2005b); lMortality rates refer to 2009, expressed per 1 000 births (National Bureau of Statistics of China, 2008b; UNICEF, 2011); mExpressed in % of all measles, with or without complications; 
nExpressed in % of all corneal scarring (children under 5 years); oBased on a meta-analysis of West et al. (2010); pThe prevalence rates of non-fatal outcomes of zinc deficiency in China are based 
on Chen et al. (2004), expressed in %; qExpressed in times per year, except for the stunting incidence rate of Chen et al. (2004), i.e. 5.95 % of all infants; rBased on a zinc supplementation study by 
Bhutta et al. (1999); sAttribution level as reported by the Bellagio Child Survival Study Group (Jones et al., 2003); tThe prevalence of IDA in children below 5 years refers to 2004 (Micronutrient 
Initiative, 2011b); uOwn calculations, derived from the total anemia rates in children/men (WHO, 2006b) and women (Ma et al., 2007), and the attribution level of ID to anemia, i.e. 85 % in China (Ma 
et al., 2007). Depending on the target group, the IDA prevalence rate refers to the year 2000 (children/men) or 2002 (women); vThe mortality rate of pregnant women is expressed per 100 000 births 
(National Bureau of Statistics of China, 2008b); wAccording to Rastogi and Mathers (2000), three different IDA types can be distinguished, depending on their severity. In China, the estimated share 
of each type is as follows: mild (0.4 %), moderate (0.562 %) and severe IDA (0.038 %); xAbout 30 % percent of all IDA-related fatal pregnancies are assumed to result in a stillbirth (Jones et al., 
2003); yOf the 70 % newborns that survive their mothers death that is caused by iron deficiency, about 13 % would not die during childhood if they would have been breastfed (Jones et al., 2003). 
Taking into account the share of exclusively breastfed children, i.e. 28 % in China (UNICEF, 2011), the incidence of deaths in children below 5 years that is indirectly related to maternal IDA, is 
calculated as: 0.019*0.7*0.13*0.28*‘maternal mortality’; zThe average age of fatal pregnancies refers to the average age of Chinese women at the time of their first birth, i.e. 27 years in 2007 
(CPDRC, 2010). 
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5.2.2. Evaluating the potential health impact 
 
The framework to assess ex-ante the health benefits of FBR and MBR is built upon previous health 
impact studies (Zimmermann and Qaim, 2004; Qaim et al., 2007) and depends on different factors, as 
Figure 20 depicts.  
 
Two important determinants are directly related to these folate interventions, namely the product 
characteristics of the biofortified food vehicle and the coverage rate. While the former determines the 
micronutrient dose, the latter defines the market potential of the crop and, thus, the response to this 
dose. Information about the micronutrient dose, the current folate intake levels and the current rice 
consumption patterns is used to calculate the total folate intake after biofortification, which reduces the 
number of maternal folate deficiencies and, thus, reduces the number of NTDs, i.e. the health benefits. 
As for MBR, additional data about other micronutrient intake levels, before and after biofortification, is 
required to estimate the potential impact of MBR on China’s nutritional health status. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 The potential health impact of folate biofortified and multi-biofortified rice 
Note:  Product characteristics = (nutritional content in rice, µg per g)*(nutrient retention after processing, %)*(degree of bio- 
availability, %)  
Additional nutrient intake = (Product characteristics, µg per g) - (nutritional content in rice, µg per g)  
 Coverage rate = (acceptance rate, %)*(‘access’ = farmers’ acceptance rate, %)  
Total nutrient intake after biofortification = (current intake, µg) + (additional intake, µg per g)*(rice consumption, g) 
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5.2.2.1. Data and assumptions to calculate the health impact of folate biofortification 
 
The calculation method and the assumptions to measure the potential health benefits of FBR in China 
are described below. Because the health impact of FBR is closely related to the number of NTDs in 
China, two target groups are considered. On the one hand, due to the relationship between maternal 
folate deficiency and the risk of delivering a baby with an NTD, women of childbearing age are the 
target group for FBR consumption. On the other hand, newborns are considered as the primary 
beneficiaries of the health benefits, as they carry the risk of having an NTD.  
 
Based on the product characteristics of FBR, the folate content of FBR is calculated by multiplying the 
amount of additional folate in rice with the retention of folate after processing the rice and the 
bioavailability of folate.  
Through genetic modification, different transgenic lines of FBR were obtained (see section 2.4.4.2). 
For the calculations, the amount of 1 200 µg per 100 g raw polished grains is used. This folate content 
will be reduced by 50 % during rice processing, i.e. cooking (Storozhenko et al., 2007). To take into 
account the bioavailability upon ingestion, the remaining folate concentration will then be reduced by 
50 % (Bailey, 2004; FSAI, 2006). Combining these three product parameters results in a total folate 
intake of biofortified rice of 300 µg per 100 g rice. Given the initial folate content of rice, 8 µg per 100 g 
(USDA, 2008), the total added folate intake amounts 292 µg per 100 g. In the multi-biofortification 
scenario we will also show a pessimistic scenario, where the folate losses due to processing amounts 
75 % (see Table 45). 
 
Assuming that the current rice patterns do not differ after introducing FBR, the total folate intake of 
Chinese women of childbearing age after biofortification can be estimated by adding the additional 
folate intake to the current folate consumption levels. The average daily rice consumption of women of 
childbearing age can be calculated for each administrative area, based on the China National Nutrition 
and Health Survey 2002 (Zhai and Yang, 2006) and updated with data from the China’s National Grain 
and Oils Information Center (CNGOIC, 2009a). On average, a Chinese women of childbearing age 
consumes 218.32 g of rice per day. However, rice consumption in Southern China is twice as large as 
in Northern China. Also the current daily folate intake of woman of childbearing age is higher in 
Southern China (212.9 µg) than in Northern China (188.0 µg). 
 
Based on the current rice consumption, the current folate intake and the additional folate intake of 
biofortifying rice, a scenario where Chinese women completely switch to FBR and do not alter their 
rice consumption pattern results in an average folate intake of 837.3 µg per day, per woman of 
childbearing age (Table 44). This is more than two times the required intake or 209 % of the 
recommended nutrient intake (RNI). Regional folate intake levels after biofortification vary from 433.7 
µg, per day, per person in Xinjiang (northwest) to 1 410.7 µg, per day, per person in Hunan 
(southeast). The contribution of the total folate intake after biofortification to the recommended dose 
varies between 108.4 % in Xinjiang (northwest) and 352.7 % in Hunan (southeast). Although rice 
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consumption and folate intake levels in the northern regions are significantly lower, the daily folate 
recommendation can still be achieved if FBR would be consumed.  
Below the table, a geographical presentation of this relationship shown, where rice consumption 
(Figure 21) and production (Figure 22) and folate intake after biofortification (Figure 23) in China are 
juxtaposed.    
 
Table 44 Folate biofortification of rice in China in an optimal scenario (100 % consumption of biofortified rice). 
Current rice and folate consumption, added and total folate intake after biofortification, and % of RNI, per 
administrative area and region 
Region/  
Administrative area 
Current  Added Total  
rice cons.a folate intakeb folate intakec folate intaked % of RNIe 
g /day/person µg /day/cba µg /day/cba µg /day/cba  
NORTH 125.43 188.0 366.25 554.25 138.56 
Northeast 129.13 190.9 377.05 567.95 141.99 
Beijing  262.78 190.9 767.32 958.22 239.56 
Tianjin  198.41 190.9 579.36 770.26 192.57 
Hebei  93.03 190.9 271.65 462.55 115.64 
Shanxi  108.81 190.9 317.73 508.63 127.16 
Inner Mongolia  115.29 190.9 336.65 527.55 131.89 
Liaoning  193.68 190.9 565.55 756.45 189.11 
Jilin  222.73 190.9 650.37 841.27 210.32 
Heilongjiang 203.76 190.9 594.99 785.89 196.47 
Shandong  85.68 190.9 250.17 441.07 110.27 
Henan  92.22 190.9 269.28 460.18 115.05 
Northwest 108.06 182.7 315.54 498.24 124.56 
Shaanxi  110.24 182.7 321.91 504.61 126.15 
Gansu  106.05 182.7 309.66 492.36 123.09 
Qinghai 111.68 182.7 326.12 508.82 127.20 
Ningxia  175.04 182.7 511.10 693.80 173.45 
Xinjiang  85.95 182.7 250.96 433.66 108.42 
SOUTH 285.91 212.9 834.86 1047.76 261.94 
Southeast 301.58 215.1 880.61 1095.71 273.93 
Shanghai  249.34 215.1 728.08 943.18 235.79 
Jiangsu 270.23 215.1 789.06 1004.16 251.04 
Zhejiang 341.89 215.1 998.33 1213.43 303.36 
Anhui 197.31 215.1 576.15 791.25 197.81 
Fujian  335.18 215.1 978.74 1193.84 298.46 
Jiangxi  360.33 215.1 1052.15 1267.25 316.81 
Hubei  273.33 215.1 798.14 1013.24 253.31 
Hunan 409.43 215.1 1195.55 1410.65 352.66 
Guangdong  248.19 215.1 724.70 939.80 234.95 
Guangxi  398.53 215.1 1163.70 1378.80 344.70 
Hainan  193.01 215.1 563.59 778.69 194.67 
Southwest 241.52 210.4 705.23 915.63 228.91 
Sichuan  247.48 210.4 722.64 933.04 233.26 
Guizhou  208.32 210.4 608.30 818.70 204.67 
Yunnan  212.66 210.4 620.96 831.36 207.84 
Tibet 99.00 210.4 289.08 499.48 124.87 
Chongqing  328.93 210.4 960.48 1170.88 292.72 
CHINA 218.32 199.8 637.49 837.29 209.32 
 
cba, woman of childbearing age; RNI, the recommended nutrient intake (i.e. folate) 
aThe daily rice consumption is expressed per women of cba, in 2007 (Zhai and Yang, 2006; CNGOIC, 2009b); bThe current, 
regional folate intake before biofortification refers to findings from Zhao et al. (2009); cThe total added folate intake due to 
biofortification is based on the total current rice intake (column 1), folate intake (column 2) and additional folate content of 
biofortified rice, 2.92 µg per g (based on optimistic product parameters, as defined in Table 45); dSum of the current and 
additional folate intake; eCalculated by comparing the total folate intake after biofortification with the RNI of folate, i.e. a daily 
average folate intake of 400 µg folate per person. 
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Figure 21 Current rice consumption patterns, in g per day per women of childbearing age, in China, per 
administrative region  
Source: Own illustration, based on Table 44  
 
 
 
 
 
 
Figure 22 Share of rice production in cropland usage in %, in China, per administrative region  
Source: Based on IIASA, International Institute for Applied Systems Analysis 
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Figure 23 Total daily folate intake after biofortification in China, per women of childbearing age 
Source : Own illustration, based on Table 44 
 
In order to assess the health impact of folate biofortification, assumptions have to be made with 
respect to the effect of additionally absorbed folate on folate deficiency, the so-called “dose-response”. 
According to the state transition model, this relationship should define the share of a population that 
moves to or through different possible health states, ranging from the various degrees of illness, 
including death, to complete health (Chisholm, 2006).  
Here, the ‘dose’ is understood as the average daily folate intake after biofortification in China and its 
regions (see Table 44, column 5). Although a few studies investigated the effect of different folate 
doses on the reduction of NTD incidence (Daly et al., 1997; Moore et al., 2003), there is still a lack of 
scientific evidence to measure the health impact of each of the regional total folate intake levels in 
China. To overcome this problem, the “response” is defined by evaluating whether the total folate 
intake level of women of childbearing age in each of the Chinese administrative areas achieves the 
recommended folate intake (see Table 44, column 6). In accordance to previous literature, the 
‘response’ to a daily folate intake of 400 µg or higher is understood as the prevention of folate 
deficiency and its adverse health outcomes, e.g. NTDs (Lumley et al., 2001; Molloy and Scott, 2001). 
The introduction of this benchmark is useful when applying average instead of individual nutrient 
intake data, especially if the impact of different micronutrient doses on functional outcomes is not 
known. Given that each administrative area in China exceeds the recommended daily folate intake of 
400 µg per childbearing woman, consumption of FBR with an initial folate content of approximately     
1 200 µg per 100 g rice is assumed to prevent maternal folate deficiency and the risk of having a baby 
affected with an NTD caused by folate deficiency.  
 
Because only women who agree to consume FBR will recover from folate deficiency and its health 
risks, the dose after biofortification only refers to a part of the market. This part is determined by the 
coverage rate, which combines the FBR acceptance of women and their access to favorable farmers. 
According to the consumer study in Shanxi Province (see chapter 3), 55.4 % of female rice consumers 
are willing to accept rice with high folate content, while 32.3 % react indifferent and 12.3 % are 
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reluctant. The findings for farmers are even more positive, with 66.7 % accepting and only 6.6 % of the 
farmers rejecting the rice. When one would combine acceptance and access to farmers, a low and 
high coverage rate would amount 37 % and 82 %, respectively.  
However, in close consultation with scientists from the Golden Rice Project, we have decided to adjust 
these figures for two main reasons. First, the results are derived from a consumer study in Shanxi 
Province, a high-risk region of folate deficiency. Although it still needs to be proven, the acceptance 
rates could be lower in regions where the need to improve folate intake levels is less high. Second, in 
order to compare the different single biofortification interventions in the study on multi-biofortification 
(see Table 45), we decided to use the same coverage rate for each biofortified crop.  
Therefore, the coverage rates in this study amounts 20 % in the pessimistic and 60 % in the optimistic 
scenario. These coverage rates are defined as the percentage of women that switch completely to 
FBR, compared to women that hold on to traditional rice. In this way, they determine the percentage of 
women that can recover from folate deficiency by a biofortified diet. As these coverage rates are lower 
than what would be obtained from the Shanxi consumer study, they are assumed to be conservative 
estimates. The reasons to select these specific coverage rates is further elaborated in the next 
section. 
  
5.2.2.2. Data and assumptions regarding the health impact of multi-biofortification 
 
The multi-biofortified crop of interest contains not only an enhanced zinc and iron content, which can 
be delivered through conventional technology, but also involves GM technology to elevate the folate 
and beta-carotene (pro-vitamin A) levels. Although genetic modification of rice could further raise the 
levels of both minerals, as shown by Vasconcelos et al. (2003) and Johnson et al. (2011),  it may be 
advantageous to include two conventional traits, as this could reduce complications in the approval 
process and speed up the commercialization. Because folate or vitamin A enriched rice can only be 
successfully developed through transgenic engineering, multi-biofortification as explored in this study 
refers to a combined GM rice crop, which will influence both product and market characteristics (see 
also Figure 20).  
 
The data and assumptions regarding the main product parameters are presented in Table 45. To 
account for uncertainty with respect to key parameters, two scenarios have been designed, one with 
pessimistic and the other one with more optimistic assumptions. The initial folate and vitamin A 
content of rice is marginal to non-existent, which also explains why conventional approaches are less 
likely to be as successful. This is different for iron and zinc, where the conventional rice varieties 
contain certain amounts that can be further increased through cross-breeding. The assumptions on 
improved micronutrient contents after biofortification, as well as on post-harvest losses and 
bioavailability, are based on the previous literature, as detailed in the footnotes to Table 45. Some of 
the values were updated based on statements by scientists involved in the respective biofortification 
projects. 
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Building on the current micronutrient intake levels in China, and assuming that current rice 
consumption patterns are maintained, total vitamin and mineral intakes after multi-biofortification were 
calculated for each target group, as shown in Table 46. As in the previous section, the dose-response 
relationship, i.e. the effect of a higher nutrient intake level on functional outcomes for each 
micronutrient, is interpreted by evaluating the degree to which improved intakes reach recommended 
levels (RNI). While levels beyond the RNI will fully protect consumers from any adverse functional 
outcomes, improvements below the RNI can still be associated with positive health impacts. If the RNI 
for a specific target group and micronutrient is not achieved, the technological efficacy (E) is calculated 
as follows (Zimmermann and Qaim, 2004): 
 
Efficacy (E) =
ln (
MIL𝑎𝑓𝑡𝑒𝑟
MIL𝑏𝑒𝑓𝑜𝑟𝑒
) − (
MIL𝑎𝑓𝑡𝑒𝑟 − MIL𝑏𝑒𝑓𝑜𝑟𝑒
RNI )
ln (
RNI
MIL𝑏𝑒𝑓𝑜𝑟𝑒
) − (
RNI − MIL𝑏𝑒𝑓𝑜𝑟𝑒
RNI )
 
 
MIL, micronutrient intake level; RNI, recommended nutrient intake 
Note: before = scenario without biofortification; after = scenario with biofortification 
 
In addition to the technological efficacy, the health impact is further determined by the coverage rate of 
multi-biofortified rice varieties. The addition of vitamin A into the multi-biofortified rice crop has 
important implications for the coverage rate. The yellowish color of Golden Rice might lead to a 
diminished acceptance rate (Brooks, 2010). Our consumer survey in Shanxi Province, for example, 
showed that the acceptance rate of favorable and indifferent Chinese rice consumers would be 16.4 % 
lower if the external appearance of FBR is negatively affected (see chapter 3, section 3.3.4.1). 
However, value elicitation studies demonstrated that WTP values of Golden Rice and other vitamin A 
enriched biofortified crops are not consequently lower than the WTP values for FBR (Lusk, 2003; 
Deodhar et al., 2008; Depositario et al., 2009a; Gonzalez et al., 2009; De Groote et al., 2011)(see 
section 4.4.2.3).  
Although recent acceptance studies on single GM biofortified rice in Southeast Asia are optimistic, it is 
unclear how Chinese consumers will react to the yellowish transgenic rice with multiple health and 
nutrition benefits. As a consequence, we build on previous coverage rate assumptions that were used 
for Golden Rice studies in India (Stein et al., 2006) and the Philippines (Zimmermann and Qaim, 
2004). One of the big advantages of multi-biofortification is that all micronutrients are included in the 
same rice varieties. We assume that several varieties will be multi-biofortified, catering for different 
agro-ecological environments. Accordingly, 20% and 60% of the Chinese consumers are assumed to 
switch to multi-biofortified rice in the pessimistic and optimistic scenario, respectively (see in Table 45).  
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Table 45 Estimates of the technology characteristics and coverage of multi-biofortification, per micronutrient and 
impact scenario 
 Pessimistic Scenario Optimistic Scenario 
 Folatec Vitamin Ab Zincf Irong Folatec Vitamin Ae Zincf Irong 
Technology characteristics                    
Initial micronutrient content  
(µg per g rice)a 
0.08 0 16 3 0.08 0 16 3 
Improved micronutrient 
content (µg per g rice) 
12 20 25 8 12 30 35 14 
Post-harvest losses, incl. 
cooking (%) 
75 80 0 0 50 20 0 0 
Bioavailability (%) 50d 4:1e 100 100 50d 2.3:1e 100 100 
Added micronutrient content 
(µg per g rice) 
1.4 1.0 9.0 5.0 2.9 6.52 19.0 11.0 
Coverage rate (%)b 20 60 
 
NA, not applicable 
aBased on USDA (2008); bBased on Zimmerman and Qaim (2004) and Stein et al. (2006), and updated by scientists from the 
Golden Rice Project; cThe optimistic scenario is derived from section 5.2.2.1. In the pessimistic scenario, post-harvest losses 
refer to folate degradation after cooking (50 %) but takes also into account long-term storage losses (unpublished work); dBased 
on Bailey (2004); eBioconversion factors are based on Tang et al. (2009) and additional feeding trials carried out within the 
Golden Rice project. They refer to the bioavailability of provitamin A (beta-carotene) and its conversion into vitamin A; fBased on 
Stein et al. (2007), and updated by scientists from the International Rice Research Institute; gBased on Stein et al. (2008a), and 
updated by scientists from the International Rice Research Institute. 
 
Table 46 Rice consumption, micronutrient intake with and without multi-biofortification in China, per micronutrient 
and impact scenario 
Daily rice  
consumption (per 
person)c 
  Daily micronutrient intake (per person) 
Status  
Quod 
 With biofortification  
RNI 
Pessimistic Optimistic 
          
Vitamins g µg µg 
%  
RNI 
% 
Efficacy 
µg 
%  
RNI 
% 
Efficacy 
µg 
Folate          
Women of cbaa 218.32 199.8e 509.81 127.45 RNI 837.29e 209.32e RNI 400f 
Vitamin A          
Children < 5 years 119.70 276.0 395.70 79.14 82.7 1056.65 211.33 RNI 500g 
Pregnant women 224.20 572.4 796.63 99.58 99.9 2034.61 254.33 RNI 800g 
Minerals g mg mg 
%  
RNI 
% 
Efficacy 
mg 
%  
RNI 
% 
Efficacy 
mg 
Zinc          
Infants 92.12 4.9 5.73 83.07 69.0 6.65   96.42 98.7 6.9h 
Children 1-5 yearsb 119.70 6.0 7.04 88.06 80.2 8.24 103.02 RNI 8.0h 
Iron          
Children < 5 years 119.70 11.9 12.50 87.59 45.9 13.21 92.63 81.6 14.3i 
Children 6-14 years 204.20 18.7 19.67 83.71 39.8 20.90 88.92 73.2 23.5i 
Men 15 + 256.00 24.4 25.70 93.78 68.5 27.23 99.39 99.7 27.4i 
Women 15 + 218.32 21.2 22.31 37.94 0.08 23.62 40.17 17.5 58.8i 
Pregnant women 224.20 21.2 22.34 37.99 0.09 23.68 40.28 17.9 58.8i 
 
cba, childbearing age NA, not applicable; RNI, recommended nutrient intake  
aDue to the focus on NTDs as the main outcomes of folate deficiency, women of childbearing age are included as the target 
group of biofortified rice consumption, whereas the health impact refers to the newborns; bDue to a lack of data on the below 4 
years age category, this category is covered by the 1-5 years age category. cBased on the China National Nutrition and Health 
Survey 2002 (Zhai and Yang, 2006). Due to data constraints, rice consumption of women of childbearing age (15-64) and 
women 15+ is assumed to be equal; dBased on the China National Nutrition and Health Survey 2002 (Chai et al., 2009); eSee 
Table 44; fBased on the WHO folic acid supplementation recommendations for pregnant women, i.e. 400 µg folate per day, per 
person (WHO, 2006a); gInternational RNI for children and pregnant women, as proposed by IOM (2002) and FAO/WHO (2004); 
hBased on the WHO recommended RNI levels for zinc, adjusted for developing countries (Allen et al., 2006); iBased on the 
FAO/WHO RNI levels for developing countries (FAO/WHO, 2004). 
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5.3. Measuring the cost-effectiveness 
 
Without evaluating the importance of the DALY-based health impact analyses of folate and multi-
biofortified crops, potential stakeholders, like policy makers and health planners, look for a 
complementary evaluation tool in order to compare, prioritize, underpin and justify their decisions to 
support, fund and implement such public health interventions. Given the budgetary constraints for 
allocating resources to public health interventions, the costs of the health strategy need to be 
incorporated in this health impact study. An essential tool is CEA, which compares the expected costs 
and benefits of an intervention to assess its ‘value for money’ (Musgrove and Fox-Rushby, 2006). As a 
primary economic evaluation technique to evaluate whether a health intervention is eligible for 
implementation or not, CEA measures the cost per unit of the health benefits (see section 1.3.3.3). 
The ‘cost per DALY saved’ is a common indicator to evaluate the cost-effectiveness of health 
programs (World Bank, 1993; Jamison et al., 2006), in Asia (Liu et al., 2008) and, in particular, with 
respect to policy interventions to combat micronutrient malnutrition (Stein et al., 2005b). Similar to the 
DALY framework, the result is a single indicator, US$ per gained DALY.  
Because the cost-effectiveness is expressed in natural health units, unlike cost-benefit analysis (see 
section 1.3.3.3), the results can only be compared with other health impact studies if there is a 
common health measure unit (e.g. DALYs) and a common currency (e.g. US$). Although some 
declare that using a cut-off level in CEA is arbitrary and inappropriate (Laxminarayan et al., 2006), the 
need for a reference point to interpret the profitability of this relative measure is generally 
acknowledged (Musgrove and Fox-Rushby, 2006). In most cases, an international benchmark is 
selected as the reference value to evaluate whether the intervention is considered cost-effective. 
According to the World Bank (1993), a highly cost-effective intervention in 1990 amounts between 
US$ 50 and US$ 150 per DALY saved. Converted into 2011 US dollars, the recommended threshold 
of a saved DALY increases to US$ 86.04 and US$ 258.12 (BLS, 2011). At present, intervention costs 
below US$ 43.21 per DALY saved are considered to be remarkably low, with costs per gained DALY 
below US$ 5.19 categorized as the most cost-effective. WHO (WHO, 2001b; Tan-Torres Edejer et al., 
2003) and its CHOICE (Choosing Interventions that are Cost-Effective) project (Evans et al., 2005) on 
the other hand, propose to use the national (or regional) single or triple per capita income level to 
evaluate whether the cost-effectiveness of an intervention is, respectively, moderate or very high 
(WHO, 2011a).  
 
Building upon the investigated health impact, the cost-effectiveness of the introduction of FBR and 
MBR in China can be assessed by juxtaposing the costs to develop and distribute the biofortified rice 
and the estimated health benefits. The time frame used in this study is 30 years, which corresponds 
with previous health impact studies (Horton, 2006; Stein et al., 2008b), and includes the key steps of 
implementing the biofortified crop. From development to commercialization, the following categories of 
costs occur: (advanced) R&D costs, country-specific costs (field trials, backcrossing costs, large scale 
feeding tests and regulatory costs), social marketing costs and maintenance breeding costs. In this 
way, the CEA aims to evaluate the intervention from the point of view of the broad society, in line with 
the WHO (Evans et al., 2005), U.S. Panel on Cost-Effectiveness in Health and Medicine (Gold et al., 
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1996) and CDC (Grosse et al., 2007). The WHO states: “Costs are measured from the perspective of 
society as a whole, to understand how best to use resources regardless of who pays for them, or 
indeed, whether they are paid for at all” (Evans et al., 2005, p. 1137). Following Musgrove & Fox-
Rushby (2006), the underlying CEA does not include indirect costs, such as individual costs of buying 
and consuming the biofortified crop (travel costs, work time losses), nor the costs related to the 
decreased share of other interventions (e.g. potential economic losses due to diminished 
production/use of supplements). Health interventions could also reduce the costs related to health 
care and, thereby, further improve the cost-effectiveness. These cost savings refer to the lower 
diagnostic, clinic attendance, hospitalization (Grosse et al., 2008) and rehabilitation costs (Hertrampf 
and Cortes, 2008), and the related travel costs (Jentink et al., 2008); the reduced use of medication 
(Bentley et al., 2009) and the absence of special education costs (Jentink et al., 2008). 
 
Based on the number of DALYs saved through the introduction of biofortification and the cost 
estimates of the intervention, the cost-effectiveness is measured by comparing the Net Present Value 
(NPV) of the two components, both discounted at 3 % (see section 5.2): 
 
NPVcosts
NPVDALYs saved
=
∑ [(Ct)(1+r)
−t]30t=1
∑ [(DALYs savedt)(1+r)−t]
30
t=1
   
 
The input parameters of the formula are year (t), ranging from 1 to 30, the total costs at year t (Ct), and 
the discount rate for future life years (r).  
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5.4. Results and Discussion 
5.4.1. Burden and potential health impacts of folate biofortified rice 
in China  
 
5.4.1.1. Current burden of folate deficiency (DALYs lost) 
 
The present burden of folate deficiency in China, i.e. the situation ‘without’ biofortification, can be 
calculated by entering the input parameters of Table 42 into the DALY formula. This burden is 
expressed as the number of DALYs lost per administrative area (Table 47).  
 
Table 47 Burden of folate deficiency in China, per functional outcome, expressed in the number of DALYs lost, 
per year, per region and administrative area 
Administrative 
Area/ Regiona 
Non-Fatal Fatal Total 
Spina Enceph. Total (YLD) Abortions Stillbirths Total (YLL)  
NORTH 59 067 13 502 72 569 97 100 90 554 187 654 260 223 
Northeast 45 642 9 600 55 242 73 791 68 816 142 608 197 849 
Beijing  623 137 760 1 016 948 1 964 2 724 
Tianjin  702 129  831 1 107 1 032 2 139 2 970 
Hebei  7 429 1 832 9 261 12 411 11 574 23 986 33 246 
Shanxi  11 381 2 414 13 794 18 429 17 187 35 616 49 411 
Inner Mongolia  3 725 879 4 604 6 165 5 749 11 913 16 517 
Liaoning  2 660 341 3 001 3 976 3 708 7 684 10 685 
Jilin  1 601 146 1 747 2 305 2 150 4 455 6 202 
Heilongjiang 1 637 359 1 995 2 668 2 488 5 155 7 151 
Shandong  5 239 861 6 100 8 112 7 565 15 677 21 777 
Henan  10 645 2 502 13 148 17 602 16 415 34 018 47 165 
Northwest 13 425 3 902 17 327 23 309 21 737 45 046 62 374 
Shaanxi  5 473 1 907 7 380 9 972 9 300 19 272 26 652 
Gansu  4 560 845 5 404 7 202 6 716 13 918 19 323 
Qinghai  586 158 744  999 931 1 930 2 674 
Ningxia  963 150 1 113 1 479 1 379 2 858 3 971 
Xinjiang  1 843 843 2 686 3 657 3 411 7 068 9 754 
SOUTH 10 978 3 954 14 931 20 194 18 832 39 026 53 957 
Southeast 8 169 2 968 11 137 15 066 14 050 29 115 40 252 
Shanghai  57 25 82 112 104  216  299 
Jiangsu 667 106 773 1 028 958 1 986 2 759 
Zhejiang 753 79 832 1 099 1 025 2 125 2 957 
Anhui 1 742 600 2 343 3 165 2 951 6 116 8 459 
Fujian  466 327 793 1 094 1 021 2 115 2 908 
Jiangxi  695 271 966 1 309 1 221 2 529 3 495 
Hubei  565 315 880 1 205 1 124 2 329 3 209 
Hunan 1 257 309 1 565 2 098 1 956 4 054 5 619 
Guangdong  1 159 508 1 667 2 266 2 114 4 380 6 047 
Guangxi  698 408 1 107 1 518 1 415 2 933 4 040 
Hainan  110 19 129 172  160  332  461 
Southwest 2 809 985 3 794 5 128 4 783 9 911 13 705 
Sichuan  554 340  894 1 228 1 145 2 373 3 267 
Guizhou  1 511 143 1 654 2 184 2 036 4 220 5 874 
Yunnan  308 270 578  803 749 1 553 2 131 
Tibet 96 0 96  125 116  241 337 
Chongqing  340 232 572  789  736 1 524 2 097 
CHINA 70 044 17 456 87 500 117 294 109 386 226 680 314 180 
  
DALYs, Disability-Adjusted Life Years; YLD, years lived in disability; YLL, years of life lost 
a A geographical presentation of the different administrative areas and regions is shown in Annex 1.  
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Based on the present consumption pattern, folate deficiency in China is responsible for an annual loss 
of 314 180 DALYs. With respect to the regional differences, the number of DALYs lost is significantly 
higher in Northern China, especially in the northeast. But when these numbers are weighted according 
to the total population, the current situation is worst in Northwest China, with 6.39 DALYs lost per      
10 000 persons, per year (see also Table 49, column 3). By way of comparison, the annual number of 
DALYs lost in the northeast is 4.31 per 10 000 persons. Due to the differences in NTD prevalence and 
the regional attribution level of folate deficiency to NTDs, the relative burden in Southern China is 
significantly lower with 0.71 DALYs lost. The burden of morbidity and mortality caused by folate 
deficiency amounts to 27.85 % and 72.15 %, respectively. Within these categories, spina bifida 
obtains the highest number of years lived with disability, while the lost life years are more or less 
equally divided between the two fatal outcomes. 
 
5.4.1.2. Potential health benefits of folate biofortified rice (DALYs saved) 
 
Based on the estimated product and market characteristics of FBR, described in the previous sections, 
the benefits to public health can be assessed by comparing the number of DALYs lost under the 
current situation (‘without’) with two biofortification scenario’s (‘with’). A low and high impact scenario 
are defined by the coverage rate of FBR, i.e. 20 % (low) and 60 % (high) of Chinese women who are 
willing to accept and have access to this crop. These scenarios start from the assumption that the total 
folate intake under biofortification in each administrative area in China is significantly higher than the 
threshold to recover from folate deficiency and the associated risk of delivering a baby that is affected 
with an NTD (see Table 44).  
 
Table 48 summarizes the potential health benefits of FBR in China under a low and high impact 
scenario. The results are expressed as the number of DALYs saved through the implementation of 
folate enriched rice. This is the difference between the number of DALYs lost under the current 
situation, shown in Table 47, and the DALYs lost under a folate biofortification scenario. The health 
impact is based on the number of mothers that recover from folate deficiency through a biofortified 
diet, i.e. the coverage rate. This rate also represents the percentage of NTDs caused by folate 
deficiency that can be prevented by a mother’s biofortified diet. 
The potential introduction of FBR in China increases the folate intake for women of childbearing age to 
837 µg per day, and saves annually 62 836 DALYs in the low and 188 508 DALYs in the high 
biofortification scenario. Fatal outcomes gain the largest number of DALYs, followed by spina bifida 
and encephalocele. While the burden in the low biofortification scenario is still around 250 000 DALYs 
per year, the high impact scenario reduces the annual number of DALYs lost to approximately         
125 000.  
When focusing on the four Chinese regions, the highest number of DALYs saved is obtained in 
Northeast China. Shanxi Province, characterized by one of the highest NTD prevalence rates in the 
world, benefits the most from the introduction of FBR. The health impact in the northwest, southwest 
and southeast of China is significantly lower. 
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Table 48 The health impact of folate biofortification of rice in China, per impact scenario, functional outcome and region, in the number of DALYs saved, per year 
Region/ 
Administrative 
area 
Low impact High impact 
Non-Fatal Fatal Total Non-Fatal Non-Fatal Total 
      Spina  Enceph. YLD   Abortions Stillbirths  YLL       Spina    Enceph. YLD   Abortions Stillbirths YLL  
NORTH 11 813 2 700 14 514 19 420 18 111 37 531 52 045 35 440 8 101 43 541 58 260 54 332 112 592 156 134 
Northeast 9 128 1 920 11 048 14 758 13 763 28 522 39 570 27 385 5 760 33 145 44 275 41 290 85 565 118 709 
Beijing  125 27 152 203 190 393 545 374 82 456 610 569 1 178 1 634 
Tianjin  140 26 166 221 206 428 594 421 77 499 664 619 1 283 1 782 
Hebei  1 486 366 1 852 2 482 2 315 4 797 6 649 4 457 1 099 5 557 7 447 6 944 14 392 19 948 
Shanxi  2 276 483 2 759 3 686 3 437 7 123 9 882 6 829 1 448 8 276 11 057 10 312 21 370 29 647 
Inner Mongolia  745 176 921 1 233 1 150 2 383 3 303 2 235 527 2 762 3 699 3 449 7 148 9 910 
Liaoning  532 68 600 795 742 1 537 2 137 1 596 205 1 801 2 386 2 225 4 610 6 411 
Jilin  320 29 349 461 430 891 1 240 961 88 1 048 1 383 1 290 2 673 3 721 
Heilongjiang 327 72 399 534 498 1 031 1 430 982 215 1 197 1 601 1 493 3 093 4 291 
Shandong  1 048 172 1 220 1 622 1 513 3 135 4 355 3 143 517 3 660 4 867 4 539 9 406 13 066 
Henan  2 129 500 2 630 3 520 3 283 6 804 9 433 6 387 1 501 7 889 10 561 9 849 20 411 28 299 
Northwest 2 685 780 3 465 4 662 4 347 9 009 12 475 8 055 2 341 10 396 13 985 13 042 27 028 37 424 
Shaanxi  1 095 381 1 476 1 994 1 860 3 854 5 330 3 284 1 144 4 428 5 983 5 580 11 563 15 991 
Gansu  912 169 1 081 1 440 1 343 2 784 3 865 2 736 507 3 242 4 321 4 030 8 351 11 594 
Qinghai 117 32 149 200 186 386 535 352 95 446 599 559 1 158 1 604 
Ningxia  193 30 223 296 276 572 794 578 90 668 887 827 1 715 2 383 
Xinjiang  369 169 537 731 682 1 414 1 951 1 106 506 1 612 2 194 2 047 4 241 5 852 
SOUTH 2 196 791 2 986 4 039 3 766 7 805 10 791 6 587 2 372 8 959 12 116 11 299 23 416 32 374 
Southeast 1 634 594 2 227 3 013 2 810 5 823 8 050 4 901 1 781 6 682 9 040 8 430 17 469 24 151 
Shanghai  11 5 16 22 21 43 60 34 15 49 67 62  130  179 
Jiangsu 133 21 155 206 192 397 552 400 64 464 617 575 1 192 1 655 
Zhejiang 151 16 166 220 205 425 591 452 47 499 659 615 1 275 1 774 
Anhui 348 120 469 633 590 1 223 1 692 1 045 360 1 406 1 899 1 771 3 670 5 075 
Fujian  93 65 159 219 204 423 582 280 196 476 656 613 1 269 1 745 
Jiangxi  139 54 193 262 244 506 699 417 163 580 785 733 1 517 2 097 
Hubei  113 63 176 241 225 466 642 339 189 528 723 674 1 397 1 925 
Hunan 251 62 313 420 391 811 1 124 754 185 939 1 259 1 174 2 432 3 371 
Guangdong  232 102 333 453 423 876 1 209 695 305 1 000 1 360 1 268 2 628 3 628 
Guangxi  140 82 221 304 283 587  808 419 245 664  911  849 1 760 2 424 
Hainan  22 4 26 34 32 66 92 66 11 77 103 96  199  277 
Southwest 562 197 759 1 026 957 1 982 2 741 1 685 591 2 276 3 077 2 870 5 947 8 223 
Sichuan  111 68 179 246 229 475 653 332 204 536  737  687 1 424 1 960 
Guizhou  302 29 331 437 407 844 1 175 907 86 992 1 310 1 222 2 532 3 524 
Yunnan  62 54 116 161 150 311 426 185 162 347 482 449 932 1 279 
Tibet 19 0 19 25 23 48 67 58 0 58 75 70 145 202 
Chongqing  68 46 114 158 147 305 419 204 139 343 473 442 914 1 258 
CHINA 14 009 3 491 17 500 23 459 21 877 45 336 62 836 42 026 10 474 52 500 70 376 65 632 136 008 188 508 
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As the health benefits of FBR depend on demographic characteristics, such as the population size and  
the birth rate, a comparison of these regional results should be carefully interpreted. One way to 
overcome this, is to standardize the regional saved DALYs (Table 49). When the number of DALYs is 
expressed per 10 000 persons, the burden and health impact is relatively the highest in the Northwest 
China, while the absolute numbers are the highest in the Northeast. The current situation is most 
problematic in Shanxi (northeast), Gansu (northwest), Anhui (southeast) and Guizhou (southwest). 
 
Table 49 Burden of folate deficiency (DALYs lost) and the health impact of folate biofortification (DALYs saved) in 
China, expressed in absolute and relative (per 10 000 persons) numbers, per year, per region and administrative 
area  
Region/ 
Administrative 
area 
Current burden 
(DALYs lost) 
Folate biofortification 
(DALYs saved) 
  Low impact High impact 
Total  Relative Total Relative Total  Relative 
NORTH 260 223 4.68 52 045 0.94 156 134 2.81 
Northeast 197 849 4.31 39 570 0.86 118 709 2.59 
Beijing  2 724 1.68 545 0.34 1 634 1.01 
Tianjin  2 970 2.70 594 0.54 1 782 1.62 
Hebei  33 246 4.71 6 649 0.94 19 948 2.83 
Shanxi  49 411 14.31 9 882 2.86 29 647 8.59 
Inner Mongolia  16 517 6.74 3 303 1.35 9 910 4.04 
Liaoning  10 685 2.45 2 137 0.49 6 411 1.47 
Jilin  6 202 2.23 1 240 0.45 3 721 1.34 
Heilongjiang 7 151 1.83 1 430 0.37 4 291 1.10 
Shandong  21 777 2.29 4 355 0.46 13 066 1.37 
Henan  47 165 4.91 9 433 0.98 28 299 2.95 
Northwest 62 374 6.39 12 475 1.28 37 424 3.83 
Shaanxi  26 652 6.98 5 330 1.40 15 991 4.19 
Gansu  19 323 7.25 3 865 1.45 11 594 4.35 
Qinghai 2 674 4.77 535 0.95 1 604 2.86 
Ningxia  3 971 6.43 794 1.29 2 383 3.86 
Xinjiang  9 754 4.65 1 951 0.93 5 852 2.79 
SOUTH 53 957 0.71 10 791 0.14 32 374 0.43 
Southeast 40 252 0.71 8 050 0.14 24 151 0.43 
Shanghai   299 0.16 60 0.03  179 0.10 
Jiangsu 2 759 0.36 552 0.07 1 655 0.22 
Zhejiang 2 957 0.58 591 0.12 1 774 0.35 
Anhui 8 459 1.35 1 692 0.27 5 075 0.81 
Fujian  2 908 0.80 582 0.16 1 745 0.48 
Jiangxi  3 495 0.79 699 0.16 2 097 0.47 
Hubei  3 209 0.55 642 0.11 1 925 0.33 
Hunan 5 619 0.87 1 124 0.17 3 371 0.52 
Guangdong  6 047 0.64 1 209 0.13 3 628 0.38 
Guangxi  4 040 0.84  808 0.17 2 424 0.50 
Hainan   461 0.54 92 0.11  277 0.32 
Southwest 13 705 0.69 2 741 0.14 8 223 0.41 
Sichuan  3 267 0.39 653 0.08 1 960 0.23 
Guizhou  5 874 1.53 1 175 0.31 3 524 0.92 
Yunnan  2 131 0.46 426 0.09 1 279 0.28 
Tibet 337 1.17 67 0.23 202 0.70 
Chongqing  2 097 0.73 419 0.15 1 258 0.44 
CHINA 314 180 2.38 62 836 0.48 188 508 1.43 
 
 
DALYs, Disability-Adjusted Life Years 
Note: In each of the four regions, the administrative area with the highest burden and health impact is indicated in bold.  
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5.4.2. Burden and potential health impacts of multi-biofortified rice 
in China  
 
Table 50 summarizes how the most important micronutrient deficiencies affect the Chinese population, 
i.e. the current burden, and how multi-biofortification could help to reduce this burden. At present, 
micronutrient malnutrition in China is responsible for 10.6 million DALYs lost per year. Iron deficiency 
causes by far the biggest burden, followed by zinc, vitamin A and folate deficiency. The important role 
of vitamin A in the body’s immune system and the close association with child mortality make VAD the 
most fatal micronutrient deficiency in China. The relatively low burden of folate deficiency is partly 
caused by the limited focus in this study, where only one folate related functional outcome (NTDs) and 
one target group (women of childbearing age) is included. Still, due to the high folate intake after multi-
biofortification, raising this vitamin level results in substantial health benefits. The findings confirm that 
both conventional and transgenic traits in multi-biofortified rice are effective in tackling their respective 
micronutritional deficiency.  
 
Depending on the assumptions made, the introduction of multi-biofortified rice in China could save 
between 1.2 and 4.9 million DALYs per year. Stated differently, the Chinese burden of micronutrient 
malnutrition could be reduced by 11 % in the pessimistic and by 46 % optimistic scenario, respectively.  
These combined results assume that the effects for each individual micronutrient can simply be added 
up. This is the best assumption one can make, because knowledge about micronutrient interactions is 
extremely thin. On the one hand, adding up may potentially lead to an overestimation of the health 
burden and the impacts of multi-biofortification, because of potential double-counting with respect to 
some functional outcomes. For instance, vitamin A and zinc deficiency are both associated with child 
mortality and certain infectious diseases. On the other hand, adding up may also lead to an 
underestimation of the positive impacts, as simultaneously improving the intake of multiple 
micronutrients may potentially lead to synergistic health benefits (Sandstrom, 2001). As these effects 
work in opposite directions, we do not expect a systematic bias in our analysis, but the assumptions 
should be improved when better knowledge on micronutrient interactions becomes available. 
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Table 50 Multi-biofortified rice in China, current burden and potential health impacts, per micronutritional 
deficiency and impact scenario, in the number of DALYs  
  Folate Vitamin A Zinc Iron ALL 
Current Burden (DALYs lost) 
 YLD 87 500  71 799 2 017 847 5 679 207 7 856 354 
 YLL 226 680 1 919 321 631 115 10 693 2 787 809 
 Total 314 180 1 991 120 2 648 962 5 689 900 10 644 163 
 % all  3 19 25 53 100 
Health impact (DALYs saved)  
Pessimistic YLD 17 500 12 083 310 983 389 105 729 671 
 YLL 45 336 317 304 94 531  182 457 353 
 Total 62 836 329 387  405 514 389 287 1 187 024 
 % all  5 28 34 33 100 
 % burden  20 17 15 7 11 
Optimistic YLD 52 500 43 080 1 206 480 1 944 587 3 246 646 
 YLL 136 008 1 151 592 376 420 1 148 1 665 168 
 Total 188 508 1 194 672 1 582 900 1 945 735 4 911 814 
 % all  4 24 32 40 100 
 % burden  60 60 60 34 46 
 
DALY, Disability-Adjusted Life Year; YLD, years lived in disability; YLL years of life lost 
 
5.4.3. Cost-effectiveness of folate and multi-biofortified rice in 
China  
 
Based on a 30-year time horizon, Table 51 provides an overview of the different costs that are 
incurred for the development to the commercialization of multi-biofortified rice in China. The costs of 
each individual trait, thus each single biofortified crop, are separately included and summed. Although 
the first research initiatives regarding Golden rice date goes back to the 1990’s, and subsequent 
biofortification research, such as enriching folate, definitely builds upon these efforts, the same time 
frame is applied to each cost-calculation. Given that GM rice is not produced and due to the 
uncertainty regarding the process (and costs) to introduce this product in China (see section 6.5), the 
cost figures are estimates. 
 
We assume that each micronutrient trait is developed independently and then combined with the other 
traits through conventional backcrossing. While the research initiatives for each micronutrient started 
at different points in time, for better comparison we use the same time frame for each of the 
calculations, namely 2002-2032. The costs for more basic research components, which occur at the 
international level, are included only partially in this study. The reason is that the basic research 
components will not only be used in China, but may also lead to benefits in several other countries. 
The more adaptive development costs are country specific. They include the costs of adaptive 
breeding and variety development in a magnitude of US$ 1.5 million per trait (Stein et al., 2007; Stein 
et al., 2008a). Moreover, the costs for the regulatory process of transgenic events are covered here. 
Table 51 also shows projected costs for social marketing of the new varieties. This will be required 
especially for the folate and provitamin A traits, as these are transgenic and also associated with color 
changes. Especially for provitamin A (Golden Rice), this color change will be very notable. Hence, 
without specific awareness campaigns, widespread acceptance cannot be expected (Stein et al., 
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2006, 2008b). Regarding FBR as a single GM biofortified strategy, social marketing costs are 
expected to be halved, as we assume that no other rice attributes, except for the folate content, will be 
altered. Finally, after technology release and adoption, only some maintenance breeding will be 
necessary to preserve the purity of the biofortified varieties and seeds. 
For some components, the cost for multi-biofortification is simply the sum of the costs for individual 
trait development. A case in point is the basic research cost. For other components, additional costs 
will occur, such as backcrossing all four traits into the same rice varieties. And yet for other 
components, multi-biofortification may allow significant cost savings. For instance, social marketing for 
the combined product will render marketing for individual traits unnecessary. As shown in Table 51, we 
expect the total cost of developing and implementing FBR and MBR in China to be in a magnitude of 
US$ 31.6 and US$ 85.4 million, respectively. 
 
Saving one folate deficiency related DALY in China would cost between US$ 64.2 and US$ 21.4. In 
the case of MBR, the scenario where the two transgenic traits are backcrossed results in a cost-
effectiveness between US$ 9.6 and US$ 2.3 per saved DALY (Using single insertion through genetic 
modification would lower these figures due to lower R&D and regulatory costs; see section 5.4.5.2). As 
the cost-effectiveness is a relative measure, the results need to be benchmarked. The World Bank 
(1993) cut-off levels for a highly cost-effective strategy should vary between US$ 86.04 and US$ 
258.12 per gained DALY (in 2011; BLS, 2011). Both folate and multi-biofortification of rice achieve the 
upper limit of this threshold and can be considered as potential highly cost-effective health 
interventions. The high, aggregated benefits of tackling the main micronutrient deficiencies in China 
outweigh the relatively high intervention costs, even when the transgenic traits need to be separately 
backcrossed through conventional breeding. The low one-time R&D investments of folate 
biofortification show that the DALYs that could be saved with single biofortification are also worth to 
consider.  
 
For the CEA, we juxtapose the cost stream over time with the benefit stream (the number of DALYs 
saved). We assume that multi-biofortified varieties may be released starting in 2014. After that, 
technology adoption and coverage will increase gradually. We assume a linear diffusion profile, with 
maximum coverage rates to be achieved 15 years after the first release, i.e. in 2029. The last two 
columns in Table 51 show the CEA results expressed in the cost per DALY saved. While we assume 
equal costs in the two scenarios, the benefits differ according to the more pessimistic and optimistic 
assumptions, as discussed above. The upper part of the Table shows the potential cost-effectiveness 
for the single trait technologies. While these results are interesting, they should be interpreted with 
some caution, because when four separate rice technologies were released, there would be 
competition in terms of achieving high coverage rates. This competition is avoided when rice varieties 
simultaneously carry all four traits, which is one of the major advantages of multi-biofortification. 
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Table 51 Costs and cost-effectiveness of multi-biofortified rice in China, per trait  
 Costs  
(million US$) 
 Cost-effectivenessj 
(US$ per DALY saved) 
 
Basic R&Df 
Country-
specificg 
Social 
marketing 
Maintenance 
breeding 
Total Pessimistic Optimistic 
 (8 years) (6 years) (Until end) (Until end) (30 years) scenario scenario 
Single biofortification        
Folate 5.7a 9.5a 15.0a 2.1a 31.6 64.2 21.4 
Vitamin A 7.6b 9.5b 30.7b 2.1b 48.9 18.1 5.0 
Zinc 8.7c 1.5c /h 2.6c 16.9 4.8 1.2 
Iron 6.0c 1.5c /h 2.6c 13.7 3.8 0.8 
Sum 28.1 22.0 45.7        9.5 105.3 / k / k 
Multi-biofortification 28.1     24.0d 30.7i        2.6i       85.4 9.6 2.3 
 
aBased on estimates from experts of the Chinese Academy of Agricultural Sciences and the scientists involved in folate 
biofortification; bBased on Stein et al. (2006, 2008b) study on Golden Rice; c Estimates based on previous health impact 
analyses on rice biofortified with zinc (Stein et al., 2007) or iron (Stein et al., 2008a); dFor multi-biofortified varieties, in addition 
to the country-specific research costs for each single micronutrient, a total cost of US$ 2.0 million is added to account for the 
backcrossing of all four traits into the same varieties. We assume that 10 multi-biofortified rice varieties will be developed, each 
involving a backcrossing cost of US$ 200 000; fThe basic R&D cost is only partially attributed to China, using China’s share in 
total rice production of China, India, Bangladesh and the Philippines, which are all potential target countries for rice 
biofortification. China’s share is 48% (FAOSTAT Database, 2008); gWhile for conventional traits only adaptive breeding costs 
are taken into account, the transgenic traits additionally have to comply with Chinese biosafety regulations. Regulatory costs are 
assumed to be US$ 8 million per event, using a recent analysis for the US by Kalaitzandonakes et al. (2007); hAs zinc and iron 
are traits that are invisible to consumers and included through conventional breeding, no significant marketing efforts will be 
necessary to achieve widespread coverage; iRegarding the social marketing and maintenance breeding costs of multi-
biofortification, the highest cost of the single biofortified traits was selected; jThe pessimistic and optimistic scenario differ in 
terms of the health impact, as shown in Table 50; kBecause the cost-effectiveness of introducing four independent biofortified 
rice products would influence the coverage rates, due to the presence of four products, no estimates are given for four single 
biofortified crops as a combined health intervention. Moreover, the advantage of multi-biofortified rice is its ability to tackle four 
micronutrient deficiencies simultaneously, without creating a differentiated market for biofortified products. 
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5.4.4. Putting the results in perspective   
 
Another way to evaluate the cost-effectiveness of FBR and MBR is to look at health interventions that 
use the same approach (e.g. biofortification) or other alternative health interventions that aim to 
address the same health problem, i.e. reducing folate deficiency and NTDs (Laxminarayan et al., 
2006; Musgrove and Fox-Rushby, 2006). These issues are discussed in section 5.4.4.1 and 5.4.4.2, 
respectively. Furthermore, FBR is evaluated in two of the most important high-risk regions, the 
Chinese Shanxi Province and the Indian Balrampur District (see section 5.4.4.3). 
 
5.4.4.1. A comparison with other cost-effectiveness studies on biofortification   
 
One of the key advantages of CEA is that it provides straightforward information which can be 
compared in different settings and different interventions (Stein, 2006). By expressing the number of 
DALYs gained per 10 000 persons, the potential health impact of FBR and MBR in China can be 
compared with findings from other, similar health impact studies that applied the DALY approach.  
 
Table 52 presents the estimated potential health impacts of different transgenic and non-transgenic 
biofortified staple crops in several developing countries. For ease of comparison, costs are presented 
in US$, i.e. the international standard in CEA (Tan-Torres Edejer et al., 2003; Chisholm, 2006). 
In comparison with the burden of micronutrient deficiencies in other health impact studies, the relative 
burden of folate deficiency and micronutrient malnutrition in China is the lowest and one of the highest, 
respectively. However, as only NTDs caused by folate deficiency are included as functional outcomes, 
only a part of the folate burden is calculated. If other functional outcomes would be included, such as 
heart diseases, the investigated target group could be extended to the total population. Given the 
estimated total number of folate deficient people in China, 258 million, the actual burden of folate 
deficiency would be much higher.  
With respect to the health impact, most of the DALYs can be saved through the introduction of Vitamin 
A biofortification in Uganda (sweet potato) and Congo (cassava roots). The relative impact of iron or 
zinc biofortification on public health is the highest in India and Pakistan, and North-East Brazil (iron) 
and Bangladesh (zinc). While the burden of FBR in China is relatively low, this intervention could be 
one of the most effective strategies to save DALYs. This is mainly due to the high folate intake levels 
after biofortification and the assumption that these intake levels prevent maternal folate deficiency and 
the risk of having a baby with an NTD (see section 5.2.2.1). 
According to the pessimistic and optimistic impact scenario, FBR is ranked, respectively 15th and 20th 
out of 27 cost-effectiveness analyses. MBR holds the fifth (pessimistic) and seventh position 
(optimistic). The cost-effectiveness of the latter, for instance, is in line with other biofortified rice 
products, wheat and sweet potatoes, except for the less cost-effective iron biofortified rice study in the 
Philippines, and are substantially lower than biofortified maize, beans and cassava roots, regardless of 
the deficiency that is addressed. 
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Although this comparison is useful to put folate and multi-biofortification in the context of policy 
interventions to tackle micronutrient deficiencies in developing countries, these findings should be 
interpreted with caution. First, the parameters of the DALY framework and the characteristics of the 
impact scenarios differ from one study to another. As a consequence, the cost-effectiveness figures 
are scale-dependent, by which small-scale projects might be highly cost-effective in the long term, but 
less desirable to further increase the coverage rate (Laxminarayan et al., 2006). Second, as there is 
currently no transgenic biofortified staple crop commercialized, and most of the figures are derived 
from ex-ante evaluation studies, the expected micronutrient content after biofortification is mostly 
based on estimates from plant breeders. This is, for instance, the case in the HarvestPlus health 
impact analyses of conventionally enriched staple crops (Meenakshi et al., 2007).  
Evans et al. (2005, p. 1140) express their concerns about the comparison of CE studies as follows: 
“[…] it is not possible to recommend that an intervention shown to cost $45 per DALY averted is more 
efficient than one costing $60, given the nature of the uncertainties. For the broad comparison across 
goals we, therefore, interpret cost effectiveness figures in broad order of magnitude ranges”. 
Therefore, the cost-effectiveness figures are also compared with the lower and upper thresholds of 
cost-effective health interventions (Table 52). The results show that most of the biofortified crops are 
highly cost-effective. Only 7 out of 27 CEAs do not achieve the lower limit of cost-effectiveness, of 
which only one study (zinc enriched beans in North-East Brazil) is considered cost-ineffective in the 
pessimistic and the optimistic impact scenario.  
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Table 52 Comparison of the burden of micronutrient deficiencies (DALYs lost), the potential benefits (DALYs saved) and the cost-effectiveness (US$/DALY saved) of biofortified 
staple crops, per crop, nutrient, and target country, in relative numbers (per 10 000 persons), in the reduction of the burden or compared to the World Bank thresholds.  
Crop  Nutrient Technique  Target country 
Burden of 
Deficiencies 
(DALYs lost) 
Health impact  
(DALYs saved) 
Cost-effectiveness  
(US$/DALY saved) 
      Pessimistic     Optimistic Pessimistic   Optimistic 
Relative  Relative  % Relative    %     Total  Thresholdi      Total  Thresholdi 
Rice Vitamin A TB Indiab 20.52 1.80 8.8 12.19 59.4 19.4 <WB High 3.1 <WB High 
   Philippinesc 32.06 1.82 5.7 10.11 31.5          / / / / 
 Iron CB Bangladesha  34.36 2.75 8.0 0.91 2.6 17.9 <WB High 4.8 <WB High 
   Indiaa  35.27 1.76 5.0 7.22 20.5 16.7 <WB High 3.4 <WB High 
   Indiae 35.27 4.41 12.5 5.29 15.0 3.9 <WB High 0.3 <WB High 
   Philippinesa  8.31 0.33 4.0 1.22 14.7 234.4 <WB Low 54.5 <WB High 
 Zinc CB Bangladesha 30.86 5.25 17.0 10.18 33.0 6.8 <WB High 1.5 <WB High 
   Indiaa  24.96 4.99 20.0 13.98 56.0 5.7 <WB High 1.3 <WB High 
   Philippinesa  9.50 1.23 12.9 4.08 42.9 55.0 <WB High 12.2 <WB High 
 Folate TB Chinaf 2.38 0.48 20.0 1.43 60.0 64.2 <WB High 21.4 <WB High 
 Multi TB Chinag 80.59 8.99 11.1 37.19 46.2 9.6 <WB High 2.3 <WB High 
Wheat Iron CB Indiae 35.27 2.65 7.5 13.76 39.0 9.8 <WB High 1.1 <WB High 
  CB Indiaa 35.27 2.47 7.0 13.23 37.5 8.7 <WB High 0.6 <WB High 
   Pakistana  57.65 3.46 6.0 8.82 15.3 13.0 <WB High 3.1 <WB High 
 Zinc CB Indiaa  24.96 2.25 9.0 11.98 48.0 10.6 <WB High 1.3 <WB High 
   Pakistana  40.11 2.01 5.0 13.24 33.0 18.4 <WB High 2.4 <WB High 
Maize Vitamin A CB Ethiopiaa 52.76 0.53 1.0 8.97 17.0 289.0 Above  10.7 <WB High 
   Kenyaa 32.27 2.58 8.0 10.33 32.0 112.7 <WB Low 18.4 <WB High 
Cassava  
roots 
Vitamin A CB Congoa 1206.93 36.21 3.0 386.22 32.0 123.8 <WB Low 7.6 <WB High 
  Nigeriad 100.26 7.05 7.0 21.11 21.1         / / / / 
  Nigeriaa 57.14 1.71 3.0 16.00 28.0 137.4 <WB Low 7.9 <WB High 
   North-East Brazila 10.00 0.40 4.0 1.90 19.0 1006.5 Above  126.5 <WB Low 
Beans Iron CB Hondurasa  57.65 1.06 1.8 16.14 28.0 401.6 Above  65.5 <WB High 
   Nicaraguaa 53.61 1.61 3.0 5.84 10.9 439.2 Above  64.5 <WB High 
   North-East Brazila 40.00 3.60 9.0 8.58 21.5 133.9 <WB Low 20.0 <WB High 
 Zinc CB Hondurasah  13.27 0.40 3.0 1.99 15.0 1494.3 Above  160.2 <WB Low 
   Nicaraguaa  17.87 0.36 2.0 1.97 11.0 5939.6 Above  576.4 Above 
   North-East Brazila 20.00 1.00 5.0 4.00 20.0 1899.7 Above  152.6 <WB Low 
Sweet potato Vitamin A CB Ugandaa 56.64 21.52 38.0 36.25 64.0 29.5 <WB High 8.6 <WB High 
 
DALYs, Disability-Adjusted Life Years; TB, biofortification using transgenic methods; CB, biofortification using conventional methods; WB, World Bank 
Note: Bold refers to the findings of the CEA in this PhD dissertation. 
aOwn calculations, based on Meenakshi et al. (2007);  bOwn calculations, based on Stein et al. (2006); cOwn calculations, based on Zimmermann & Qaim (2004); dOwn calculations, based on 
Manyong (2004); eOwn calculations, based on Stein et al. (2008a); fBased on Table 50 (burden, impact) and Table 51 (costs); hAccording to Suarez (2010), the cost-effectiveness is even more 
positive, with a range between US$ 96-379. iWorld Bank thresholds are expressed in 2011. WB Low = lower World Bank threshold (US$ 258.12 per gained DALY); WB High = upper World Bank 
threshold (US$ 86.04 per DALY saved). 
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5.4.4.2. A comparison with other folate interventions 
 
Due the different characteristics of folate interventions, e.g. fortifying staple crops versus distributing 
supplements, which imply a different cost structure, gathering evidence on - or data to measure - the 
cost-effectiveness of supplementation and food fortification activities is a difficult challenge (Fiedler et 
al., 2007). Another important factor which complicates a comparison of micronutrient intervention 
evaluations, is the use of different cost measures. Depending on the investigated intervention, 
previously published CEA or CBA measures are, for example, the cost per dose or cost per averted 
death (supplementation) and the cost per metric ton (MT) of the food vehicle or the increased retail 
price (fortification)(Fiedler et al., 2008). Given the lack of reliable country-specific information about the 
potential folate program characteristics and the affiliated costs, the cost-effectiveness of other folate 
interventions in China is not included in this PhD dissertation. However, this section attempts to shed a 
light on the potential costs of the two currently most important folate interventions, i.e. supplementation 
versus food fortification, by reviewing the literature on the costs and cost-effectiveness of folate and 
other micronutritional interventions. The general characteristics, success factors and bottlenecks of all 
folate strategies are discussed in section 2.4. 
When juxtaposing supplementation and food fortification programs to reduce micronutrient 
malnutrition, whether it is iron, iodine or vitamin A deficiency, the cost per DALY is often below the 
World Bank threshold (World Bank, 1994; IOM, 1998b; Hunt, 2001; Laxminarayan et al., 2006). 
Although targeted supplementation generates the largest impact on the short term, population-wide 
fortification appears to be 2 to 10 times more cost-effective given its lower costs (Hunt, 2005; Horton, 
2006). Therefore, supplementation is still considered a valuable, cost-effective strategy when there is 
no appropriate food vehicle or convenient staple crop available (Baltussen et al., 2004). Similar 
conclusions were drawn in the only Chinese study that roughly estimated the cost-effectiveness of iron 
and zinc interventions (Ma et al., 2007). In terms of the cost per capita, tackling both deficiencies could 
be highly cost-effective when choosing biofortification (US$ 0.01) or food fortification (US$ 0.01 - 
0.06). Supplementation is a better option when aiming to increase zinc (US$ 0.05) instead of iron 
intake (US$ 11.4). When aiming to minimize the costs, dietary diversification is the least 
recommended option, with a cost of US$ 1148 per capita. 
 
Folic acid supplementation   
CEA studies of folic acid supplementation programs are rarely existing (Grosse et al., 2007). Another 
difficulty is that folic acid is often promoted in combination with iron, i.e. iron-folic acid supplements 
(Klemm et al., 2009; Horton et al., 2010). It is widely acknowledged that such multiple micronutrient 
interventions are effective (Sanghvi et al., 2010). When targeting the high-risk group, the costs are 
estimated at US$13 per DALY averted (Durkin et al., 2006) or US$ 2.0 per pregnancy (Horton et al., 
2008). Such cost measures do not address periconceptional intake and, therefore, do not take into 
account the negative impact of unplanned pregnancies, which mainly occur in high-risk groups (Cornel 
and De Smit, 2010). The cost-effectiveness to promote the use of periconceptional, single 
micronutrient supplements with folic acid is generally low. In the Netherlands, for instance, the costs to 
reach a 50 % coverage rate was estimated at around 2 545 US$ per DALY saved (Postma et al., 
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2002). However, cost estimates differ between and within countries and across different types of 
programs and their characteristics (Fiedler et al., 2007). 
Based on the cost structure of vitamin A and iron supplementation programs in developing countries, 
Fielder et al. (2007) showed that the costs of the supplements only accounts for 6 % of the total 
program costs. The personnel costs, including health workers, are considered to have the largest 
contribution (65 %). Training and promotion constitute 5 and 10 %, respectively. In other words, the 
cost to deliver the doses outweigh the costs of these doses. According to Horton et al. (2010), the 
delivery costs of iron-folic acid supplementation programs constitutes roughly 90 % of the total cost. 
Regarding the cost structure, there is still a lot of variation across regions (Baltussen et al., 2004) and 
between supplementation programs (Fiedler et al., 2008). First of all, compared to iron (daily or 
weekly) and vitamin A (every 4 to 6 months), folic acid supplements need to be taken each day, which 
will increase the cost per dose per person. Also the country-specific characteristics of the targeted 
micronutrient deficiency (e.g. high-risk regions in poor rural risk regions) influences the costs to 
adequately deliver the supplements to those in need. Programs differ according to the type of 
intervention: in-facility versus field-based delivery programs (Fiedler et al., 2008); long-term routine 
service-based programs (e.g. the Chinese premarital folic acid supplementation program;(Hesketh 
2003; Li and Hao, 2008), versus campaign-based interventions (e.g. the Chinese free folic acid 
supplement campaign in 2009; see below). 
 
Folic acid supplementation in China 
Regarding the aforementioned Chinese free folic acid supplement campaign (Juan, 2009)(thoroughly 
described in section 2.4.1.2), only the costs of the supplements could be retrieved through interviews 
with two of the scientific program coordinators (Lu Ciyong and Aiguo Ren; personal communication, 
respectively, 08-01-2011 and 03-03-2010). The aim of this program is to provide 12 million rural 
women of childbearing age with free folic acid pills during 6 months (or more, if a participant became 
pregnant). Based on the targeted population per province and the price per dose (¥ 24 per person), 
the total estimated cost of the pills amounts ¥ 284 million or US$ 42.9 mi, of which, on average 56 % is 
funded by the central government. These costs only refer to the dose and given the high share of 
delivery costs in supplementation programs, underestimate the overall program costs. Based on the 
review of the cost structure of Vitamin A (Fiedler et al., 2007) or folic acid supplementation (Horton et 
al., 2010), the total costs of this large-scale intervention may range from 428.8 mi. and 714.6 mi. US 
dollars, regardless of the number of DALYs that will be saved. Although the cost data does not allow 
measuring a full economic evaluation, the high costs might make such a program less cost-effective 
than biofortification, especially if it would be implemented on a 30-year time scale. 
 
Folic acid fortification 
Folic acid fortification have shown its high potential as a cost-effectiveness strategy for different food 
vehicles (CDC, 2010), including grains in the US (Bentley et al., 2009), wheat flour in Chili (Hertrampf 
and Cortes, 2008) and the Netherlands (Jentink et al., 2008), and wheat flour and maize meal in South 
Africa (Sayed et al., 2008). In Chili and the United States, for instance, each invested dollar in folic 
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acid fortification saves US$ 11 (Llanos et al., 2007) and US$ 100 (Grosse et al., 2005), respectively. 
However, folic acid fortification is in most cases combined with other micronutrients, like iron, zinc, and 
niacin (Durkin et al., 2006). The total costs to add folic acid in staple foods are estimated at US$ 0.01 
per person, per year (Mason et al., 1999; Mannar, 2001; Horton et al., 2008), while the annual cost of 
iron-folic acid fortification varies between US$ 0.12 (Horton and Ross, 2003), US$ 0.20 (Horton et al., 
2010) and US$ 0.54 per person (Fiedler et al., 2008)54. Expressed in volumes, the estimated average 
cost of folic acid and iron-folic acid fortification amounts US$ 0.16 (Durkin et al., 2006; Llanos et al., 
2007; Hertrampf and Cortes, 2008) and US$ 0.4 per metric ton of grain (Fiedler et al., 2008), 
respectively.  
 
Folic acid fortification in China 
In their Country Investment Plans (CIPs), the Asian Development Bank (ADB, 2004a) proposed and 
evaluated the potential of the 10-year implementation plans of two fortification programs in China, 
which included folic acid among other micronutrients (iron, zinc) in their fortification mix: a large-scale 
wheat flour program in Western China (250 million consumers) and a country-wide soy sauce 
intervention (500 million consumers). The ten-year costs amount, respectively, US$ 184 mi. and US$ 
240 mi., of which 55 % and 82 % are attributable to the costs of the fortification mix. These two folic 
acid fortification strategies also differ in terms of the start-up costs (US$ 54.5 mi. versus US$ 5.6 mi.) 
and the costs of a marketing and education campaign (US$ 26.4 mi. versus US$ 15.9 mi.). The 
monitoring and food control costs account for less than 1 % of the total costs. Except for the lower 
share of the latter, these cost-structures are in line with estimates from vitamin A and iron fortification 
(Mason et al., 1999; Mannar, 2001; Fiedler et al., 2008). Although both fortification strategies are 
considered cost-beneficial, especially in rice consuming populations (ADB, 2004a; Durkin et al., 2006), 
the high start-up costs pose difficulties to wheat fortification in China. As in other fortification programs, 
the structure of the food vehicle industry plays a crucial role in the success of the fortification program 
(Fiedler et al., 2007). Contrary to the concentrated soy sauce industry, wheat milling is a segmented 
sector with about 100 000 small-scale mills in Western China, which hampers communication and 
(food) quality assurance (ADB, 2004a). 
As the Chinese PNDC mainly supports research on wheat flour and soy sauce fortification, there is 
little information on folic acid fortification of rice in China (PNDC, 2011). Rice fortification is generally 
more expensive than adding folic acid to soy sauce or wheat (Susan Horton, Wilfrid Laurier University, 
personal communication, 15-12-2010). The use of the traditional fortification technology to lay a 
micronutrient coat is not a sustainable option because consumers typically wash rice before cooking 
(Shrestha et al., 2003). Nevertheless, there are two strategies of rice fortification being explored: the 
market-driven approach of DSM-Buhler and the socially-supported approach of PATH (Wailes and 
Lee, 2008). While the first approach is represented by leading rice milling equipment manufacturers, 
the latter is advocated by an international non-profit organization, who seeks to introduce fortification 
in governmental feeding programs. Therefore, the former aims at the high-income users, e.g. in 
Jiangsu Province, while the undernourished populations are the primary target group of the latter. 
                                                 
54 In general, adding micronutrients to staple crops costs U$ 0.40-0.50 per person, per year (Hunt, 2001; Durkin et al., 2006), with Vitamin A and Vitamin E 
considered as the most expensive fortificants (Mason et al., 1999; Mannar, 2001).  
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Regardless of the selected strategy/technology, a company-based cost analysis reveals that fortified 
rice in china would raise the price of rice up to 3.5 to 4.0 %, which reflects an annual cost of US$ 1.60 
per consumer and a significantly higher cost per MT (US$ 139 per MT) compared to other fortification 
food vehicles (Wailes and Lee, 2008). It is important to notice that these cost estimates are built upon 
the assumption of an industry that is based on a few large rice milling companies. At present, the 
Chinese rice milling industry consists of more than 300 000 companies, of which no more than 10 
millers are capable of producing more than 80 tons per hour (Wailes and Lee, 2008). Fortification in 
small mills is technically feasible, but the associated monitoring costs will be extremely high (Bertebos 
Foundation, 2008). Furthermore, many families in rural areas are milling rice themselves or rely on 
small, local millers, which limits their access to fortified food. The decentralized, segmented rice milling 
sector is considered one of the major constraints of future rice fortification in China. Choosing for rice 
as the fortification vehicle will likely negatively affect the cost-effectiveness of the intervention, as more 
efforts are needed to guarantee quality control and technical barriers imply a more expensive 
technology (Susan Horton, personal communication, 15-12-2010). 
 
5.4.4.3. A comparison with other high-risk regions – the case of the Balrampur District 
(India) 
 
This section explores the impact of folate biofortification in Shanxi Province (see section 5.4.1) and 
another major high-risk region, namely the Balrampur District in India. 
Historically, the average folate consumption in India are substantially below the recommended nutrient 
intake levels (Krishnaswamy and Madhavan Nair, 2001; Chakravarty and Sinha, 2002; Mallikharjuna 
Rao et al., 2010), leading to a high number of NTDs (see Figure 10 in section 2.3.3), especially in the 
sugar cane milling Balrampur District. Situated in the Uttar Pradesh State of Northern India, this rural 
district is considered as one of the least developed and poorest regions of the country. What Shanxi 
Province is to China in terms of NTD prevalence and folate intake levels, Balrampur District is 
supposed to be for India. Yearly, between 65.7 and 82.1 per 10 000 births are affected with an NTD 
(Cherian et al., 2005). Notwithstanding the lack of (recent) evidence of NTD prevalence in India, it can 
be expected that this high NTD risk region can be expanded to the whole Uttar Pradesh State 
(Sharma et al., 1994; Krishnaswamy and Madhavan Nair, 2001) or even neighboring States 
(Mahadevan and Vishnu Bhat, 2005).  
 
Table 53 presents the health gap of folate deficiency in the current situation and after the 
implementation of FBR. The methodology is similar as in the main analysis of this chapter, but here 
the results are expressed in relative numbers. Because this section focuses on two high-risk regions, 
the high coverage rates as derived from the Shanxi consumer survey were selected: 36.95 % and      
81.91 % (section 5.2.2.1.). As a consequence, the health impact figures are slightly higher than in the 
main study (see Table 49). 
Given the NTD prevalence rates and the NTD attribution levels to folate deficiency, the relative burden 
of folate deficiency in Balrampur varies between 22.83 and 39.93 DALYs lost per 10 000 persons. As 
these figures do not take into account the large difference in birth rate between Balrampur (29.5) and 
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Shanxi (11.3)55, the burden is also expressed per 1 000 births. By doing so, both the burden and the 
potential health benefits in Shanxi Province approximate the high impact scenario of Balrampur, which 
supports the high NTD risk status in these regions.  
 
Folate deficiency is increasingly acknowledged by the Indian government. For example, they 
integrated a large iron-folic acid supplementation program for young, pregnant and lactating women 
(79.82 mi. US$ per year) in their Micronutrient National Investment Plan (IMNIP)(Micronutrient 
Initiative, 2006). Unfortunately, micronutritional programs in India are often characterized by poor fund 
allocation, poor community involvement, ineffective distribution strategies, a lack of monitoring and 
build-in evaluation, and the absence of a social marketing strategy, including nutritional education, 
which lead to an unsatisfactory coverage rate (Vijayaraghavan, 2002). Together with the governmental 
support, the large production of GM crops (especially Bt cotton, see section 2.5, Figure 11), the 
involvement in the Golden Rice projects (e.g. recently started field trials, (ISAAA, 2009), the positive 
reactions of Indian consumers towards Golden Rice (Deodhar et al., 2008), the high rice production 
rates (FAOSTAT Database, 2008) and the effectiveness of enriching rice with folate (see section 
5.2.2.1), FBR might be considered a valuable intervention to reduce folate deficiency in both risk 
regions.  
   
                                                 
55 China has one of the lowest birth rates in Asia, together with Singapore, South-Korea and Japan (ESCAP, 2009). This is mainly due to its ‘one-child family 
policy’, which started in 1979, and aims to curtail the population growth (Kane and Choi, 1999). Despite its success, one of the most important pitfalls of this 
policy is the sex discrimination, by which girls are significantly more a victim of abortions and orphans. For an overview of the Chinese birth rates per 
administrative region, see Table 40. 
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Table 53 Demographic profile of Uttar Pradesh, the current burden and health impact of FBR, and a comparison between Balrampur and Shanxi Province, in relative numbers.  
Numbers for  Balrampura  Current burden  Folate intake levels  Potential health impact 
Total population 1 682 350b  Balrampur Shanxia  Balrampur Shanxia  Balrampur Shanxia 
Birth rate  29.5c  Low High  Befor
e 
After Befor
e 
after  Low High Low High 
Births 49 629  DALYs lost per 
10 000 persons 
µg /day/cba 
 DALYs saved per 
10 000 persons 
Life expectancy at birth 64 yearsd    
Scenario  Low High    
   NTD prevalence ratee  65.7 82.1  22.83 39.93 14.31  249.3j 1290.8k 190.9 508.6  8.43 32.71 5.29 11.72 
   NTD attribution levelf 50 70  DALYs lost  
per 1 000 births 
      DALYs saved  
per 1 000 births 
   Coverage rateg 36.95 % 81.91 %     
Total NTDs 163 284     
   NTD Morbidity 65 114  77.38 135.37 126.70    28.59 110.8
9 
46.8 103.89 
a. Spina bifidae 45 80            
b. Encephalocelee 20 34            
NTD Mortality 98 170            
2. NTD Stillbirthsh 47 82            
3. NTD Abortionsh 51 88            
Rice consumptioni 356.67 g/day/person            
 
cba, women of childbearing age; NTD, neural tube defects 
Note: unless otherwise mentioned, the parameters of the DALY framework to measure the health impact of China are used, e.g. discount rate of 3 % (Table 42). 
aNumbers for Shanxi Province are presented in section 5.2.1.1 (population data) and section 5.2.2.1 (health impact); bFigures derived from the 2001 census for India; cThe birth rate is expressed per 
1 000 births, in 2007 (Govt. of India, 2008); dBased on WHO life tables for India, in 2008 (WHO, 2008b); eBoth the NTD prevalence rates and the composition of the two non-fatal NTDs, i.e. 70 % (a) 
and 30 % (b), are derived from the NTD study in Balrampur District (Cherian et al., 2005); fDue to the lack of region-specific evidence, the attribution level of NTDs to folate deficiency is based on the 
global percentages, i.e. 50 % and 70 % (see section 2.3.3); gThe coverage rate in both provinces are derived from the Shanxi consumer study in 2008 (see section 5.2.2.1); hDue to the lack of 
region-specific evidence, the figures are derived from the data assumptions for Shanxi Province (see section 5.2.1.1); iRice consumption in Balrampur refers to purchases through the Public 
Distribution System (P.D.S.) and other channels (Govt. of India, 2001); jThe current daily folate intake level is based on a folate study in Lucknow, the capital of Balrampur (Misra et al., 2010). When 
maternal figures for rural areas would be available and included, the mean folate intake levels are expected to be lower; kThe calculation method is similar as in section 5.2.2.1.  
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5.4.5. Sensitivity analysis  
 
5.4.5.1. Impact of NTD prevalence rates and NTD attribution levels in Shanxi Province 
 
Although a sensitivity analysis cannot justify the use of specific parameters in the DALY framework 
(WHO, 2000), it provides the reader with information about their impact on the results. For example, 
using different NTD prevalence rates could influence the potential health impact of folate enriched rice. 
This is explored for Shanxi Province because this region was subject of several folate and NTD 
research publications.  
Table 54 lists published evidence on studies that measured the prevalence of NTDs in Shanxi 
Province (Moore et al., 1997; Li et al., 2006; Gu et al., 2007), Northern China (Moore et al., 1997) or  
in different regions of China (Xiao, 1989; Dai et al., 2002). All NTD prevalence rates differ in terms of 
the time of the research (i.e. 1987 until 2004), the method of data collection (hospital-based, 
population-based or combined approaches), and the research location (rural versus urban 
populations).  
The selection of the NTD rate directly influences the total number of DALYs that are lost or saved due 
to folate deficiency and FBR, respectively. If the lowest prevalence rate of NTDs would be used, the 
burden of folate deficiency and the health benefits of biofortification would be 43.89 % lower than the 
NTD rate of Li et al. (2006). However, this percentage refers to the absolute reduction of the burden 
and the health benefits. Although the total number of DALYs saved will change, the reduction of the 
burden of folate deficiency through the introduction of folate biofortification remains the same, whether 
a low or high NTD prevalence rate is selected. This is because the health impact is determined by the 
coverage rate. If the coverage rate would increase, for instance, this would have a direct positive effect 
on the reduction of the folate deficiency burden, regardless of the selected NTD prevalence rate. Thus, 
while the NTD prevalence rate affects the absolute figures of the current burden and health benefits, 
the coverage rate determines the health gap, i.e. the discrepancy between these numbers.  
 
Table 54 Comparison of the impact of using different NTD prevalence rates to measure the health impact of folate 
biofortified rice in Shanxi Province 
NTD prevalence rate 
in Shanxi Provincea 
Study characteristics Change in 
burden (%) 
 
Period Method Research location Source 
60.88b 1996-2000 HB 31 provincesc Dai et al., 2002 -56.11 
105.50 1987 HB 29 provincesc Xiao, 1989 -23.14 
              138.70 2003 PB Shanxi Province Li et al., 2006              0.00f 
149.00 1997 PB 4 provincesd Moore C et al., 1997 +7.43 
199.38 2002-2004 HB + PB Shanxi Provincee Gu et al., 2007 +43.75 
 
HB, hospital-based; PB, population-based 
aExpressed per 10 000 births; bNTD prevalence rate used in the health impact study of chapter 5; cIncluding Shanxi Province; 
dHebei and Shanxi in Northern China, and Jiangsu and Zhejiang in Southern China; eOnly Jiaokou and Zhongyang, i.e. two 
counties in the Lvliang mountain area of Shanxi Province, are included; fReference rate in this sensitivity analysis. 
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Using other attribution rates of folate deficiency to NTDs also has direct implications. If the 85 % 
attribution level of Berry et al. (1999)(see section 5.2.1.1) would be replaced by the 80 % level found in 
the Chinese study of Chen et al. (2008) or the world attribution rates (50-70 %, see section 2.3.3), the 
size of the burden of folate deficiency would be directly influenced. For example, the burden and 
health impact would be 41.18 % and 17.66 % lower when an attribution level of 50 % or 70 % would 
have been used.  
Another commonly addressed issue in sensitivity analyses of health impact studies is the effect of 
discount rates (Murray, 1996). The current study confirms the conclusions of the sensitivity analysis of 
the GBD study: a zero discount rate increases the burden before and after the intervention, and, thus, 
its absolute impact. 
 
5.4.5.2. Potential cost-effectiveness of the single-insertion approach in MBR   
 
So far, we assumed that the four micronutrient traits would be developed independently and combined 
later on through backcrossing to obtain multi-biofortified rice varieties with all four traits. Hence, two 
transgenic single trait events, one for provitamin A and the other for folate, need to be deregulated, 
while the other two (iron and zinc) are conventionally bred. As argued above, for the concrete example 
of multi-biofortified rice in China, this is the most realistic avenue, given that the four traits are being 
developed by different research organizations. However, multi-biofortified rice may also be used in a 
number of other countries. Moreover, the individual technology components may be further improved 
over time, or new biofortification technologies in rice and other crops may be developed. Hence, it is 
also instructive to analyze how the cost-effectiveness might change if a single-insertation approach 
were used in future. 
In our example of multi-biofortified rice we assume that the two transgenic traits would be stacked in 
one gene construct, while iron and zinc as conventional traits would be added through backcrossing. 
This would reduce the country-specific costs, as only one transgenic event would need to be 
deregulated. In particular, US$ 8.0 million could be saved, lowering the country-specific costs by 33 % 
from US$ 24.0 million to US$ 16.0 million (compare with Table 51). We further assume that such a 
stacking approach would help reduce the basic R&D costs by 20%, as this research would be carried 
out in one single organization with resulting synergies. For social marketing and maintenance 
breeding, no cost advantages are expected. Thus, the total cost would drop by 16 % from US$ 85.4 
million to US$ 71.8 million, with all cost savings occurring in the first half of the 30 year time horizon. 
With these new cost assumptions, the cost per DALY saved would be US$ 7.91 and US$ 1.91 in the 
pessimistic and optimistic scenario, respectively. This is significantly lower than the values calculated 
above, demonstrating that the cost-effectiveness of multi-biofortification can be further increased by 
improving the efficiency of technology development. A single-insertion approach is of particular 
interest when multiple transgenic traits are involved.  
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5.5. Conclusions 
 
This chapter evaluates the potential health benefits and cost-effectiveness of introducing GM folate 
enriched rice in China, both as a single and multi-biofortified staple crop. Application of the DALY 
method reveals that the current burden of folate deficiency amounts up to an annual loss of 314 180 
DALYs. The introduction of GM rice with a folate content of 1 200 µg per 100 g rice in China would 
save 62 863 DALYs in the low impact scenario and 188 508 DALYs in the high impact scenario. The 
burden and the health impact are the highest in Northern China, in absolute (northeast) as well as 
relative numbers (northwest). The region with the highest NTD prevalence rate, Shanxi Province, will 
benefit the most from folate biofortification. The regional health benefits in China are based on 
average daily folate intakes between 433 µg and 1 411 µg per woman of childbearing age, which are 
significantly higher than the recommended folate intake of 400 µg. Although these numbers refer to 
averages, the high folate intake level in China demonstrates that FBR can be a valuable means to 
reduce folate deficiency and NTDs, especially in poor, rural regions where other folate interventions 
are less feasible. Even in the northern regions, where wheat is more popular than rice, folate 
biofortification of rice could contribute to achieve the recommended folate dose.  
According to the target group, newborns or their mothers, the health impact of FBR can be interpreted 
in two ways. First, the health benefits can be expressed in terms of DALYs saved, based on the 
reduced number of births affected with an NTD, which is due to their mothers biofortified diet. Second, 
based on the coverage rate of FBR, the health impact can also be understood as the number of 
women of childbearing age, including mothers, recovering from folate deficiency. This “double” health 
impact is an important argument to underpin future communication strategies in order to tackle folate 
deficiency and its adverse health outcomes. 
The results on MBR show that out of the 10.64 million DALYs that are yearly lost due to micronutrient 
malnutrition in China, between 1.19 million and 4.91 million DALYs could be saved when multi-
biofortified rice would be introduced. Despite its favorable cost-effectiveness, the biggest contribution 
of multi-biofortification refers to its large health benefits, rather than to reduce the costs of single 
biofortification initiatives. The cost implications of the backcrossing approach are mainly reflected in 
the basic R&D costs, where the costs of developing each trait are aggregated, next to the 
backcrossing costs. This means that the costs to develop multi-biofortification are likely to be higher 
than the sum of developing each single biofortified crop. But the same goes for the coverage and, 
thus, health benefits of a multi-biofortified crop, which is likely to outweigh the simultaneous 
commercialization of four biofortified crops. Still, a first glance at the costs of introducing FBR in China 
reveals that even single-nutrient policy interventions can be a cost-effective method to reduce folate 
deficiency and its negative outcomes. 
 
Although the application of the DALY approach in CEA analyses of health interventions is generally 
acknowledged, several limitations need to be taken into consideration. The analysis is highly 
dependent on the availability of data, such as the DALY parameters associated with the functional 
outcomes of micronutrient deficiencies, but also rice consumption and nutritional data. Not all 
functional outcomes could be entered, due to unknown prevalence rates (e.g. nightblindness of 
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Chinese lactating women; multiple NTD malformations; non-reported births) or the uncertainty of the 
attribution level (e.g. attribution of anemia to folate deficiency), which underestimates the total burden 
of micronutrient malnutrition in China.  
With respect to the impact of consuming biofortified rice, the analysis relies on average nutrient and 
rice intake levels. To cope with this aggregated data level, the dose-response relationship compares 
the average micronutritional dose after (multi-)biofortification with the Recommended Nutrient Intake 
(RNI). These nutritional thresholds differ from the Estimated Average Requirements (EAR), which are 
often recommended in health impact analyses based on individual household data (Stein et al., 2006). 
While an EAR defines the average daily nutrient intake level to meet the requirements for half of the 
individuals of a given gender and age category, the RNI is a higher reference standard which meets 
the daily requirements of nearly all these individuals (97-98 %)(FAO/WHO, 2004). As some 
micronutrient intake levels in the optimistic impact scenario significantly exceed the RNI level, 
achieving the tolerable upper level (UL) might become an issue. Very high intakes of folic acid (>1 000 
µg/day), for instance, could mask Vitamin B12 deficiency (Scott et al., 2000; Bailey, 2004; Bekaert et 
al., 2008) and lead to a higher risk for colorectal cancer (Smith et al., 2008)(see also section 2.3.1). 
However, FBR and MBR increase the natural folate levels in rice, instead of inserting folic acid, which 
is assumed to be less problematic (Storozhenko et al., 2007)56 and makes an early diagnosis of 
Vitamin B12 deficiency possible (Tam et al., 2009). In regions with folate intake levels higher than        
1 000 µg after folate biofortification, such as in most of Southeast China, a transgenic line with a lower 
folate content could be deployed to avoid potential negative side effects associated with high folate 
intake levels. As the uptake of Vitamin A and iron increases through biofortified rice is homeostatically 
controlled, toxicity issues and associated adverse health effects are also less likely to occur (Stein et 
al., 2005b). Regarding zinc, its UL is too high to be achieved through conventional biofortification 
techniques (IOM, 2002). On the other hand, not all administrative areas have high folate intake levels 
after biofortification. In Shandong and Xinjiang, for instance, the average folate intake levels are 
slightly above the RNI. This could be tackled by implementing a transgenic line with higher folate 
content, such as 1 700 µg per 100 g of raw polished grains. 
 
This is the first attempt to measure the cost-effectiveness of folate and multi-biofortification. Some 
recommendations can be made to further improve the research results.  
First, collecting primary or fine tune secondary data would significantly benefit this health impact study. 
While some parameters of the DALY framework have to be further explored (e.g. a stable folate 
content of folate enriched rice and the exact degree of bioavailability), others need to be adapted 
according to the study location (e.g. the current folate intake and the attribution level of folate 
deficiency to NTDs, per administrative area). Since several parameters are based on different years 
(i.e. NTD prevalence rate in 2004, rice consumption in 2007, FBR coverage rate in 2008), the health 
impact has to be perceived as a theoretical number, rather than a real figure.  
                                                 
56 Vitamin B12 deficiency is characterized by macrocytic anemia and neurological impairment. The diagnosis of Vitamin B12 may be delayed by folic acid 
(reduction to H4folate), as the latter can correct the macrocytosis (Gutstein et al., 1973). Because (natural) folate biofortified rice contains 5-methyl-
tetrahydrofolate (MTHF), the synthesis of H4folate from 5-MTHF is catalyzed by a Vitamin B12 dependent enzyme, which eliminates the effect of masking 
Vitamin B12 deficiency (Storozhenko et al., 2007; Tam et al., 2009). 
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Furthermore, the DALY is a disease burden measure that is related to health outcomes, just as 
morbidity, mortality, life expectancy, DALE (disability-adjusted life expectancy) and QALY. The focus 
could also have been put on or extended to the costs of the burden, e.g. using a cost-of illness 
analysis (COI) to calculate both direct and indirect costs attributable to the disease, such as the (non-) 
medical costs and the costs related to productivity losses, respectively. Although such an analysis 
could have provided additional arguments regarding the importance of the burden of folate deficiency, 
as the Dutch study of Jentink et al. (2008) shows, data constraints hamper the measurement of such 
costs. 
Second, to be able to calculate all health benefits of FBR, additional research is required to define the 
attribution of folate deficiency to each of its functional outcomes or, when the focus of the intervention 
is on reducing NTDs, explore the impact of other micronutrient deficiencies. NTDs, for instance, have 
also been associated with zinc deficiency (Sandstead, 1994). In this respect, the effect of micronutrient 
interactions in the case of MBR should deserve more attention. Some interactions could generate 
additional health benefits. For example, improving the Vitamin A status might enhance iron absorption 
(Schultink and Gross, 1996), while tackling zinc deficiency could increase folate bioavailability 
(Sandstrom, 2001) and folic acid supplementation could alter zinc absorption (Sandstead, 1994). On 
the other hand, combining traits may also impair micronutrient absorption and reduce its health effects. 
Iron supplementation, for instance, could negatively influence zinc absorption and vice versa 
(Winichagoon, 2008). Nevertheless, evidence of the effect of micronutrient interactions between zinc, 
iron, folate and vitamin A is mixed and it still remains unclear how these interactions will be affected 
through multi-biofortification. This study assumes that the health impact of four traits is equal to the 
aggregated impact of each individual trait. 
Third, when the regional data in the FBR health impact study would be available (or collected) at 
individual level, the burden could be further refined and the characteristics of high-risk regions and 
individuals could be more precisely mapped and, thus, better addressed.  
Fourth, in-depth analysis and verification of the different cost estimates are needed to further underpin 
the introduction of FBR or MBR in China. Therefore, policy issues regarding the price of folate 
enriched rice, promotion campaigns, the selected variety, and so on, need to be explored and 
incorporated into the analysis (see also section 6.5). Also the availability of, and access to the product, 
and the final product attributes (see section 3.3.4) will define whether women will actually be able (and 
willing) to switch to FBR.  
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6 General conclusions 
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6.1. Answering the research questions 
 
This PhD dissertation addresses eight research questions concerning the market potential of FBR in 
China, and Shanxi Province in particular (see section 1.4). Hereunder, I provide an answer to each of 
the research questions and their sub-questions, based on the results presented in the different 
research chapters.  
 
RQ1. Is consumer acceptance of FBR determined by socio-demographic indicators, 
knowledge and consumer perceptions related to GM food? 
RQ1A.       How do consumer perceptions of GM food affect FBR acceptance? 
RQ1B. Does objective GM knowledge determine FBR acceptance? 
RQ1C. How do socio-demographic variables influence FBR acceptance? 
 
As expected, socio-demographic indicators, GM knowledge and consumer perceptions influence FBR 
acceptance (see section 3.3.2). By using four multi-item scales of GM food perceptions, the study 
found a positive association between risk and benefit perceptions of GM food and a favorable opinion 
of FBR, which is in accordance with the general literature findings (Baker and Burnham, 2001; Li et al., 
2002). The appropriateness to use these perception categories is also shown in the cluster analysis 
(see RQ2). 
 
Compared to previous research that found a one-sided, positive effect of objective knowledge (and 
education level)(Hoban, 1998; Koivisto Hursti and Magnusson, 2003; Traill et al., 2004; Chen and Li, 
2007; Costa-Font et al., 2008), or no effect at all (Hamstra, 1995; House et al., 2004), high objective 
GM knowledge increases the likelihood of being either reluctant or favorable. People who are 
indifferent to FBR are more likely to be those without any understanding of the GM concept. This 
provides evidence to use a categorical acceptance construct that distinguishes acceptance from 
indifference.  
 
Due to the low explained variance of the model, one could argue that socio-demographic variables are 
not powerful factors of FBR acceptance, in line with several GM studies (Bredahl et al., 1998; Li et al., 
2002; Kontoleon and Yabe, 2006; Anand et al., 2007). The lack of significant family-related indicators 
in our study further underpins this. On the contrary, FBR acceptance is determined by four socio-
demographic factors (gender, age, education and farmer status), which advocates to take into account 
the socio-demographic profile of consumers in GM food research. Somewhat surprising, men are 
more likely to accept this GM food product. Nevertheless, the majority of the Shanxi rice consumers 
and farmers are favorable to FBR. 
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RQ2. What kind of segments of Shanxi rice consumers can be distinguished based 
on GM food knowledge, consumer perceptions and trust in information 
sources/channels? 
 
The consumer study in a Chinese Province with a high risk of folate deficiency provides further insight 
in the existence of three market segments for FBR as a GM food product, denoted as cautious      
(44.6 %), opposing (41.2 %) and enthusiastic consumers (14.2 %)(see section 3.3.3).  
Objective knowledge, trust in information sources and channels, and FBR acceptance is the highest in 
the group of enthusiasts, followed by the cautious segment. The former also have generally the most 
positive view on the GM food consumer perception categories, whereas the opponents and cautious 
cluster are more concerned about the primary (safety, risks) and secondary conditions (benefits, price 
impact) of GM food, respectively. Regarding the acquisition of GM food information, opponents rely 
less on audio-visual information channels and more on anti-GM sources, while having less trust in 
typically pro-GM sources, such as the government and the biotech industry.  
The small size of the enthusiastic segment is due to its general positive values on nearly all examined 
variables, such as knowledge, acceptance, trust in information sources and channels. This means that 
consumers, whose high objective knowledge and positive consumer perceptions led to higher 
acceptance, are clustered in a homogenous group of (extremely) favorable consumers. As a 
consequence, the cautious are considered less enthusiastic, rather than being averse.  
 
RQ3. Which negative changes in rice attributes would deter FBR acceptance? 
 
Depending on which attributes are negatively altered, different segments of the favorable consumers 
may become resistant, which will hamper the coverage rate and the success of FBR (see section 
3.3.4). In general, the relatively high acceptance rate of FBR in Shanxi Province (62.2 %) would be 
drastically reduced when the final product generates a negative taste (-34.1 %) or environmental effect 
(-33.3 %). The reduction is substantially smaller when the cultivation potential, the external 
appearance, the availability or price impact would be negatively affected. When selecting the rice 
varieties to insert the folate trait, sensory aspects and environmental impacts should be taken into 
account. Regarding multi-biofortification of rice, developers and health planners should anticipate the 
potential negative reactions associated with color changes due to vitamin A enrichment.  
Cluster analysis identified four different consumer segments on the acceptance of negative rice 
attributes in Shanxi Province, namely “Traditional attribute buyers”, “Market consciousness”, “Intrinsic 
attribute buyers”, and “Health seekers”, which demonstrates the heterogeneity of those holding a 
favorable position towards FBR.  
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RQ4. How much are consumers willing to pay for FBR in a high-risk region? 
RQ4A. What determines consumers’ valuation of FBR? 
RQ4B. How does information about the applied GM technology affects WTP for FBR? 
RQ4C. What is the effect of providing information about the regional situation on WTP for 
FBR? 
RQ4D. Is there a difference between non-student and student samples in experimental 
auctions?          
RQ4E. Does the provision of a non-GM substitute influence WTP for FBR? 
RQ4F. Do design characteristics (time, day, size) matter in auctions? 
 
Here, WTP for FBR correspondents with the WTP values in the third auction round, i.e. where no 
specific GM information was given, except for the application of the technology. In general, Shanxi 
female rice consumers are willing to pay 1.73 ¥ or 33.7 % more for the improved folate content in a     
1 kg regular rice bag (see section 4.4.2). This average premium is in line with research on other 
biofortified crops (Li et al., 2002; Deodhar et al., 2008; Depositario et al., 2009a; De Groote et al., 
2011) and represents an increase in the perceived quality of a regular rice bag to the next (higher) 
quality level. Given the low income levels in the sample, the results show that even poor consumers 
are prepared to pay for quality, a finding that has been confirmed in other food auction studies in 
developing countries (Gonzalez et al., 2009; Wayua et al., 2009; Demont et al., 2011; Rutsaert et al., 
2011). 
 
Dependent on the applied technology, different determinants are at stake in the valuation of biofortified 
crops. Whereas knowledge of folate benefits is the main determinant to pay more for conventional 
folate enriched rice, WTP for FBR is largely determined by objective GM knowledge and consumers’ 
acceptance of GM food. The former shows that a higher value is linked to information that confirms 
prior knowledge of folate benefits, which indicates the presence of confirmation or congeniality bias. 
Furthermore, both sWTP and WTP values contradict previous research (Lusk et al., 2001a; Umberger 
and Feuz, 2004) by demonstrating the importance of socio-demographic indicators.  
 
The experimental auctions also showed that the valuations of the folate benefits are high enough to 
compensate potential negative valuations of awareness of the applied GM technology. This supports 
the potential of FBR, especially in the non-student sample, where the information about the GM nature 
of FBR did not significantly alter consumers’ valuations. When looking at zero bidding behavior, 
however, awareness of the GM technology increased the share of zero bidders by 12.7 %. 
 
Provision of relevant information about the current situation in the high-risk region led to increased 
WTP values and substantially reduced zero bidding behavior. As the last information round, this 
information treatment even reduced the negative effects of the previous GM related information 
rounds.  
 
The WTP valuations clearly differ between the student and non-student sample of rice consuming 
women of childbearing age, both in their amount of WTP, as well as in the probability to bid. Whereas 
students are less supportive of FBR, the general target group reacts more positively towards this GM 
201 
 
rice variant with consumer benefits. This contradicts previous literature that found no significant 
differences in GM food auctions between student and non-student samples (Lusk et al., 2005; 
Depositario et al., 2009b). The inter-group variations are likely to be the result of differences in the 
degree of involvement, i.e. less concerned about pregnancy, the socio-demographic profile and GM 
food acceptance. 
 
Offering rice with free folic acid supplements alongside the auctioned FBR bag was not as successful 
as might have been expected. Even when the GM technology in FBR is mentioned, having the option 
to bid on a GM-free folate alternative did not lower the FBR bids. Especially in the non-student sample 
of the auctions, FAR was considered an unattractive folate product.  
 
Regarding the other design characteristics, no significant difference in bidding behavior could be found 
when auctions were held on a different time, during the weekend, or in larger groups. 
 
RQ5. Is there a difference between stated willingness-to-pay (sWTP) and auction-
based values (WTP)? 
RQ5A.       Do the WTP values reveal a hypothetical bias in the stated valuation method? 
RQ5B. Are the auction-based values subject to a social desirability bias? 
 
In general, the stated values are about ¥ 0.7 (40.5 %) higher than the auction-based values (WTP), 
which might indicate the presence of a (small) hypothetical bias in the latter (see section 4.4.3). In the 
student sample, for example, zero bidding behavior is significantly higher when monetary 
consequences are attached to the stated preferences. However, as the values of the two value 
elicitation methods differ according to the target group, i.e. student versus non-student sample, with 
only a small discrepancy in the latter, one could argue that the differences between the hypothetical 
versus non-hypothetical bids are not large enough to underpin a general hypothetical bias of this 
open-ended contingent valuation, as other authors have postulated (Brown et al., 1996; Balistreri et 
al., 2001). But the risk of a hypothetical bias might be masked by the relatively high auction values. 
This could be due to the separate, comprehensive information rounds about a relevant product, 
gender biased bidding behavior by which women bid higher in auctions (Lusk et al., 2004a), the 
inclusion of extensive trial sessions (Drichoutis et al., 2010), the political climate (see also section 6.5), 
the bidding procedures, the data constraints to compare target groups, auction fever and social 
desirability.  
 
The presence of the latter two were investigated by comparing the auction-based (WTP) and indirect 
values (iWTP) for FBR. The difference between the two valuation methods is below ¥ 1, and a 
discrepancy is found between both target groups, by which it is hard to support high bidding behavior 
as an act of SDB (and auction fever). Also the false consensus effect (Ross and House, 1977), which  
could offer an alternative explanation for SDB when people consider their value as the ‘normal’ value, 
but is less likely to occur. For example, indirect bidding behavior deviates from the individual bids in  
41 % of the cases.  
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Thus, although methodological and sample characteristics between the three valuation methods could 
account for value differences and mask biases, a general hypothetical and social desirable bias are 
expected to be less likely to occur. 
 
RQ6. To which GM information are consumers most susceptible when valuing FBR? 
RQ6A.       What information dominates in conflicting GM information? 
RQ6B. Is there a primacy or recency effect in the evaluation of conflicting GM information? 
RQ6C. Does the GM information effect differ according to consumer acceptance of GM food? 
 
Unlike WTP for FAR, the FBR valuations in the fourth auction round differ according to the GM 
information treatment, i.e. one of six randomly distributed GM information sheets. Evidence from the 
experimental auctions show that Shanxi rice consumers are most susceptible to one-sided positive or 
negative GM information. The largest WTP reduction occurs in the latter, followed by objective 
information. Contrary to other GM information studies (Tegene et al., 2003), the impact of objective 
information appears to be more negatively evaluated than conflicting information. As a consequence, 
the combined treatment (all = positive + negative + objective) is slightly lower valued than negative + 
positive information.  
 
Conflicting information results in a significant downward adjustment of WTP values, which supports 
the alarmist hypothesis that is found in previous auction literature (Fox et al., 2002; Tegene et al., 
2003; Parkhurst et al., 2004; Hu et al., 2006). However, the WTP reduction is smaller when positive 
precedes negative information, indicating the potential presence of a primacy effect. The absence of a 
similar information order effect in the ‘all’ information treatment might be attributed to the negative 
perception of the objective statements, by which an alarmist reaction appears to dominate this effect. 
Thus, when consumers have to deal with conflicting information, they seem to be subject to an 
alarmist reaction and a small primacy effect, so that negative information prevails, but appears to be 
less effective when positive information is presented prior to the negative statements.  
 
GM food acceptance is associated with higher WTP values for FBR. Favorable consumers are found 
to be more susceptible to information that does not align with their approval of GM food. On the 
contrary, opponents are significantly more reinforcing their reluctance when learning about negative 
statements of GM. Thus, consumer’s acceptance of GM food is likely to be triggered when receiving 
GM food information, as stated by Fazio (1990), but it appears not capable of mitigating the effect of 
deviating information treatments (Frewer et al., 2000; Colson and Huffman, 2009). The presence of 
confirmation bias might be an explanation for this tendency (see RQ4). 
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RQ7. What is the current burden of folate deficiency in China and Shanxi Province?    
RQ7A.       What is the relative importance of folate deficiency in micronutrient malnutrition in 
China? 
RQ7B. How large is the burden of folate deficiency in two of the most important high-risk 
regions, Shanxi Province (China) and Balrampur District (India)? 
 
Application of the DALY framework in chapter 5 shows that an annual number of 314 180 DALYs are 
lost due to folate deficiency in China, of which 82.8 % in Northern China and 15.7 % in Shanxi 
Province. About 72.2 % of this burden is attributed to fatal outcomes of folate deficiency, namely 
abortions and stillbirths related to an NTD that is caused by a low maternal folate intake. Compared to 
the burden of other micronutrient deficiencies (vitamin A, zinc and iron) in China and other developing 
countries, this burden is substantially smaller but, as NTDs are the only measurable functional 
outcomes of folate deficiency and women of childbearing age are the only included target population, 
presumably underestimated. Micronutrient malnutrition in China leads to an annual loss of 10.6 million 
DALYs, of which about 3 % is caused by (maternal) folate deficiency. 
 
Due to the substantially lower birth rate and higher population size in Shanxi Province, the burden of 
folate deficiency per 10 000 population or per 1 000 births is, respectively, lower and higher than in the 
Balrampur District. Nevertheless, the findings show that both regions are highly comparable. The high 
NTD prevalence scenario of Balrampur (135.4 DALYs lost per 1 000 births), for instance, 
approximates the current situation in Shanxi Province (126.7 DALYs lost per 1 000 births). 
 
RQ8. How cost-effective would folate and multi-biofortified rice be when introduced 
in China? 
RQ8A.       Does the cost-effectiveness of FBR and MBR in China achieve the World Bank 
thresholds of highly cost-effective health interventions? 
RQ8B. When compared with other biofortified crops in other developing regions, how cost-
effective is FBR and MBR in China? 
RQ8C. What is the health impact of FBR when introduced in the most important high-risk 
regions of China and India? 
 
Based on a 30-year time horizon, the comparison of the potential health benefits (DALYs saved) and 
the estimated costs to develop and introduce FBR and MBR in China demonstrates that saving a 
DALY would cost between US$ 21.4 and US$ 64.2 in the former, and between US$ 2.3 and US$ 9.6 
in the latter (see section 5.4.3). As a consequence, both health interventions are well below the World 
Bank ‘high cost-effectiveness’ threshold (US$ 86.04 in 2011), especially in the high impact scenario.  
 
When comparing these figures with other cost-effectiveness studies of biofortification in developing 
countries, the relative burden of folate deficiency and micronutrient malnutrition in China is, 
respectively, the lowest and one of the highest. This is mainly due to the fact that measurement of the 
former is only based on the main functional outcome of folate deficiency, i.e. NTDs, while the latter 
addresses more functional outcomes than any other health impact study. Although health impact 
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studies differ in terms of the applied parameters of the DALY framework, the assumptions of the 
impact scenarios and the characteristics of the research location, the benchmarking exercise provides 
further evidence that FBR and MBR could be a highly cost-effective intervention to reduce the burden 
of the respective micronutrient deficiencies in China (see Table 52). 
 
If FBR would be implemented in Shanxi Province and the Balrampur District, both high-risk regions 
could achieve an average folate intake level that is significantly higher than the recommended daily 
folate intake of 400 µg, respectively 1290.8 µg and 508.6 µg. Although the health impact figures differ 
according to the benchmark indicator, per 10 000 population or per 1 000 births, the potential number 
of DALYs that could be saved are in the same order of magnitude. In the optimistic scenario, for 
instance, between 111 and 104 DALYs could be saved per 1 000 births in Balrampur District and 
Shanxi Province, respectively. 
 
6.2. Policy implications  
 
In this section, I will briefly reflect on the (potential) implications of the research on the market potential 
of FBR. The primary audiences for the results obtained in this study are not limited to the government 
and its policy makers, but are also of importance to the health sector, aid agencies, consumer 
organizations, NGO’s (e.g. The Hunger Project), the biotechnology industry, stakeholders in folate 
interventions, and scientific researchers involved in the field of developing, (ex-ante) evaluating and 
introducing novel GM technologies and health strategies (see section 6.5). Here, the 
recommendations and expectations will primarily refer to the specific case of FBR in China and Shanxi 
Province, but might be generalizable to 2nd generation GM crops in other high-risk regions or 
developing, rice consuming countries. 
 
Awareness of burden of folate deficiency 
The (political) recognition of FBR as a major health problem is a crucial step to (investigate the need 
to) fund programs to reduce its burden (Brooks, 2010). In this respect, the results of the burden of 
disease study can be useful broadly in two ways. First, the health gap assessment in this thesis sheds 
a light on the importance of folate deficiency in China and its provinces. The regional burden analysis 
is useful to health policy by enhancing the awareness of this problem and through the identification of 
problematic regions.  
Second, the results are expected to increase awareness on the need to put folate deficiency and 
micronutrient malnutrition on the Chinese health agenda and to generate a broader debate where 
public health specialists, epidemiologists, agricultural and biotechnology experts, and policy makers 
are involved. The relatively lower size of the burden of folate deficiency, compared to other main 
micronutritional deficiencies in China, shows that combating folate deficiency is to be approached as a 
targeted intervention, i.e. addressing birth defects through women of childbearing age. It also raises 
awareness about the data constraints, e.g. epidemiological relations, that partly account for an 
underestimation of the burden of folate deficiency. This means that current health policy should 
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address this deficiency based on the health impact of its main functional outcome, i.e. NTDs. While 
priority should be given to further unlock this ‘hidden hunger’, by stimulating research to reveal its 
attribution to other functional outcomes. In other words, this first burden analysis should stimulate 
governments to improve and update the results, in order to evaluate the progress and impact of FBR 
over time. 
 
Economic evaluation of FBR as a health priority-setting tool  
The thesis further demonstrates that this folate intervention, whether it would be combined with other 
micronutrients or not, would be a highly cost-effective health strategy to alleviate the current burden of 
folate deficiency. The cost-effectiveness study contributes to priority-setting of micronutrient 
interventions and, thus, to allocate resources related to R&D and the implementation of FBR. 
Governments typically seek health interventions that aim to avert a large public health problem in a 
cost-effective way (Jamison, 2006; Laxminarayan et al., 2006).  
In the case of FBR, our regional approach provides decision-makers an alternative tool to effectively 
reduce the burden of folate deficiency in regions where the burden is highest and current policy 
interventions are less successful, which is the case in Shanxi Province. Although FBR is often less 
(but still highly) cost-effective than other single biofortified crops, one could advocate for FBR because 
the expected health impact is among the highest. Moreover, as about 258 million Chinese people are 
assumed to be folate deficient, a national population-based approach would even be more cost-
effective than our study on women of childbearing age indicated. When incorporated in a multi-
micronutritional strategy, the scope of the intervention is expanded to micronutrient malnutrition as a 
whole, which further increases the benefits of biofortification as a cost-effective strategy. 
Although policy makers will take into account several factors when deciding which (micronutrient) 
burden needs to be addressed, this thesis offers them a cost-effective option that could be considered 
when planning to develop programs to improve folate intake. Furthermore, application of the DALY 
approach makes it possible to go beyond the cost-effectiveness rates by providing in-depth 
information on the health impact of specific functional outcomes and separate cost components.  
 
Fostering the approval of FBR and GM biofortified crops in China 
As Hotz and Brown (2004, p. 168) concluded in their zinc risk assessment report: “If results from 
scientific studies indicate that [zinc] fortification is an efficacious and effective strategy to reduce [zinc] 
deficiency, the government should create legislation to implement an intervention program”. One could 
make a similar conclusion regarding folate deficiency. However, like other more advanced GM 
biofortification strategies, such as Golden Rice, the high cost-effectiveness of FBR is a prerequisite, 
but not a guarantee for its future approval or commercialization.  
As an agricultural health intervention that is based on GM technology, several issues need to be 
addressed before governments will finally approve the commercialization, e.g. biosafety requirements, 
IPR issues, involvement of seed companies, … (see section 6.5.1). However, as public (and farmer) 
acceptance is considered a crucial determinant of the political approval of GM crops, the general 
positive reactions that are found in the study on acceptance and WTP are expected to be important 
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arguments towards future commercialization of FBR and other GM rice crops with health benefits 
(member of the Chinese Biosafety committee, personal communication, 18-04-2011). It might further 
speed up the implementation of the approved Bt rice, encourage the development and submission of 
similar applications and thereby facilitate the process and progress of GM crop regulation, which is 
currently delayed by anti-GM actions (see section 6.5).  
Some experts even expect that GM biofortification will be the precursor to finally commercialize GM 
staple crops with agronomic traits in China (Biotechnology industry representative, personal 
communication, 19-04-2011). This means that biofortification can lead to create a more favorable 
public and political climate to advocate for 1st generation GM rice crops, such as Bt rice. Despite these 
potential policy implications, it is important to note that there is still no solid proof that policy makers 
will adopt GM rice in China. Even if China would not choose to begin the production of GM rice, the 
results are not considered to be useless for health policy. As Grosse et al. (2007) state, economic 
evaluation study results that do not influence policy makers in their resource allocation towards GM 
biofortified interventions could contribute by helping them to apply other, alternative interventions to 
tackle malnutrition. 
 
Providing a better understanding of the potential market (demand) for FBR as a prerequisite for future 
health policy interventions  
From a marketing point of view, knowing the needs and potential reactions of the population and the 
different target groups, contributes to a successful implementation of GM foods (Lusk and Norwood, 
2006) and biofortified crops (Dubock, 2008). Musgrove and Fox-Rushby stated (2006, p. 227): “The 
effectiveness of an intervention and, therefore, the degree to which it deserves priority depend on how 
far it is culturally appropriate or acceptable for the population it is intended to benefit”. This thesis 
defined the potential coverage of FBR as a GM crop with health benefits in a high-risk region, which 
represents the key beneficiaries of this pro-poor, pro-rural strategy, by investigating the needs (e.g. 
information, product attributes) and potential demand (e.g. WTP) of consumers.  
While Shanxi rice consumers are generally not reluctant to FBR, policy makers, health planners, and 
agricultural stakeholders will have to take into account some areas of special attention when aiming to 
introduce and promote this intervention towards specific target groups (see also the discussion section 
of chapter 3). If the goal of FBR is to reduce the number of birth defects, female consumers, who are 
less supportive of FBR than men, but are still willing to pay for it, should be primarily targeted. The 
large cautious segment of women supports that there is potential to further increase the coverage rate. 
Broadening the objective of the intervention to the population as a whole necessitates a shift in the 
focus towards those at risk. Unfortunately, poor consumers mainly belong to the opposing segment, 
i.e. a segment with less positive views on GM food and FBR. The need to address these opponents is 
acknowledged by Kalaitzandonakes and Bijman (2003), who stated that the approval and market 
acceptance of GM food is most likely driven by the extreme, reluctant consumer instead of the 
average consumer. Rather than increasing objective GM knowledge as such, attention should be paid 
to learn opponents about the specific benefits and improve their risk perceptions in order to ensure a 
widespread coverage. On the supply side, farmers seem to be even more enthusiastic than 
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consumers. Although this does not necessarily imply that they will adopt FBR when it would be 
available, it is a crucial first step of future farmer adoption.  
 
From a purely economic perspective, consumers’ WTP could be used, and juxtaposed with the 
production costs, in order to decide whether it is beneficial and commercially viable to adopt it or to set 
its price level, e.g. based on a premium that still achieves a sufficient market share (Breidert et al., 
2006; Lusk and Norwood, 2006). Despite the importance of consumers’ valuation in price-setting (Lusk 
and Hudson, 2004), it is certainly not the only key factor that affects pricing decision (Monroe and Cox, 
2001). Even though the study revealed that poor consumers are prepared to pay for FBR, the ability-
to-pay might be an important constraint of the empirical validity of consumers’ WTP, as shown in 
valuation studies on health care options in poor populations (Donaldson, 1999). Poor Shanxi rice 
consumers may not be able to pay the high premium they have stated in the auctions. Therefore, the 
high WTP values should be interpreted as consumers’ preferences of FBR over regular rice. 
Moreover, an agricultural commodity like FBR is developed by the public sector and has to be also 
considered as a health policy intervention. As such, the strong preferences for FBR in Shanxi 
Province, as reported in chapter 4, are useful to provide governments with information on - the 
direction of - consumer preferences and the potential market demand among specific target groups 
(e.g. women of childbearing age and rice consumers from a folate deficient region). This could be 
incorporated in the decision regarding the implementation of this pro-poor strategy. As Pearce and 
Özdemiroglu (2002, p. 22) stated: “Economic values expressed in money terms, […], will reflect 
people’s preferences and can thus be used as weights to inform any policy analysis or decision 
process”. Gaining insight in consumer preferences through ex-ante non-hypothetical WTP studies 
makes it possible to determine the value for consumer benefits in GM rice, predict the impact of 
information on attributes, develop activities to adequately address the target population and, thus, 
increase its success rate in rural areas. Thereby, it will be a challenge to simultaneously attract 
farmers, who seek to make profits out of the added value of their products; poor consumers, who will 
have different rice varieties at their disposal; and other stakeholders, who will need to be involved to 
commercialize, distribute and promote FBR, while taking into account the costs of the developers (see 
section 6.5). 
 
To further increase the health impact of FBR in China, intervention strategies should pay attention to 
attribute changes of the end-product and, once commercialization would be approved, the kind of 
information that will be disseminated. The importance of negative information from anti-GM sources on 
WTP for FBR confirms the current political hesitance to bring GM staple crops to the market. The 
experimental auctions have demonstrated that it will be hard to convince the reluctant consumer 
through an information campaign, if they have access to opposite information. Such a situation could 
discourage those that are not resistant to GM food, which may deter consumer acceptance of GM rice 
with health benefits. Although one-sided positive GM information was highly successful in removing 
the effect of prior attitudes about GM food, it is less realistic in the current Chinese debate, where 
positive GM information is immediately countered by leading anti-GM activist groups, like Greenpeace 
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China, or local NGOs, such as Utopia (Stone, 2011). In order to reduce the substantial negative 
impact of anti-GM campaigns, the focus should be on the (non-GM) product- and the context-specific 
advantages of FBR, such as nutritional knowledge and the regional burden of folate deficiency. For 
example, it would be valuable to organize public education actions to promote FBR at community level, 
as the Micronutrient Initiative (2009) recommended. The mandatory labeling issues (see section 
6.5.2), which are not negatively perceived by Chinese consumers, is another opportunity to provide 
consumers with correct and relevant information. For example, adding a picture of NTDs is expected 
to reinforce the effect of folate information. Future FBR communication campaigns should also attempt 
to improve the low trust levels regarding GM proponents, which might be related to consumers’ 
opposition. 
 
 
Despite the market potential of FBR, through its positive consumer reactions and cost-effectiveness, it 
is important to note that biofortification alone will not be sufficient to completely eradicate the burden of 
micronutrient malnutrition. But interventions should not be evaluated in terms of their potential to 
eliminate diseases. As Underwood (1999) suggests, interventions should eliminate the nature of the 
problem, i.e. being of major public significance. A combination of different nutrition interventions, such 
as supplementation or fortification (Fiedler et al., 2008) and biofortification (Horton et al., 2008), is then 
considered the best option to achieve this level of elimination at a large scale. As such, micronutrient 
interventions are recently included among the best investments in global development (CC, 2011).  
When FBR would be launched, activities are needed to convince opponents of FBR, to provide them 
an alternative solution to increase their folate intake (e.g. FAR to students), or to introduce other folate 
products for those who do not (frequently) consume rice. The experimental auctions, for instance, 
revealed that opposition towards FBR may drive a consumer towards an alternative, non-GM 
intervention with folic acid supplements (e.g. in the student sample; see section 4.4.2.2). However, 
folic acid supplementation is largely seen as an unattractive folate substitute for FBR, which is further 
reflected in the low usage levels of women of childbearing age (see section 4.4.2.1).   
Addressing the widespread prevalence of different micronutrient deficiencies in China and the world 
also advocates the combination of multiple micronutrient interventions, such as the investigated, highly 
cost-effective multi-biofortified rice. Although such an approach might be more desirable from a public 
health view, additional difficulties could arise when aiming to obtain approval and commercialize 
additional GM biofortified traits (see section 5.4.5.2 and 6.5). 
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6.3. Limitations  
 
This section will reflect upon the main limitations of this PhD dissertation. I will mainly focus on 
general, cross-chapter constraints. Chapter specific limitations are primarily tackled in the respective 
research oriented chapters. 
First of all, the scope of this thesis as presented in section 1.2 is a limitation in itself. Although many 
considerations underpin the choice to focus on China and Shanxi Province, gathering data led to 
additional limitations, such as the limited access to and availability of nutritional data. Therefore, 
prudence is in order when aiming to generalize the findings from the consumer studies in Shanxi 
Province. Investigating consumer behavior in this poor, rural region of China implied that the surveys 
and the auction procedures needed to be easy to understand and culturally adapted. In the auctions, 
for instance, some survey questions needed to be deleted (e.g. SDB-scale), recruitment procedures 
had to be facilitated (e.g. illiterate persons could not participate in the auctions) and design 
characteristics were relaxed (e.g. fixed auction size). Besides these practical implications, the main 
limitation regarding the selected research location, is the level of rice consumption. Situated in 
Northern China, wheat consumption in Shanxi Province is typically higher than rice consumption. 
Although the daily rice consumption in Shanxi Province is still high enough to advocate for the 
implementation of folate or multi-biofortification of rice (see Table 46), the results refer to a scenario 
where women of childbearing age either switch to FBR or stick to their regular rice diet. Assuming a 
dietary mix of rice varieties instead would lead to a lower health impact of folate biofortification. 
Nevertheless, the coverage rate will be highly determined by the targeted rice varieties (e.g. preferably 
popular, pro-poor varieties; see section 6.5.2). 
 
Second, this PhD dissertation is limited in its scope with respect to the subject of analysis, i.e. GM rice 
with improved folate content. Except for the study on MBR in chapter 5, the focus is solely on folate 
enriched rice. Therefore, I initially considered other (agronomic) rice attributes to be unchanged.  
Regarding the consumer research on FBR, in the surveys or during the auctions I did not give any 
details about the GM technology (e.g. the transferred genes, the source of these genes, the gene 
transfer mechanism, …). This is an important limitation that could have masked additional negative 
reactions (Schnettler et al., 2008a; Colson and Huffman, 2009; Novotorova and Mazzocco, 2009). 
However, the low socio-education levels in the research location support our choice to focus on the 
comparison between a GM product and its conventional counterpart, based on consumers’ awareness 
of the applied GM technology. 
 
Third, the conceptual framework takes some assumptions for granted. In general, the consumer is 
expected to be the strong determinant of the (market potential of the) implementation of biofortified 
staple crops. The limitation of putting the consumer central in this thesis, directly and through the 
societal benefits of the impact study of FBR, is acknowledged when dealing with the stakeholder 
approach, as discussed in section 6.5. Further, the conceptual framework also considers the CEA 
study to be an important tool to influence priority-setting and resource allocation regarding  
biofortification as a micronutrient intervention. Although CEA is useful and recommended to 
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demonstrate the potential of such interventions, it is likely to be only one indicator in the decision 
process of policy makers and program planners. 
 
Fourth, there are some limitations attached to the way some of the concepts of the conceptual 
framework were measured. FBR acceptance, for instance, refers to consumers’ evaluation of the 
product as a whole, rather than distinguishing its different characteristics (GM technology, NTD 
benefits, other benefits, other rice attributes, …). As a consequence, it is difficult to understand to 
which part of the product consumers are reacting negatively or positively. Someone largely opposed to 
FBR could be not interested in its health benefits or concerned about the applied GM technology.  
The stated preferences as operationalized in the 2008 survey are prone to criticism (see section 
1.3.2.1 and 4.2.1). I attempt to cope with the limitations of the stated valuation study in the non-
hypothetical valuation study. One of the most important limitations of the latter is the fixed auction 
design structure to measure different (information) effects. One could argue that the whole auction 
process might be affected by a primacy effect, by which different information effects would be obtained 
when starting with the controversial GM information, followed by the folate related rounds. However, it 
was practically not feasible to include a control group or to examine order effects of the rounds, except 
for the GM information order effects. Instead, I consider the difference between subsequent WTP 
rounds as the information effects. This is in line with the current experimental auction literature 
(Roosen et al., 1998; Hobbs et al., 2006). Other limitations and potential biases of the methodological 
choices to measure WTP are largely discussed in section 1.3.2 and the methodology sections of 
chapter 4. 
The DALY framework critics mainly refer to the incorporation of specific input parameters of the DALY 
formula, e.g. discounting (see section 5.2), and the interpretation and comparability of the DALY 
approach as a health measure in economic evaluation studies (see section 1.3.3). Although cost-
effectiveness may be a crucial factor in priority-setting, it is certainly not the only factor that is taken 
into consideration (Laxminarayan et al., 2006; Musgrove and Fox-Rushby, 2006). For example, our 
cost-effectiveness measurement fails to directly address equity (e.g. more costly interventions might 
be a better investment when it aims to reach the poor, rural areas) and non-health benefits (e.g. 
educational progress, poverty reduction, improved productivity; see section 5.3)57.  
 
Fifth, the analyses regarding the Shanxi consumer survey in chapter 3 are based on specific parts of 
the dataset. For example, by including objective GM knowledge, only those who stated to know what 
GM food is, could be entered in the analysis. This limitation makes it not possible to compare the 
subjective and objective GM knowledge as determinants of FBR acceptance. Although some studies 
found more predicting power in subjective knowledge as a determinant of acceptance and WTP (Moon 
and Balasubramanian, 2001; House et al., 2004; Han and Harrison, 2006), this could not be verified in 
this thesis. 
Furthermore, the research on acceptance of negative rice attributes is based on exploratory statistical 
techniques. There are more advanced techniques to analyze consumer preferences for different 
                                                 
57 Two other indicators to decide whether health interventions should be (partly) funded or subsidized, i.e. the public attitudes and the demand for an 
intervention (Musgrove, 1999; WHO, 2000), are addressed in Chapter 3 and 4, respectively. 
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(combinations of) product attributes simultaneously (e.g. conjoint analysis), or to study the impact of 
sensory characteristics and appearance (e.g. taste panels).  
 
Sixth, notwithstanding the comparison between FBR and MBR in the CEA, or between FBR and folic 
acid supplements in the experimental auctions, I did not include other folate interventions in both 
studies. The main reasons are a lack of available data (e.g. characteristics and costs of the national 
folic acid supplementation program or data on folate biofortification of wheat), practical feasibility to 
include a folate intervention (e.g. auctioning biofortification and folic acid fortification requires one to 
explain the difference between folate and folic acid, which is difficult in Chinese language), and the 
relevance of the intervention (e.g. promoting folate-rich foods in poor regions). As a consequence, I 
did not fully address the need to incorporate the main health interventions into a CEA (WHO, 2000; 
Lopez et al., 2006). Moreover, the effect of adding an improved agronomic trait in order to evaluate 
and compare the potential of combining 1st and 2nd generation GM crops was not investigated. 
 
Seventh and final, the CEA is highly dependent on secondary data sources (e.g. nutritional data, 
functional outcomes), assumptions (e.g. dose-response relationship and coverage rates) and cost 
estimates, which may have influenced the results. As Schneider (2001) pointed out, the extensive data 
requirements related to the DALY framework makes it difficult to conduct health impact studies where 
they are most needed, i.e. in developing areas. Gathering cost data in developing countries, for 
example, is considered extremely challenging (Laxminarayan et al., 2006; Musgrove and Fox-Rushby, 
2006). However, the assumptions and data constraints are more likely to result in an underestimation 
instead of an overestimation of the potential health benefits. With respect to FBR, this is mainly 
because not all folate related outcomes are included (e.g. births with multiple NTDs and non-reported 
births), and only women of childbearing age are considered as the target group of FBR consumption. 
For example, including other functional outcomes than NTDs, such as anemia, would have increased 
the cost-effectiveness of FBR in China. Regarding MBR, health interactions of multi-biofortification are 
assumed to be absent and conservative attribution levels are used (e.g. the attribution of Vitamin A to 
childhood mortality).  
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6.4. Directions for future research  
 
In this section, I address various pathways to conduct research in order to improve, extend or go 
beyond the findings of this thesis. In most cases, future research is recommended to overcome the 
above mentioned limitations. Therefore, some research needs are already tackled in the previous 
section, e.g. comparison of subjective and objective GM knowledge. 
  
Firstly, it is recommended to shift or broaden the focus in order to compare and validate the 
generalizability of the results that were obtained for Shanxi Province. This could be done by 
investigating consumer acceptance and WTP for FBR in other high-risk regions. In the health impact 
analysis, I compared the situation in Shanxi with the Balrampur District in India. Although our results 
are in line with other GM food consumer studies in China, it would be worthwhile to examine whether 
different consumer reactions could be observed in regions where income and rice consumption levels 
are higher, and folate deficiency rates are lower, such as in urban areas of Southern China. This might 
also help to set a regional coverage rate in the health impact study. 
 
Secondly, economic evaluations should ideally be made by comparing the burden of diseases (Lopez 
et al., 2006) and the outcomes and costs of all available health interventions (WHO, 2000). Therefore, 
to fully evaluate the potential of FBR in China, and make optimal resource allocation decisions, 
information about the potential cost-effectiveness of different folate improving programs is needed. I 
briefly discussed the cost implications and the potential drawbacks of folic acid supplementation or 
fortification, but an in-depth CEA is needed to evaluate the relative cost-effectiveness of FBR among 
other folate interventions. For example, previous studies on vitamin A (Bertebos Foundation, 2008), 
zinc and iron (Ma et al., 2007) interventions have shown that the costs of biofortification are generally 
below other strategies, especially supplementation. Furthermore, future research should discover why 
folic acid supplements (in Shanxi) may not be seen as attractive product, as was shown in the 
experimental auctions, and how this could influence national programs on folic acid supplements.  
Research is also required to analyze the cost-effectiveness of dietary diversification initiatives, as this 
has been rarely done (Hotz and Brown, 2004) and might be considered the most sustainable, albeit 
the most expensive solution. When targeting the poor consumers, however, it might be more 
appropriate to investigate the potential of - and incorporate - educational efforts to maintain folate 
concentrations when processing food products.  
Another future research direction in economic evaluation is to depart from the budget that is available 
for micronutrient interventions or, in this case, birth defect programs, and determine the health impacts 
and the potential coverage that could be generated (Musgrove and Fox-Rushby, 2006). Nevertheless, 
comparing folate interventions would be useful to further evaluate the potential of biofortification and 
select the most appropriate strategy given the budgetary constraints, but cost-effectiveness should not 
be the only determining factor in decision-making (Lopez et al., 2006)(see also section 6.3) 
 
Thirdly, given the future commercialization of the first GM rice crop in China (Waltz, 2010) and the first 
GM biofortified rice crop in the Philippines (Serapio, 2010; NCBP, 2011), future research should 
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further explore the bottlenecks and success factors to implement FBR as an effective and efficient 
intervention to further alleviate the burden of folate deficiency. Therefore, it needs to be determined 
how FBR will be efficiently distributed, which varieties will be selected and how they will be positioned. 
These and other (policy) issues that need to be investigated, are tackled in section 6.5.  
Regarding the evaluation of the market potential of FBR, research should go beyond the consumer by 
investigating the positions of other key stakeholders, such as farmers, governmental agencies and 
seed companies. As an agriculture-based health intervention, special attention needs to be paid to 
explore farmers’ reaction as potential future FBR producers (Lusk and Hudson, 2004). Although the 
investigated farmers’ acceptance in Shanxi Province has shown to be high (see chapter 3), farmers’ 
WTP for biofortified seeds (among other seeds) needs to be assessed, e.g. through experimental 
auctions. Nevertheless, as many rural households in China are considered small-scale farmers, the 
reported consumers’ WTP (e.g. valuations of female members of a farming family) might be an 
indication of their potential demand.  
 
Fourthly, it would be interesting to expand the unit of analysis, i.e. GM rice with improved folate 
content. Given the novel character of multi-biofortification, the next step is to explore the potential 
acceptance of and WTP for multiple micronutritional traits. One could also determine consumer and 
farmer preferences of other folate biofortified staple crops, such as wheat (McIntosh et al., 2008). 
Other folate enriched products, such as lettuce (Nunes et al., 2009) and tomato (Diaz de la Garza et 
al., 2007) are less relevant to introduce in Shanxi Province and China, given the current dietary 
patterns of the poor. 
Even more important is to combine first and second generation GM crops, such as Bt rice with high 
folate content, which provides an additional economic incentive to farmers through its increased 
yielding potential. Similar to our health impact study on MBR, the combined health and economic 
impacts of adding an agronomic and micronutritional trait to rice could be assessed. In China, for 
example, the impact of the commercialized Bt cotton (Huang et al., 2006a; Rozelle et al., 2006) and 
the ex-ante effects of Bt rice (Huang et al., 2005b) have been examined. Although first generation 
(farmer oriented) GM products are assumed to be less popular than their second generation 
counterparts (Frewer et al., 1997a; Lähteenmäki et al., 2002; Hossain et al., 2003; Lusk et al., 2005; 
O’Conner et al., 2005; Anand et al., 2007; Schnettler et al., 2008a), it needs to be determined how 
consumer and farmers will react to stacked GM food products, when several farmer and consumer 
benefits are attached.  
 
Fifthly, regarding future consumer (and farmer) acceptance studies, it might be worthwhile to take into 
account additional factors, such as FBR related variables (e.g. involvement, planned pregnancy and 
curiosity to try), the presence of other (high quality) rice varieties, and labeling, which may further 
influence consumer and farmer acceptance. With respect to the study about FBR acceptance of 
negative rice attributes, choice modeling could be applied in order to validate and strengthen our 
results (see also previous section). In this respect, sensory research may be incorporated into 
consumer (folate) biofortification research. One could, for instance, organize a taste session as a 
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specific round in the experimental auctions, or include it as a (hypothetical) consumption requirement. 
Unlike our rice auctions, other attributes, such as appearance, could have been altered and 
incorporated to measure their impact on consumer valuations.  
 
Sixthly, future auction research can validate our value elicitation method by evaluating how Chinese 
consumers behave to other auction mechanisms. Also the impact of additional auction design 
characteristics could be subject of future auction research with biofortification research, such as 
information order effects throughout the auctions, price feedback, additional alternative folate 
substitutes (e.g. detaching the folic acid pills from the rice bags), various rice bag weights and different 
folate contents (and benefits). The way that information is provided could also be improved and further 
explored by using, for example, uncensored picture warnings, GM labels, a newspaper lay-out or 
audio-visual material, such as an informative newsflash or an interactive GM discussion round, or 
specific wordings (e.g. transgenic). 
 
Seventhly, the cost-effectiveness study in chapter 5 could be improved in several ways. Primary data 
collection of nutrient intake and rice consumption, such as (24-hour) dietary recalls (for an example on 
zinc and iron, see(Gibson and Ferguson, 2008), would make it possible to apply the framework to an 
individual household level. Some of the parameters of the DALY approach need to be included (e.g. 
micronutrient interactions), refined, (e.g. folate stability after processing), extended (e.g. functional 
outcomes), updated (e.g. NTD data), adapted to the different regions (e.g. regional coverage rates) or 
validated (e.g. cost estimates). But even more important is the urgent need to define the (attribution 
level of) functional outcomes of folate deficiency, besides NTDs. 
 
Finally, some recommendations for future (bio)technological R&D could be formulated. Although such 
issues are beyond the scope of this thesis, advanced breeding efforts would allow to further evaluate 
the market potential by using up-to-date information of the technological characteristics of this GM 
crop. For instance, it is plausible that some of the investigated attributes of FBR, such as taste, folate 
stability and bioavailability, will be different from our expectations when crossed with certain local or 
stacked varieties (e.g. MBR), processed, or long-term stored. Additional laboratory tests will have to 
further refine and define the final product characteristics of FBR and MBR, which might influence the 
findings of the health impact assessment. This might open up research opportunities to examine and 
set up promotion activities of home processing techniques to enhance absorbable folate in food, as 
mentioned above. And if FBR would be approved, agricultural workshops could be then organized to 
increase the adoption rates of farmers and learn them how to maintain the beneficial product attributes 
through production and storage. 
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6.5. Issues to advance towards  a successful implementation of 
FBR in China 
 
China is one of the first countries that commercially released a GM crop, namely Bt cotton (Falck-
Zepeda, 2010). The widely adopted Bt cotton in China, with 7.5 million small farmers growing this 
insect-resistant crop, is considered one of the most important achievements in the history of GM 
production. The cost reductions, higher yields and lower rice prices made Bt-cotton a successful pro-
farmer and pro-poor strategy (Huang et al., 2002; Raney, 2006; Rozelle et al., 2006). Despite its key 
role in the development and commercial introduction of transgenic plant varieties, China has not yet 
commercialized a transgenic food crop for consumption (Campos-Bowers and Wittenmyer, 2007). This 
‘commercialization slowdown’ took place on a global scale (Paarlberg, 2002), by which any optimistic 
expectation towards a fast, successful implementation of FBR based on this PhD dissertation should 
take into account the broad context.  
Below, I will present some key barriers and challenges that need to be taken into account when aiming 
to successfully introduce FBR in China. Due to the focus on the regulation and practical 
implementation of FBR, which is beyond the scope of this PhD dissertation, this section also refers to 
the experiences with Golden Rice, i.e. the most advanced biofortified rice crop (HUMBO, 2011b); Bt 
cotton, a success story of GM crop production in China (Raney, 2006); and the Chinese approval of Bt 
rice, i.e. probably the first commercialized GM rice crop (Waltz, 2010). Thereby, reference is also 
made to the stakeholder interviews that were held in China (see section 1.6.1). Although some 
commercialization bottlenecks are closely related to, or grounded in the global debate on the benefits 
and risks of GM food, I explicitly avoid entering this discussion58. 
 
6.5.1. Regulatory and IPR issues 
 
Due to the GM technology in transgenic biofortified food, (political) approval necessarily implies to 
comply with the regulatory requirements and deals with intellectual property management.  
  
Regulatory process 
In China, biosafety regulations on agricultural GM products are defined and implemented by the 
Chinese Ministry of Agriculture (MoA) and its Office of Agricultural Genetic Engineering Biosafety 
Administration (OGEBA) in particular (Pray et al., 2006). The National Agricultural GMO Biosafety 
Committee is in charge of the risk assessment evaluation, in close consultation with its Provincial 
Management Offices. The Ministry of Health (MoH) is involved to ensure the food safety of 
biotechnology products. 
In general, GM food regulators are interested in the characterization and hazard assessment of all 
elements that are associated with the developed GM food, including the parent crop, the donor, the 
delivery process, the gene products (e.g. allergenicity, toxicity) and the safety of the new GM crop 
                                                 
58 The current debate on transgenic biofortification mainly focuses on Golden Rice. For a pro-GR viewpoint of the inventor, see Potrykus (2010a) or Qaim 
(2010). For an anti-GR viewpoint, see Greenpeace (2010). 
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(Barry, 2008). The Chinese regulatory process requires applicants to pay specific attention to 
biodiversity risks, such as cross-pollination and the preservation of locally grown crops (Campos-
Bowers and Wittenmyer, 2007; Wang and Johnston, 2007a). 
 
Apart from its financial implications, the regulation of GM food is seen as the main reason for the 10-
year delay in the commercialization of Golden Rice (Powell, 2007; Potrykus, 2010b). According to Ingo 
Potrykus (2008), one of the founding fathers59, GR would have been commercialized in 2002 if it was 
not genetically modified. The preparation of the GR regulatory dossier took seven years. In Asia alone, 
the annual economic loss of the delayed adoption of GR was estimated at about $15.6 billion 
(Anderson et al., 2005). Whether the stringent regulation procedures are justified or not (for a 
discussion, see Potrykus, 2010a), this further underpins the involvement of private companies in this 
phase of biofortification R&D (Tang et al., 2009). If one would aim to deploy a multi-biofortified crop 
with several transgenic traits, this regulatory process would become even more complex (Chunyi 
Zhang, CAAS, personal communication, 18-04-2011; see also section 5.4.3). 
Despite the fact that China has one of the most advanced biosafety regulatory and monitoring systems 
throughout Asia, there is still a need to improve efficiency and transparency of evaluation and approval 
procedures (Huang et al., 2008). This could speed up and improve the adoption of GM technology 
(Falck-Zepeda, 2010). The weaknesses of the Chinese monitoring system became clear when the 
introduction of transgenic Bt cotton resulted in an enormous amount of illegal, less efficient varieties 
(Huang et al., 2005a). To cope with such issues, it is recommended to organize frequent interactions 
with the regulator (Barry, 2008).  
 
IPR issues 
In the case of GR, for example, about 70 patents are owned by approximately 30 private and public 
institutions (Brewster et al., 2005). Due to the involvement of the private sector, freedom to operate 
could easily be achieved without delaying the progress (Potrykus, 2008; Brooks, 2010; Potrykus, 
2010a). With respect to China, a lot of progress has been made to protect Intellectual Property Rights 
(IPR), but its IPR framework is still criticized for a lack of coordination and enforcement (Campos-
Bowers and Wittenmyer, 2007). Patent registration likely needs to be reformed and centralized in 
order to improve IPR-protection for biofortified crops (Campos-Bowers and Wittenmyer, 2007; Pray 
and Huang, 2007). This did not hold back the growing interest of companies to make this technology 
available in China (Paarlberg, 2002). An excellent example is the large-scale piracy of Monsanto’s Bt 
cotton, which demonstrates not only China’s openness towards transgenic crops, but also the IPR 
weaknesses due to insufficient monitoring and protection of IPRs (Campos-Bowers and Wittenmyer, 
2007). 
 
When dealing with intellectual property rights for FBR as a pro-poor, pro-rural health strategy, the 
introduction of humanitarian licenses for adoption in developing countries deserves attention. The 
inventors of GR, for example, licensed their patents through a spin-off company to Syngenta under a 
                                                 
59 Together with Adrian Dubock, Gary Toenniessen and its co-inventor, Peter Beyer (Brooks, 2010). All of them are members of the GR Humanitarian Board 
(2011a), which is chaired by Ingo Potrykus.  
217 
 
license agreement with humanitarian access to innovation, also known as a Humanitarian Use 
Technology Transfer (HUTT)(Lybbert, 2002; Brewster et al., 2005). This institutional arrangement 
allows poor farmers (i.e. farmers who earn less than US$ 10 000 per year) from developing countries 
to use GR royalty-free. It also creates a free transfer of the rights to public research institutions in the 
targeted countries through (sub)licenses (Kowalski and Kryder, 2002; Dawe and Unnevehr, 2007). 
Currently, licenses have been granted via IRRI to research institutes in five major rice producing 
countries, namely Philippines, India, Vietnam, Indonesia, and China (Brooks, 2010). Syngenta can 
then claim their IP rights on GR in cases where farmers are above the threshold, by which the latter 
should pay royalties to grow GR. Private companies involved in such an arrangement will forgo 
substantial IP revenues, but might improve the acceptance and coverage rate where GR is needed the 
most. This is one of the reasons why Monsanto largely relinquished their IPRs for the freely pollinated 
Bt cotton in China (Paarlberg, 2002). Other strategies to retain the commercial rights include the 
introduction of hybrid GM varieties (Campos-Bowers and Wittenmyer, 2007), e.g. Monsanto’s cotton in 
India. As China is the world largest hybrid rice producer, with 17 million hectares (60 %) of its rice area 
planted with hybrid varieties, i.e. 85 % of the global hybrid rice production (Barcley, 2010 ), introducing 
hybrid biofortified crops might be more successfully and quickly adopted than in other countries 
(Gouse et al., 2005). 
 
The Golden Rice example demonstrates the potential to donate the technology rights for humanitarian 
use to stimulate research and commercialization of biofortified rice in developing countries. As a 
consequence, organizations or small-scale farmers can freely distribute or replant seeds (but not 
export) without being required to buy new seeds each year (Dawe and Unnevehr, 2007). However, the 
practical implementation of such biofortification licenses in agriculture is not fully explored (De Groote 
et al., 2008). One example of successful humanitarian sharing of IPR in developing countries is found 
in the pharmaceutical sector, i.e. AIDS inhibitors in Africa (Lybbert, 2002), which led to lower product 
prices and increased accessibility. 
 
Private-Public partnership 
Due to the complex regulatory and IPR process for GM products, additional financial support is likely 
to be gathered beyond the proof-of-concept to develop, test and refine the product according to the 
needs. A donor funded public-private partnership is typically set up for transgenic biofortification 
(Stein, 2006), such as a collaboration with Syngenta to advance the progress of Golden Rice 
(Potrykus, 2008, 2010b). With respect to China, the typically strong protective and anti-multinational 
attitudes might be an additional bottleneck when private investments are required to implement 
biofortified crops (Pray et al., 2006). 
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6.5.2. Implementation issues 
 
In addition to the market potential, as investigated in this thesis, a successful commercialization of 
FBR will be determined by the selected varieties, how well they will be adopted by farmers, and how 
the stakeholders will support and be involved in the implementation. 
 
Variety selection 
The selection of the transgenic line and the rice variety will not only influence the regulatory process, 
but also consumer and farmer acceptance, and thus political support. It will be important that the 
selected FBR event are tailored to local varieties in order to reach the poorest consumers in the rural 
regions, similar to the GR events that have been backcrossed into the Indian (Indica) varieties (Virk, 
2008). South-East Asia, and China in particular, is characterized by a heterogeneous, segmented 
market for rice varieties, grown by various substance farmers on numerous small-scale farms. Since 
1960s, more than 4 000 rice varieties (inbred and hybrid) were grown in China (IRRI World Rice 
Statistics, 2011a). In general, the short-grained, sticky Japonica rice is the dominant rice variety in 
Northern China, while the long-grained, non-sticky Indica rice is mainly planted in Southern China 
(Alavi et al., 2008). These varieties differ in terms of whiteness, sweetness, stickiness, and hardness 
(Yau and Huang, 1996). As Brooks (2010, p.5) stated: “[rice] is complicated by a contradiction: it is 
both the largest and smallest of cereals – large in terms of aggregate production and consumption, but 
small scale and highly diverse in practice”. One needs to take into account these differences and their 
impacts on the product characteristics of FBR when aiming to address the various regions of China. 
 
Stakeholder approach 
As the large-scale adoption of transgenic Bt-cotton in China shows, a well-adapted and integrated 
strategy is a prerequisite for success (Raney, 2006). With respect to biofortification, the involvement of 
stakeholders should go beyond the agricultural research community (Brooks, 2010), as it is also a 
nutrition and health intervention. It should address the bottlenecks of nutrition programs, by ensuring 
accessibility and availability (ADB, 2004b); adequately allocating resources, installing an efficient 
monitoring and supervising system, defining distribution strategies and a social marketing strategy 
(Vijayaraghavan, 2002); and integrating key stakeholders, such as the Ministry of Health (Alavi et al., 
2008; Brooks, 2010).  
The most important stakeholders involved in the introduction of FBR, besides the consumers, are the 
government and its relevant ministries, private companies, farmers, millers, vendors and seed 
companies (Meenakshi, 2008b). Their position towards biofortification could further influence public 
acceptance (Kalaitzandonakes and Bijman, 2003; Gonzalez et al., 2011). It will also be important to 
interact with NGOs (Aerni and Rieder, 2000); aid agencies (Laxminarayan et al., 2006); advocates of 
the key target groups (Dawe and Unnevehr, 2007), e.g. WHO and consumer organizations; and the 
media, which are largely controlled by the Chinese government. The need to involve the scientific 
community in the ex-ante evaluation studies, as argued by Hotz and Brown (2004), is addressed in 
this PhD dissertation. Future research should examine the reactions of all stakeholders in order to 
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evaluate the success and impact of adopting biofortified food (Dawe and Unnevehr, 2007), such as 
FBR. 
 
Incentives for farmers 
Although this PhD dissertation demonstrates that farmers (and their families) might be supportive of 
GM rice, additional incentives could be undertaken to ensure that Chinese farmers will be motivated to 
produce the folate enriched variety. The aforementioned humanitarian license for poor, subsistence 
farmers is one example. Another option is to cross the folate trait into a variety that has a high yielding 
potential or is better resistant to diseases, which is done for GR in the Philippines (Barry, 2008). The 
combination of a nutritional and an agronomic trait in staple food crops is considered to be more than 
the sum of parts. Besides its potential to reduce costs through synergies, these crops improve farmer’s 
health directly through consumption, and indirectly through increased yields, improved productivity and 
higher income (Juma et al., 2007). Together with the investigated multi-biofortification of rice, which 
could further increase consumer demand and thus attract farmers, crossing the folate trait into a 1st 
generation GM crop are considered valuable pathways of the future development of transgenic 
biofortified crops. Mark Chong (2003, p. 971) puts it as follows: “[GM biofortified crops] must 
demonstrate yields or cost savings equivalent to (or higher than) those of the best currently grown 
non-transgenic varieties if it is to be successfully introduced and adopted by rice farmers […]”. 
Furthermore, farmers could be convinced to produce a GM rice product when they could sell it at a 
higher price (Dawe and Unnevehr, 2007; Meenakshi, 2008b). In the Philippines, for instance, a 
premium rice variety was used to deploy GR (Brooks, 2010). The downside of such a strategy is its 
contradiction with the pro-poor mission of biofortification. An alternative solution to improve the 
adoption of poor farmers is to provide governmental subsidized credit to purchase biofortified seeds, 
as the case of Bt cotton in South Africa has shown (Gouse et al., 2005). 
 
 
Seed companies and seed distribution 
When biofortified seeds would be available, they should be incorporated into existing marketing and 
distribution systems to ensure that the crop will be produced and consumed (Bekaert et al., 2008; 
Dubock, 2008). Since 2000, private companies are allowed to enter the Chinese seed market and sell 
their seeds all over China, next to the initial state-owned seed producers (Huang et al., 2005a). This 
led to a complex situation of several large distribution and retail networks alongside thousands of small, 
local seed distributers. As a consequence, Chinese farmers are still facing difficulties to discover 
attractive rice varieties (Falck-Zepeda, 2010), which supports the need for a successful distribution 
strategy for biofortified crops. One option could be to subsidize the production and/or consumption 
through public distribution systems in order to facilitate farmer adoption and consumption in poor areas 
(Dawe and Unnevehr, 2007). With respect to iron and folic acid fortified food, which is only available in 
the largest cities of China, a collaboration with Carrefour China is set up to sell fortified foods in a 
separate section of the supermarket (Wang Bo, CDC Food Fortification Office, personal 
communication, 19-04-2011).  
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Currently, international biotech companies are only allowed to do research in China, but cannot 
produce or commercialize GM seeds. These restrictions reflect China’s concern about food security 
and self-sufficiency. Before opening the market to multinationals, which is expected in the next decade 
at the earliest, the Chinese government aims to protect the local companies and increase their 
competitiveness. With respect to GM rice in particular, the MoA still needs to revise the regulations of 
GM cotton and formulate guidelines for GM rice seed distribution (Biotechnology industry 
representative, personal communication, 19-04-2011). 
 
Governmental support and political climate 
Of course, the support and involvement of the government and its related ministries, e.g. MoA, MoH 
and Ministry of Science and Technology (MOST), is a crucial success factor to introduce agricultural 
innovation, like GM food, as a health intervention (Hotz and Brown, 2004; Dawe and Unnevehr, 2007; 
Barry, 2008; Faillace et al., 2008; Potrykus, 2010a). Governments could facilitate or impede the 
adoption of biotechnology, and support or discourage (agricultural) health interventions, through the 
implementation of different policy instruments, such as R&D expenditures, taxes and subsidies, 
regulation and legislation, and dissemination activities (Laxminarayan et al., 2006). Whereas Chinese 
governmental R&D expenditures and regulation procedures in the field of GM food and biofortified 
crops were and will be crucial for the (facilitation of the) approval of FBR (see section 2.5), 
dissemination and subsidy policy will become important if this GM rice variant will actually be brought 
on the market.  
In China, food nutrition issues are not coordinated by a specific ministry (Alavi et al., 2008). Although 
most governmental agencies support transgenic (biofortified) crops (Campos-Bowers and Wittenmyer, 
2007), except for the State Environmental Protection Administration (SEPA)(Pray and Huang, 2007), 
political acceptance could be hampered by the political climate, both at national or international level.  
 
The insect-resistant Bt rice is an illustrative example of the Chinese context. It was already approved 
in 2005, but needed to repeat several regulatory procedures to test the allegations of the anti-GM 
sources (Stone, 2011). Due to the reactions from Greenpeace and Utopia after the announcement of 
the safety certificates for this transgenic rice crop in 2009, the Ministry of Agriculture is currently 
putting the commercialization of Bt rice on-hold. According to Pray and Huang (2007), this hesitance 
and delay is mainly due to the importance of rice as a staple, food safety concerns, a lack of 
knowledge on consumer acceptance and the absence of stem borer problems, or because there is no 
urgent need to create rice surpluses (see for instance,(Gong, 2011). If one or more of these issues 
would change, MoA would probably proceed the commercialization, notwithstanding the opposition 
(Pray and Huang, 2007). But until then, transgenic biofortified foods may be struggling to pass the 
biosafety regulatory process and obtain political approval. Not to mention multi-biofortified foods. More 
recent expert interviews stress that the anti-GM backlash after the Bt rice approval - which is 
reinforced by the aforementioned lack of transparency in the regulatory and approval process - is 
probably the most important factor that will hinder the final approval (Chunyi Zhang, CAAS; 
Biotechnology industry representative, personal communication, respectively 18-04-2011 and 19-04-
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2011). Thus, the Chinese government appears to be influenced by the (growing) resistance, even 
though GM food acceptance rates are still substantially high (as shown in this thesis), a finding which 
is in line with Kalaitzandonakes and Bijman (2003). Nevertheless, rather than withdrawing the 
certificates, the Chinese MoA is currently funding initiatives to increase the transparency of GM risk 
evaluation (ca. ¥ 10 million or US$ 1.5 million) and to improve GM communication (ca. ¥ 2.6 million or 
US$ 0.4 million) (Jiao, 2011). Although GM rice received far more public opposition (Zi, 2005) than 
other approved GM crops, such as Bt cotton (Pray and Huang, 2007) or the imported GM soybean oil 
(Lin et al., 2006), experts estimate that this GM rice variant will be released within 4 (Juan and Zhu, 
2010) to 10 years (Stone, 2011). 
The impact of international events can be illustrated by the US StarlinkTM Bt maize incident in 200060, 
after which China has put their GM crop releases temporary on-hold (Paarlberg, 2002). Other 
examples throughout Chinese history are extensively described by Pray and Huang (2007). Closely 
related, Paarlberg (2002) states that the risk of losing important export markets in the GM-reluctant 
developed world, such as Europe, is one of the main reasons for the delayed and postponed GM crop 
production in developing countries. With respect to GM rice, however, trade issues such as potential 
trade bans are expected to have a marginal effect on China, due to its low international rice exports 
(Huang et al., 2004). Compared to the largest rice exporters, Thailand (31.1 %) and Vietnam (17.9 %), 
China’s share in the global exports is about 4.5 % (IRRI World Rice Statistics, 2011b). Thus, a period 
of political prudence in China might be more related to the opposition within the country, and the 
potential, global impact of approving the first GM staple crop. Of course, there might be also pressure 
from (neighboring) rice exporting countries to avoid cross-border contamination (Biotechnology 
industry representative, personal communication, 19-04-2011). 
 
Although the importance of the safety approval does not need to be underestimated, Bt rice still needs 
to obtain 4 other licenses, including a business license, a GM variety registration, a GM seed 
production and a GM seed operation license (Chunyi Zhang, CAAS; Biotechnology industry 
representative, personal communication, respectively 18-04-2011 and 19-04-2011). Once approved, 
some argue that it would be a catalyst for the release of future GM staple crops (James, 2009a). As a 
consequence, developing countries might follow to stay competitive, while developed countries, such 
as US and Canada, may see China as a potential export market (Huang et al., 2004; Huang et al., 
2005b).  
 
Table 55 gives an estimation on how the main stakeholders are expected to react towards FBR as a 
transgenic (biofortified) crop in China. Government agencies, except for SEPA, are generally 
supporters, while NGOs are the main opponents of transgenic (biofortified) crops in China. As 
mentioned above, foreign biotechnology companies, seed producers and farmers are initially in favor, 
but could be further attracted by ensuring a sufficient coverage rate of FBR. When looking at farmers 
in particular, the lack of a mobilized political organization could further help to deploy the adoption of 
GM rice (Pray and Huang, 2007). 
                                                 
60 In September 2000, US StarlinkTM maize was detected in the food system, although it was not approved for human consumption, leading to allergenic 
reactions and a recall of more than 300 products and worldwide repercussions for the trade of GM crops (Sheumack), 2003).  
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Table 55 The position of main stakeholders regarding FBR in China. 
Stakeholder  Position towards GM food and transgenic biofortification 
Government  
MOST Pro-GM; continues to invest in transgenic crop R&D 
MoA Initially in favor, but might be affected by the international political climate or public 
resistance. 
SEPA Most opposed Chinese Ministry; collaborates with Greenpeace. 
Foreign companies  Interested in entering the Chinese market, especially if the IPR framework would be 
improved and China would further open their markets. 
Seed companies Both government-owned and private seed companies are interested, if the demand 
is sufficient or when the distribution to the poor would be organized by government. 
NGO’s, 
e.g. Greenpeace, Utopia 
Against GM adoption, could influence political actions and consumers. 
Farmers Generally in favor (see chapter 3 and 4); could be attracted through incentives, e.g. 
improved agronomic traits, royalty-free production, or a price premium. 
Consumers Generally in favor (see chapter 3 and 4) 
 
MoA, Ministry of Agriculture; MOST, Ministry of Science and Technology; NGO, Non-Governmental Organization; SEPA, State 
Environmental Protection Administration 
Source: Pray and Huang (2007), Campos-Bowers and Wittenmyer (2007) and an expert interview (Biotechnology industry 
representative, personal communication, 19-04-2011). 
 
GM food labeling  
Since 2001, China requires GM-labels for food products based on GM technology, as outlined by the 
Chinese State Council (Campos-Bowers and Wittenmyer, 2007). Besides MoA, MoH and MOST, all 
trade related ministries support transgenic food labeling (Campos-Bowers and Wittenmyer, 2007). 
Their mandatory labeling policy is the first to apply a 0 % level of detection, i.e. a zero tolerance 
approach. Others require labeling if 0.9 % (EU) to 5 % (e.g. Philippines) of the (imported) product 
contains GM material (Jia, 2003; Gruère and Rao, 2007). Although the Chinese threshold is officially 
communicated, it is less likely to be implemented in practice (Gruère and Rao, 2007). Due to the GM 
technology in FBR, labeling would be required in China. A GM-label for FBR could be beneficial as it 
could increase consumer confidence through informed food choices, i.e. the ‘right-to-know’ (Tegene et 
al., 2003). It also allows one to position a GM biofortified crop in a segmented market, especially when 
external rice attributes would not differ from regular rice. One of the downsides of labeling is the 
associated cost (market segregation, identity preservation), which is expected to increase the retail 
price by 10 % (Tegene et al., 2003; Gruère and Rao, 2007). This is especially valid for China, as such 
costs are negatively associated with the targeted detection level (Qaim, 2009). 
Besides labeling, one could also consider the introduction of an attractive brand name for the 
biofortified crop, like ‘Golden Rice’ for vitamin A enriched rice, in order to favor its image and avoid its 
biotechnological connotation (Brooks, 2010), which is expected to negatively influence acceptance 
(Novotorova and Mazzocco, 2009).   
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Summary 
 
Despite the increasing efforts to alleviate the burden of micronutrient malnutrition in the world, over 
two billion people are facing a chronic lack of essential vitamins and minerals, especially children and 
pregnant women from less developed countries, who mainly rely on staple crops, such as rice, maize 
or potatoes. Biofortification, the enhancement of the micronutrient content of staple crops through 
conventional or transgenic technology, is more and more put forward as an alternative solution to 
reach poor, rural areas where the currently available micronutrient interventions, such as 
supplementation, industrial fortification and dietary diversification, are less successful or appropriate.  
Unlike conventional biofortification, transgenic biofortified crops are currently not available at the 
market place. In spite of the direct health benefits associated with such 2nd generation genetically 
modified (GM) crops, the controversial nature surrounding the use of biotechnology in food remains a 
subject of discussion, which impedes its commercialization. 
 
The overall objective of this thesis has been defined to contribute to a better understanding of the 
market potential of biofortified crops, in particular of folate biofortified rice (FBR). This GM biofortified 
rice crop was recently developed in order to tackle folate (or vitamin B9) deficiency and its adverse 
health outcomes, such as an increased risk of delivering a baby with a neural-tube defect (NTD; e.g. 
spina bifida).  
This PhD dissertation is a compilation of research papers that evaluates ex-ante the market potential 
of FBR in China and in particular, Shanxi Province, a poor, rural region in Northern China. Folate 
deficiency is an important public health problem in China, with about 258 million people being folate 
deficient. Especially in Shanxi Province, which is characterized by one of the highest NTD prevalence 
rates in the world, the need to increase folate intake levels is obvious. Given China’s position as the 
world leader in rice production and one of the key players in GM rice research, commercialization of 
folate biofortification of the world’s major staple crop might be considered an alternative solution to the 
high prevalence of NTDs and the low intake of folic acid pills. 
 
The market potential of FBR is investigated through three lines of inquiry. While the first and second 
line analyze consumer acceptance and willingness-to-pay (WTP) in Shanxi Province, the third 
evaluates the regional health impact and the cost-effectiveness of its introduction in China. Along 
these three main lines of inquiry, different research questions are formulated and tackled, building 
upon theory, empirical evidence and/or knowledge gaps. Data is collected within the frame of the 
Special Research Fund – Concerted Research Action (2004 - 2009) project, entitled “Enhancement of 
folate content in rice: an analytical-molecular and economic study”, based on primary and secondary 
sources. Insights are obtained through different exploratory and conclusive research methods. A 
consumer survey with 944 Shanxi rice consumers was conducted in order to examine the acceptance 
of FBR. The study on WTP was largely build upon fourteen experimental auctions with 252 Shanxi 
female rice consumers of childbearing age. And to assess the potential health impacts and cost-
effectiveness of FBR, the Disability-Adjusted Life Years (DALY) framework was applied, using primary 
and secondary data. 
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The results showed that consumers in Shanxi Province are generally accepting (62.2 %) this GM rice 
variant with higher folate content, and provides evidence that GM products with consumer benefits are 
positively embraced by consumers in developing regions. Through multinomial logistic regression, 
objective GM knowledge, perceptions of the GM risks and benefits, and socio-demographic indicators, 
like gender, age, education and farmer status, are found to be important determinants of FBR 
acceptance. When also taking into account consumers’ acquisition of GM food information, market 
segmentation identified an enthusiastic (14.2 %), a cautious (44.6 %) and an opposing market 
segment (41.2 %). An estimation of the effects of negative rice attribute changes on FBR acceptance 
provided insight in the critical success factors to select the rice varieties wherein the folate trait could 
be inserted, such as taste or environmental impacts.  
Evidence from experimental auctions with women of childbearing age, split up between student and 
non-student auctions, lend support for the large potential of biofortified staple crops in high-risk 
regions. Female Shanxi rice consumers are prepared to pay a premium of ¥ 1.73 or 33.7 %, which 
corresponds with switching to a rice variety that is one price/quality level higher than regular rice. 
Offering a GM-free folate substitute did not reveal significant differences in bidding behavior. Besides 
a significant target group effect, by which students are less likely to buy and pay more for FBR, WTP is 
mainly determined by consumers’ GM food acceptance and objective knowledge. Despite lower bids 
after providing information about the GM technology, the perceived benefits seem to be high enough 
to compensate for potential negative reactions to GM food. Nevertheless, when conflicting GM 
information is provided, negative outweighs positive information.  
The health evaluation study further supports folate biofortification of rice as a valuable micronutrient 
intervention to drastically increase folate intake and reduce the prevalence of NTDs in China. 
Implementing rice with a folate content of 1 200 µg per 100 g rice in China would increase the total 
daily folate intake for Chinese women of childbearing age to 837 µg, which is more than two times the 
recommended nutrient intake level. As a consequence, between 62 863 DALYs and 188 508 DALYs 
could be saved by implementing biofortified rice. Although rice consumption is lower in northern areas, 
these regions account for the biggest health impact of biofortification in China. As expected, regions 
with high NTD prevalence rates, such as Shanxi Province, will benefit most from folate biofortification 
of rice. Moreover, FBR could be introduced as a highly cost-effective health intervention to reduce the 
burden of folate deficiency, with an estimated cost between US$ 21.4 and US$ 64.2 per DALY saved. 
This PhD thesis provides an important basis for stakeholders in the fields of GM (biofortified) food 
research, development and commercialization, health prevention and intervention planning, e.g. 
micronutrient interventions and birth defect programs. It will stimulate the academic debate and the 
public awareness regarding micronutrient malnutrition, including folate deficiency and biofortification 
as a self-targeted means to alleviate its burden. 
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Samenvatting 
  
Ondanks de vele inspanningen om de globale ziektelast van micronutritionele ondervoeding aan te 
pakken, kampen meer dan 2 miljard mensen nog steeds met een chronisch gebrek aan essentiële 
vitamines en mineralen, voornamelijk kinderen en zwangere vrouwen uit minder ontwikkelde landen, 
wiens voedingspatroon hoofdzakelijk uit basisvoedsel zoals rijs, maïs en aardappelen bestaat. 
Biofortificatie, het verhogen van het natuurlijk, micronutritioneel gehalte van basisvoedsel door middel 
van conventionele of op genetische modificatie gebaseerde teelttechnieken wordt meer en meer naar 
voren geschoven als een alternatieve oplossing om arme, rurale gebieden te bereiken, waar de 
huidige micronutritionele interventies, zoals supplementatie, industriële fortificatie en diversificatie van 
het voedingspatroon, minder succesvol of haalbaar zijn. In tegenstelling tot de conventionele 
biofortificatie, zijn transgeen verrijkte gewassen vandaag de dag niet beschikbaar op de markt. 
Ondanks de directe gezondheidsvoordelen van dergelijke genetisch gemodificeerde (GM) gewassen 
van de 2e generatie, blijft de controverse omtrent het gebruik van biotechnologie in voeding ter 
discussie staan, die de commercialisering ervan in de weg staat.   
  
De algemene doelstelling van deze thesis wordt gedefinieerd als het verkrijgen van een beter inzicht in 
het marktpotentieel van gebiofortificeerde gewassen en folaat verrijkte rijst (FBR) in het bijzonder. Dit 
GM rijstgewas werd recent ontwikkeld met het oog op het verminderen van negatieve 
gezondheidsgevolgen van een folaat- of vitamine-B9-tekort, waaronder het verhoogd risico om een kind 
met een neurale buisafwijking (NTD; e.g. spina bidifa) op de wereld te zetten.  
Deze doctoraatsthesis compileert een reeks onderzoekspapers omtrent de ex-ante evaluatie van het 
marktpotentieel van folaat verrijkte rijst in China en in de provincie Shanxi, een arme, rurale regio ten 
noorden van China in het bijzonder. Het gebrek aan folaat in China is een belangrijk 
gezondheidsprobleem, met ongeveer 258 miljoen mensen die onvoldoende folaat opnemen. China is 
de wereldleider in rijstproductie en -consumptie. Bovendien wordt de Chinese overheid beschouwd als 
een voorstander van GM voeding en (GM) gebiofortificeerde gewassen. Hierdoor is China een van de 
belangrijkste spelers in de productie van GM gewassen en kende het recent een certificaat voor 
bioveiligheid toe aan Bt rijst, dat in de toekomst hoogstwaarschijnlijk het eerste gecommercialiseerde 
GM rijstgewas zal zijn.  
Voornamelijk in Shanxi Province, waar de prevalentie van NTDs tot één van de hoogste ter wereld 
behoort, ligt de nood om het folaatgehalte te verhogen voor de hand. Gegeven de positie van China 
als wereldleider in rijstproductie en als één van de hoofdspelers in GM rijst onderzoek, zou het 
commercialiseren van het folaat verijken van het meest geconsumeerde gewas ter wereld beschouwd 
kunnen worden als een alternatieve oplossing voor de hoge prevalentie van NTDs en de lage inname 
van foliumzuurpillen.  
 
Het marktpotentieel van folaat verrijkte rijst wordt onderzocht volgens drie onderzoekslijnen. Terwijl de 
eerste en tweede lijn de acceptatie en bereidheid tot betalen van consumenten onderzoekt in Shanxi, 
evalueert de derde onderzoekslijn de regionale gezondheidsimpact en kosteneffectiviteit van de 
introductie van deze rijst in China.  
227 
 
In het licht van deze onderzoekslijnen werden op basis van theorieën, empirisch bewijs of bepaalde 
kennishiaten verschillende onderzoeksvragen opgesteld en beantwoord. De gegevens werden 
verzameld in het kader van het Bijzonder Onderzoeksfonds – Geconcerteerde Onderzoeksactiviteiten 
(2004-2009) project “Enhancement of folate content in rice: an analytical-molecular and economic 
study”, op basis van primaire en secundaire data. De resultaten werden verkregen door het toepassen 
van verschillende beschrijvende en verklarende onderzoeksmethoden. Een consumentenonderzoek 
met 944 rijstconsumenten uit Shanxi werd uitgevoerd om de acceptatie van de met folaat verrijkte rijst 
in kaart te brengen. De studie over de bereidheid tot betalen is hoofdzakelijk gebaseerd op veertien 
experimentele veilingen met 252 vrouwen op vruchtbare leeftijd uit Shanxi. En om de potentiële 
gezondheidsvoordelen en de kosteneffectiviteit te berekenen, werd de (voor beperkingen 
corrigerende) levensjaren (DALY) benadering toegepast, waarbij zowel primaire als secundaire data in 
het model ingevoerd werd.  
 
De resultaten tonen aan dat consumenten uit de Chinese provincie Shanxi deze GM rijstvariant met 
een verhoogd folaatgehalte over het algemeen aanvaarden (62.2 %), wat het bewijs vormt dat GM 
producten met consumentenvoordelen warm onthaald worden door consumenten uit 
ontwikkelingsregio’s. 
Door middel van multinomiale logistische regressie kwam naar voren dat zowel de objectieve kennis 
over GM voeding, als de percepties ten aanzien van de risico’s en de voordelen verbonden aan GM, 
als de socio-demografische indicatoren, zoals geslacht, leeftijd, educatie en het al dan niet 
landbouwer zijn, in belangrijke mate de acceptatie van folaat verrijkte rijst bepalen. Wanneer ook het 
vergaren van informatie over GM voeding in beschouwing wordt gebracht, konden drie 
marktsegmenten geïdentificeerd worden: enthousiaste (14.2 %), voorzichtige (44.6 %) en 
weigerachtige consumenten (41.2 %). Het onderzoek naar de impact van negatief gewijzigde 
rijstattributen op de acceptatie van de folaatrijst bracht de kritische succesfactoren die bij het 
selecteren van de rijstvariëteiten waarin het folaatkenmerk kan ingebracht worden, zoals smaak of de 
milieu-impact, aan het licht.   
De resultaten van de experimentele veilingen met vrouwen op vruchtbare leeftijd, die werden 
opgesplitst in veilingen met studenten en niet-studenten, ondersteunt het belangrijke potentieel van 
verrijkte gewassen in risicogebieden. De vrouwelijke rijstconsumenten uit Shanxi zijn bereid om een 
meerprijs van ¥ 1.73 of 33.7 % te betalen, wat overeenkomt met een rijstvariëteit die een prijs-
kwaliteitsniveau hoger ligt dan de traditionele rijst. Het aanbieden van een niet-GM folaatsubstituut 
leverde geen significante verschillen op bij het veilen. Naast een significant doelgroep-effect, waarbij 
studenten minder geneigd zijn om (meer) te betalen voor folaat verrijkte rijst, wordt de bereidheid tot 
betalen voornamelijk bepaald door de acceptatie en objectieve kennis van GM voeding. Ondanks de 
lagere biedingen na het aanbieden van informatie over de GM-technologie, zijn de gepercipieerde 
voordelen hoog genoeg om de potentiële negatieve reacties ten aanzien van GM voeding op te 
vangen. Niettemin, wanneer zowel positieve als negatieve informatie over GM wordt aangereikt, is die 
laatste dominant.  
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De studie omtrent gezondheidsevaluatie studie biedt verder bewijs voor het potentieel van 
rijstbiofortificatie met folaat als een waardevolle gezondheidsinterventie. Deze interventie kan de 
folaatinname drastisch verhogen en de prevalentie van neurale buisafwijkingen in China verminderen. 
Het implementeren van rijst met een folaatgehalte van 1 200 µg per 100 g rijst in China zal de totale 
dagelijkse folaatinname door Chinese vrouwen op vruchtbare leeftijd doen toenemen tot 837 µg, dat is 
ongeveer drie keer zoveel als wat aanbevolen wordt. Als gevolg daarvan zullen er ongeveer 62 863 
DALYs en 188 508 DALYs gered kunnen worden. Hoewel de rijstconsumptie in de noordelijke 
gebieden van China aanzienlijk lager ligt, is de gezondheidsimpact van biofortificatie er het hoogst. 
Zoals verwacht, zullen de regio’s met de hoogste prevalentie van neurale buisafwijkingen, waaronder 
Shanxi, het meest baat hebben bij de folaat verrijkte rijst. Bovendien zou een dergelijke biofortificatie 
een zeer kosteneffectieve methode kunnen zijn om de ziektelast van folaattekorten succesvol aan te 
pakken, met een geschatte kost tussen US$ 21.4 en US$ 64.2 per geredde DALY. 
Deze doctoraatsthesis vormt een belangrijke basis voor stakeholders in het onderzoek, de 
ontwikkeling en de commercialisering van GM voeding, en de planning van gezondheidsinterventies, 
zoals micronutritionele strategieën en programma’s om geboortedefecten te verminderen. Dit alles 
teneinde het academisch debat te stimuleren en de publieke bekendheid van micronutritionele 
ondervoeding, waaronder het folaattekort, en biofortificatie als een op een doelgroep gerichte 
interventie om de ziektelast te verlichten. 
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Annex 1 Administrative areas and provinces in China, per region 
 
 
Figure 24 Administrative areas and provinces in China, per region  
Source: own illustration 
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Annex 2 Global burden of folate deficiency 
 
Below the current number of DALYs lost due to folate deficiency in the world is presented (Table 56). 
This rough estimation is based on the number of NTD (types) that are attributable to folate deficiency, 
i.e. 200 000 births per year (UNICEF, 2004a, b), the global life expectancy (WHO, 2008b). Due to the 
lack of global estimates on the share of the different functional outcomes, these figures are derived 
from the composition of NTDs in different Chinese studies. China has the highest relative and absolute 
number of NTDs, which justifies this selection. First, based on the Chinese study of Li et al. (2006), 
31.0 %, 40.1 % and 28.9 % of all NTDs are considered to be abortions, live births and stillbirths, 
respectively. Similar findings are found in other Chinese NTD studies (USDA, 1989; Moore et al., 
1997). Second, the share of the three NTD types in the total number of NTD live births is based on 
findings from two country-wide Chinese (Berry et al., 1999; Liu et al., 2007) and two Shanxi studies (Li 
et al., 2006; Gu et al., 2007). As anencephaly is a fatal NTD type, only the average prevalence of 
spina bifida and encephalocele is considered, based on a share between respectively 47.5-59.3 % 
and 7.5-34.4 % of all NTDs. These figures are in line with studies in the United States (Feuchtbaum et 
al., 1999), Canada (Gucciardi et al., 2002; De Wals et al., 2007) and Ireland (FSAI, 2006). Based on 
the assumptions and input parameters of the DALY framework, such as the disability weights of the 
non-fatal NTD outcomes (Mathers et al., 1999) and the discount rate of 3 % (see section 5.2.1.1) the 
current, global burden of folate deficiency is assessed. The estimations indicate that worldwide, folate 
deficiency and folate related NTDs in particular, are responsible for an annual loss of about 4.8 million 
DALYs. Blencowe et al. (2010) previously estimated the burden of all NTDs at 2.3 mi DALYs, based 
on the global burden of congenital malformations (WHO, 2008a). Our figures demonstrate that the 
public health problem caused by folate deficiency could be significantly bigger than what is previously 
thought and show that research to improve these estimations is warranted.  
 
Table 56 Input parameters and global burden of folate deficiency, in mi. DALYs lost  per year 
Input parameters of the 
DALY framework 
 Global burden of folate deficiency 
  Spina bifida Encephalocele YLD 
NTDs caused by FD 200 000  1 008 462 324 757 1 333 219 
Spina bifida 58 644  Abortions Stillbirths YLD 
Encephalocele 21 536  1 797 941 1 676 725 3 474 665 
Abortions 62 000    TOTAL 
Stillbirths 57 820    4 807 884 
Life expectancy  
at birth 
68.0 years  
Disability weights  
Spina bifida 0.593  
Encephalocele 0.52  
Discount rate 3 %  
 
DALYs, Disability-Adjusted Life Years; FD, folate deficiency; YLD, years lived in disability; YLL, years of life lost 
Note: the different input parameters of the DALY framework are further elaborated in chapter 5. 
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Annex 3 Rice prices in China 
 
 
Figure 25 Wholesale and retail rice prices in China, in Yuan per kg, 2001-2011 
Source: Own compilation, adapted from the National Bureau of Statistics of China (2011b)(Japonica retail) and data from the China National Grain and Oils Information Center (CNGOIC, 2011). 
Data provided by Fred Gale from the USDA Economic Research Service, Washington D.C. 
Note: Due to data constraints, Indica retail data could not be retrieved for 2009 and later. Wholesale pricing data, initially expressed in Yuan per metric ton, refers to Jiangsu Province (Japonica) and 
Jiangxi Province (Indica). Shanxi Province is situated in Northern China, which mainly consumes and produces Japonica rice. The regular rice prices as mentioned in the consumer survey (see 
chapter 3) and the experimental auctions (see chapter 4) are based on the province specific retail prices of regular rice, but approximate the above retail figures.  
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